NCT Number,Study Title,Study URL,Study Status,Study Results,Conditions,Interventions,Sponsor,Collaborators,Sex,Age,Enrollment,Funder Type,Study Type,Study Design,Start Date,Completion Date,Locations
NCT03838952,The Efficacy of Traditional Chinese Herbal Medicine for Dementia,https://clinicaltrials.gov/study/NCT03838952,UNKNOWN,NO,Dementia|Alzheimer Disease,DRUG: Herbal medicine,"Taipei Veterans General Hospital, Taiwan",,ALL,OLDER_ADULT,20,OTHER_GOV,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-02-11,2020-12-31,"Taipei Veterans General Hospital, Taipei, 112, Taiwan"
NCT00564473,Use of Herbal Medicine in Internal Medicine Wards,https://clinicaltrials.gov/study/NCT00564473,COMPLETED,NO,Herb-drug Interactions,BEHAVIORAL: questionnaire,Shaare Zedek Medical Center,,ALL,"ADULT, OLDER_ADULT",200,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-06,2010-02,"Shaare Zedek Medical Center, Jerusalem, 91031, Israel|Shaare Zedek Medical Center, Jerusalem, Israel"
NCT04104113,Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial,https://clinicaltrials.gov/study/NCT04104113,UNKNOWN,NO,Cancer|Fatigue|Cognitive Impairment,OTHER: Modified Xiang Bei Yang Rong Tang|OTHER: Placebo,National University of Singapore,"National Cancer Centre, Singapore|Singapore Thong Chai Medical Institute",ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-10-24,2022-06-09,"National Cancer Centre Singapore, Singapore, 169610, Singapore"
NCT06048276,Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study,https://clinicaltrials.gov/study/NCT06048276,ACTIVE_NOT_RECRUITING,NO,Pregnancy|Birth Defects|Drug Exposures,"DRUG: Herbal medicines (e.g., Yunkang granules, Duzhong granules)",West China Hospital,Xiamen Health Commission|Xiamen Health and Medical Big Data Center,FEMALE,"CHILD, ADULT",200000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-01-01,2024-12-31,"Xiamen Health and Medical Big Data Center, Xiamen, Fujian, 361008, China"
NCT04702659,Chinese Medicine Zhengyi Prescription Tea Bag,https://clinicaltrials.gov/study/NCT04702659,COMPLETED,NO,Herbal Interaction,,"Taipei Veterans General Hospital, Taiwan",,ALL,"ADULT, OLDER_ADULT",70,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-01-10,2022-06-15,"Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei, 112, Taiwan"
NCT06187376,Chinese Herbal Medicine for Gynecologic Patients,https://clinicaltrials.gov/study/NCT06187376,WITHDRAWN,NO,Dysmenorrhea,DRUG: Chinese Herbal Medicine (CHM) supplement|DRUG: Placebo,Icahn School of Medicine at Mount Sinai,"Zenchi, Inc.",FEMALE,ADULT,0,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2024-07,2024-07-16,"Mount Sinai Faculty Practice Associates, New York, New York, 10029, United States"
NCT05045469,Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea,https://clinicaltrials.gov/study/NCT05045469,UNKNOWN,NO,Rosacea|Chinese Herbal Medicine,DRUG: dian dao san,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-08-04,2023-08-04,"Keelung Chang Gung Memorial Hospital, Keelung, Taiwan"
NCT04668222,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,https://clinicaltrials.gov/study/NCT04668222,UNKNOWN,NO,COVID19|Herbal Medicine,"DRUG: Yu-Ping-Feng formula|DRUG: Xiang-Sha-Liu-Jun formula|DRUG: Liu-Wei-Di-Huang formula|DRUG: Placebo for ""Deficiency of Qi and Yang""|DRUG: Placebo for ""Deficiency of Qi and Yin""",The University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",480,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2021-04-30,2022-11-30,"The University of Hong Kong, Hong Kong, Hong Kong, China, 999077, Hong Kong"
NCT06315101,Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China,https://clinicaltrials.gov/study/NCT06315101,COMPLETED,NO,Unresectable Hepatocellular Carcinoma,DRUG: Chinese Herbal Medicine,Guangzhou University of Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",142,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-09-01,2023-12-31,"the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510407, China"
NCT03072225,Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine,https://clinicaltrials.gov/study/NCT03072225,UNKNOWN,NO,Carotid Artery Plaque,DRUG: Herbal Medicine C-117|DRUG: The Placebo of Herbal Medicine C-117,Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-03,2018-12,
NCT02299739,Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine,https://clinicaltrials.gov/study/NCT02299739,COMPLETED,NO,Drug-Induced Liver Injury|Musculoskeletal Diseases,DRUG: Herbal medicine|PROCEDURE: Acupuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Chuna manipulation,Jaseng Hospital of Korean Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",6894,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2005-12,2013-12,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT03008798,Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117,https://clinicaltrials.gov/study/NCT03008798,UNKNOWN,NO,Occlusion and Stenosis of Unspecified Cerebral Artery,DRUG: Herbal Medicine C-117|DRUG: The Placebo of Herbal Medicine C-117,Guangzhou University of Traditional Chinese Medicine,"Liaocheng People's Hospital|Liaoning Cancer Hospital & Institute|Zhongshan People's Hospital, Guangdong, China",ALL,"ADULT, OLDER_ADULT",180,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2017-01,2019-12,
NCT05066620,Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial,https://clinicaltrials.gov/study/NCT05066620,UNKNOWN,NO,Intracerebral Hemorrhage,DRUG: Chinese herbal medicine FYTF-919,Guangzhou University of Traditional Chinese Medicine,The George Institute,ALL,"ADULT, OLDER_ADULT",1504,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-10,2025-01,"Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China"
NCT03942198,Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome,https://clinicaltrials.gov/study/NCT03942198,UNKNOWN,NO,Psoriasis Vulgaris,DRUG: Taodan Granules|DRUG: Taodan Granules Placebo,Shanghai Yueyang Integrated Medicine Hospital,Shaanxi Provincial Hospital of Traditional Chinese Medicine|The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine|Shijiazhuang Hospital of Traditional Chinese Medicine|Heilongjiang University of Chinese Medicine,ALL,"ADULT, OLDER_ADULT",216,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-06-01,2021-12-31,"Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, He Bei, China|First Affiliated Hospital of Heilongjiang Chinese Medicine University, Harbin, Heilongjiang, China|Affiliated hospital of jiangxi university of traditional Chinese medicine, Nanchang, Jiangxi, China|Shanghai Yueyang Integrated Medicine Hospital, Shanghai, Shanghai, China|Shanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shanxi, China"
NCT03961230,Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome,https://clinicaltrials.gov/study/NCT03961230,UNKNOWN,NO,Psoriasis Vulgaris,DRUG: Jueyin granules|DRUG: Jueyin Granules Placebo,Shanghai Yueyang Integrated Medicine Hospital,Beijing Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Anhui University of Traditional Chinese Medicine|Gansu University of Chinese Medicine|Guangxi Zhuang Autonomous Region Dermatology Hospital,ALL,"ADULT, OLDER_ADULT",196,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-06-01,2021-12-31,"First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, China|Beijing Hospital of Traditional Chinese Medicine, Beijing, Beijing, China|Affiliated Hospital of Gansu University of Chinese Medicine, Nanchang, Gansu, China|Guangxi Zhuang Autonomous Region Dermatology Hospital, Nanning, Guizhou, China"
NCT05266079,Comparison Study for Perimenopausal Syndrome With Chinese Herbal Medicine,https://clinicaltrials.gov/study/NCT05266079,COMPLETED,NO,Menopausal Syndrome,DRUG: Intervention Group|DRUG: Control Group,Hong Kong Baptist University,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-03-14,2023-06-30,"HKFTU Workers' Medical Clinics - Hong Kong Baptist University Chinese Medicine Clinic cum Training and Research Centre (North District), Hong Kong, Hong Kong"
NCT03186079,Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation,https://clinicaltrials.gov/study/NCT03186079,COMPLETED,NO,Constipation|Chinese Herbal Medicine,DRUG: Xiaojidaozhi Decoction|DRUG: Placebo|DRUG: Fiberform|BEHAVIORAL: Toilet training,Shengjing Hospital,,ALL,CHILD,200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2017-05-01,2018-05-01,"Shengjing Hospital, Shenyang, Liaoning, 110004, China"
NCT05269511,Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts,https://clinicaltrials.gov/study/NCT05269511,COMPLETED,NO,Healthy Participants,"DRUG: Chinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs.",Hong Kong Baptist University,,ALL,"CHILD, ADULT, OLDER_ADULT",2163,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2022-03-14,2022-06-22,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China"
NCT03941431,Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine,https://clinicaltrials.gov/study/NCT03941431,UNKNOWN,NO,Plaque Psoriasis,DRUG: Jueyin granules|DEVICE: moving cupping therapy|DEVICE: NB-UVB therapy|DRUG: Jueyin placebo granules|DEVICE: moving cupping placebo therapy|DEVICE: NB-UVB placebo phototherapy,Shanghai Yueyang Integrated Medicine Hospital,Shanghai Dermatology Hospital|Chinese Medicine Hospital Affiliated to Southwest Medical University|Wuhan No.1 Hospital|The Second People's Hospital Affiliated to Fujian University of TCM|Jiangsu Province Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",378,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2019-06-01,2021-12-31,"The Second People's Hospital Affiliated to Fujian University of TCM, Fuzhou, Fujian, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, China|Chinese Medicine Hospital Affiliated to Southwest Medical University, Luzhou, Sichuan, China|Shanghai Dermatology Hospital, Shanghai, China|Shanghai Yueyang Integrated Medicine Hospital, Shanghai, China"
NCT05360004,The Use of Chinese Herbal Medicine and Vitamin C by Hospital Care Workers in HK to Prevent COVID-19,https://clinicaltrials.gov/study/NCT05360004,UNKNOWN,NO,COVID-19,DRUG: Chinese herbal medicine,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",652,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2022-05,2022-06,
NCT04380870,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,https://clinicaltrials.gov/study/NCT04380870,RECRUITING,NO,Coronavirus Infection,DIETARY_SUPPLEMENT: Chinese Herbal Medicine,Center for Integrated Care,"University of Utah|University of California, San Francisco",ALL,"ADULT, OLDER_ADULT",500,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-05-11,2025-05-11,"Seattle Intstitute of East Asian Medicine, Seattle, Washington, 98108, United States"
NCT04593849,Therapeutic Effects of Traditional Chinese Medicine in Topical Use on Upper Extremities Fracture,https://clinicaltrials.gov/study/NCT04593849,COMPLETED,NO,Bone Fractures|Traditional Chinese Medicine|Chinese Herbal Medicine,"OTHER: Ru-Yih-Jin- Huang-Saan(RYJHS), Wan-Yin-Gao-Jia-Jean-Wey(WYGJJW), placebo ( topical agent without therapeutic effects)",YUAN-CHIEH YEH,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-09-23,2023-04-20,"Keelung Chang Gung Memorial Hospital, Keelung, 20401, Taiwan"
NCT04269486,A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting,https://clinicaltrials.gov/study/NCT04269486,ACTIVE_NOT_RECRUITING,NO,Drug Induced Liver Injury|Drug-Induced Kidney Injury|Herbal Medicine Adverse Reaction,,Korea Institute of Oriental Medicine,Semyung University|Dongshin Seoul Korean Medicine Hospital|CHUNG YEON Korean Medicine Hospital|Korean Medicine Hospital of Pusan National University|DongGuk University,FEMALE,"ADULT, OLDER_ADULT",287,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-07-01,2023-12-31,"Five tertiary Korean Medicine Hospital (Jecheon, Yangsan, Gwangju, Seoul, Bundang), Seoul, Korea, Republic of"
NCT05494008,Evaluation of Effectiveness and Safety of Korean Herbal Medicine for Post-accident Syndromes After Acute Phase,https://clinicaltrials.gov/study/NCT05494008,COMPLETED,NO,Traffic Accident|Whiplash Syndrome,PROCEDURE: Korean herbal medicine treatment|PROCEDURE: Non-Korean herbal medicine treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2021-07-24,2022-09-13,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT05035979,Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris,https://clinicaltrials.gov/study/NCT05035979,UNKNOWN,NO,Acne Vulgaris,DRUG: BaidI Quzhi granule|DRUG: Ju Yin cream|DRUG: Baidi Quzhi placebo granule|DRUG: Ju Yin placebo cream,Shanghai Yueyang Integrated Medicine Hospital,Shanghai Skin Disease and Venereal Disease Hospital,ALL,"CHILD, ADULT",472,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-12-01,2023-08-31,
NCT06319729,A Chinese Herbal Medicine for IBS-C,https://clinicaltrials.gov/study/NCT06319729,NOT_YET_RECRUITING,NO,Constipation-predominant Irritable Bowel Syndrome,DRUG: CDD-2105|DRUG: Placebo,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",78,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-03-25,2024-11-30,
NCT04032574,Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis,https://clinicaltrials.gov/study/NCT04032574,COMPLETED,NO,Urinary Tract Infection Lower Acute,COMBINATION_PRODUCT: Herbal Medicinal Product|OTHER: Placebo,Medice Arzneimittel Pütter GmbH & Co KG,Dr. Wiedey GmbH - Institut Für Klinische Forschung|Medidata Dr. Möller GmbH,FEMALE,"ADULT, OLDER_ADULT",200,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",1991-10-08,1992-03-27,
NCT04349878,Anaysis of Phytotherapy Agent Against Periodontitis,https://clinicaltrials.gov/study/NCT04349878,COMPLETED,NO,Periodontitis,DIAGNOSTIC_TEST: gingival crevicular fluid evaluation,University of Messina,,ALL,"ADULT, OLDER_ADULT",34,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2019-09-01,2020-03-05,"University of Messina, Messina, 98125, Italy"
NCT01414374,Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency,https://clinicaltrials.gov/study/NCT01414374,COMPLETED,NO,Iron Deficiency Anemia,DRUG: Herbal medicine|DRUG: Iron,Casa Espirita Terra de Ismael,University of Sao Paulo,ALL,ADULT,50,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-01,2013-03,"Laboratorio M. F. Teixeira, Monte Santo de Minas, Minas Gerais, Brazil"
NCT05530226,A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis,https://clinicaltrials.gov/study/NCT05530226,UNKNOWN,NO,Plasma Cell Mastitis,DRUG: Traditional Chinese medicine,Shengjing Hospital,,FEMALE,ADULT,50,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-10-01,2023-03-31,"Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China"
NCT02923622,Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer,https://clinicaltrials.gov/study/NCT02923622,UNKNOWN,NO,Advanced Colorectal Cancer|Traditional Chinese Medicine,OTHER: Traditional Chinese medicine herbals|OTHER: Integrated traditional Chinese and Western medicine|OTHER: Western medicine,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing Municipal Science & Technology Commission,ALL,"ADULT, OLDER_ADULT",384,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-09,,"Oncology Department of Xiyuan hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, 100091, China"
NCT01338714,The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function,https://clinicaltrials.gov/study/NCT01338714,COMPLETED,NO,Liver Dysfunction,OTHER: Compound Herbal Formula (RHD-1)|OTHER: dilute RHD-1,Taipei City Hospital,National Yang Ming Chiao Tung University,ALL,"ADULT, OLDER_ADULT",58,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2011-05,2012-09,"Taipei City Hospital, Taipei, 886, Taiwan"
NCT01512238,Improvement of Intentional and Unintentional Non-adherence in the Elderly,https://clinicaltrials.gov/study/NCT01512238,COMPLETED,NO,Medication Adherence,OTHER: Pharmaceutical care,University of Aarhus,,ALL,OLDER_ADULT,630,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-02,2013-11,
NCT05040425,Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis,https://clinicaltrials.gov/study/NCT05040425,UNKNOWN,NO,Head and Neck Cancer|Oral Mucositis,DRUG: Zi-Yin-Liang-Ge-San,Chang Gung Memorial Hospital,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare",ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2021-08-30,2023-04-01,
NCT05001217,Chinese Herbal Medicine Treatment as Adjunct Therapy for Parkinson's Disease,https://clinicaltrials.gov/study/NCT05001217,COMPLETED,NO,Parkinson Disease,DRUG: Conventional medication|DRUG: Chinese herbal medicine treatment,Hong Kong Baptist University,Chinese University of Hong Kong,ALL,"ADULT, OLDER_ADULT",160,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2022-01-01,2024-01-31,"Department of Medicine, Queen Elizabeth Hospital, Hong Kong, Hong Kong|Hong Kong Parkinson's Disease Association, Hong Kong, Hong Kong"
NCT04584775,Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care,https://clinicaltrials.gov/study/NCT04584775,WITHDRAWN,NO,Advanced Cancer|Lung Cancer|Breast Cancer|Colo-rectal Cancer|Pancreas Cancer|Cholangiocarcinoma|Quality of Life|Symptoms and Signs,"OTHER: Treatment modalities of Traditional Chinese Medicine (Acupuncture, Chinese herbal medicine, Tunia, Chinese dietetics)|OTHER: Standard care",Medical University of Graz,,ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2021-02,2022-07,"Medical University of Graz, Graz, Styria, 8036, Austria"
NCT06515652,To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome,https://clinicaltrials.gov/study/NCT06515652,RECRUITING,NO,Metabolic Syndrome,"DRUG: rosuvastatin, METFORMIN, Sitagliptin, Telmisartan, Cinnamon. garlic, Ginger, Methi dana, Arjun",Hamdard University,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-09-01,2024-08-30,"Prof. Dr. M. Sajid Abbas Jaffri, Karachi, Sindh, 75600, Pakistan"
NCT04128865,PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy,https://clinicaltrials.gov/study/NCT04128865,UNKNOWN,NO,Cancer,,Paul Gougis,,ALL,"ADULT, OLDER_ADULT",200,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-04-13,2019-11-11,"Centre d'Investigation Clinique Paris-Est, Paris, 75013, France|Centre d'Investigation Clinique Paris-Est, Paris, 75013, France"
NCT04851821,The Effectiveness of Phytotherapy in SARS-COV2(COVID-19),https://clinicaltrials.gov/study/NCT04851821,COMPLETED,NO,a Randomized Double-blind Study|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|PHYTOTHERAPIE,DRUG: Quercetin,Hôpital Universitaire Sahloul,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2021-01-04,2021-06-30,"Riadh Boukef, Sahloul, Sousse, Tunisia"
NCT01142479,Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy,https://clinicaltrials.gov/study/NCT01142479,COMPLETED,NO,Breast Cancer|Radiotherapy|Chinese Herbal Medicine,DRUG: Chinese herbal medicine decoction,Taipei City Hospital,Taipei Medical University Shuang Ho Hospital,FEMALE,"ADULT, OLDER_ADULT",60,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2010-05,,"Shuang Ho Hospital, Taipei, 886, Taiwan"
NCT03797248,Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer,https://clinicaltrials.gov/study/NCT03797248,UNKNOWN,NO,Early-stage Breast Cancer,COMBINATION_PRODUCT: Chinese herbal medicine,Chang Gung Memorial Hospital,,FEMALE,"ADULT, OLDER_ADULT",310,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-11-12,2020-10-24,"Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan"
NCT00601263,Safety Study of Chinese Herbal Therapy to Treat Asthma,https://clinicaltrials.gov/study/NCT00601263,COMPLETED,NO,Asthma,DRUG: Anti-Asthma Herbal Medical Intervention (ASHMI),Xiu-Min Li,National Center for Complementary and Integrative Health (NCCIH),ALL,ADULT,35,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2006-10,2008-07,"Mount Sinai School Medicine, New York, New York, 10029, United States"
NCT04414605,Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis,https://clinicaltrials.gov/study/NCT04414605,UNKNOWN,NO,Psoriasis,DRUG: Gu Ben Hua Yu Fang decoction (Chinese herbal medicine)|DRUG: Secukinumab Auto-Injector [Cosentyx],Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",10,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-06-04,2021-12-31,"Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, 510000, China"
NCT04054284,Safety and Efficacy of Herbal Tea in Type 2 Diabetics,https://clinicaltrials.gov/study/NCT04054284,COMPLETED,NO,Type 2 Diabetes|Herbal Medicine Adverse Reaction,DIETARY_SUPPLEMENT: Antidiabetic Herbal Tea|DIETARY_SUPPLEMENT: Herbal Tea,Josip Juraj Strossmayer University of Osijek,Dom zdravlja Osijek (Health Centre Osijek)|Osijek University Hospital,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING",2019-07-01,2020-02-12,"Department of Food and Nutrition Research, Faculty of Food Technology, Osijek, 31000, Croatia|Health Centre Osijek, Osijek, 31000, Croatia|University Hospital Centre, Osijek, 31000, Croatia"
NCT00712296,Effectiveness of Chinese Herbal Therapy for Asthma,https://clinicaltrials.gov/study/NCT00712296,TERMINATED,YES,Asthma,DRUG: ASHMI 4|DRUG: ASHMI 12|DRUG: Placebo,Icahn School of Medicine at Mount Sinai,National Center for Complementary and Integrative Health (NCCIH),ALL,ADULT,66,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-08,2009-09-29,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT04492670,Tui-na and Oral Chinese Medicine on KOA,https://clinicaltrials.gov/study/NCT04492670,UNKNOWN,NO,Knee Osteoarthritis,PROCEDURE: Tui-na|DRUG: Du-Huo-Ji-Sheng-Tang (DHJST),Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",70,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-09-14,2023-03,"The Chinese University of Hong Kong, Hong Kong, Hong Kong"
NCT01975454,Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer,https://clinicaltrials.gov/study/NCT01975454,COMPLETED,NO,Metastatic Colorectal Cancer,DRUG: Chemotherapy|DRUG: Herbal therapy,Shanghai University of Traditional Chinese Medicine,Chongqing Three Gorges Central Hospital,ALL,"ADULT, OLDER_ADULT",62,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2012-04,2017-12,"Chongqing Three Gorges Central Hospital, Chongqing, Chongqing, 404000, China|Longhua Hospital, Shanghai, Shanghai, 200032, China"
NCT01431352,Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS),https://clinicaltrials.gov/study/NCT01431352,UNKNOWN,NO,Polycystic Ovary Syndrome,DRUG: Letrozole|DRUG: Chinese herbal medicine granules or Chinese herbal medicine granules placebo,Heilongjiang University of Chinese Medicine,,FEMALE,ADULT,420,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-09,2014-08,"Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China|Guangzhou Medical School First Affiliated Hospital, Guangzhou, Guangdong, China|Daqing Longnan hospital, Daqing, Heilongjiang, China|Daqing Oilfield General Hospital, Daqing, Heilongjiang, China|First Affliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China|Dept Obs & Gyn, First Affiliated Hospital National Key Discipline and Trial Base Heilongjiang University of Chinese Medicine, Herbin, Heilongjiang, 150040, China|Mudanjiang maternal and children hospital, Mudanjiang, Heilongjiang, China|2nd Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China|First Affiliated Hospital of Hunan University of Chinese, Changsha, Hunan, China|SuqianMaternal and Child Health Hospital, Suqian, Jiangsu, China|Maternal and Child Health Hospital of Xuzhou, Xuzhou, Jiangsu, China|First Hospital, Jiangxi college of Chinese Medicine, Nanchang, Jiangxi, China|Dalian Maternal and Child Health Hospital, Dalian, Liaoning, China|Shanxi Hospital of Chinese Medicine, Taiyuan, Shanxi, China|First Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin, Tianjin, China|Second Affiliated Hospital, Tianjin University of Chinese Medicine, Tianjin, Tianjin, China|Zhejiang province hospital of integrated traditional and western medicine, Hangzhou, Zhejiang, China|Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"
NCT02981147,"PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough",https://clinicaltrials.gov/study/NCT02981147,COMPLETED,NO,Cough|Common Cold,"DRUG: Phytus (Cisti, Thyme and Ivy Leaves)",PharmEvo Pvt Ltd,,ALL,"CHILD, ADULT, OLDER_ADULT",210,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2017-03-14,2018-03-30,"KCHS Medical Center 1st Floor, Tipu Sultan Road., Karachi, Sindh, Pakistan"
NCT05483595,An Examination of Blinding for Chinese Herbal Oral Liquid and Matched Placebo,https://clinicaltrials.gov/study/NCT05483595,COMPLETED,NO,Placebo Evaluate,DRUG: Chinese herbal medicine FYTF-919,Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",48,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2022-09-29,2023-06-30,"Guangdong Province Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China"
NCT02257723,The Effect of Integrated CAM Treatment in Hospitalized Patients,https://clinicaltrials.gov/study/NCT02257723,RECRUITING,NO,Low Back Pain|Neck Pain|Knee Pain|Shoulder Pain|Intervertebral Disc Herniation|Spinal Stenosis,DRUG: Herbal medicine|PROCEDURE: Acupuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Chuna manipulation,Jaseng Hospital of Korean Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",100000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-01,2040-12,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 06110, Korea, Republic of"
NCT00935194,"Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study",https://clinicaltrials.gov/study/NCT00935194,COMPLETED,NO,Influenza,DRUG: oseltamivir|OTHER: blank|DRUG: chinese medicinal herbs|DRUG: oseltamivir and chinese medicinal herbs,Capital Medical University,,ALL,"CHILD, ADULT, OLDER_ADULT",102,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2009-07,2009-11,"Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute, Beijing, 100020, China"
NCT01715740,Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria,https://clinicaltrials.gov/study/NCT01715740,COMPLETED,NO,Chronic Urticaria,DRUG: Chinese Herbal Medicine (CHM)|DRUG: Placebo,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",74,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-11,2015-11,"Chang Gung Memorial Hospital, Taoyuan, Taiwan"
NCT00109980,Medicinal Plant Use for Treating Inflammation Among Dominicans in New York City and the Dominican Republic,https://clinicaltrials.gov/study/NCT00109980,COMPLETED,NO,Inflammation,,New York Botanical Garden,,ALL,"ADULT, OLDER_ADULT",320,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2005-03,,"Associates in Internal Medicine Clinic, New York-Presbyterian Hospital, Columbia University, New York City, New York, 10032, United States"
NCT04665713,Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls' Sexual Precocity,https://clinicaltrials.gov/study/NCT04665713,COMPLETED,NO,Precocious Puberty,,Children's Hospital of Fudan University,,FEMALE,CHILD,192,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-12-18,2023-07-04,"Children's Hospital of Fudan University, Shanghai, 201102, China"
NCT06450652,CHM for T2DM & MetS,https://clinicaltrials.gov/study/NCT06450652,NOT_YET_RECRUITING,NO,Type 2 Diabetes Mellitus With Metabolic Syndrome,DRUG: Chinese Herbal Medicine granules,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-06,2024-10,
NCT00029263,Screening Herbs for Drug Interactions,https://clinicaltrials.gov/study/NCT00029263,COMPLETED,NO,Healthy,DRUG: herbals,National Center for Complementary and Integrative Health (NCCIH),,ALL,ADULT,140,NIH,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2001-08,2004-05,"Institute of Psychiatry, Medical University of SC, Charleston, South Carolina, 29425, United States"
NCT05236309,Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.,https://clinicaltrials.gov/study/NCT05236309,COMPLETED,NO,COVID-19 Pandemic,DRUG: Jing-Guan-Fang(JGF) : Chinese herbal decoction,Taipei City Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",2000,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-01-01,2021-11-18,"Taipei City Hospital, Taipei, 886, Taiwan"
NCT01840761,Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine,https://clinicaltrials.gov/study/NCT01840761,UNKNOWN,NO,Aneurysm,DRUG: herbal drug|DRUG: placebo,Guangzhou University of Traditional Chinese Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2010-07,2015-12,"Guangdong Provincial Science and Technology Agency, Guangzhou, Guangdong, 510033, China"
NCT05072990,Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine,https://clinicaltrials.gov/study/NCT05072990,COMPLETED,NO,Type 2 Diabetes Mellitus in Obese|Dyslipidemia Associated With Type II Diabetes Mellitus,DRUG: Chinese herb medicine,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",95,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-10-27,2022-05-15,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT03335683,Phytotherapy Agent in Third Molar Surgery,https://clinicaltrials.gov/study/NCT03335683,COMPLETED,NO,Oral Soft Tissue Conditions,DRUG: Lenidase,"Gaetano Isola, DDS, PhD",,ALL,"ADULT, OLDER_ADULT",42,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-01-07,2017-06-30,"University of Messina, Messina, 98125, Italy"
NCT03176563,Observational Follow-up Study of REGATTA,https://clinicaltrials.gov/study/NCT03176563,COMPLETED,NO,Urinary Tract Infections,DRUG: Arctuvan|DRUG: Placebo to Fosfomycin|DRUG: Fosfomycin|DRUG: Placebo to Arctuvan,University Medical Center Goettingen,,FEMALE,"ADULT, OLDER_ADULT",398,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-05-03,2019-08-20,"Hausarztpraxis Dr. Raby, Achim, Germany|General Practice Aden, Braunschweig, Germany|General Practice Scheffer, Braunschweig, Germany|General Practice Coutelle, Bremen, Germany|General Practice Schelp, Bremen, Germany|General Practice Dickow, Burgwedel, Germany|General Practice Kiwit-Putzer, Burgwedel, Germany|Praxis Zietz, Celle, Germany|General Practice Kutzsche, Emmerthal, Germany|Praxis Dr. Bahr, Gieboldehausen, Germany|General Practice Müller, Gillersheim, Germany|Institute of General Medicine, University Medical Center Goettingen, Goettigen, 37075, Germany|General Practice Keske, Göttingen, Germany|General Practice Koch, Göttingen, Germany|General Practice Kolb, Göttingen, Germany|General Practice Lang, Göttingen, Germany|General Practice Lückerath, Göttingen, Germany|Praxisgemeinschaft Jacob / Kling, Göttingen, Germany|Institute of General Medicine, MHH Hannover, Hannover, 30625, Germany|General Practice Barth, Hannover, Germany|Praxis Dr. Egner, Hannover, Germany|General Practice Löber, Hardegsen, Germany|Gemeinschaftspraxis Dres Schlesier / Eckhardt, Heilbad Heiligenstadt, Germany|Gemeinschaftspraxis Hartleb / Stöcking, Heilbad Heiligenstadt, Germany|Praxis Dr. Koch, Heilbad Heiligenstadt, Germany|Praxisgemeinschaft Seitz / Eckert, Herzberg Am Harz, Germany|General Practice Wilde, Hildesheim, Germany|General Practice Beverungen, Höxter, Germany|Praxisgemeinschaft Stoltz / Raddatz, Höxter, Germany|Gemeinschaftspraxis Kasperczyk / Schindewolf-Lensch, Isernhagen, Germany|General Practice Franz, Katlenburg-Lindau, Germany|Praxis Dr. Ohlendorf, Langenhagen, Germany|General Practice Ertel, Langwedel, Germany|General Practice Wehrbein, Lemforde, Germany|General Practice Lindenblatt, Neustadt, Germany|Hausarztzentrum Nörten, Nörten-Hardenberg, Germany|General Practice Preiskorn, Rehburg-Loccum, Germany|General Practice Meier-Ahrens, Rosdorf, Germany|General Practice Woitschek, Salzgitter, Germany|General Practice Beulshausen, Sattenhausen, Germany|General Practice Schulte, Scheeßel, Germany|General Practice Böttcher, Schwanewede, Germany|General Practice Albrecht, Springe, Germany|General Practice Wolf, Uslar, Germany|General Practice Schmiemann, Verden, Germany|General Practice Annweiler, Waake, Germany|General Practice Stegemann, Wunstorf, Germany"
NCT01844050,Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms,https://clinicaltrials.gov/study/NCT01844050,COMPLETED,NO,Type 2 Diabetes Mellitus,DRUG: Chinese herbal medicine|DRUG: Placebo,Shanghai University of Traditional Chinese Medicine,Longhua Hospital|Shanghai Putuo District Center Hospital,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-09,2009-10,"Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 201108, China"
NCT06262542,Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia,https://clinicaltrials.gov/study/NCT06262542,RECRUITING,NO,"Cancer, Chemotherapy-induced Leukopenia, Chinese Herb Medicine-moxibustion",OTHER: moxibustion and Chinese herbal medicine group,Taichung Armed Forces General Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2024-03-13,2024-12-31,"Taichung Armed Force General Hospital, Taichung, Taiping, 411228, Taiwan"
NCT01503346,DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients,https://clinicaltrials.gov/study/NCT01503346,COMPLETED,NO,Non-organic Loss of Appetite,DRUG: DaHuang GanTsao Tang,Changhua Christian Hospital,,ALL,"ADULT, OLDER_ADULT",4,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2011-03,2013-03,"Changhua Christan Hospital, Changhua City, Changhua Country, 500, Taiwan"
NCT01178632,Therapeutic Effect of an Herbal Medicine on Anxiety,https://clinicaltrials.gov/study/NCT01178632,UNKNOWN,NO,Anxiety Disorders,DRUG: Passiflora|DRUG: Valeriana officinalis,Millet Roux,,ALL,"ADULT, OLDER_ADULT",136,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-10,2012-07,"Clinical Pharmacology Unit - Unifac, Fortaleza, Ceara, 60430-270, Brazil"
NCT05067998,"The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature",https://clinicaltrials.gov/study/NCT05067998,RECRUITING,NO,"Anxiety Disorders and Symptoms|Fibromyalgia|Arthritis|Chronic Pain|Hypertension,Essential",DIETARY_SUPPLEMENT: IV Vitamin Infused Therapy Treatment|DRUG: Herbal medicine,Faith A. Richardson,,ALL,"ADULT, OLDER_ADULT",25,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2024-10-21,2025-08-28,"Health for Life Holistic Wellness Center LLC, Dover, Delaware, 19901, United States"
NCT02341573,Experienced Chinese Herbal Formulas on Pediatric Asthma,https://clinicaltrials.gov/study/NCT02341573,COMPLETED,NO,Childhood Asthma,DRUG: experienced chinese herbal formulas|DRUG: leukotriene receptor antagonist and bronchial relaxant,Children's Hospital of Fudan University,,ALL,CHILD,182,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2013-03,2015-06,"Department of Chinese Traditional Medicine; Children Hospital of Fudan University, Shanghai, Shanghai, 201102, China"
NCT03942185,Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study,https://clinicaltrials.gov/study/NCT03942185,UNKNOWN,NO,Psoriasis,DRUG: Oral Chinese Herbal Medicine of Clearing heat and Cooling blood therapy|DRUG: Oral Chinese Herbal Medicine according with syndrome differentiation therapy|DRUG: Oral Chinese Herbal Medicine of Promoting blood circulation and Removing blood stasis therapy,Shanghai Yueyang Integrated Medicine Hospital,Zhejiang Provincial Hospital of TCM|Shanghai Dermatology Hospital|The First Affiliated Hospital of Henan University of Traditional Chinese Medicine|Changhai Hospital|Shanghai 10th People's Hospital|Beijing Hospital of Traditional Chinese Medicine|Wuhan No.1 Hospital|Jiangsu Province Hospital of Traditional Chinese Medicine|Chinese Medicine Hospital Affiliated to Southwest Medical University|First Affiliated Hospital of Heilongjiang Chinese Medicine University|The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine|The Second Affiliated Hospital of Jiangxi University of TCM|The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine|The Guangxi Zhuang Autonomous Region Institute of Dermatology and control|The First Affiliated Hospital of Guiyang College of TCM|The Second People's Hospital Affiliated to Fujian University of TCM|Gansu University of Chinese Medicine|Shanxi Provincial Hospital of Traditional Chinese Medicine|Shijiazhuang Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",2000,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-06-01,2021-12-31,"The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, China|Beijing Hospital of Traditional Chinese Medicine, Beijing, Beijing, China|The Second People's Hospital Affiliated to Fujian University of TCM, Fuzhou, Fujian, China|Affiliated Hospital of Gansu University of traditional Chinese Medicine, Lanzhou, Gansu, China|The Guangxi Zhuang Autonomous Region Institute of Dermatology and control, Nanning, Guangxi, China|The First Affiliated Hospital of Guiyang College of TCM, Guiyang, Guizhou, China|Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China|First Affiliated Hospital of Heilongjiang Chinese Medicine University, Ha'erbin, Heilongjiang, China|The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, China|Affiliated hospital of jiangxi university of traditional Chinese medicine, Nanchang, Jiangxi, China|The Second Affiliated Hospital of Jiangxi University of TCM, Nanchang, Jiangxi, China|Changhai Hospital, Shanghai, Shanghai, China|Shanghai 10th People's Hospital, Shanghai, Shanghai, China|Shanghai Dermatology Hospital, Shanghai, Shanghai, China|Shanghai Yueyang Integrated Medicine Hospital, Shanghai, Shanghai, China|Shanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shanxi, China|Chinese Medicine Hospital Affiliated to Southwest Medical University, Luzhou, Sichuan, China|Zhejiang Provincial Hospital of TCM, Hangzhou, Zhejiang, China"
NCT01866995,"Efficacy Study of Phytotherapy ""Raylis"" In Congestive Processes Of The Pelvic Organs (Prostatostasis)",https://clinicaltrials.gov/study/NCT01866995,UNKNOWN,NO,Congestive Processes Of The Pelvic Organs (Prostatostasis)|Erectile Dysfunction|Sexual Function,"DRUG: ""Raylis""|OTHER: standard prostatostasis therapy","The Clinic of Men's Health and Couple Longevity, Russia",,MALE,ADULT,50,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-05,,"Clinic Of Men's Health and Couple Longevity, Moscow, 123242, Russian Federation"
NCT04544605,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,https://clinicaltrials.gov/study/NCT04544605,UNKNOWN,NO,Post COVID-19,OTHER: Individualized-Chinese herbal medicine,Hong Kong Baptist University,The University of Hong Kong|Chinese University of Hong Kong,ALL,"CHILD, ADULT, OLDER_ADULT",150,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-09-07,2021-12-31,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China"
NCT01227590,Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir),https://clinicaltrials.gov/study/NCT01227590,COMPLETED,NO,Drug Interactions|Human Immunodeficiency Virus,"DRUG: Kaletra (lopinavir/ritonavir), African Potato (hypoxis obtusa)","University of California, San Francisco",,ALL,ADULT,18,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-02,2011-09,"University of California, San Francisco, San Francisco, California, 94110, United States"
NCT02967497,Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type,https://clinicaltrials.gov/study/NCT02967497,UNKNOWN,NO,Epithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer,DRUG: YQ1,"Taipei Veterans General Hospital, Taiwan",National Yang Ming Chiao Tung University,ALL,"ADULT, OLDER_ADULT",56,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2016-10,2018-09,
NCT02795390,Clinical Trial on Palliative Cancer Patients With Constipation,https://clinicaltrials.gov/study/NCT02795390,COMPLETED,NO,Constipation,DRUG: Chinese herbal medicine|DRUG: Placebo,Hong Kong Baptist University,"Caritas Medical Centre, Hong Kong|Yan Chai Hospital|Our Lady of Maryknoll Hospital|Hong Kong Buddhist Hospital|Hospital Authority, Hong Kong",ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2016-11,2018-08,"Caritas Medical Centre, Hong Kong, Hong Kong|Hong Kong Buddhist Hospital, Hong Kong, Hong Kong|Our Lady of Maryknoll Hospital, Hong Kong, Hong Kong"
NCT06520501,Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients,https://clinicaltrials.gov/study/NCT06520501,NOT_YET_RECRUITING,NO,MeSH,DIETARY_SUPPLEMENT: Herbal Medicine Sambiloto|BEHAVIORAL: Brisk Walking|COMBINATION_PRODUCT: Brisk Walking and Herbal Medicine Sambiloto,Universitas Palangka Raya,,ALL,ADULT,30,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-09-04,2024-10-01,
NCT00393510,Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers,https://clinicaltrials.gov/study/NCT00393510,COMPLETED,YES,Diabetic Foot Ulcer|Amputation,DRUG: TCM|DRUG: Placebo,Chinese University of Hong Kong,,ALL,"CHILD, ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2000-11,2006-03,"Department of Orthopaedics & Traumatology, Prince of Wales hospital, Hong Kong, China|Department of Orthopaedics and Traumatology, Kwong Wah Hospital, Hong Kong, China"
NCT03365336,Influenza Management With Polyherbal Formulation,https://clinicaltrials.gov/study/NCT03365336,UNKNOWN,NO,Influenza,DRUG: polyherbal formulation|DRUG: Oseltamivir 75mg,Composite Interceptive Med Science,,ALL,"ADULT, OLDER_ADULT",100,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-02-01,2018-05-15,"Mazumdar Shaw Medical Centre, Bangalore, Karnataka, 560099, India"
NCT04932681,Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island,https://clinicaltrials.gov/study/NCT04932681,UNKNOWN,NO,Cancer,,Centre Hospitalier Universitaire de la Réunion,APLAMEDOM,ALL,"ADULT, OLDER_ADULT",520,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-04,2023-12,"CHU La Réunion, Saint-Denis, 97400, Réunion|Clinique Saint Clotilde, Sainte-Clotilde, 97490, Réunion"
NCT00130741,Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS),https://clinicaltrials.gov/study/NCT00130741,COMPLETED,NO,"Colonic Diseases, Functional",DRUG: CHT - herbal therapy,Hadassah Medical Organization,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2005-07,2007-01,"Hadassah Medical Organization, Jerusalem, 91120, Israel"
NCT01918722,Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy,https://clinicaltrials.gov/study/NCT01918722,UNKNOWN,NO,Intracerebral Hemorrhage,"DRUG: ICH-1(herbal medicine with Hirudo, Tabanus)|DRUG: placebo|DRUG: ICH-2(herbal medicine without Hirudo, Tabanus)",Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",360,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-10,2016-12,"The hospital of Chinese Medicine of Conghua City, Conghua, Guangdong, 5109000, China|Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China|Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, China|Guangzhou Hospital of Integrated traditional and west medicine, Guangzhou, Guangdong, 510800, China|Panyu Hospital of Chinese Medicine, Guangzhou, Guangdong, 511400, China|Boluo County People's Hospital, Huizhou, Guangdong, 514610, China|Jiangmen Wuyi Traditional Chinese Medicine Hospital, Jiangmen, Guangdong, 529000, China|Lianjiang People's hospital, Lianjiang, Guangdong, 524400, China|Yangjiang Hospital of Traditional Chinese Medicine, Yangjiang, Guangdong, 529500, China|Zengcheng City Hospital of traditional Chinese Medicine, Zengcheng, Guangdong, 510000, China|Boji-affiliated Hospital of Sun Yat-sen University, Zengcheng, Guangdong, 511300, China|1st people's hospital of Yueyang city, Yueyang, Hunan, 414000, China|Shenyang No.2 traditional Chinese medical hospital, Shenyang, Liaoning, 110000, China|Liaocheng City People's Hospital, Liaocheng, Shandong, 252000, China|Shouguang City People's Hospital, Shouguang, Shandong, 262700, China"
NCT06598033,Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer,https://clinicaltrials.gov/study/NCT06598033,RECRUITING,NO,Pancreatic Cancer,DRUG: VC plus herbal medicine,Fudan University,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-11-22,2027-10-01,"Shanghai Cancer Center, Shanghai, China"
NCT03219515,Herbal Medication (Gongjin-dan) for Chronic Dizziness,https://clinicaltrials.gov/study/NCT03219515,UNKNOWN,NO,Dizziness Chronic,DRUG: Gongjin-Dan|DRUG: Placebo,Kyunghee University,,ALL,"ADULT, OLDER_ADULT",78,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-04-01,2020-08-30,"Semyung University Korean Medicine Hospital, Chungju, Chungcheongbuk-do, 27429, Korea, Republic of|Dongguk University Ilsan Oriental Hospital, Goyang, Gyeonggi-do, 10326, Korea, Republic of|Pusan National University Korean Medicine Hospital, Yangsan, Gyeongsangnam-do, 50612, Korea, Republic of|Kyung Hee University Korean Medicine Hospital, Seoul, Special Seoul City, 02447, Korea, Republic of"
NCT00602160,Therapeutic Effect of Chinese Herbal Medicine on Food Allergy,https://clinicaltrials.gov/study/NCT00602160,UNKNOWN,NO,Food Allergy,DRUG: FAHF-2 (TM),"Li, Xiu-Min, M.D.",National Center for Complementary and Integrative Health (NCCIH),ALL,"CHILD, ADULT",68,INDIV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: ",2007-12,2012-06,"University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Mount Sinai School Medicine, New York, New York, 10029, United States"
NCT03532789,Herbal Patch for Overactive Bladder,https://clinicaltrials.gov/study/NCT03532789,COMPLETED,NO,Overactive Bladder Syndrome,DRUG: herbal patch|DRUG: placebo patch,En Chu Kong Hospital,,ALL,"ADULT, OLDER_ADULT",66,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-05-14,2019-10-23,"EnChuKong hospital, New Taipei City, Sanxia Dist, 237, Taiwan"
NCT00741936,An Effectiveness and Safety Study of Chinese Herbal Medicine for Functional Constipation,https://clinicaltrials.gov/study/NCT00741936,COMPLETED,YES,Functional Gastrointestinal Disorders|Constipation,DRUG: MaZiRenWan (MZRW)|DRUG: Placebo,Hong Kong Baptist University,"Food and Health Bureau, Hong Kong|PuraPharm International (H.K.) Ltd",ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-07,2009-12,"Hong Kong Baptist University Mr. & Mrs. Chan Hon Yin Chinese Medicine Specialty Clinic and Good Clinical Practice Centre, Hong Kong, China"
NCT02244320,Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin),https://clinicaltrials.gov/study/NCT02244320,COMPLETED,NO,Prostatic Hyperplasia,DRUG: Tamsulosin,Boehringer Ingelheim,,MALE,"CHILD, ADULT, OLDER_ADULT",4150,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2002-09,,
NCT02633878,Chinese Herbal Medicine and/or Oral Progesterone Intervention Trial for Threatened Miscarriage,https://clinicaltrials.gov/study/NCT02633878,RECRUITING,NO,Threatened Miscarriage,DRUG: Chinese Herbal Medicine plus Oral Micronized Progesterone|DRUG: Chinese Herbal Medicine plus Oral Micronized Progesterone Placebo|DRUG: Chinese Herbal Medicine Placebo plus Oral Micronized Progesterone|DRUG: Chinese Herbal Medicine Placebo plus Oral Micronized Progesterone Placebo,Heilongjiang University of Chinese Medicine,,FEMALE,ADULT,1656,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-10-20,2025-08-31,"First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China|Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China|Shenzhen Hospital of Beijing University, Shenzhen, Guangdong, China|Daqing Longnan Hospital, Daqing, Heilongjiang, China|First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China|Luoyang Hospital of Traditional Chinese Medicinel, Luoyang, Henan, China|First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China|Changzhou Hospital of Chinese Medicine, Changzhou, Jiangsu, China|Siyang People's Hospital, Suqian, Jiangsu, China|Suqian Obstetrics and Gynecology Hospital, Suqian, Jiangsu, China|Xuzhou Central Hospitall, Xuzhou, Jiangsu, China|Xuzhou Maternal and Child Health Hospital, Xuzhou, Jiangsu, China|Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China|The Second Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China|Dalian Maternal Hospital, Dalian, Liaoning, China|Dalian Municipal Women And Children's Medical Center, Dalian, Liaoning, China|Affiliated Hospital, Liaoning University of Chinese Medicine, Shenyang, Liaoning, China|Ningxia Hui Autonomous Region Hospital of traditional Chinese Medicine, Yinchuan, Ningxia Hui Autonomous Region, China|Taian City Central Hospital, Tai'an, Shandong, China|Shanxi Province Hospital of Chinese Medicine, Taiyuan, Shanxi, China|Hangzhou Hospital of Chinese Medical, Hangzhou, Zhejiang, China|Wenzhou Hospital of Chinese Medicine, Wenzhou, Zhejiang, China"
NCT00243022,"Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme",https://clinicaltrials.gov/study/NCT00243022,TERMINATED,YES,Brain and Central Nervous System Tumors|Cerebral Edema,DRUG: Boswellia serrata extract|DIETARY_SUPPLEMENT: cyanocobalamin,Ali Altunkaya,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",12,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2004-09,2011-03,"Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States"
NCT06758752,A Herbal Compound for Eczema,https://clinicaltrials.gov/study/NCT06758752,ACTIVE_NOT_RECRUITING,NO,Eczema|Atopic Dermatitis|Inflammation,DIETARY_SUPPLEMENT: ZAX.1400.EC.02|DRUG: Placebo,Fasa University of Medical Sciences,Herbmedx Co|Zarrin Avaye Kowsar Salamat (ZAX company),ALL,ADULT,110,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-10-01,2026-12-30,"Fasa university of medical sciences, Fasa, Fars, 7461686688, Iran, Islamic Republic of"
NCT04407871,Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct),https://clinicaltrials.gov/study/NCT04407871,UNKNOWN,NO,In Vitro Fertilization,OTHER: Acupuncture and Chinese Herbal Medicine,Heilongjiang University of Chinese Medicine,,FEMALE,ADULT,2728,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-11-01,2022-12-31,"The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|The First Hospital of Lanzhou University, Lanzhou, Gansu, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan, Hubei, China|Huaian Maternal and Child Health Hospital, Huai'an, Jiangsu, China|The First Affiliated Hospital of Nanjing University Medical School (Nanjing Drum Tower Hospital), Nanjing, Jiangsu, China|Xuzhou Central Hospital, Xuzhou, Jiangsu, China|Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China|Dalian Municipal Women and Children's Medical Center, Dalian, Liaoning, China|Shengjing Hospital of China Medical University, Shenyang, Liaoning, China|Xibei Women and Children's Hospital, Xi'an, Shanxi, China|The Chinese University of Hong Kong, Hong Kong, China"
NCT04173923,Long Term Follow-up of Cervical Myelopathy Inpatients Treated With Integrated Complementary and Alternative Medicine,https://clinicaltrials.gov/study/NCT04173923,COMPLETED,NO,Cervical Myelopathy,DRUG: Herbal medicine|PROCEDURE: Chuna manual medicine|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|PROCEDURE: Other intervention(s),Jaseng Medical Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",40,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-11-20,2020-11-19,"Haeundae Jaseng Hospital of Korean Medicine, Busan, 48102, Korea, Republic of"
NCT06301997,A Herbal Compound for Psoriasis,https://clinicaltrials.gov/study/NCT06301997,ACTIVE_NOT_RECRUITING,NO,Psoriasis|Inflammation|Skin Diseases,DIETARY_SUPPLEMENT: ZAX.1400.P03|DRUG: Placebo,Fasa University of Medical Sciences,Zarrin Avaye Kowsar Salamat (ZAX company),ALL,ADULT,104,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-02-01,2024-12-30,"Fasa university of medical sciences, Fasa, Fars, 7461686688, Iran, Islamic Republic of"
NCT04073511,Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold,https://clinicaltrials.gov/study/NCT04073511,UNKNOWN,NO,Common Cold,DRUG: Eungyosan|DRUG: Samsoeum|DRUG: Placebo,Korean Medicine Hospital of Pusan National University,,ALL,ADULT,375,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-09-16,2020-12-31,"Semyung University Korean Medicine Hospital, Jecheon, Chungcheongbuk-do, 27136, Korea, Republic of|Korean Medicine Hospital, Pusan National University, Yangsan, Gyeongsangnam-do, 50612, Korea, Republic of|Korean Medicine Hospital of Daejeon University, Daejeon, 35235, Korea, Republic of|KyungHee University Medical Center, Seoul, 02447, Korea, Republic of"
NCT05504447,"To Evaluate the Efficacy and Safety of ""Rongyang Zhengyifang"" Tea Bag With COVID-19 Variant Virus",https://clinicaltrials.gov/study/NCT05504447,ENROLLING_BY_INVITATION,NO,Herbal Interaction,"OTHER: Rong-Yang Zhengyifang"" tea bag|OTHER: placebo tea bag","Taipei Veterans General Hospital, Taiwan",,ALL,"ADULT, OLDER_ADULT",92,OTHER_GOV,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2022-08-15,2024-06-01,"Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei county, 112, Taiwan"
NCT03645889,Traditional Chinese Medicine in Management of Childhood Asthma,https://clinicaltrials.gov/study/NCT03645889,UNKNOWN,NO,Asthma in Children,OTHER: PLTG|OTHER: Placebo,KK Women's and Children's Hospital,Singapore Thong Chai Medical Institution,ALL,CHILD,130,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-10-15,2021-09,"KK Women's and Children's Hospital, Singapore, 229899, Singapore"
NCT04686955,The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine,https://clinicaltrials.gov/study/NCT04686955,UNKNOWN,NO,Atopic Dermatitis,DRUG: Xiao-Xian-Gui-Fu-Tang,"Taipei Veterans General Hospital, Taiwan",,ALL,"CHILD, ADULT",24,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-01-01,2022-12-31,"Center for Traditional Medicine, Taipei VGH, Taipei, 11217, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan"
NCT00936013,"Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study",https://clinicaltrials.gov/study/NCT00936013,UNKNOWN,NO,Influenza,DRUG: oseltamivir|DRUG: oseltamivir and chinese medicinal herbs,Capital Medical University,,ALL,"CHILD, ADULT, OLDER_ADULT",400,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2009-08,2011-07,"Capital Medical University affiliated Bejing Chaoyang Hospital, Beijing Respiratory Medicine Institute, Beijing, 100020, China"
NCT01706484,Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis,https://clinicaltrials.gov/study/NCT01706484,COMPLETED,NO,Chronic Sinusitis,DRUG: BNO 1016,Bionorica SE,,ALL,"ADULT, OLDER_ADULT",927,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-09,2014-07,"Claus Bachert, Prof. Dr., Ghent, Belgium"
NCT00376415,A Safety Study of Lessertia Frutescens in Adults.,https://clinicaltrials.gov/study/NCT00376415,COMPLETED,NO,Drug Safety,DRUG: Lessertia Fructescens|DRUG: Placebo,University of Missouri-Columbia,National Center for Complementary and Integrative Health (NCCIH)|University of the Western Cape,ALL,ADULT,25,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2004-09,2005-01,"Tiger Trial Centre, Tygerberg, Western Cape, 7535, South Africa"
NCT03221894,A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease,https://clinicaltrials.gov/study/NCT03221894,COMPLETED,NO,Alzheimer Disease,DIETARY_SUPPLEMENT: GRAPE granules,"Dongzhimen Hospital, Beijing",Beijing Hospital|Chinese PLA General Hospital|Peking University Third Hospital,ALL,"ADULT, OLDER_ADULT",120,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-07-15,2021-07-31,"Dongzhimen Hospital, Beijing, China"
NCT00071149,Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis,https://clinicaltrials.gov/study/NCT00071149,COMPLETED,NO,Rheumatoid Arthritis,,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",120,NIH,OBSERVATIONAL,Observational Model: |Time Perspective: p,2001-11,2004-04,"University of Maryland, Baltimore, Maryland, 21201, United States"
NCT00028977,Herbal Therapy in Treating Women With Metastatic Breast Cancer,https://clinicaltrials.gov/study/NCT00028977,COMPLETED,NO,Breast Cancer,DRUG: herba scutellaria barbata|OTHER: herba scutellaria Barbatae (HSB),"University of California, San Francisco",National Cancer Institute (NCI),FEMALE,"ADULT, OLDER_ADULT",21,OTHER,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2001-08,2006-04,"UCSF Comprehensive Cancer Center, San Francisco, California, 94115, United States|Cancer Research Network, Incorporated, Plantation, Florida, 33324, United States"
NCT04249869,The Efficacy of Traditional Chinese Herbal Medicine for Alzheimer's Disease,https://clinicaltrials.gov/study/NCT04249869,UNKNOWN,NO,Alzheimer Disease,DRUG: VGH-AD1,"Taipei Veterans General Hospital, Taiwan",,ALL,OLDER_ADULT,28,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-02-01,2020-12-31,
NCT05319041,Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women,https://clinicaltrials.gov/study/NCT05319041,RECRUITING,NO,Dry Eye,DRUG: Wei's Qi Ju Gan Lu Formula|DRUG: Placebo,Singapore National Eye Centre,Singapore Chung Hwa Medical Institution,FEMALE,"ADULT, OLDER_ADULT",150,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2022-04-11,2024-11,"Singapore National Eye Centre, Singapore, Singapore"
NCT04785027,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,https://clinicaltrials.gov/study/NCT04785027,RECRUITING,NO,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,DRUG: PSORI-CM01 formula|DRUG: Gu Ben Hua Yu formula|BIOLOGICAL: adipose-derived multipotent mesenchymal stem cells,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",16,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-03-17,2024-09-30,"Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, 510000, China"
NCT00972062,Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis,https://clinicaltrials.gov/study/NCT00972062,COMPLETED,NO,Multiple Sclerosis,OTHER: Bach's Rescue Remedy Cream|OTHER: Placebo Cream,"University of North Carolina, Charlotte","Teva Branded Pharmaceutical Products R&D, Inc.",ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2009-06,2010-03,"University of North Carolina at Charlotte, Charlotte, North Carolina, 28223, United States"
NCT05657132,Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication,https://clinicaltrials.gov/study/NCT05657132,UNKNOWN,NO,Infection Primary,DRUG: herbal intracanal medication paste|DRUG: Meta paste,Nahda University,,ALL,CHILD,24,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-08-19,2022-12-30,"NUB University, Cairo, Bani Suif, Egypt"
NCT05901532,Nasal Irrigation With Chinese Herbal Medicine as an Adjunctive Treatment in Allergic Rhinitis,https://clinicaltrials.gov/study/NCT05901532,COMPLETED,NO,"Rhinitis, Allergic|Nasal Lavage|Medicine, Chinese Traditional","DRUG: Szechwan Lovage Rhizome, Biod Magnolia Bud, Taiwan Angelica Root, Wild Mint Herb, Baikal Skullcap Root, and Borneol|DRUG: edible caramel",Taichung Veterans General Hospital,,ALL,"ADULT, OLDER_ADULT",38,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-11-01,2023-02-28,"Rong-San Jiang, Taichung, 40705, Taiwan"
NCT05055427,Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients,https://clinicaltrials.gov/study/NCT05055427,COMPLETED,NO,COVID-19 Respiratory Infection|Herbal Medicine,DRUG: Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng),University of Medicine and Pharmacy at Ho Chi Minh City,,ALL,ADULT,300,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-08-20,2021-12-25,"University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam"
NCT02027194,Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis,https://clinicaltrials.gov/study/NCT02027194,COMPLETED,NO,Allergic Rhinitis,DRUG: Cure-Allergic Rhinitis Syrup|DRUG: Yu-ping-fung San|DRUG: Placebo,The Hong Kong Polytechnic University,,ALL,ADULT,298,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-06,2014-10,"School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong"
NCT04566939,A Long Term Follow-Up of Rotator Cuff Tear Patients Treated With Integrated Complementary and Alternative Medicine,https://clinicaltrials.gov/study/NCT04566939,COMPLETED,NO,Rotator Cuff Tear,DRUG: Herbal medicine|PROCEDURE: Chuna manual medicine|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|PROCEDURE: Herbal hot pack|PROCEDURE: Physical therapy|PROCEDURE: Other intervention(s),Jaseng Medical Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",168,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-09-21,2021-03-31,"Haeundae Jaseng Hospital of Korean Medicine, Busan, 48102, Korea, Republic of"
NCT03577938,Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment,https://clinicaltrials.gov/study/NCT03577938,COMPLETED,NO,Acute on Chronic Liver Failure|Traditional Chinese Medicine|Hepatitis B,DRUG: Chinese herbal medicine|OTHER: Control (blank),Beijing 302 Hospital,Beijing YouAn Hospital|ShuGuang Hospital|Sun Yat-sen University|Huazhong University of Science and Technology|Fuzhou Infectious Hospital|The Sixth People's Hospital of Shenyang|Public Health Clinical Center of Chengdu|Hepatology hospital of Jilin Province|Shanghai Public Health Clinical Center|Guangxi University of Chinese Medicine|Hubei Hospital of Traditional Chinese Medicine|Beijing Ditan Hospital|Shenzhen traditional Chinese medical hospital|The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine|Shenzhen Third People's Hospital|Tianjin Second People's Hospital|Hangzhou Xixi hospital,ALL,"CHILD, ADULT, OLDER_ADULT",516,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-01-10,2021-06-30,"302 military hospital of China, Beijing, Beijing, China|Beijing Ditan hospital, Beijing, Beijing, China|Beijing youan hospital, Beijing, Beijing, China|Fuzhou infectious hospital, Fuzhou, Fujian, 350025, China|Xiamen hospital of traditional Chinese medicine, Xiamen, Fujian, China|Hubei hospital of traditional Chinese medicine, Wuhan, Hubei, China|Tongji hospital, Huazhong university of science and technology, Wuhan, Hubei, China|The first affiliated hospital of Hunan university of traditional Chinese medicine, Changsha, Hunan, 410000, China|Jilin hepatology hospital, Changchun, Jilin, China|The sixth people's hospital of Shenyang, Shenyang, Liaoning, China|Shanghai public health clinical center, Shanghai, Shanghai, China|Shuguang hospital, Shanghai university of traditional Chinese medicine, Shanghai, Shanghai, China|Chengdu public health clinical center, Chengdu, Sichuan, China|The second people's hospital of Tianjin, Tianjin, Tianjin, China|Hangzhou Xixi hospital, Hangzhou, Zhejiang, China"
NCT03274544,Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF),https://clinicaltrials.gov/study/NCT03274544,TERMINATED,NO,Idiopathic Pulmonary Fibrosis,OTHER: PROLUNG,The University of Hong Kong,"Queen Mary Hospital, Hong Kong",ALL,"ADULT, OLDER_ADULT",6,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2018-08-14,2020-06-01,"Queen Mary Hospital, Hong Kong, Hong Kong"
NCT05436938,To Evaluate the Mechanism of Jing Si Herbal Tea Liquid Packets and Traditional Western Medicine for Psoriasis,https://clinicaltrials.gov/study/NCT05436938,UNKNOWN,NO,DLQI|PHQ-9|PSAI|Serum Cytokine Survey,COMBINATION_PRODUCT: Jing Si herbal tea liquid packets use,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-07-01,2023-06-30,"Hualien Tzu Chi Hospital, Hualien City, Hualien, 970, Taiwan"
NCT00299975,A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation,https://clinicaltrials.gov/study/NCT00299975,COMPLETED,YES,Constipation,DRUG: MaZiRenWan (MZRW) Low dose|DRUG: MaZiRenWan (MZRW) Median dose|DRUG: MaZiRenWan (MZRW) High dose,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",97,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2006-10,2007-10,"Hong Kong Baptist University Chinese Medicine Clinic, Hong Kong, China"
NCT00636103,Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma,https://clinicaltrials.gov/study/NCT00636103,COMPLETED,NO,Asthma,DRUG: CUF2|OTHER: Placebo,Chinese University of Hong Kong,"University Grants Committee, Hong Kong|Tuen Mun Hospital",ALL,CHILD,90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2002-07,2003-08,"Department of Paediatrics, Prince of Wales Hospital, Hong Kong, Hong Kong|Department of Paediatrics, Tuen Mun Hospital, Hong Kong, Hong Kong"
NCT04500730,Evaluate the Efficacy of Herbal Medicine (Shaoyao Gancao Decoction Jiawei) in Sleep-related Leg Cramps,https://clinicaltrials.gov/study/NCT04500730,COMPLETED,NO,Sleep-related Leg Cramps,DRUG: Shaoyao Gancao Decoction Jiawei,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-08-01,2019-12-31,"The Chinese University of Hong Kong, Hong Kong, Hong Kong"
NCT05720442,Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy,https://clinicaltrials.gov/study/NCT05720442,NOT_YET_RECRUITING,NO,Diabetic Gastroenteropathy,DRUG: Tangweian Recipe|DRUG: Mosapride Citrate,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-02-01,2026-01-01,
NCT04481464,Evaluation of the Efficacy of Chinese Herbal Medicine in Patients With Obesity,https://clinicaltrials.gov/study/NCT04481464,UNKNOWN,NO,Obesity,,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",500,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-11-01,2021-11-01,
NCT01053533,A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza,https://clinicaltrials.gov/study/NCT01053533,UNKNOWN,NO,"Influenza A Virus, H1N1 Subtype",DRUG: Chinese herbal medicines plus western therapy|DRUG: western therapy,Beijing Ditan Hospital,Beijing University of Chinese Medicine|State Administration of Traditional Chinese Medicine of the People's Republic of China|China Academy of Chinese Medical Sciences,ALL,"CHILD, ADULT, OLDER_ADULT",1100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2010-01,2010-04,"Mao Yu, Beijing, Beijing, 100015, China"
NCT03354026,Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy,https://clinicaltrials.gov/study/NCT03354026,UNKNOWN,NO,"Intracerebral Hemorrhage, Hypertensive|Traditional Chinese Medicine",DRUG: AICH-PXZY|DRUG: AICH-without PXZY|DRUG: AICH-placebo,Guangzhou University of Traditional Chinese Medicine,Lianjiang people's Hospital|Shenyang Second Hospital of traditional Chinese Medicine|The Third People's Hospital of Hubei Province|Liaocheng People's Hospital|Zengcheng Hospital of traditional Chinese Medicine|Shouguang people's Hospital,ALL,"ADULT, OLDER_ADULT",306,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-11,2022-12,"Guangdong Provincial Science and Technology Agency, Guangzhou, Guangdong, 510033, China|Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China"
NCT06785649,The Efficacy of Lavender Herbal Tea in Misophonia,https://clinicaltrials.gov/study/NCT06785649,NOT_YET_RECRUITING,NO,Misophonia|Misophonia Treatment|Anxiety|Depression|Anger|Complementary Medicine,OTHER: Lavender herbal tea,Sakarya University,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2025-02-01,2025-02-28,
NCT01033630,Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen,https://clinicaltrials.gov/study/NCT01033630,COMPLETED,NO,Hypertension,DRUG: D&G 2g|DRUG: D&G 1g|DRUG: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2006-01,2008-05,"Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Hong Kong, Hong Kong|Yan Chai Hospital, Hong Kong, Hong Kong"
NCT05199545,Efficacy Study in Phytotherapy of an Association of Plants in the Improvement of Psychological Well-being,https://clinicaltrials.gov/study/NCT05199545,RECRUITING,NO,Psychological Well-being,DIETARY_SUPPLEMENT: Dietary supplement|OTHER: Placebo,Larena SAS,Université Catholique de Louvain,ALL,"ADULT, OLDER_ADULT",126,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2022-04-26,2024-05-01,"CICN - Université Catholique de Louvain, Louvain-la-Neuve, Belgium"
NCT04655833,Integrative Korean Medicine Treatment for Inpatients With Failed Back Surgery Syndrome: A Retrospective Study With Survey,https://clinicaltrials.gov/study/NCT04655833,COMPLETED,NO,"FBSS|Medicine, Korean Traditional",OTHER: phone survey,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",106,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-10-22,2020-12-24,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT04462666,Oral Huzhang Granules for Acute Gouty Arthritis,https://clinicaltrials.gov/study/NCT04462666,UNKNOWN,NO,Gouty Arthritis,DRUG: Huzhang granule|DRUG: Etoricoxib|DRUG: Huzhang granule Placebo|DRUG: Etoricoxib Placebo,Shanghai Yueyang Integrated Medicine Hospital,,ALL,"ADULT, OLDER_ADULT",267,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-07-01,2023-08-31,
NCT00071682,Evaulation of Interaction Between Herbal Products and Anticoagulants,https://clinicaltrials.gov/study/NCT00071682,WITHDRAWN,NO,Coagulation Disorders,,"University of California, San Francisco",National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",0,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2007-10,2007-12,"San Francisco VA Medical Center, San Francisco, California, 94121, United States"
NCT06605495,"Using Dry Eye As a Disease Model, Investigators Demonstrated the Optimal Selection of Individualized Clinical Interventions and the Superiority of Dynamic Treatment Discrimination in Chinese Medicine.",https://clinicaltrials.gov/study/NCT06605495,NOT_YET_RECRUITING,NO,Dry Eye Disease (DED),COMBINATION_PRODUCT: fumigation with Chinese medicine|DRUG: Oral herbal medicine|DRUG: Modern Western Medicine,Xuejing Lu,,ALL,"ADULT, OLDER_ADULT",4000,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-09-25,2025-10-01,
NCT04572360,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,https://clinicaltrials.gov/study/NCT04572360,UNKNOWN,NO,Coronavirus Disease (COVID-19),OTHER: Cardiorespiratory Exercise|OTHER: Modified Bai He Gu Jin Tang,Hong Kong Baptist University,"The University of Hong Kong|Chinese University of Hong Kong|The Hong Kong Polytechnic University|University of South Wales|Yale University|University of California, San Diego",ALL,"ADULT, OLDER_ADULT",172,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-10-01,2023-06-30,"Linda Zhong, Kowloon Tong, Kowloon, Hong Kong"
NCT03789760,The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule,https://clinicaltrials.gov/study/NCT03789760,COMPLETED,NO,Vascular Dementia,DRUG: SaiLuoTong capsule|DRUG: placebo,"Shineway Pharmaceutical Co.,Ltd",,ALL,"ADULT, OLDER_ADULT",493,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-04-10,2024-05-19,"Xuan Wu Hospital of Capital Medical University, Beijing, Beijing, 100053, China|Peking University Shougang Hospital, Beijing, Beijing, 100144, China|Xiyuan Hospital, Beijing, Beijing, China|Affiliated Hospital of Hebei University, Baoding, Hebei, China|Affiliated Hospital of Chengde Medical College, Chengde, Hebei, 067000, China|Handan First Hospital, Handan, Hebei, 056000, China|Hebei Central Hospital of petrochina, Langfang, Hebei, 065000, China|The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, China|The Fourth Hospital of Medical University, Harbin, Hei Longjiang, China|The First People's Hospital of Luoyang, Luoyang, Henan, 471000, China|The First affiliated Hospital of Nanyang Medical college, Nanyang, Henan, 473000, China|Nanyang Second People's Hospital, Nanyang, Henan, 473003, China|The First Hospital of Changsha, Changsha, Hunan, 41000, China|Xiangya Boai Rehability Hospital, Changsha, Hunan, China|Yueyang Second People's Hospital, Yueyang, Hunan, 414000, China|Baogang Hospital, Baotou, Inner Mongolia, 014000, China|Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China|Taizhou Hospital of Chinese Medicine, Taizhou, Jiangsu, 225300, China|Jiujiang University Clinical Medical College ▪ Jiujiang University Hospital, Jiujiang, Jiangxi, 332000, China|Nanchang Hongdu Hospital of TCM, Nanchang, Jiangxi, China|Changzhi People's Hospital, Changzhi, Shanxi, 046000, China|Jinzhong First People's Hospital, Jinzhong, Shanxi, China|Xianyang Hospital of Yan'an University, Xianyang, Shanxi, 712000, China|Yuncheng Central Hospital, Yuncheng, Shanxi, China|The Second people's Hospital of Neijiang, Neijiang, Sichuan, China|Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, Tianjin, 300250, China|The Second Hospital of Xingjiang Medical University, Ürümqi, Xingjiang, China|The Central Hospital of Lishui City, Lishui, Zhejiang, 323000, China"
NCT05613062,Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT05613062,RECRUITING,NO,Atopic Dermatitis,DRUG: Modified Huang-Lian-Jie-Du Decoction (MHLJDD)|DRUG: Placebo,Chinese University of Hong Kong,,ALL,CHILD,20,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-04-11,2024-06,"School of Chinese Medicine, Hong Kong, Hong Kong"
NCT04446221,Long Term Follow-Up of Post Neck Pain Patients Accompanying Ossification of Posterior Longitudinal Ligament Treated With Integrated Complementary and Alternative Medicine: Observational Study,https://clinicaltrials.gov/study/NCT04446221,COMPLETED,NO,"OPLL|Medicine, Korean Traditional",OTHER: phone survey,Jaseng Medical Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",78,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-06-12,2021-12-31,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT01695850,"A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation",https://clinicaltrials.gov/study/NCT01695850,COMPLETED,NO,Functional Constipation|Gastrointestinal Disorders,DRUG: MZRW|DRUG: Senna|DRUG: placebo,Hong Kong Baptist University,"Queen Elizabeth Hospital, Hong Kong|Prince of Wales Hospital, Shatin, Hong Kong",ALL,"ADULT, OLDER_ADULT",291,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-06,2015-08,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China"
NCT06205030,Efficacy of NOSHINtrial in Diabetic Patients,https://clinicaltrials.gov/study/NCT06205030,NOT_YET_RECRUITING,NO,"Diabetes Mellitus, Type 2|Insulin Resistance",DRUG: anti-diabetic herbal drug,Kerman Medical University,Afzalipour Hospital,ALL,"ADULT, OLDER_ADULT",70,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2025-03-14,2025-07-16,"Kerman University of Medical Sciences, Kerman, Iran, Islamic Republic of"
NCT06601283,Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer,https://clinicaltrials.gov/study/NCT06601283,RECRUITING,NO,Pancreatic Cancer,DRUG: Vitmain C plus herbal medicine,Fudan University,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-11-22,2027-11-22,"Shanghai Cancer Center, Shanghai, 200032, China"
NCT00153751,The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS),https://clinicaltrials.gov/study/NCT00153751,COMPLETED,NO,"Colonic Diseases, Functional",DRUG: Traditional Chinese Medicine|DRUG: Holopon|OTHER: placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",84,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2005-09,2007-05,"Li Ka Shing Specialist Clinic, Prince of Wales Hospital, Hong Kong (SAR), China"
NCT02029118,Acupoint Application in Patients With Stable Angina Pectoris (AASAP),https://clinicaltrials.gov/study/NCT02029118,COMPLETED,NO,Stable Angina Pectoris,"DRUG: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)|DEVICE: acupoint|DRUG: Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.",Chengdu University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-10,2015-08,"Affiliated hospital of Chengdu University of TCM, Chengdu, Sichuan, 610072, China"
NCT05801575,CHM Teabag Decrease Stroke Risk Among Hong Kong Elderly,https://clinicaltrials.gov/study/NCT05801575,RECRUITING,NO,Stroke|Risk Reduction|Elderly,DRUG: Chinese Herbal Medicine (CHM) teabag,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",912,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION,2023-02-02,2023-10-31,"Hong Kong Baptist University Mr. & Mrs. Chan Hon Yin Chinese Medicine Specialty Clinic and Good Clinical Practice Centre, Hong Kong, China"
NCT04650256,Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences,https://clinicaltrials.gov/study/NCT04650256,RECRUITING,NO,Skin Toxicity,OTHER: Complementary and alternative medicine (CAM),University of Miami,"VAUGHN-JORDAN FOUNDATION, INC.|Florida Breast Cancer Foundation",FEMALE,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2021-07-01,2024-12-31,"University of Miami, Miami, Florida, 33136, United States"
NCT04974073,Development of PHY606 as Adjunct Therapy for Anemia Patients,https://clinicaltrials.gov/study/NCT04974073,COMPLETED,NO,Anemia|Herbal Interaction,DRUG: PHY606,Sheng-Teng Huang,,ALL,"ADULT, OLDER_ADULT",39,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2017-08-22,2019-11-18,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT01978730,The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule,https://clinicaltrials.gov/study/NCT01978730,UNKNOWN,NO,Vascular Dementia,DRUG: high dose group of SaiLuoTong capsule|DRUG: low dose group of SaiLuoTong|DRUG: the control group,"Shineway Pharmaceutical Co.,Ltd",,ALL,"ADULT, OLDER_ADULT",372,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-12,2014-07,"Xuan Wu Hospital of Capital Medical University, Beijing city, Beijing, 100053, China|Dongzhimen Hospital affiliated to Beijing University of Chinese Traditional Medicine, Beijing, Beijing, 100007, China|Beijing Friendship Hospital of Capital Medical University, Beijing, Beijing, 100050, China|The Chinese Traditional Medical Hospital of Guangdong Province, Guangzhou city, Guangdong, 510006, China|Southern Hospital of Southern Medical, Guangzhou, Guangdong, 510515, China|The First Hospital of Hunan University of Chinese Traditional Medicine, Changsha, Hunan, 410007, China|The First people's Hospital of Chenzhou, Chenzhou, Hunan, 423000, China|The Central Hospital of Baotou, Baotou city, Inner Mongolia, 014040, China|The Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China|Chinese Traditional Medical Hospital of Jiangsu Province, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The Hospital of Traditional Chinese and Western Medicine of Jilin Province, Changchun, Jilin, 132012, China|The Shuguang Hospital of Shanghai University of Chinese Traditional Medicine, Shanghai, Shanghai, 201203, China|The Affiliated Hospital of Chengdu Chinese Traditional Medicine, Chengdu, Sichuan, 610072, China|The First Hospital of Tianjin University of Chinese Traditional Medicine, Tianjin, Tianjin, 300193, China|The First Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China"
NCT04275024,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,https://clinicaltrials.gov/study/NCT04275024,COMPLETED,NO,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,DRUG: Calcipotriol ointment|DRUG: PSORI-CM01 Granule|BIOLOGICAL: adipose-derived multipotent mesenchymal stem cells,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",8,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-04-01,2021-02-03,"Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China"
NCT02490813,Pilot Study on Traditional Chinese Medicine and Food Allergy,https://clinicaltrials.gov/study/NCT02490813,TERMINATED,NO,Allergy to Fish|Allergy to Shrimp|Allergy to Crab,DIETARY_SUPPLEMENT: Treatment - Chinese Herbal Formula - X|DIETARY_SUPPLEMENT: Placebo,Hong Kong Sanatorium & Hospital,Chinese University of Hong Kong,ALL,"CHILD, ADULT, OLDER_ADULT",18,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2015-06-18,2023-02-18,"Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong"
NCT05219214,China Rheumatoid Arthritis Registry of Patients With Chinese Medicine,https://clinicaltrials.gov/study/NCT05219214,UNKNOWN,NO,Rheumatoid Arthritis,OTHER: Chinese medicine,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",12000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-09-01,2024-12-31,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China"
NCT01146860,Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis,https://clinicaltrials.gov/study/NCT01146860,COMPLETED,YES,Acute Rhinosinusitis,DRUG: BNO 1016|DRUG: Placebo,Bionorica SE,,ALL,"ADULT, OLDER_ADULT",386,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-01,2010-04,"Dr. Rainer Jund, Specialist in Otorhinolaryngology, Puchheim, 82178, Germany"
NCT06534996,A Single Arm Pilot Study of the Chinese Herbal Medicine Formula (SCD-2101) for the Functional Constipation in the Elderly,https://clinicaltrials.gov/study/NCT06534996,RECRUITING,NO,Functional Constipation,DRUG: SCD-2101,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",14,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-08-01,2024-11-30,"Hong Kong Baptist University, Kowloon Tong, Hong Kong"
NCT01554475,Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction,https://clinicaltrials.gov/study/NCT01554475,COMPLETED,NO,Dementia|Cognitive Impairment,,University Hospital of North Norway,"Kløveråsen Center for dementia, Bodø",ALL,"CHILD, ADULT, OLDER_ADULT",151,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-03,2014-10,"Kløveråsen, Bodø, N-8076, Norway"
NCT03232528,The Promotion Plan of Moxibustion on Ulcerate Colitis,https://clinicaltrials.gov/study/NCT03232528,COMPLETED,NO,Ulcerative Colitis,OTHER: Herb-partitioned moxibustion|OTHER: Sham herb-partitioned moxibustion,"Shanghai Institute of Acupuncture, Moxibustion and Meridian",,ALL,"ADULT, OLDER_ADULT",128,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2016-11-01,2019-12-30,"Shanghai Research Insititute of Acupuncture and Meridian, Shanghai, Xuhui, 20000, China"
NCT05199623,The Effect of Chinese Herbal Medicine as an Adjuvant Therapy in the Treatment of Traumatic Anosmia,https://clinicaltrials.gov/study/NCT05199623,COMPLETED,NO,Traumatic Anosmia,DRUG: tailored Guizhi decoction|BEHAVIORAL: Olfactory training (OT),Taichung Veterans General Hospital,,ALL,"ADULT, OLDER_ADULT",77,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2018-09-01,2021-07-09,"Taichung Veterans General Hospital, Taichung, Taiwan"
NCT02210377,A Preliminary Randomized Study of Tianjiu (Auto-moxibustion) Effects in Patients With Intradialytic Hypotension,https://clinicaltrials.gov/study/NCT02210377,UNKNOWN,NO,Intradialytic Hypotension,OTHER: Tianjiu|OTHER: Placebo (non-Tianjiu),Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",45,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2015-03,2016-06,"Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan"
NCT04790240,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),https://clinicaltrials.gov/study/NCT04790240,UNKNOWN,NO,Covid19 Virus Infection,DIETARY_SUPPLEMENT: Inflammation (I)|DIETARY_SUPPLEMENT: Inflammation (II)|DIETARY_SUPPLEMENT: Inflammation (III)|DRUG: Standard of care,"All Natural Medicine Clinic, LLC",,ALL,"CHILD, ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2021-02-01,2023-03,"All Natural Medicine Clinic, LLC, Rockville, Maryland, 20852-2235, United States"
NCT02616952,A Chinese Herbal Decoction for Stress Urinary Incontinence,https://clinicaltrials.gov/study/NCT02616952,COMPLETED,NO,"Urinary Incontinence, Stress",DIETARY_SUPPLEMENT: Chinese herbal therapy|BEHAVIORAL: Pelvic floor muscle training,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,FEMALE,"ADULT, OLDER_ADULT",72,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2015-12,2017-12,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT02580071,Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients,https://clinicaltrials.gov/study/NCT02580071,COMPLETED,NO,Acute Leukemia,DIETARY_SUPPLEMENT: Sheng-Yu-Tang,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",18,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2015-10,2017-08,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT05684952,The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue,https://clinicaltrials.gov/study/NCT05684952,RECRUITING,NO,Long COVID,DRUG: Shenlingcao Oral Liquid,Hong Kong Baptist University,"Jiangzhong Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",152,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-05-30,2024-02-01,"Hong Kong Baptist University Chinese Medicine Clinic, Hong Kong, China"
NCT01631032,Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis,https://clinicaltrials.gov/study/NCT01631032,COMPLETED,NO,Allergic Rhinitis,DRUG: Qi-tonifying Chinese herbal products,Chang Gung Memorial Hospital,Committee on Chinese Medicine and Pharmacy,ALL,ADULT,112,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-07,2013-12,"Chang Gung Memorial Hospital, Taoyuan, Taiwan"
NCT06760351,Pulse Diagnosis and Anemia: Exploring Integrated Traditional Chinese and Western Medicine Approaches,https://clinicaltrials.gov/study/NCT06760351,COMPLETED,NO,Moderate to Severe Anemia|Traditional Chinese Medicine (TCM)|Pulse Diagnosis,DRUG: TCM Herbal Therapy|DRUG: Standard Western Medicine Treatment,Chia-Ying Chuang,,ALL,"ADULT, OLDER_ADULT",28,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-02-26,2023-12-31,"Taichung Tzu Chi Hospital, Taichung, 403, Taiwan"
NCT00669656,Herbal Therapy for Treatment of Recurrent Prostate Cancer,https://clinicaltrials.gov/study/NCT00669656,COMPLETED,NO,Prostate Cancer,DRUG: Prostate Health Cocktail,University of Southern California,,MALE,"ADULT, OLDER_ADULT",43,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2008-07-06,2014-10-14,"USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States"
NCT06794502,Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment,https://clinicaltrials.gov/study/NCT06794502,COMPLETED,NO,Tuberculosis (TB)|Tuberculosis Treatment Effectiveness,DRUG: Herbal medicine|OTHER: Tuberculosis (TB) treatment,Universitas Muhammadiyah Semarang,,ALL,"ADULT, OLDER_ADULT",28,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-03-14,2024-08-31,"West Kotawaringin Health Department, Pangkalan Bun, Central Kalimantan, 74112, Indonesia|Mendawai Community Health Center, Pangkalan Bun, Central Kalimantan, 74115, Indonesia"
NCT02746042,Sinupret Extract Coated Tablets in Chronic Rhinosinusitis,https://clinicaltrials.gov/study/NCT02746042,COMPLETED,NO,Chronic Rhinosinusitis,DRUG: Sinupret extract coated tablets|DRUG: Placebo coated tablets,Bionorica SE,,ALL,"ADULT, OLDER_ADULT",572,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-04-28,2017-08-23,"Bionorica Investigative Site, Berlin, 13353, Germany|Bionorica Investigative Site, Braunschweig, Germany|Bionorica Investigative Site, Chemnitz, Germany|Bionorica Investigative Site, Dresden, 01067, Germany|Bionorica Investigative Site, Dresden, 01139, Germany|Bionorica Investigative Site, Dresden, 01159, Germany|Bionorica Investigative Site, Dresden, 01307, Germany|Bionorica Investigative Site, Duisburg, Germany|Bionorica Investigative Site, Essen, Germany|Bionorica Investigative Site, Frankfurt am Main, Germany|Bionorica Investigative Site, Goettingen, Germany|Bionorica Investigative Site, Heidelberg, 69120, Germany|Bionorica Investigative Site, Heidelberg, 69126, Germany|Bionorica Investigative Site, Markkleeberg, Germany|Bionorica Investigative Site, Mittweida, Germany|Bionorica Investigative Site, Munich, 80331, Germany|Bionorica Investigative Site, Neuenhagen, Germany|Bionorica Investigative Site, Nuremberg, Germany|Bionorica Investigative Site, Röthenbach/Pegnitz, Germany|Bionorica Investigative Site, Schluchtern, Germany|Bionorica Investigative Site, Schorndorf, Germany|Bionorica Investigative Site, Wuppertal, Germany|Bionorica Investigative Site, Bialystok, 15-270, Poland|Bionorica Investigative Site, Bialystok, 15-879, Poland|Bionorica Investigative Site, Bydgoszcz, Poland|Bionorica Investigative Site, Gdansk, Poland|Bionorica Investigative Site, Gdynia, Poland|Bionorica Investigative Site, Katowice, 40-036, Poland|Bionorica Investigative Site, Katowice, 40-611, Poland|Bionorica Investigative Site, Katowice, 40-954, Poland|Bionorica Investigative Site, Kielce, Poland|Bionorica Investigative Site, Krakow, 30-349, Poland|Bionorica Investigative Site, Krakow, 30-548, Poland|Bionorica Investigative Site, Krakow, 31-624, Poland|Bionorica Investigative Site, Limanowa, Poland|Bionorica Investigative Site, Lodz, Poland|Bionorica Investigative Site, Lublin, 20-552, Poland|Bionorica Investigative Site, Piaseczno, Poland|Bionorica Investigative Site, Szczecin, Poland|Bionorica Investigative Site, Tychy, Poland|Bionorica Investigative Site, Warszawa, 01-868, Poland|Bionorica Investigative Site, Wieliczka, Poland|Bionorica Investigative Site, Wroclaw, Poland|Bionorica Investigative Site 222, Zgierz, Poland|Bionorica Investigative Site 224, Zgierz, Poland"
NCT05792813,Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility,https://clinicaltrials.gov/study/NCT05792813,NOT_YET_RECRUITING,NO,Male Infertility|Asthenozoospermia|Oligoasthenozoospermia,DRUG: LGYY|DRUG: LGYY mimetic|DRUG: WZYZ|DRUG: WZYZ mimetic,Xiyuan Hospital of China Academy of Chinese Medical Sciences,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine|Shandong University of Traditional Chinese Medicine|Chengdu Fifth People's Hospital|Shenzhen Traditional Chinese Medicine Hospital,MALE,ADULT,162,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-06,2024-12,
NCT06103656,"E-B-FAHF-2, Multi OIT and Xolair for Food Allergy",https://clinicaltrials.gov/study/NCT06103656,COMPLETED,NO,Food Allergy,DRUG: Drug: Chinese Herbal Medication|DRUG: Drug: Placebo|DRUG: Drug: Omalizumab,New York Medical College,Icahn School of Medicine at Mount Sinai,ALL,"CHILD, ADULT",33,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-08-20,2021-02-22,
NCT05406960,Therapeutic Effect of Herbal Infusion on Menometrorrhagia,https://clinicaltrials.gov/study/NCT05406960,COMPLETED,NO,Abnormal Uterine Bleeding|Menorrhagia; Postmenopausal|Metrorrhagia|Hysterectomy|Heavy Menstrual Bleeding,DIETARY_SUPPLEMENT: Tea infusion,"Faculty of Medicine, Sousse",Centre Hôpital Universitaire Farhat Hached,FEMALE,ADULT,13,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-05-10,2021-02-10,"faculty of medicine Sousse, Sousse, 4000, Tunisia"
NCT01875562,"A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy",https://clinicaltrials.gov/study/NCT01875562,UNKNOWN,NO,Cervical Radiculopathy,DRUG: Qishe Pill,Shanghai University of Traditional Chinese Medicine,Huadong Hospital|Shanghai East Hospital|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|Shanghai No.1 Hospital|Shanghai No.6 Hospital|Changhai Hospital,ALL,"ADULT, OLDER_ADULT",2400,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-05,2013-11,"Longhua Hospital, Shanghai University of TCM, Shanghai, Shanghai, 200032, China"
NCT03506919,Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis,https://clinicaltrials.gov/study/NCT03506919,UNKNOWN,NO,Treatment of Arthritis,DRUG: Allopurinol,Shifa Ul Mulk Memorial Hospital,,ALL,"CHILD, ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2018-01-01,2018-06-30,"clinical trial was conducted in Bahawalpur, and Rawalpindi, Bahawalpur, Punjab, 062, Pakistan"
NCT02676713,Traditional Chinese Medicine Sequential Treatment for Endometriosis Associated Infertility,https://clinicaltrials.gov/study/NCT02676713,UNKNOWN,NO,Endometriosis|Infertility,DRUG: pre-ovulation Decoction|DRUG: post-ovulation Decoction|DRUG: pre-ovulation Decoction(placebo)|DRUG: post-ovulation Decoction(placebo),Guang'anmen Hospital of China Academy of Chinese Medical Sciences,"Peking Union Medical College Hospital|Beijing Hospital|Guangdong Provincial Hospital of Traditional Chinese Medicine|The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine|The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine",FEMALE,ADULT,204,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-12,2017-12,"The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, 230031, China|Beijing Obstetrics and Gynecology Hospital,Captial Medical University, Beijing, Beijing, 100026, China|GAMHospital, Beijing, Beijing, 100053, China|The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, 510405, China|Traditional Chinese Medicine Hospital of Guangdong Province, Guangzhou, Guangdong, China|Beijng Hospital, Beijng, 100730, China"
NCT06608017,Study of Yupingfeng Powder Treating Allergic Rhinitis (AR),https://clinicaltrials.gov/study/NCT06608017,NOT_YET_RECRUITING,NO,Allergic Rhinitis,DRUG: Chinese Herbal Medicine granules|OTHER: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",140,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-10-01,2025-10-31,
NCT06711263,Role of Herbal Based Mouthwashes in Plaque Control,https://clinicaltrials.gov/study/NCT06711263,NOT_YET_RECRUITING,NO,Plaque Induced Gingival Disease,OTHER: Mouthwash Product,Ajman University,,ALL,ADULT,80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING,2024-12-20,2025-03-20,
NCT00351806,AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine,https://clinicaltrials.gov/study/NCT00351806,COMPLETED,NO,Cerebral Infarction,DRUG: Erigeron breviscapus injection|DRUG: hua tuo zai zao wan (a herbal medicine pill)|DRUG: Compound stroke herbal medicine (8 herbal),Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",500,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT,2005-07,2006-11,"Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Beijing, Beijing, 100700, China|Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, 528000, China|2nd hospital of Zhongshan University, Guangzhou, Guangdong, 510120, China|Neurology Center, Guangdong Province Hospital of Tradtional Chinese Medicine, Guangzhou, Guangdong, 510120, China|Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong, China|Ruikang Hospital of Traditional Chinese Medicine, Nan Ning, Guangxi, 530011, China|1st Hospital of Guangxi college of Traditional Chinese Medicine, Nanning, Guangxi, 530023, China|The 1st Hospital of He'nan College of Traditional Chinese Medicine, Zhengzhou, Henan, 450006, China|The teahing hospital of Hubei College of Traditional Chinese Medicine, Wuhan, Hubei, 430006, China|Taizhou Hospital of Traditional Chinese Medicine, Taizhou, Jiangsu, China|Jinan Hospital of Traditional Chinese Medicine, Jinan, Shandong, China|Longhua Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China|Shanghai Hospital of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China|Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China|Yueyang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China|zhongshan hospital of Fudan Unversity, Shanghai, Shanghai, 200032, China|Huashan Hospital of Fudan Unveristy, Shanghai, Shanghai, 200040, China|The Hosptial of Shanxi College of Traditional Chinese Medicine, Xian yang, Shanxi, 712000, China|The People's Hospital of Sichuan Province, Chengdu, Sichuan, 610072, China|Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830001, China|Zhejiang Province Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China|The 2nd Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, China"
NCT04443738,Long Term Follow up of Spinal Stenosis Inpatients Treated With Korean Integrative Medicine Treatment.,https://clinicaltrials.gov/study/NCT04443738,COMPLETED,NO,"Spinal Stenosis Lumbar|Medicine, Korean Traditional",OTHER: phone survey,Jaseng Medical Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",378,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-06-12,2020-09-16,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT03018821,The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B,https://clinicaltrials.gov/study/NCT03018821,UNKNOWN,NO,Hepatitis B， Chronic,DRUG: Standard - Yinchengao Decoction plus Ganlu Detoxification Pill|DRUG: Entecavir or Tenofovir|DRUG: Standard - Ge Xia Zhu Yu Decoction|DRUG: Advanced - Supplemented Taohong Huazhuo Decoction|DRUG: Standard - Chaihu Shugan San|DRUG: Advanced - Soothe the liver and regulate qi Decoction|DRUG: Standard - Xiaoyao powder|DRUG: Advanced - Supplemented Ganbi Decoction|DRUG: Standard - Yiguan Decoction|DRUG: Advanced - Supplemented Zimu Dan|DRUG: Standard - Fuzilizhong Decoction plus Jinkui Shenqi Bolus|DRUG: Advanced - Guifu Erxian Decoction|DRUG: Advanced - Supplemented Ganji Decoction,Xi'an Traditional Medicine Hospital,,ALL,"ADULT, OLDER_ADULT",250,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2017-01,2017-12,"Xi'an Traditional Medicine Hospital, Xi'an, Shaanxi, China"
NCT02737735,The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation,https://clinicaltrials.gov/study/NCT02737735,UNKNOWN,NO,"Carcinoma, Non-Small-Cell Lung",DRUG: standard chemotherapy medicine combined with Chinese herbs|DRUG: standard chemotherapy medicine,"First Affiliated Hospital, Sun Yat-Sen University",,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-03,2020-01,"The First Affiliated Hospital of Sun-yat Sen University, GuangZhou, Guangdong, 510080, China"
NCT02215525,Treatment of Chronic HCV Infected Egyptian Patients With Electromagnetic Waves and Herbal Therapy,https://clinicaltrials.gov/study/NCT02215525,UNKNOWN,NO,Hepatitis C,DEVICE: UVA|DIETARY_SUPPLEMENT: Herbal,Egyptian Military Medical Services,EMS,ALL,ADULT,160,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2014-04,2015-05,"EMMS, Cairo, Heliopolis, 11613, Egypt"
NCT01898000,"""Triphala"" - A New Herbal Mouthwash in Gingivitis",https://clinicaltrials.gov/study/NCT01898000,COMPLETED,NO,Gingivitis,BEHAVIORAL: Triphala mouthwash|BEHAVIORAL: Chlorhexidine mouthwash,"Government Dental College and Research Institute, Bangalore",,ALL,ADULT,90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-01,2013-04,
NCT04388644,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,https://clinicaltrials.gov/study/NCT04388644,UNKNOWN,NO,Corona Virus Infection,,Taipei City Hospital,National Yang Ming Chiao Tung University,ALL,"ADULT, OLDER_ADULT",300,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-02-20,2020-05-30,"Branch of Chinese Medicine, Taipei City Hospital, Taipei, 886, Taiwan|Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital, Taipei, 886, Taiwan|Taipei City Hospital, Taipei, 886, Taiwan"
NCT05047809,"The Effect of ""Jinchuang Ointment"" (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.",https://clinicaltrials.gov/study/NCT05047809,COMPLETED,NO,Leprosy|Hansen's Disease|Wounds,"OTHER: ""Jingchuang Ointment""(JCO)|OTHER: Regular Treatment",Lo-Sheng Sanatorium,,ALL,"ADULT, OLDER_ADULT",20,OTHER_GOV,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-08-07,2022-05-05,"Lo-Sheng Sanatorium, Taoyuan City, 33351, Taiwan"
NCT01183624,A Controlled Study of an Herbal Topical Patch in Treating Osteoarthritis (OA) of the Knee,https://clinicaltrials.gov/study/NCT01183624,COMPLETED,NO,"Osteoarthritis, Knee",OTHER: Herbal Patch|OTHER: Placebo Patch,Johnson & Johnson Consumer and Personal Products Worldwide,,ALL,"ADULT, OLDER_ADULT",626,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-07,2011-04,"Luoyang Orthopedic & Traumatologic Hospital of Henan Province, Luoyang, Hubei, China|Union Hospital affiliated to Tong Ji Medical College, Wu Han, Hubei, China|Xiangya Hospital Central-South University, Changsha City, Hunan, 410008, China|Jiang Su Province Hospital of TCM Hospital, Nanjing, Jiangsu, China|Su Zhou Chinese Medicine Hospital, Suzhou, Jiangsu, 215003, China|Wu Xi Chinese Medical Hospital, Wuxi, Jiangsu, China|Affiliated Hospital of Shan Xi TCM College, Xianyang, Shaanxi, China|Shanghai Chinese Medical Hospital, Shanghai, Shanghai, China|Shanghai Rui Jin Hospital, Shanghai, Shanghai, China|Shan Xi Provincial People's Hospital, Xi'an, Shanxi, China|Affiliated Hospital of Chengdu University of TCM, Chengdu, Sichuan, China|1st Affiliated Hospital of Tian Jin TCM College, TianJin, Tianjin, China"
NCT01410058,Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction,https://clinicaltrials.gov/study/NCT01410058,COMPLETED,YES,HIV,DIETARY_SUPPLEMENT: Moringa oleifera|DRUG: Efavirenz 600mg|DRUG: Nevirapine 200Mg Oral Tablet,University of Zimbabwe,State University of New York at Buffalo|Biomedical Research and Training Institute,ALL,"ADULT, OLDER_ADULT",19,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-01,2013-09,"Parirenyatwa Hospital OI Clinic, Harare, Zimbabwe"
NCT05982223,Integrative Medicine in Lymphoma Survivors,https://clinicaltrials.gov/study/NCT05982223,RECRUITING,NO,Lymphoma,PROCEDURE: Acupuncture|PROCEDURE: Mind-body therapy|PROCEDURE: Touch therapy|PROCEDURE: Movement therapy|DIETARY_SUPPLEMENT: Herbal supplements|BEHAVIORAL: Emotional treatment,Bnai Zion Medical Center,,ALL,"ADULT, OLDER_ADULT",90,OTHER_GOV,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2023-07-13,2028-07,"Bnai Zion Medical Center, Haifa, 3339419, Israel"
NCT02345447,Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence,https://clinicaltrials.gov/study/NCT02345447,COMPLETED,NO,Acute Otitis Media,DRUG: Herbal-based medication|DRUG: Placebo,University Hospital Tuebingen,,ALL,CHILD,296,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2013-10,2017-10,"University Children's Hospital Tuebingen, Tuebingen, 72076, Germany"
NCT00201578,Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency Department,https://clinicaltrials.gov/study/NCT00201578,UNKNOWN,NO,Acute Hepatitis,,National Taiwan University Hospital,,ALL,"ADULT, OLDER_ADULT",,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,,,"National Taiwan University Hospital, Taipei, 100, Taiwan"
NCT01017432,Compliance Of Medication After Discharge From the Hospital in the Elderly,https://clinicaltrials.gov/study/NCT01017432,COMPLETED,NO,Compliance of Medications|Factors That May Affect Compliance,,William Beaumont Hospitals,,ALL,OLDER_ADULT,200,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-12,2011-01,"William Beaumont Hospital, Royal Oak, Michigan, 48073, United States|William Beaumont Hospital, Troy, Michigan, 48314, United States"
NCT06538753,Silver Leaf During Pregnancy in French Guiana : Use and Impact on Health,https://clinicaltrials.gov/study/NCT06538753,COMPLETED,NO,Pregnancy Complications|Herbal Medicine Adverse Reaction,,Centre Hospitalier de Cayenne,,FEMALE,"CHILD, ADULT, OLDER_ADULT",332,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-03-21,2023-07-07,"Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana"
NCT04296500,A Development of Inflammatory Bowel Disease Pattern Identification Algorithm Using Case Series Data,https://clinicaltrials.gov/study/NCT04296500,COMPLETED,NO,Inflammatory Bowel Diseases,OTHER: Decision tree modeling,"Hyangsook Lee, KMD, PhD",,ALL,"CHILD, ADULT, OLDER_ADULT",67,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2007-11-01,2015-10-28,"Acupuncture & Meridian Science Research Centre, Seoul, 02447, Korea, Republic of"
NCT03054974,TCM Clinical Practice Rehabilitation of Post-stroke Spasticity,https://clinicaltrials.gov/study/NCT03054974,UNKNOWN,NO,Stroke,OTHER: Modern rehabilitation treatment|OTHER: Modern rehabilitation &TCM|OTHER: modern rehabilitation &Baimai Ruangao|OTHER: modern rehabilitation &Tibetan medicine,The First Affiliated Hospital with Nanjing Medical University,,ALL,"ADULT, OLDER_ADULT",1208,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-01,2018-12,"Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China"
NCT00002149,Acupuncture and Herbal Treatment of Chronic HIV Sinusitis,https://clinicaltrials.gov/study/NCT00002149,COMPLETED,NO,HIV Infections|Sinusitis,DRUG: Clavulanate potassium|DRUG: Pseudoephedrine hydrochloride|DRUG: Amoxicillin trihydrate,Immune Enhancement Project,,ALL,ADULT,40,OTHER,INTERVENTIONAL,Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT,,,"Immune Enhancement Project, San Francisco, California, 94114, United States"
NCT03959098,Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation,https://clinicaltrials.gov/study/NCT03959098,ACTIVE_NOT_RECRUITING,NO,Neck Pain|Cervical Radiculopathy|Intervertebral Disc Displacement,DRUG: Herbal medicine|PROCEDURE: Chuna manual medicine|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|PROCEDURE: Other intervention(s),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",120,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-06-24,2027-12-01,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT01147835,Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers,https://clinicaltrials.gov/study/NCT01147835,TERMINATED,NO,Asthma|Dental Caries,DIETARY_SUPPLEMENT: Chinese Licorice Root,University of Nebraska,,ALL,CHILD,39,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2009-09-23,2011-09-27,"University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States"
NCT00676975,The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome,https://clinicaltrials.gov/study/NCT00676975,COMPLETED,NO,Irritable Bowel Syndrome,DRUG: Traditional Chinese Medicine|DRUG: Traditional Chinese Medicine Placebo,Chinese University of Hong Kong,University of Maryland|National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",104,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-05-26,2011-08-30,"Li Ka Shing Specialist Clinic, Prince of Wales Hospital, Hong Kong (SAR), 852, China"
NCT04170504,Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis,https://clinicaltrials.gov/study/NCT04170504,COMPLETED,NO,Rheumatoid Arthritis,DRUG: Qing Re Huo Xue (QRHX) granule|DRUG: Methotrexate|DRUG: Qing Re Huo Xue (QRHX) granule placebo,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",204,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-11-14,2022-06-28,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China"
NCT05363956,Antiplaque Efficacy of Two Novel Commercially Available Herbal Toothpastes.,https://clinicaltrials.gov/study/NCT05363956,COMPLETED,NO,"Gingivitis|Plaque, Dental",DRUG: salvadora|DRUG: Eucalyptus Oil,Ajman University,,ALL,ADULT,30,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: DIAGNOSTIC,2021-09-01,2021-12-20,"Ajman University, Ajman, 009716, United Arab Emirates"
NCT05846451,Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints,https://clinicaltrials.gov/study/NCT05846451,RECRUITING,NO,Herbal Interaction,DIETARY_SUPPLEMENT: Kratom|DRUG: Oxycodone,Washington State University,National Center for Complementary and Integrative Health (NCCIH),ALL,ADULT,16,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2023-06-01,2025-05-01,"Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane, Washington, 99202, United States"
NCT02618148,Hormone Estradiol Replacement Therapy Additional Herbals,https://clinicaltrials.gov/study/NCT02618148,COMPLETED,NO,Menopause,DRUG: ESTROGEN HERBALS 21|DRUG: ESTROGEN HERBALS 28,"Trieu, Nguyen Thi, M.D.",,FEMALE,"ADULT, OLDER_ADULT",60,INDIV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: HEALTH_SERVICES_RESEARCH,2009-01,2015-06,"Saigon Biopharma Company Limited, Ho Chi Minh City, 700000, Vietnam"
NCT04046393,Investigating the Effect of Herbal Medicine Nasal Irrigation on Treatment of Chronic Rhinitis and Sinusitis,https://clinicaltrials.gov/study/NCT04046393,UNKNOWN,NO,Nasal Disease,"DEVICE: Taiwan Scientific"" noninvasive blood pressure meter TS-0411|DEVICE: Meridian Energy Analysis Device(MEAD)|PROCEDURE: bacteria culture|PROCEDURE: nasopharyngoscopic examination|COMBINATION_PRODUCT: TCM nasal irrigation",Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",250,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-12-31,2022-02-14,"Chang Gung Memorial Hospital, Chiayi City, Taiwan"
NCT03450902,Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence,https://clinicaltrials.gov/study/NCT03450902,COMPLETED,NO,Urinary Incontinence,COMBINATION_PRODUCT: Chinese herb & acupuncture|COMBINATION_PRODUCT: Chinese herb & sham acupuncture|COMBINATION_PRODUCT: Placebo & acupuncture|OTHER: Placebo & sham acupuncture,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,FEMALE,"ADULT, OLDER_ADULT",136,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-03-14,2021-04-18,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT02982603,Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment,https://clinicaltrials.gov/study/NCT02982603,COMPLETED,NO,Mild Cognitive Impairment|Herbal Medicine Allergy,DRUG: Qinggongshoutao Bolus|DRUG: Ginkgo Biloba Extract 761|DRUG: Placebos,"Dongzhimen Hospital, Beijing",,ALL,"ADULT, OLDER_ADULT",350,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-05,2017-12,"Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT01145664,A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease,https://clinicaltrials.gov/study/NCT01145664,UNKNOWN,NO,"Hand, Foot and Mouth Disease",DRUG: Herbal concentrate-granules plus western therapy|DRUG: Reduning Injection plus western therapy|DRUG: Western therapy,Beijing YouAn Hospital,State Administration of Traditional Chinese Medicine of the People's Republic of China|China Academy of Chinese Medical Sciences|Beijing University of Chinese Medicine,ALL,CHILD,390,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2010-05,,"Guangzhou Women and Children Hospital, Guangzhou, Guangdong, China|The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China|Kaifeng Municipal Children's Hospital, Kaifeng, Henan, China|Hunan Provincial Children's Hospital, Changsha, Hunan, China|Anhui Provincial Children's Hospital, Anhui, China|Beijing YouAn Hospital，Capital Medical University, Beijing, China"
NCT03716518,Herbal Treatment to Improve Chemotherapy Delivery,https://clinicaltrials.gov/study/NCT03716518,UNKNOWN,NO,Colon Cancer,DRUG: Tonifying Spleen and Kidney Sequential Regimen|DRUG: Placebo of 'Tonifying Spleen and Kidney Sequential Regimen,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing University of Chinese Medicine|Peking University Third Hospital|Beijing Chao Yang Hospital|Jiangsu Province Hospital of Traditional Chinese Medicine|Shanghai Zhongshan Hospital|Guangdong Provincial Hospital of Traditional Chinese Medicine|Tianjin Union Medical Center|Henan Provincial People's Hospital|Zhengzhou Hospital of Traditional Chinese Medicine|Peking University Cancer Hospital & Institute|Chongqing University Cancer Hospital|Civil Aviation General Hospital,ALL,"ADULT, OLDER_ADULT",400,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-12-12,2021-05-31,"Beijing Chao Yang Hospital, Beijing, Beijing, 100020, China|Civil Aviation General Hospital, Beijing, Beijing, 100025, China|Oncology Department of Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, 100091, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Chongqing University Cancer Hospital, Chongqing, Chongqing, 400030, China|Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong, Guangzhou, 510120, China|The Third People's Hospital of Zhengzhou, Zhengzhou, Henan, 450000, China|Henan Provincial People's Hospital, Zhengzhou, Henan, 450003, China|Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, 450007, China|Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, 210029, China|Shanghai Zhongshan Hospital, Shanghai, Shanghai, 200032, China|Tianjin Union Medical Center, Tianjin, Tianjin, 300121, China"
NCT06601608,Efficacy of Locally Delivered Rosemary Extract Gel in Management of Periodontitis,https://clinicaltrials.gov/study/NCT06601608,NOT_YET_RECRUITING,NO,Periodontitis (stage 3)|Periodontal Pocket,DRUG: Herbal therapy|DRUG: Placebo Drug,Ain Shams University,,ALL,ADULT,16,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-10,2025-06,"Faculty of Dentistry - Ain Shams University, Cairo, 02, Egypt"
NCT00729014,A Study of Drug-Induced Kidney Disease,https://clinicaltrials.gov/study/NCT00729014,UNKNOWN,NO,End Stage Renal Disease,,National Taiwan University Hospital,"Department of Health, Executive Yuan, R.O.C. (Taiwan)",ALL,"CHILD, ADULT, OLDER_ADULT",2000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-05,,"National Taiwan University Hospital, Taipei, 100, Taiwan"
NCT01745328,Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine,https://clinicaltrials.gov/study/NCT01745328,UNKNOWN,NO,Recurrent Urinary Tract Infection,DRUG: LVX-AMX|DRUG: TCM|DRUG: LVX-AMX,Beijing Institute of Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2009-01,2013-07,"Wangjing Hospital, Beijing, Beijing, 100020, China"
NCT06703788,Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome,https://clinicaltrials.gov/study/NCT06703788,RECRUITING,NO,Obesity|Metabolic Syndrome|Dyslipidemias|Diabetes Mellitus,DRUG: A fiixed combination of Chinese herbal medicine|DEVICE: Laser acupuncture,Chang Gung Memorial Hospital,"Ministry of Health and Welfare, Taiwan",ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-11-20,2025-12,"Chang Gung Memorial Hospital, Taoyuan and Linkou branches, Taoyuan, 330, Taiwan"
NCT02194946,Chinese Medicine on Deferring Dialysis Initiation,https://clinicaltrials.gov/study/NCT02194946,UNKNOWN,NO,End-Stage Renal Disease,DRUG: CM therapies|DRUG: CKD-related management,Guangdong Provincial Hospital of Traditional Chinese Medicine,Ministry of Science and Technology of the People´s Republic of China,ALL,"ADULT, OLDER_ADULT",875,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-07,2020-12,"Anhui Provincial Hospital of Chinese Medicine, Hefei, Anhui, 230000, China|China PLA General Hospital, Beijing, Beijing, 100000, China|China-Japan Friendship Hospital, Beijing, Beijing, 100000, China|Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, Beijing, 100000, China|First Hospital of Peking University, Beijing, Beijing, 100000, China|Guang'anmen Hospital China Academy of traditional Chinese Medicine, Beijing, Beijing, 100000, China|Xiyuan Hospital, Academy of traditional Chinese Medicine, Beijing, Beijing, 100000, China|Third Military Medical University Xinqiao Hospital, Chongqing, Chongqing, 400037, China|General hospital of Guangzhou Military command of PLA, Guangzhou, Guangdong, 510000, China|Guangzhou No.1 People's Hospital, Guangzhou, Guangdong, 510000, China|Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, 510000, China|TCM Integrated Hospital of Southern Medical University, Guangzhou, Guangdong, 510000, China|Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China|Liuzhou Hospital of traditional Chinese Medicine, Liuzhou, Guangxi, 545000, China|First Affiliated Hospital of Guangxi University Of Chinese Medicine, Nanning, Guangxi, 530000, China|First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, 550000, China|First Affiliated Hospital of Heilongjiang University Of Chinese Medicine, Ha'erbin, Heilongjiang, 150000, China|Heilongjiang Academy of Traditional Chinese Medicine, Ha'erbin, Heilongjiang, 150000, China|Hubei Provincial Hospital of Chinese Medicine, Wuhan, Hubei, 430000, China|Jiangsu Provincial Hospital of Chinese Medicine, Nanjing, Jiangsu, 210000, China|Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710000, China|Xijing Hospital of The Fourth Military Medical University, Xi'an, Shaanxi, 710000, China|Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China|The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, Shanghai, 200000, China|First hospital of Shanxi Medical University, Taiyuan, Shanxi, 030000, China|Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610000, China|First Affiliated Hospital of Tianjin University Of Chinese Medicine, Tianjin, Tianjin, 300000, China|Hangzhou Hospital of Chinese Medicine, Hangzhou, Zhejiang, 310000, China|Tong De Hospital, Zhejiang Province, Hangzhou, Zhejiang, 310000, China"
NCT02153840,Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis,https://clinicaltrials.gov/study/NCT02153840,TERMINATED,NO,Plaque Psoriasis,DRUG: PSORI-CM01（YXBCM01） granule|DRUG: placebo,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",35,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-12,2015-10,"Chronic Disease Prevention and Control Station of Panyu District in Guangzhou, Guangzhou, Guangdong, China|Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China|The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, China"
NCT00887172,Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs),https://clinicaltrials.gov/study/NCT00887172,COMPLETED,NO,Acute Upper Respiratory Tract Infections,DRUG: Jing Fang Bai Du san|DRUG: Placebo|DRUG: Ying Qiao san,The University of Hong Kong,"The Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, the Government of the Hong Kong SAR",ALL,"ADULT, OLDER_ADULT",327,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2005-06,2007-06,"Two General Outpatient Clinics, Hong Kong, Hong Kong, China"
NCT01047605,Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers,https://clinicaltrials.gov/study/NCT01047605,COMPLETED,NO,Healthy,DRUG: Neurapas balance|DRUG: Pascoflair 425 mg|DRUG: P-Tabletten weiß,Pascoe Pharmazeutische Praeparate GmbH,,ALL,"ADULT, OLDER_ADULT",16,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2010-01,2010-03,"Neurocode AG, Wetzlar, D-35578, Germany"
NCT05477472,Low Dose St John's Wort for Depression,https://clinicaltrials.gov/study/NCT05477472,COMPLETED,NO,Major Depression,DRUG: St John's Wort,Ceres Heilmittel AG,University of Zurich,ALL,"CHILD, ADULT, OLDER_ADULT",55,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2005-08,2007-01,"CERES Heilmittel AG, Kesswil, Thurgau, 8593, Switzerland"
NCT03756324,The Effect of Chinese Herbal Medicine for Reducing the Application of Antibiotics in the Treatment of Acute Mastitis,https://clinicaltrials.gov/study/NCT03756324,UNKNOWN,NO,Mastitis Acute Female,DRUG: CHPM (Chinese Herbal Patent Medicine )|DRUG: Antibiotics Cefdinir Capsules|BEHAVIORAL: Education|DRUG: Antibiotics Cefdinir Capsules,Beijing University of Chinese Medicine,Beijing Hospital of Traditional Chinese Medicine,FEMALE,"ADULT, OLDER_ADULT",306,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2018-12-20,2021-03-31,"Beijing Hospital of Traditional Chinese Medicine, Beijing, China|Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China|Tongzhou Maternal & Child Health Hospital of Beijing, Beijing, China"
NCT06492083,A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package,https://clinicaltrials.gov/study/NCT06492083,NOT_YET_RECRUITING,NO,Chemotherapy,OTHER: traditional Chinese medicine hot bag,The Fourth Affiliated Hospital of Zhejiang University School of Medicine,,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: OTHER",2024-10-30,2025-10-30,
NCT06419764,Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery,https://clinicaltrials.gov/study/NCT06419764,RECRUITING,NO,Traditional Chinese Medicine Treatment|Weight Change,DRUG: Spleen Invigorating and Weight Reducing Decoction|OTHER: Diet and meal replacements,China-Japan Friendship Hospital,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-02-01,2025-07,"China-Japan Friendship Hospital, Beijing, China"
NCT01059487,Bringing Acute and Wellness Care to Underserved Populations Using Traditional Chinese Medicine,https://clinicaltrials.gov/study/NCT01059487,UNKNOWN,NO,Pain Management|Traditional Chinese Medicine,OTHER: Traditional Chinese Medicine,Chicago College of Oriental Medicine,Agency for Healthcare Research and Quality (AHRQ)|QualityMetrics|Inspire Tech Group,ALL,"ADULT, OLDER_ADULT",,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-09,2012-08,"Chicago College of Oriental Medicine, Inc. dba Chicago College of Asian Medicine, Chicago, Illinois, 60656, United States"
NCT00456755,Herbal Treatment for Perennial Allergic Rhinitis,https://clinicaltrials.gov/study/NCT00456755,COMPLETED,YES,Perennial Allergic Rhinitis,DRUG: Shi-Bi-Lin|OTHER: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",126,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2004-03,2006-04,"Department of ENT, Prince of Wales Hospital, Hong Kong, Hong Kong|Department of ENT, Yan Chai Hospital, Hong Kong, Hong Kong"
NCT04661709,Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris,https://clinicaltrials.gov/study/NCT04661709,UNKNOWN,NO,Coronary Heart Disease|Unstable Angina|Chinese Herbal Medicine,DRUG: Wen Xin granule|DRUG: Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet|DRUG: Atorvastatin Calcium|DRUG: Isosorbide Mononitrate Tab 20 MG|DRUG: Metoprolol Tartrate Tab 25 MG|DRUG: Aspirin Enteric-coated Tablets|DRUG: WXG placebo|DRUG: Trimetazidine Dihydrochloride Tablets|DRUG: glyceryl trinitrate,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,Special Project of National Traditional Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine|National Natural Science Foundation of China,ALL,"ADULT, OLDER_ADULT",502,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-03-01,2023-06-01,
NCT00799734,Chinese Medicine Therapy on Menopausal Symptoms,https://clinicaltrials.gov/study/NCT00799734,COMPLETED,NO,Menopause,DRUG: EXD,The University of Hong Kong,,FEMALE,ADULT,108,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-04,2011-06,"Department of Obstetrics and Gynecology, the University of Hong Kong, Hong Kong, Hksar, China|Chinese Medicine Clinic cum Training and Research Centers of the University of Hong Kong, Hong Kong, Hong Kong, China"
NCT05341206,"Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.",https://clinicaltrials.gov/study/NCT05341206,NOT_YET_RECRUITING,NO,Head and Neck Neoplasms|Chemoradiotherapy|Stomatitis and Ulceration,DRUG: Herbal gargle|OTHER: Normal saline,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-04-15,2025-12-31,"Keelung Chang Gung Memorial Hospital, Keelung, Keelung, Taiwan, 20401, Taiwan"
NCT04417101,Chinese Herbal Medicine for Dialysis-related Myofascial Pain: Study Protocol for A Pilot Randomized Study,https://clinicaltrials.gov/study/NCT04417101,UNKNOWN,NO,Myofascial Pain Syndrome,DRUG: Chinese Herb,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2020-07-01,2021-06-30,
NCT01274936,Qishe Pill for Cervical Radiculopathy,https://clinicaltrials.gov/study/NCT01274936,UNKNOWN,NO,Cervical Radiculopathy,DRUG: Qishe Pill|DRUG: Qishe Placebo,Shanghai University of Traditional Chinese Medicine,Fudan University|Changchun University of Chinese Medicine|Lanzhou Hospital of Traditional Chinese Medicine|Suzhou Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",240,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-03,2015-06,"No.1 Hospital, Changchun University of TCM, Changchun, China|Gansu Hospital of TCM, Lanzhou, China|Huadong Hospital, Shanghai, 200032, China|Longhua Hospital, Shanghai, 200032, China|Suzhou Hospital of TCM, Suzhou, China"
NCT05130138,"Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia",https://clinicaltrials.gov/study/NCT05130138,RECRUITING,NO,Chronic Myeloid Leukemia,OTHER: Pharmaceutical intervention,Centre Hospitalier Universitaire de Saint Etienne,Institut de Cancérologie de la Loire,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2022-01-27,2025-11-01,"CHU de Saint-Etienne, Saint-Étienne, 42055, France"
NCT01342718,Effect of Herbal Extract Granules Combined With Probiotics on Irritable Bowel Syndrome With Diarrhea,https://clinicaltrials.gov/study/NCT01342718,COMPLETED,NO,Irritable Bowel Syndrome,DIETARY_SUPPLEMENT: Herbal extract granule and probiotics|DIETARY_SUPPLEMENT: Herbal extract granule and placebo probiotics|DIETARY_SUPPLEMENT: Placebo herbal extract granule and probiotics|DIETARY_SUPPLEMENT: Placebo herbal extract granule and placebo probiotics,Kyunghee University Medical Center,,ALL,"ADULT, OLDER_ADULT",48,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-04,2012-04,"Kyung Hee University Hospital at Gangdong, Seoul, Gangdong-gu, 130-701, Korea, Republic of"
NCT04493476,Using a Herbal Remedy Extract for the Treatment of Endometriosis Symptoms,https://clinicaltrials.gov/study/NCT04493476,UNKNOWN,NO,Endometriosis,DRUG: Chinese herbal formula,Carmel Medical Center,,FEMALE,ADULT,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-10-01,2022-12-01,
NCT01389362,The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01389362,COMPLETED,NO,Diabetic Foot Ulcer,DRUG: Chinese herbal medicine (Radix Rehmanniae and Radix Astragali)|DRUG: Placebo comparator,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",16,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-05,2011-05,"Diabetes and Endocrine Centre, Hong Kong SAR, Hong Kong SAR, China"
NCT04438564,Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients,https://clinicaltrials.gov/study/NCT04438564,UNKNOWN,NO,Breast Cancer|Colorectal Cancer|Cancer of Ovary|Cancer of Endometrium,"OTHER: Cases for patients diagnosed with breast cancer, colonrectal cancer, ovarian cancer and endometrial cancer",China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",300,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2020-05-18,2023-07-31,"China Medical University Hospital, Taichung, Taiwan"
NCT00894491,Complementary and Alternative Medical Trends: A Patient Survey in a University Based Clinic,https://clinicaltrials.gov/study/NCT00894491,WITHDRAWN,NO,Complementary and Alternative Therapies,,"University of California, Irvine",,ALL,"ADULT, OLDER_ADULT",0,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-05,2006-05,"UCI Samueli Center Clinic, Newport Beach, California, 926660, United States"
NCT03323697,Chinese Herb for the Treatment of Depression and Anxiety Disorders,https://clinicaltrials.gov/study/NCT03323697,UNKNOWN,NO,"Depression, Anxiety",OTHER: SZ-05|DRUG: Escitalopram Pill,Mazra Mental Health Center,The Academic College of Tel-Aviv Yaffo,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-08-28,2018-12-30,"Mazor MHC, Akko, 25201, Israel"
NCT02841163,Disc Resorption in Lumbar and Cervical Disc Herniation Patients Receiving Integrative Korean Medicine Treatment,https://clinicaltrials.gov/study/NCT02841163,COMPLETED,NO,Lumbar Intervertebral Disc Displacement|Cervical Intervertebral Disc Displacement,DRUG: Herbal medicine|PROCEDURE: Acupuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Chuna manipulation,Jaseng Medical Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",505,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-04,2017-01,"Jaseng Medical Foundation, Bucheon, Gyeonggi Province, 14598, Korea, Republic of"
NCT04557553,Effects of Lagenbone on Bone Mineral Density,https://clinicaltrials.gov/study/NCT04557553,COMPLETED,NO,Osteoporosis,DIETARY_SUPPLEMENT: Lagenbone,Southern California University of Health Sciences,"Sun Ten Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",10,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-07-15,2022-07-13,"Southern California University of Health Sciences, Whittier, California, 90604, United States"
NCT06335602,TCM for Post-operative Edema,https://clinicaltrials.gov/study/NCT06335602,NOT_YET_RECRUITING,NO,Anterior Cruciate Ligament Injuries,DEVICE: LASER acupuncture,Chang Gung Memorial Hospital,,MALE,ADULT,120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-03-30,2025-12-31,
NCT01224496,"Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders",https://clinicaltrials.gov/study/NCT01224496,COMPLETED,NO,Myelodysplastic Syndrome (MDS)|Aplastic Anaemia (AA)|Myelofibrosis (MF)|Thalassemia Intermedia,DRUG: Chinese herbal concoction twice a day for 6 months,Singapore General Hospital,Shanghai Yueyang Integrated Medicine Hospital|Singapore Bao Zhong Tang TCM Center,ALL,"CHILD, ADULT, OLDER_ADULT",38,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2009-07,2011-08,"Singapore General Hospital, Singapore, 169608, Singapore"
NCT04855058,Long Term Follow-Up of Traumatic Fracture Patients Treated With Integrated Complementary and Alternative Medicine: Observational Study,https://clinicaltrials.gov/study/NCT04855058,COMPLETED,NO,"Fractures, Bone|Medicine, Korean Traditional",OTHER: online survey(or phone survey),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",665,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-03-29,2021-12-31,"Jaseng Medical Foundation, Seoul-si, Korea, Republic of"
NCT01895816,Herbal Tonic Fertile Supplement(ZO2C5),https://clinicaltrials.gov/study/NCT01895816,COMPLETED,NO,Male Infertility,DIETARY_SUPPLEMENT: coated tablet,Arash Khaki,Islamic Azad University of Tabriz|Tabriz University,MALE,ADULT,1,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE,2012-06,2012-06,"Womens Reproductive Health Research Center,Tabriz University Of Medical Sciences,Iran, Tabriz, Azarbyjan, 51388, Iran, Islamic Republic of"
NCT05398965,Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19),https://clinicaltrials.gov/study/NCT05398965,COMPLETED,NO,COVID-19,DRUG: Eucalyptus Oil|DRUG: Standard COVID medication,Hasanuddin University,"Ministry of Agriculture, Republic of Indonesia",ALL,ADULT,54,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-11-18,2022-03-01,"Hasanuddin University Hospital, Makassar, South Sulawesi, 90245, Indonesia"
NCT02545036,Combined Western and Traditional Chinese Medicine Daycare for CKD Patients,https://clinicaltrials.gov/study/NCT02545036,COMPLETED,NO,Chronic Kidney Disease,OTHER: Traditional Chinese Medicine (TCM) daycare model,China Medical University Hospital,"Ministry of Health and Welfare, Taiwan",ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-06,2017-09-20,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT03990935,Remineralization Potential of Ginger and Rosemary Herbals Versus Sodium Fluoride in Treatment of White Spot Lesions,https://clinicaltrials.gov/study/NCT03990935,UNKNOWN,NO,White Spot Lesions,OTHER: ginger and rosemary gel,Cairo University,,ALL,"CHILD, ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-07,2020-06,"Cairo University, Cairo, Egypt"
NCT03147443,Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials,https://clinicaltrials.gov/study/NCT03147443,UNKNOWN,NO,Bronchiectasis|Quality of Life|Traditional Chinese Medicine|Sputum|Symptoms|Individuality,DRUG: Individualized Decoction|DRUG: placebo|DRUG: Tested drug minus heat-clearing herbs,Shanghai University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",36,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-03-01,2019-12-31,"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China"
NCT00175110,The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure,https://clinicaltrials.gov/study/NCT00175110,COMPLETED,NO,Hypertension,BEHAVIORAL: herbal therapy/botanical therapy (Hibiscus sabdariffa),Tufts University,Celestial Seasonings|Tufts Medical Center,ALL,"ADULT, OLDER_ADULT",66,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",,2007-12,"Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, 02111, United States"
NCT06336993,Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP,https://clinicaltrials.gov/study/NCT06336993,COMPLETED,NO,Low Back Pain,DRUG: herbal compound|DRUG: Celecoxib,Zhejiang Provincial Tongde Hospital,,ALL,"ADULT, OLDER_ADULT",71,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-01-01,2023-12-15,"Tongde Hospital, Hangzhou, Zhejiang, 310000, China"
NCT01486186,Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease,https://clinicaltrials.gov/study/NCT01486186,UNKNOWN,NO,"Pulmonary Disease, Chronic Obstructive",DRUG: Traditional Chinese Medicine|DRUG: placebo chinese medicine,Henan University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",504,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-12,2014-12,
NCT01997814,Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis,https://clinicaltrials.gov/study/NCT01997814,COMPLETED,NO,Chronic Periodontitis,DRUG: herbal immunomodulator|DRUG: Placebo,Tatyasaheb Kore Dental College,,ALL,ADULT,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-03,2013-10,"Tatyasaheb Kore Dental College and Research Centre, New Pargaon, Kolhapur, Maharashtra, 416137, India"
NCT02642250,Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea,https://clinicaltrials.gov/study/NCT02642250,COMPLETED,NO,Chronic Diarrhea,DRUG: Metronidazole|DRUG: Entoban,Shifa Ul Mulk Memorial Hospital,,ALL,ADULT,70,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-01,2015-12,"Shifa Ul MUlk Memorial Hospital, Karachi, Pakistan"
NCT01613183,Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia,https://clinicaltrials.gov/study/NCT01613183,UNKNOWN,NO,Primary Insomnia,DRUG: Chinese herbal Medicine|OTHER: the dummy of a Chinese Medicine prescription,China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",2,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-05,,"Guang'anmen hospital, China Academy of Chinese Medical Sciences, Beijing, 100700, China"
NCT05458687,Traditional Chinese Medicine for Complications in Critically Ill Patients,https://clinicaltrials.gov/study/NCT05458687,UNKNOWN,NO,Critically Ill Patients,OTHER: Chinese herbal medicine decoction、Acupuncture or Laser acupuncture pen treatment、Acupoint Tuina massage、Acupoint application、Nursing/Diet and health education and guidance,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-06-21,2023-06-20,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT05420987,Effect of Jing Si Herbal Tea on Inflammation in Patients With Cardiovascular Disease,https://clinicaltrials.gov/study/NCT05420987,UNKNOWN,NO,Inflammatory Response|Gut Microbiome|Life Quality|Trimethylamine N-oxide|Cardiovascular Diseases|Herbal Medicine,DIETARY_SUPPLEMENT: Jing Si herbal tea liquid packet,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2022-06,2024-12,
NCT06807515,Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission,https://clinicaltrials.gov/study/NCT06807515,NOT_YET_RECRUITING,NO,Cancer|Cancer Survivor,,Thong Chai Institute of Medical Research,,ALL,"ADULT, OLDER_ADULT",24,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2025-02-10,2027-08-09,
NCT02975011,Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica,https://clinicaltrials.gov/study/NCT02975011,TERMINATED,NO,Lumbar Spinal Stenosis,DRUG: Herbal medicine|PROCEDURE: Chuna manipulation|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|OTHER: Other intervention(s),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",38,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-03-04,2018-11-02,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT02442960,Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis,https://clinicaltrials.gov/study/NCT02442960,COMPLETED,NO,Ulcerative Colitis,DRUG: Herbal treatment (SA100),Stanford University,,ALL,"CHILD, ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-12,2017-07-26,"Stanford University, Palo Alto, California, 94306, United States"
NCT02879006,"E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy",https://clinicaltrials.gov/study/NCT02879006,UNKNOWN,NO,Food Allergy,DRUG: Chinese Herbal Medication|DRUG: Placebo|DRUG: Omalizumab|DRUG: Multi OIT,Xiu-Min Li,,ALL,"CHILD, ADULT",33,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-08,2020-11,"Johns Hopkins University, Baltimore, Maryland, 21287, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT02032251,Reduction of Sperm DNA Fragmentation by Oral Ginger,https://clinicaltrials.gov/study/NCT02032251,COMPLETED,NO,Infertility,DRUG: oral administration of ginger|DRUG: Placebo,Royan Institute,,MALE,ADULT,71,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2009-12,2010-11,"Royan Institute, Tehran, Iran, Islamic Republic of"
NCT00329212,The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans,https://clinicaltrials.gov/study/NCT00329212,COMPLETED,NO,Healthy,DRUG: San Huang Xie Jin Tang,Committee on Chinese Medicine and Pharmacy,,ALL,ADULT,,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,,,"Committee on Chinese Medicine and Pharmacy, Department of Health, Taipei, Taiwan, China"
NCT00817024,Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD),https://clinicaltrials.gov/study/NCT00817024,COMPLETED,NO,Coronary Heart Disease,"DRUG: Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules,|DRUG: Sheng Mai Capsules Plus Placebo of Xuefu Zhuyu Capsules|DRUG: Placebo of Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules",Guang'anmen Hospital of China Academy of Chinese Medical Sciences,Beijing Anzhen Hospital,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-03,2009-03,"Guang'an Men Hospital, Beijing, 100053, China"
NCT05459493,A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve,https://clinicaltrials.gov/study/NCT05459493,UNKNOWN,NO,Diminished Ovarian Reserve,DRUG: TJAOA101,Tongji Hospital,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-11-01,2023-11-01,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"
NCT05499312,An Innovative Chinese Herbal Formula for the Treatment of Gout,https://clinicaltrials.gov/study/NCT05499312,UNKNOWN,NO,Gout,DRUG: HKIIM-KU formula|DRUG: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-10-11,2025-02,"The Chinese University of Hong Kong, Sha Tin, Hong Kong"
NCT05415579,Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM),https://clinicaltrials.gov/study/NCT05415579,NOT_YET_RECRUITING,NO,Demyelinating Diseases of the Central Nervous System (DDC),OTHER: Traditional Chinese medicine (TCM),"Dongzhimen Hospital, Beijing",,ALL,"ADULT, OLDER_ADULT",2000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-06-20,2030-05-31,
NCT06023420,Efficacy of a Herbal Formula for Bone Metastases,https://clinicaltrials.gov/study/NCT06023420,NOT_YET_RECRUITING,NO,Bone Metastases,DRUG: 4 Herbs Formula,Chinese University of Hong Kong,,FEMALE,"ADULT, OLDER_ADULT",36,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2024-02-01,2025-01-01,
NCT05739071,JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer,https://clinicaltrials.gov/study/NCT05739071,ENROLLING_BY_INVITATION,NO,Lower Urinary Tract Symptoms|Intravenous Drug Usage|Bladder Cancer|Herbal Interaction,DIETARY_SUPPLEMENT: JING SI HERBAL TEA|DIETARY_SUPPLEMENT: Placebo,"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation",,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2023-03,2027-12-31,"Buddhist Tzu Chi General Hospital, Taipei branch, Taipei, 231, Taiwan"
NCT03173040,The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis,https://clinicaltrials.gov/study/NCT03173040,UNKNOWN,NO,Niu Bang Zi Pill|Rheumatoid Arthritis,DRUG: NiuBangZi pill or NiuBangZi pill placebo,Cui xuejun,Shanghai Yueyang Integrated Medicine Hospital|Longhua Hospital|Shanghai 7th People's Hospital,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-07,2018-12,"Longhua Hospital, Shanghai, Shanghai, China"
NCT01419210,Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer,https://clinicaltrials.gov/study/NCT01419210,COMPLETED,NO,Ovarian Cancer,OTHER: Pre-study Questionnaire|OTHER: Educational Presentations|OTHER: CAM Therapies|OTHER: Post-study Questionnaire,H. Lee Moffitt Cancer Center and Research Institute,University of South Florida,FEMALE,"ADULT, OLDER_ADULT",28,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2010-01,2015-09,"H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States"
NCT05897203,Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral Infections,https://clinicaltrials.gov/study/NCT05897203,RECRUITING,NO,Acute Respiratory Infection,DRUG: TAZCOV|DRUG: Vidicine,Makerere University,"Makerere University Lung Institute|MRC/UVRI and LSHTM Uganda Research Unit|Directorate of Government Analytical Laboratories|Makerere University College of Veterinary Medicine, Animal Resources and Bio-security|Makerere University Biomedical Research Centre|Natural Chemotherapeutics Research Institute",ALL,"ADULT, OLDER_ADULT",510,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2023-03-03,2024-01,"Mulago National Referral Hospital, Kampala, Central, Uganda"
NCT05522621,A Muticenter Clinical Study of Chinese Herbal Compound TJAOA102 in Alleviating Menopausal Syndrome,https://clinicaltrials.gov/study/NCT05522621,NOT_YET_RECRUITING,NO,Menopausal Syndrome,DRUG: TJAOA102,Tongji Hospital,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-10-01,2025-10-01,
NCT01408849,Use of Maytenus Ilicifolia in the Treatment of Dyspepsia,https://clinicaltrials.gov/study/NCT01408849,TERMINATED,NO,Dyspepsia,DRUG: Maytenus ilicifolia leaves infusion|DRUG: Omeprazole,Casa Espirita Terra de Ismael,University of Sao Paulo,ALL,"ADULT, OLDER_ADULT",4,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2015-02,2016-01,"Hospital das Clinicas FMRP-USP, Ribeirao Preto, SP, 14049-900, Brazil"
NCT02855658,Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome,https://clinicaltrials.gov/study/NCT02855658,UNKNOWN,NO,Sjögren's Syndrome,DRUG: SS-1|DRUG: Placebo,China Medical University Hospital,"Chang Gung Memorial Hospital|China Medical University, China|National Research Program for Biopharmaceuticals, Taiwan",ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-02,2017-04,"Taoyuan Chang Gung Memorial Hospital, Gueishan Township, 333, Taiwan|China Medical University Hospital, Taichung, 404, Taiwan"
NCT04275219,Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia,https://clinicaltrials.gov/study/NCT04275219,UNKNOWN,NO,Stroke|Complication,DRUG: Tongfu capsules|DRUG: The Placebo of Tongfu capsules,Guangzhou University of Traditional Chinese Medicine,People's Hospital of Ganzhou City|People's Hospital of Lianjiang City|Yangjiang Hospital of Traditional Chinese Medicine|Shenyang No. 2 Hospital of Traditional Chinese Medicine|Guangdong Provincial Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",218,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-03-15,2021-12,"Guangdong Province Hospital of Tradtional Chinese Medicine, Guangzhou, Guangdong, 510120, China"
NCT04601792,A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method,https://clinicaltrials.gov/study/NCT04601792,UNKNOWN,NO,Bronchiectasis|Quality of Life|Traditional Chinese Medicine|Sputum|Symptoms|Individuality,DRUG: Individualized Decoction|DRUG: placebo|DRUG: Tested drug minus heat-clearing herbs,Shanghai University of Traditional Chinese Medicine,Guangzhou University of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",71,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-12-01,2022-12-31,"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China"
NCT01674374,Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy,https://clinicaltrials.gov/study/NCT01674374,WITHDRAWN,NO,Mucositis|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Tongue Cancer,OTHER: placebo|PROCEDURE: quality-of-life assessment|OTHER: questionnaire administration|DRUG: Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia extract granules,Roswell Park Cancer Institute,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: SUPPORTIVE_CARE,2013-05,,
NCT04967755,Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients,https://clinicaltrials.gov/study/NCT04967755,UNKNOWN,NO,Coronavirus,DRUG: Jing-Si-Herbal-Tea,Yao-Kuang Wu,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-06-01,2021-09-30,"Taipei Tzu chi hospital,The Buddhist medical fundation., Taipei, 231, Taiwan"
NCT01780480,Dynamic Combination Therapy on Chinese Herbal Granules to Improve the Symptoms in Convalescent Phase of Ischemic Stroke,https://clinicaltrials.gov/study/NCT01780480,COMPLETED,NO,Ischemic Stroke|Convalescence,DRUG: Dynamic Chinese herbal granule formula|DRUG: Placebo|PROCEDURE: Standard medical care,China Academy of Chinese Medical Sciences,National Natural Science Foundation of China,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-01,2014-12,"The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China"
NCT00001695,Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials,https://clinicaltrials.gov/study/NCT00001695,COMPLETED,NO,Neoplasm,,National Cancer Institute (NCI),,ALL,"CHILD, ADULT, OLDER_ADULT",125,NIH,OBSERVATIONAL,Observational Model: |Time Perspective: p,1998-04,2002-01,"National Cancer Institute (NCI), Bethesda, Maryland, 20892, United States"
NCT01347658,Drug Interactions Between Echinacea Purpurea and Etravirine,https://clinicaltrials.gov/study/NCT01347658,COMPLETED,NO,HIV,DIETARY_SUPPLEMENT: Echinacea purpurea,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",,ALL,"ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-04,2011-08,"Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain"
NCT05212298,Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus,https://clinicaltrials.gov/study/NCT05212298,RECRUITING,NO,Sleep Disturbances|Tinnitus,DIETARY_SUPPLEMENT: The gel contains a mixture of glucose and maltodextrin|DIETARY_SUPPLEMENT: Herbal compound low-dose|DIETARY_SUPPLEMENT: Herbal compound high-dose,Dalin Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE",2021-09-16,2025-01-30,"Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi City, 66247, Taiwan"
NCT04108832,Traditional Chinese Medicine Formula Liu-Wei-Die-Huang-Wan in the Treatment of Osteoarthritis.,https://clinicaltrials.gov/study/NCT04108832,COMPLETED,NO,Osteoarthritis,DRUG: TCM OA2|DRUG: PLACEBO,Chung Shan Medical University,,ALL,"ADULT, OLDER_ADULT",81,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2012-01,2013-10,"Chung Shan Medical University Hospital, Taichung, 402, Taiwan"
NCT05054023,Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge,https://clinicaltrials.gov/study/NCT05054023,COMPLETED,NO,Acute Pain,DRUG: Soulagel®|DRUG: Arthrosyl®,University of Monastir,,ALL,ADULT,1525,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-10-21,2022-03-21,"Nouira Samir, Monastir, Emergency Department Monastir, Tunisia 5000, 5000, Tunisia"
NCT02988232,Evaluation of the Efficacy and Safety of Herbal Medicine for Treating Work-related Chronic Low Back Pain,https://clinicaltrials.gov/study/NCT02988232,COMPLETED,NO,Low Back Pain|Workplace,DRUG: Sogyeonghwalhyeol-tang|DRUG: Placebo,Gachon University Gil Oriental Medical Hospital,"Sangji University Oriental Medical Center, Korea|Semyung University Korean Medicine Hospital in Chungju, Korea|Daejeon University",ALL,"ADULT, OLDER_ADULT",72,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-07-01,2020-12-30,"Gachon University Gil Oriental Medical Hospital, Incheon, Korea, Republic of"
NCT05455060,Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05455060,NOT_YET_RECRUITING,NO,Atopic Dermatitis,DRUG: Chinese herbal formula (CHF)|DRUG: Placebo,Chang Gung Memorial Hospital,"National Yang Ming Chiao Tung University|Taipei Veterans General Hospital, Taiwan|Taipei Medical University",ALL,"CHILD, ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2022-12-15,2025-07-31,
NCT00656253,Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease,https://clinicaltrials.gov/study/NCT00656253,COMPLETED,NO,Parkinson's Disease,"DRUG: Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)|DRUG: Placebo",Fudan University,State Administration of Traditional Chinese Medicine of the People's Republic of China,ALL,"ADULT, OLDER_ADULT",158,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-08,2011-02,"Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences, Beijing, Beijing, 100053, China|Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|Department of Integrative Medicine, Zhongshan hospital, Fudan University, Shanghai, Shanghai, 200032, China|Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200032, China|Tongji Hospital of Tongji University, Shanghai, Shanghai, 200065, China|Shanghai Chinese Medical Hospital, Shanghai, Shanghai, 200071, China|Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, 200127, China|The Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, Shanghai, 200233, China|Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China|Department of Neurology, The second people's hospital of Wenzhou, Wenzhou, Zhejiang, 325000, China"
NCT04434924,The Construction of Precision Medicine in Chinese Medicine,https://clinicaltrials.gov/study/NCT04434924,COMPLETED,NO,Hypertension,,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",600,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-06-24,2022-05-31,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT05976308,Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT05976308,RECRUITING,NO,Polycystic Ovary Syndrome,DRUG: Bushen Huatan Decoction|DRUG: Placebo,Jiangxi University of Traditional Chinese Medicine,,FEMALE,ADULT,68,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-09-01,2025-12-01,"The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China"
NCT02733731,The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis,https://clinicaltrials.gov/study/NCT02733731,UNKNOWN,NO,Atrophic Vaginitis,DRUG: Chinese Herbal Compound Ointment|DRUG: Estriol,"First Affiliated Hospital, Sun Yat-Sen University",,FEMALE,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-02,2016-06,"The First Affiliated Hospital of Sun-yat Sen University, Guangzhou, Guangdong, 510000, China"
NCT05522634,A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency,https://clinicaltrials.gov/study/NCT05522634,UNKNOWN,NO,Premature Ovarian Failure,DRUG: TJAOA101,Tongji Hospital,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-11-01,2024-11-01,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"
NCT00083980,Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD),https://clinicaltrials.gov/study/NCT00083980,TERMINATED,NO,Anxiety Disorders,DRUG: Venlafaxine ER|DRUG: Sugar pill|DRUG: Kava,National Center for Complementary and Integrative Health (NCCIH),,ALL,"CHILD, ADULT, OLDER_ADULT",16,NIH,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2002-06,2004-08,
NCT04310501,Interactive E-health Database for the Identification of Potential Interactions Among Drugs Prescribed to CKD Patient,https://clinicaltrials.gov/study/NCT04310501,UNKNOWN,NO,"Renal Insufficiency, Chronic",,University of Ioannina,,ALL,"ADULT, OLDER_ADULT",150,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-04-23,2022-03,"University Hospital of Ioannina, Ioánnina, 45110, Greece"
NCT05976295,Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT05976295,RECRUITING,NO,Polycystic Ovary Syndrome,DRUG: Jianpi Qushi Huatan Decoction|DRUG: Placebo,Jiangxi University of Traditional Chinese Medicine,,FEMALE,ADULT,68,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-08-31,2025-12-01,"The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nancang, Jiangxi, China"
NCT02110446,Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome,https://clinicaltrials.gov/study/NCT02110446,UNKNOWN,NO,Sjögren's Syndrome,DRUG: SS-1|DRUG: Placebo,Chang Gung Memorial Hospital,"Chang Gung University|National Science Council, Taiwan|China Medical University, China|China Medical University Hospital",ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-02,2016-07,"Center for Traditional Chinese Medicine, Taoyuan Chang Gung Memorial Hospital, Gueishan Township, Taoyuan, 333, Taiwan"
NCT00070928,Valerian to Improve Sleep in Patients With Parkinson's Disease,https://clinicaltrials.gov/study/NCT00070928,COMPLETED,NO,Insomnia|Parkinson's Disease,DRUG: valerian,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",80,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2000-09,2006-06,"Emory University Medical School/Wesley Woods Hospital, Atlanta, Georgia, 30329, United States"
NCT03300804,Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS),https://clinicaltrials.gov/study/NCT03300804,COMPLETED,NO,Irritable Bowel Syndrome,DRUG: 20-herb formulation|DRUG: Placebo,"University of Maryland, Baltimore",Chinese University of Hong Kong|National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",104,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-05,2011-06,"Medical Gastroenterelogy Clinic Of the Prince Of Wales, Chinese University of Hong Kong, Shatin, Hong Kong"
NCT03750591,Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Due to Lumbar Intervertebral Disc Herniation,https://clinicaltrials.gov/study/NCT03750591,COMPLETED,NO,Sciatica Due to Intervertebral Disc Disorder|Intervertebral Disc Displacement|Sciatica|Sciatic Radiculopathy,DRUG: Herbal medicine|PROCEDURE: Chuna manual therapy|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|OTHER: Other intervention(s),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",1000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-03-31,2019-11-08,"Bucheon Jaseng Hospital of Korean Medicine, Bucheon, Gyeonggi Province, 14598, Korea, Republic of|Haeundae Jaseng Hospital of Korean Medicine, Busan, 48102, Korea, Republic of|Daejeon Jaseng Hospital of Korean Medicine, Daejeon, 35262, Korea, Republic of|Jaseng Hospital of Korean Medicine, Seoul, 06110, Korea, Republic of"
NCT04591795,Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II,https://clinicaltrials.gov/study/NCT04591795,UNKNOWN,NO,Osteoarthritis,DRUG: Sahastara remedy extract|DRUG: Diclofenac,Mr NARIN KAKATUM,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2018-01-01,2020-10-13,"Mr. NARIN KAKATUM, Bangkok, BKK, 11130, Thailand"
NCT02650141,Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty,https://clinicaltrials.gov/study/NCT02650141,COMPLETED,NO,Precocious Puberty,DRUG: ziyinxiehuo Granules|DRUG: zishenqinggan Granules,Children's Hospital of Fudan University,,FEMALE,CHILD,143,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2013-04,2016-04,"Department of Chinses Traditional Medcine； Children Hospital of Fudan University, Shanghai, Shanghai, 201102, China"
NCT05267925,CuraLin Herbal Supplement for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05267925,TERMINATED,NO,Type 2 Diabetes,DIETARY_SUPPLEMENT: CuraLin,National University of Natural Medicine,,ALL,"ADULT, OLDER_ADULT",1,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-01-08,2022-04-14,"National University of Natural Medicine, Portland, Oregon, 97201, United States|Institute of Complementary Medicine, Seattle, Washington, 98122, United States"
NCT03659370,Chinese Herbal Fumigation With Acupuncture for the Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT03659370,COMPLETED,NO,Osteoarthritis,OTHER: Fumigation|OTHER: Acupuncture,Taipei City Hospital,,ALL,"ADULT, OLDER_ADULT",45,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2015-01-01,2017-12-31,"Linsen Chinese Medicine and Kunming Branch, Taipei City Hospital, Taipei City, 10844, Taiwan"
NCT02725697,Treatment of Complaints Following Sports Injuries With Traditional Chinese Medicine,https://clinicaltrials.gov/study/NCT02725697,TERMINATED,NO,Athletic Injuries,OTHER: TCM treatment,Sabine Klein,,ALL,"ADULT, OLDER_ADULT",2,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-04,2018-06,"Poliklinik für Chinesische Medizin, Horgen, ZH, 8810, Switzerland|Praxis für TCM, Zürich, ZH, 8004, Switzerland|proSANUS, Zürich, ZH, 8008, Switzerland"
NCT02981238,Phytotherapy Strategy for Sleep Disorders Related to Anxiety With a Combination of Eschscholtzia and Valerian Extracts,https://clinicaltrials.gov/study/NCT02981238,COMPLETED,NO,Sleep Disorders Related to Anxiety,DIETARY_SUPPLEMENT: Phytostandard® Eschscholtzia / Valerian,PiLeJe,,ALL,"ADULT, OLDER_ADULT",36,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-09-20,2017-01-12,"Pileje Network of general practitioners, Paris, 75000, France"
NCT06393426,"The Constitution and Efficacy of Chinese Medicine of Infertility Male, Female, and Pregnant Female",https://clinicaltrials.gov/study/NCT06393426,COMPLETED,NO,Infertility|Miscarriage Threatening,DRUG: Chinese Herb,China Medical University Hospital,,ALL,ADULT,37611,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-01-01,2023-05-31,"CMUH, Taichung, 404, Taiwan"
NCT05156931,Exploration of Patient Self-medication Practices During and After Cancer in France,https://clinicaltrials.gov/study/NCT05156931,COMPLETED,NO,Cancer|Self-medication,,"University Hospital, Clermont-Ferrand",,ALL,"ADULT, OLDER_ADULT",681,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-12-14,2022-04-30,"CHU Clermont-Ferrand, Clermont-Ferrand, France"
NCT03879447,Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/spondylolisthesis,https://clinicaltrials.gov/study/NCT03879447,ACTIVE_NOT_RECRUITING,NO,Lumbar Spinal Stenosis|Lumbar Spondylolisthesis|Low Back Pain|Sciatica|Neurogenic Claudication,DRUG: Herbal medicine|PROCEDURE: Chuna manual medicine|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|PROCEDURE: Other intervention(s),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",110,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-06-24,2027-12,"Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT05916768,Management of Acute Bronchitis With Pelargonium Sidoides Extract,https://clinicaltrials.gov/study/NCT05916768,ENROLLING_BY_INVITATION,NO,Acute Bronchitis,OTHER: Pelargonium sidoides extract EPs® 7630|OTHER: usual care,University of Fribourg,,ALL,"ADULT, OLDER_ADULT",412,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-05-15,2024-08-30,"University of Fribourg, Fribourg, 1700, Switzerland"
NCT02219204,"Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye",https://clinicaltrials.gov/study/NCT02219204,COMPLETED,NO,Dry Eye,PROCEDURE: Acupuncture|OTHER: Herbal treatment,Singapore National Eye Centre,,ALL,"ADULT, OLDER_ADULT",150,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2015-03,2015-12,"Singapore National Eye Centre/ Singapore Eye Research Institute, Singapore, Type a choice below ..., 168751, Singapore"
NCT02891031,The Effects of Rhus Coriaria L. on Serum Uric Acid Levels,https://clinicaltrials.gov/study/NCT02891031,UNKNOWN,NO,Hyperuricemia,DRUG: Rhus (Somagh)|DRUG: Placebo,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",76,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-06-01,2019-12-01,"Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT00420576,Dose Finding Study of Danggui Buxue Tang (Herbal Formula)on the Treatment of Menopausal Symptoms,https://clinicaltrials.gov/study/NCT00420576,COMPLETED,NO,Postmenopausal,DRUG: DBT-Danggui Buxue Tang,Chinese University of Hong Kong,,FEMALE,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2006-06,2007-12,"Department of Obstetrics & Gynaecology, CUHK, Prince of Wales Hospital, Hong Kong, China"
NCT01724099,Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity,https://clinicaltrials.gov/study/NCT01724099,COMPLETED,NO,Obesity,DRUG: Euiiyin-tang|DRUG: Placebo,Kyunghee University Medical Center,Korea Health Industry Development Institute|Gachon University Gil Medical Center,FEMALE,"ADULT, OLDER_ADULT",149,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-04,2017-06,"Gachon University Gil Medical Center, Incheon, 405-760, Korea, Republic of"
NCT04266275,Topical Curcumin for HPV Related Cervical Disease,https://clinicaltrials.gov/study/NCT04266275,NOT_YET_RECRUITING,NO,Neoplasm Cervix,DRUG: Curcumin C3 Complex|DRUG: Placebo,Lisa Flowers,,FEMALE,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2025-09,2027-10,"Emory University, Atlanta, Georgia, 30303, United States|Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Grady Hospital - Ponce De Leon Clinic, Atlanta, Georgia, 30308, United States"
NCT04623567,Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances,https://clinicaltrials.gov/study/NCT04623567,RECRUITING,NO,Type2 Diabetes|Dyslipidemias,DRUG: Jiangtang Tiaozhi recipe|DRUG: Metformin,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",96,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-12-22,2024-06-30,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT06054763,Buyang Huanwu Decoction and Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT06054763,NOT_YET_RECRUITING,NO,Glaucoma|Visual Acuity|Visual Field|Chinese Medicine,COMBINATION_PRODUCT: Buyang Huanwu Decoction|OTHER: Placebo,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-10-01,2024-12-31,
NCT03946163,The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study,https://clinicaltrials.gov/study/NCT03946163,COMPLETED,NO,Chronic Prostatitis|Chronic Pelvic Pain Syndrome,DIETARY_SUPPLEMENT: cinnamon capsules|DRUG: Placebo oral capsule,Al-Kindy College of Medicine,,MALE,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-02-01,2019-06-30,"Harth Kamber, Baghdad, (select), 10064, Iraq"
NCT05228873,Comparison of Quality of Life After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine,https://clinicaltrials.gov/study/NCT05228873,COMPLETED,NO,COVID-19 Pandemic|Quality of Life,DRUG: Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng),University of Medicine and Pharmacy at Ho Chi Minh City,,ALL,ADULT,300,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-12-20,2023-01-20,"University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam"
NCT00745147,Comparison of TCM and Laxatives for Adults With Chronic Constipation,https://clinicaltrials.gov/study/NCT00745147,COMPLETED,NO,Chronic Constipation,DRUG: Chinese herbal formula (CCH1)|DRUG: Duphalac,National Taiwan University Hospital,,ALL,"ADULT, OLDER_ADULT",93,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2008-07,2010-04,"National Taiwan University Hospital, Yun-Lin Branch, Douliou, Yun-Lin, 640, Taiwan"
NCT05897749,Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment,https://clinicaltrials.gov/study/NCT05897749,RECRUITING,NO,Colorectal Cancer|Chinese Herbal Medicine|Progression-free Survival|Quality of Life,OTHER: Brucea javanica oil emulsion injection|OTHER: The best supportive treatment,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-06-16,2025-12-01,"The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China|Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China, 210029, China|The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China, 250014, China|Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China, 200437, China"
NCT02065271,Herbal Preparation and Glucose Homeostasis,https://clinicaltrials.gov/study/NCT02065271,COMPLETED,NO,Glucose Tolerance|Lipid Homeostasis|Vascular Function|Inflammation,DIETARY_SUPPLEMENT: herbal supplement|OTHER: placebo supplement,Wageningen University,,ALL,"ADULT, OLDER_ADULT",22,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2013-09,2014-02,"Wageningen university, Wageningen, Gelderland, 6703 HD, Netherlands"
NCT05948215,Jing Si Herbal Tea in the Treatment of Dyspeptic Symptoms,https://clinicaltrials.gov/study/NCT05948215,COMPLETED,NO,Functional Gastrointestinal Disorders|Healthy Subjects,DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet|DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet Placebo,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",26,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-01-01,2021-12-31,"Hualien Tzu Chi Hospital, Hualien City, 970, Taiwan"
NCT01708733,The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function,https://clinicaltrials.gov/study/NCT01708733,COMPLETED,NO,Liver Function,DRUG: KSY,Taipei City Hospital,,ALL,"ADULT, OLDER_ADULT",57,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2012-08,2014-03,"Taipei City Hospital, Taipei, 886, Taiwan"
NCT05066841,Chinese Herbal Medicine Formula Combined With Inhaled Corticosteroids for the Treatment of Mild to Persistent Asthma in Children,https://clinicaltrials.gov/study/NCT05066841,UNKNOWN,NO,Childhood Asthma,DRUG: CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang)|DRUG: 10% CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang),China Medical University Hospital,,ALL,CHILD,86,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-09-25,2023-09-30,"China Medical University Hospital, Taichung, 404, Taiwan"
NCT01046890,Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir,https://clinicaltrials.gov/study/NCT01046890,COMPLETED,NO,HIV Infections,DRUG: Echinacea,Germans Trias i Pujol Hospital,"IrsiCaixa|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",ALL,"ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-01,2010-04,"Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation, Badalona, 08916, Spain"
NCT03310385,Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis,https://clinicaltrials.gov/study/NCT03310385,UNKNOWN,NO,Acute Bronchitis,DRUG: GHX02|DRUG: Placebo,Daejeon University,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-03-18,2020-03,"Dunsan Korean Medicine Hospital, Daejeon University, Daejeon, Korea, Republic of"
NCT05483439,A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer,https://clinicaltrials.gov/study/NCT05483439,UNKNOWN,NO,Stage II-III Breast Cancer,"DRUG: cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)|DRUG: anti-Her2 monoclonal antibody (Trastuzumab, Pertuzumab)|DRUG: traditional herbal medicine",Shengjing Hospital,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-10-20,2023-07-01,"ShengJing ospital of China Medical University, Shenyang, Liaoning, 110022, China|Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, China"
NCT05640570,The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elderly With Qi-deficiency Constitution (CCJWBT): A Pragmatic Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT05640570,COMPLETED,NO,Preventive Effectiveness|Elderly With Qi-deficiency Constitution|The Individualized Jade Wind-Barrier Herbal Tea Bag|Common Cold|Pragmatic Randomized Controlled Trial,DRUG: The individualized Jade Wind-Barrier Herbal Tea Bag,Hong Kong Baptist University,The Hong Kong Jockey Club Charities Trust,ALL,OLDER_ADULT,304,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2022-02-21,2022-08-08,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China"
NCT00037154,Saw Palmetto Extract in Benign Prostatic Hyperplasia,https://clinicaltrials.gov/study/NCT00037154,COMPLETED,NO,Benign Prostatic Hyperplasia,DRUG: Saw Palmetto,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),National Center for Complementary and Integrative Health (NCCIH),MALE,"ADULT, OLDER_ADULT",224,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,1999-08,2002-12,"Northern California Kaiser Permanente, Oakland, California, 94611, United States|Veterans Affairs Medical Center, San Francisco, California, 94121, United States"
NCT02402959,Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study,https://clinicaltrials.gov/study/NCT02402959,UNKNOWN,NO,Sleep Initiation and Maintenance Disorders,OTHER: individualized treatment,China Academy of Chinese Medical Sciences,National Natural Science Foundation of China,ALL,"ADULT, OLDER_ADULT",600,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2015-03,2016-02,"East Hospital of Beijing University of Traditional Chinese Medicine, Beijing, Beijing, China|Guang'anmen Hospital of China Academy of China Medical Sciences, Beijing, Beijing, China|Guang'anmen Hospital of China Academy of China Medical Sciences, Beijing, Beijing, China|Guang'anmen Hospital of China Academy of China Medical Sciences, Beijing, Beijing, China|Fujian Institute of Traditional Chinese Medicine, Fuzhou, Fujian, China|Shenzhen hospital of Traditionl Chinese Medicine, Shenzhen, Guangdong, China|Affiliated hospital of He'nan university of Traditional Chinese Medicine, Zhengzhou, Henan, China|Clinic of Hubei university of Traditional Chinese Medicine, Wuhan, Hubei, China|Affiliated hospital of Shandong university of Traditional Chinese Medicine, Ji'nan, Shandong, China"
NCT03376594,Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients,https://clinicaltrials.gov/study/NCT03376594,COMPLETED,NO,Allergic Rhinitis,DRUG: Benjakul Extract|DRUG: Loratadine,Thammasat University,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-07-30,2018-03-31,"Faculty of Medicine, Khlong Luang, Pathumthani, 12120, Thailand"
NCT06288776,Efficacy of Azadirachta Indica Based Herbal Mouthwash in Treating the Tooth Hypersensitivity,https://clinicaltrials.gov/study/NCT06288776,COMPLETED,NO,Tooth Sensitivity,DIAGNOSTIC_TEST: Herbal based mouthwash,Pakistan Institute of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",120,OTHER_GOV,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2023-02-01,2023-04-30,"Afsheen Mansoor, Islamabad, 44080, Pakistan"
NCT00451516,St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety,https://clinicaltrials.gov/study/NCT00451516,COMPLETED,NO,"Depressive Disorder, Major|Anxiety Disorders",DRUG: Herbal medicine (St. John's wort and Kava),The University of Queensland,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT,2007-03,2007-10,"RBWH, Brisbane, Queensland, 4006, Australia"
NCT02983188,Berberine as Adjuvant Treatment for Schizophrenia Patients,https://clinicaltrials.gov/study/NCT02983188,COMPLETED,NO,Schizophrenia|Schizophrenia Spectrum and Other Psychotic Disorders|Metabolic Syndrome x,DRUG: Berberine|DRUG: Placebos|DRUG: Antipsychotic Agents,The University of Hong Kong,"Queen Mary Hospital, Hong Kong|Kowloon Hospital, Hong Kong|Castle Peak Hospital|Zhejiang Provincial Tongde Hospital",ALL,"ADULT, OLDER_ADULT",113,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-04-25,2021-01-04,"Castle Peak Hospital - The Department of General Adult Psychiatry, Tuen Mun, Hong Kong"
NCT01579877,Treatment of Xerostomia by Herbal Preparation,https://clinicaltrials.gov/study/NCT01579877,UNKNOWN,NO,Xerostomia,DIETARY_SUPPLEMENT: Herbal extract granule|DIETARY_SUPPLEMENT: Placebo herbal extract granule,Korea Health Industry Development Institute,,ALL,"ADULT, OLDER_ADULT",96,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-04,2013-11,"Kyung Hee University Oriental Medicine Hospital, Seoul, 130-872, Korea, Republic of"
NCT00483964,A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia,https://clinicaltrials.gov/study/NCT00483964,COMPLETED,NO,Schizophrenia,DRUG: Bacopa monnieri|DRUG: Nardostachys jatamansi|DRUG: Olanzapine,Q.Mundewadi Ayurvedic Research & Charitable Trust,Stanley Medical Research Institute,ALL,ADULT,200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2005-09,2007-09,"Q.Mundewadi Ayurvedic Research & Charitable Trust, Mumbra,Thane, Maharashtra, 400612, India"
NCT05834413,Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors,https://clinicaltrials.gov/study/NCT05834413,NOT_YET_RECRUITING,NO,Lung Cancer,DRUG: chemotherapy plus TCM 1&ICIs plusTCM2 placebo|DRUG: chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo,Shanghai University of Traditional Chinese Medicine,"Shanghai Pulmonary Hospital, Shanghai, China|Shanghai Chest Hospital|Fudan University|Shanghai Zhongshan Hospital|Ruijin Hospital",ALL,"ADULT, OLDER_ADULT",367,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-05-01,2026-06-30,"YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China"
NCT02892357,Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease,https://clinicaltrials.gov/study/NCT02892357,UNKNOWN,NO,Non-erosive Reflux Disease,DRUG: Treatment group|DRUG: Control group,Xiyuan Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",204,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01,2019-12,"Dongfang Hospital, Beijing, Beijing, 100000, China|Guanganmen Hospital, Beijing, Beijing, 100000, China"
NCT04939415,Chinese Herbal Formula for COVID-19,https://clinicaltrials.gov/study/NCT04939415,ACTIVE_NOT_RECRUITING,NO,Covid19,DRUG: mQFPD|DRUG: organic brown rice,"University of California, San Diego",,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-07-01,2024-12-31,"University of California, Los Angeles, Los Angeles, California, 90095, United States|University of California, San Diego, San Diego, California, 92093, United States"
NCT04650750,The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus,https://clinicaltrials.gov/study/NCT04650750,UNKNOWN,NO,Uremic Pruritus,DRUG: Xiao-Feng-San+Shian-Fang-Hwa-Ming-Yiin|DRUG: Placebo,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-12-01,2021-12-31,
NCT06006663,Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis,https://clinicaltrials.gov/study/NCT06006663,NOT_YET_RECRUITING,NO,Effective Intracanal Medicaments Against Enterococcus Faecalis,DRUG: Ibuprofen 400 mg.|DRUG: modified triple antibiotic paste|DIETARY_SUPPLEMENT: curcumin|DIETARY_SUPPLEMENT: olive leaves extract,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",32,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2023-08-26,2023-12-10,
NCT03033290,Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases,https://clinicaltrials.gov/study/NCT03033290,UNKNOWN,NO,Allergic Rhinitis,DRUG: Bu-Zhong-Yi-Qi-Tang|DRUG: placebo,Chang Gung Memorial Hospital,,ALL,ADULT,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-01-10,2020-07-31,"Chang Gung Memorial Hospital, Taoyuan, Taiwan"
NCT03649269,PC-300 Tea Effect on Triglyceride Levels,https://clinicaltrials.gov/study/NCT03649269,COMPLETED,NO,Hypertriglyceridemia,DIETARY_SUPPLEMENT: PC-300 tea.|DRUG: Bezafibrate,Ciprés Grupo Médico CGM SC,,ALL,"ADULT, OLDER_ADULT",34,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-01-01,2014-12-31,
NCT05668871,A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder,https://clinicaltrials.gov/study/NCT05668871,UNKNOWN,NO,Polyps Gallbladder,DRUG: Danning Tablet,Eastern Hepatobiliary Surgery Hospital,,ALL,"ADULT, OLDER_ADULT",336,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-01-01,2024-11-30,"The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 0086371, China|Xiangya Changde Hospital, Changde, Hunan, 0086736, China|The First Affiliated Hospital of University of South China, Hengyang, Hunan, 0086734, China|Loudi Central Hospital, Loudi, Hunan, 0086738, China|Yiyang Central Hospital, Yiyang, Hunan, 0086737, China|Affiliated Hospital of Nantong University, Nantong, Jiangsu, 0086513, China|First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, 0086797, China|Shangrao People's Hospital, Shangrao, Jiangxi, 0086793, China|Central Hospital Affiliated to Shandong First Medical University (Jinan Central Hospital), Jinan, Shandong, 0086531, China|Shandong Provincial Third Hospital, Jinan, Shandong, 0086531, China|The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 0086532, China|Eastern Hepatobiliary Surgery Hospital, Naval Medical University,, Shanghai, Shanghai, 0086021, China|Shanxi Provincial People's Hospital, Taiyuan, Shanxi, 0086351, China|The Sixth People's Hospital of Chengdu, Chengdu, Sichuan, 0086028, China|Anning First People's Hospital, Anning, Yunan, 0086871, China|Jinhua Municipal Central Hospital, Jinhua, Zhejiang, 0086579, China|Ningbo Municipal Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang, 0086574, China|Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, 0086575, China"
NCT04967092,Modified Xiao-Feng Powder for Chronic Urticaria,https://clinicaltrials.gov/study/NCT04967092,UNKNOWN,NO,Chronic Urticaria,DRUG: Modified Xiao-Feng Powder + Antiallergics|OTHER: Placebo + Antiallergics,Prof. Lin Zhixiu,,ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-08-15,2023-09-30,"The Chinese University of Hong Kong, Shatin, Hong Kong"
NCT05122936,Observation on Obesity Undergoing XOWI,https://clinicaltrials.gov/study/NCT05122936,ENROLLING_BY_INVITATION,NO,Obesity|Traditional Chinese Medicine,COMBINATION_PRODUCT: XRXPY-based Obesity Wellness Intervention(SOWI),Feng Tao,,ALL,"ADULT, OLDER_ADULT",500,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-11-30,2027-11-14,"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, Shanghai, 200071, China"
NCT06424535,Integrated Traditional Chinese and Western Medicine to Care for the Late Stage of Mild to Moderate Burns and Scalds,https://clinicaltrials.gov/study/NCT06424535,RECRUITING,NO,Burns and Scalds,OTHER: Chinese medicine for internal or external use、Acupuncture or Laser acupuncture pen treatment、Acupoint Tuina massage、Acupoint application of traditional Chinese herbal medicinal cake|OTHER: Western medicine,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2024-04-22,2026-12-30,"China Medical University Hospital, Taichung city, 403, Taiwan"
NCT00997490,Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance),https://clinicaltrials.gov/study/NCT00997490,TERMINATED,NO,Depressive Disorder,"DRUG: Neurapas® balance (Herbal combination out of hypericum, valerian, passionflower)|DRUG: film-coated sugar-pill",Pascoe Pharmazeutische Praeparate GmbH,,ALL,"ADULT, OLDER_ADULT",67,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2001-01,2003-02,"Dr. Urlea-Schoen, Siegen, NRW, D-57072, Germany"
NCT00622440,Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream,https://clinicaltrials.gov/study/NCT00622440,COMPLETED,YES,Anus Neoplasms,DRUG: AIJP (Arnebia Indigo Jade Pearl)|DRUG: Placebo,"University of California, San Francisco",Spring Wind Herbs,ALL,"ADULT, OLDER_ADULT",70,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-05-14,2012-12-12,"University of California, San Francisco, San Francisco, California, 94143, United States"
NCT01860365,Measuring Concerns of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within Oncology Service,https://clinicaltrials.gov/study/NCT01860365,RECRUITING,NO,Quality of Life,OTHER: Complementary medicine consultation and treatment|OTHER: Patients receiving conventional supportive care,Carmel Medical Center,,ALL,"ADULT, OLDER_ADULT",2500,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2009-07,2025-09-01,"Lin Zebulon and Carmel Medical centers, Haifa, 35152, Israel"
NCT00010816,Herbal Treatment of Hepatitis C in Methadone Maintained Patients,https://clinicaltrials.gov/study/NCT00010816,COMPLETED,NO,Hepatitis C,DRUG: Herbal remedies,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT,1998-09,2003-06,"Hennepin County Medical Center, Minneapolis, Minnesota, United States"
NCT00065221,Ginger Control of Chemotherapy Induced Nausea and Vomiting,https://clinicaltrials.gov/study/NCT00065221,COMPLETED,NO,Nausea|Vomiting|Chemotherapy,DRUG: Ginger,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",180,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2003-06,2007-01,"Northern Indiana Cancer Research Consortium CCOP, South Bend, Indiana, United States|University of Michigan Cancer Center Complementary and Alternative Medicine Research Center, Ann Arbor, Michigan, 48104, United States|St. Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|Community Clinic Oncology Program, Grand Rapids, Michigan, 49503, United States|Our Lady of Mercy Medical Center, Comprehensive Cancer Center, Bronx, New York, 10466, United States|Community Clinic Oncology Program, San Juan, Puerto Rico"
NCT00997256,Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep,https://clinicaltrials.gov/study/NCT00997256,COMPLETED,NO,Healthy|Sleep Quality,"DRUG: Neurapas® balance (Herbal product (Hypericum, Passionflower, Valerian))|DRUG: film-coated sugar-pill",Pascoe Pharmazeutische Praeparate GmbH,,MALE,ADULT,20,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2004-12,2005-02,"Phillipps University, Clinic for Psychiatry and Psychotherapy, Marburg, Hesse, 35039, Germany"
NCT05760456,Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.,https://clinicaltrials.gov/study/NCT05760456,UNKNOWN,NO,Type 2 Diabetes,DRUG: DIDALA hard capsules|DRUG: Metformin,"Centre of Clinical Pharmacology, Hanoi Medical University",,ALL,"ADULT, OLDER_ADULT",140,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-03-15,2024-08-31,"Hanoi Hospital of Traditional Medical, Hanoi, Vietnam|National Hospital of Traditional Medicine, Hanoi, Vietnam"
NCT02616120,Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease,https://clinicaltrials.gov/study/NCT02616120,UNKNOWN,NO,Parkinson's Disease,DRUG: SQJZ herbal mixtures|DRUG: Placebo,"Dongzhimen Hospital, Beijing",,ALL,"ADULT, OLDER_ADULT",240,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-12,2023-12,"Dongzhimen hospital, Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT02762136,Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS),https://clinicaltrials.gov/study/NCT02762136,UNKNOWN,NO,Postprandial Distress Syndrome,DRUG: placebo|DRUG: Xiang-sha-liu-jun granules,Xiyuan Hospital of China Academy of Chinese Medical Sciences,"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine|Wuhan Integrated TCM and Western Medicine Hospita",ALL,"ADULT, OLDER_ADULT",216,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-08,2018-04,"the first hospital affiliated to Guangzhou university of Chinese medicine, Guangzhou, Guangdong, 510405, China|Wuhan integrated TCM and western medicine hospital, Wuhan, Hubei, 430022, China"
NCT00633230,"Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C",https://clinicaltrials.gov/study/NCT00633230,WITHDRAWN,NO,Hepatitis C Virus,"DRUG: standardized herbal formula, Sho-saiko-to (SST)|OTHER: placebo capsule identical to the active herbal formula",University of Virginia,,ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",,,
NCT02413099,The Efficacy and Safety of New Herbal Formula (KBMSI-2) in the Treatment of Erectile Dysfunction,https://clinicaltrials.gov/study/NCT02413099,COMPLETED,NO,Erectile Dysfunction,DRUG: KBMSI-2,Hyun Jun Park,,MALE,ADULT,44,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2012-02,2013-01-03,"Department of Urology, Pusan National University Hospital, Busan, 602-739, Korea, Republic of"
NCT02610595,Study on the Therapeutic Effect of TCM Treatment for MDR MN,https://clinicaltrials.gov/study/NCT02610595,UNKNOWN,NO,Idiopathic Membranous Nephropathy,DRUG: Jianpixiaozhong particles and Wuse Dietotherapy,Shanghai University of Traditional Chinese Medicine,"Fudan University|Ruijin Hospital|Shanghai 6th People's Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Changhai Hospital|Shanghai Putuo District Center Hospital|ShuGuang Hospital|Shanghai Yueyang Integrated Medicine Hospital|Shanghai Changzheng Hospital|Shanghai Minhang Central Hospital|Zhujiang Hospital|Guangxi Traditional Chinese Medical University|Huashan Hospital|The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine|Xinqiao Hospital of Chongqing|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Nanjing University of Traditional Chinese Medicine|Tongji Hospital|Chinese Academy of Sciences|RenJi Hospital",ALL,"ADULT, OLDER_ADULT",220,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-12,2016-12,"Department of Nephrology,Longhua Hospital, Shanghai, 200032, China"
NCT04554446,The Effectiveness and Safety of T-MSAT on Inpatients With Acute Low Back Pain Caused by Traffic Accidents : A Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT04554446,COMPLETED,NO,"Low Back Pain|Medicine, Korean Traditional",PROCEDURE: T-MSAT(Motion style acupuncture treatment using traction)|PROCEDURE: Korean medicine treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2020-09-21,2021-06-21,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT03171597,Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.,https://clinicaltrials.gov/study/NCT03171597,UNKNOWN,NO,Unstable Angina,DRUG: Anti-Platelet Drugs|DRUG: Lipid Regulating Drugs|DRUG: Coronary Vasodilator|DRUG: Xuefu Zhuyu Decoction|DRUG: Gualou Xiebai Banxia Decoction & Danshen Decoction|DRUG: Shuanghe Decoction,Jun Li,,ALL,"ADULT, OLDER_ADULT",240,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2017-08,2019-12,
NCT06268002,Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases,https://clinicaltrials.gov/study/NCT06268002,COMPLETED,NO,Smoking Cessation,DIETARY_SUPPLEMENT: Vernonia cinerea|DIETARY_SUPPLEMENT: Placebo,Chulalongkorn University,,ALL,"ADULT, OLDER_ADULT",93,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-09-01,2021-12-31,"Krittin Bunditanukul, Bangkok, 10600, Thailand"
NCT01451749,Efficacy and Safety Study of Shenwu Capsule,https://clinicaltrials.gov/study/NCT01451749,COMPLETED,YES,Mild Cognitive Impairment,DRUG: Shenwu Capsule|DRUG: Donepezil,North China Pharmaceutical Group Corporation,,ALL,"ADULT, OLDER_ADULT",324,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-09,2010-05,"Dongzhimen Hospital,BUCM, Beijing, 100700, China"
NCT03837210,Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen,https://clinicaltrials.gov/study/NCT03837210,COMPLETED,NO,H.Pylori Infection,DRUG: Pylorin,Hamdard University,,ALL,"CHILD, ADULT, OLDER_ADULT",300,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2017-01-05,2019-01-10,
NCT02044835,The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy,https://clinicaltrials.gov/study/NCT02044835,UNKNOWN,NO,Atherosclerotic Renal Artery Stenosis,DRUG: Fu-zheng-qu-zhuo oral liquid,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2013-01,,"Guang anmen Hospital,China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT00005013,Treatment of Major Depression With St. John's Wort (Hypericum),https://clinicaltrials.gov/study/NCT00005013,COMPLETED,NO,Major Depression,DRUG: Sertraline|DRUG: Hypericum perforatum (St. John's wort),National Institute of Mental Health (NIMH),National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT,1998-12,2001-07,"Feighner Research Institute, San Diego, California, 92121, United States|Stanford Univ School of Medicine, Stanford, California, 94305, United States|Harbor-UCLA Rsch and Education Inst, Torrance, California, 90502, United States|Univ of South Florida College of Med, Tampa, Florida, 33613, United States|Emory Mood and Anxiety Disorders Clinical Trials Program, Atlanta, Georgia, 30329, United States|McLean Hospital, Belmont, Massachusetts, 02478, United States|Eastside Comprehensive Medical Services, New York, New York, 10021, United States|Duke Univ Med Ctr, Durham, North Carolina, 27710, United States|Univ of Cincinnati Medical Ctr, Cincinnati, Ohio, 45267, United States|Univ of Texas Southwestern Med Ctr, Dallas, Texas, 75235, United States|Seattle Clinical Research Center, Seattle, Washington, 98104, United States|Dean Foundation for Hlth Rsch and Education, Middleton, Wisconsin, 53562, United States"
NCT02223741,Observational Study of the Conjugated Rehabilitation on Children With Cerebral Palsy,https://clinicaltrials.gov/study/NCT02223741,COMPLETED,NO,Cerebral Palsy,OTHER: Korean medical treatment,Korean Medicine Hospital of Pusan National University,Korea Health Industry Development Institute,ALL,CHILD,207,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2014-08,2017-05-11,"Pusan national University Yangsan Hospital, Yangsan, Gyeongnam, Korea, Republic of|Pusan National University Hospital, Busan, 602-739, Korea, Republic of|Seongmo-i Oriental Medical Clinic, Daegu, 563-4, Korea, Republic of|Haema Oriental Medical Clinic, Seoul, 1605-5, Korea, Republic of|Heoyoungjin Oriental Medical Clinic, Seoul, 936-7, Korea, Republic of|Dong-Eui University Korean Medical Hospital, Ulsan, 479-7, Korea, Republic of"
NCT04930679,"Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.",https://clinicaltrials.gov/study/NCT04930679,COMPLETED,NO,"Diabetes Mellitus, Type 2",DRUG: Andiabet,"Centre of Clinical Pharmacology, Hanoi Medical University",,ALL,"ADULT, OLDER_ADULT",14,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-11-24,2019-02-22,"Centre of Clinical Pharmacology, Hanoi Medical University, Hanoi, Vietnam"
NCT03132974,"Evaluation of Efficacy and Safety of Single and Multiple Therapy of Herbal Medicine/Chuna Therapy on Non-specific Chronic Low Back Pain: A Study Protocol for Multicenter, 3-arm, Randomized, Single Blinded, Parallel Group, Incomplete Factorial Design, Pilot Study -",https://clinicaltrials.gov/study/NCT03132974,UNKNOWN,NO,Chronic Low Back Pain,DRUG: Sogyeonghwalhyeol-tang granule|OTHER: Sogyeonghwalhyeol-tang granule with manipulation procedure|OTHER: Placebo with manipulation procedure,Gachon University Gil Oriental Medical Hospital,Daejeon University|Semyung University Korean Medicine Hospital in Chungju|Woosuk University Oriental Medical Center,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-09-01,2021-12-31,"Gachon University Gil Oriental Medicine Hospital, Incheon, 22318, Korea, Republic of"
NCT03135821,Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome,https://clinicaltrials.gov/study/NCT03135821,UNKNOWN,NO,Irritable Bowel Syndrome,DIAGNOSTIC_TEST: TCM,Singapore General Hospital,Singapore College of Traditional Chinese Medicine|Duke-NUS Graduate Medical School,ALL,"ADULT, OLDER_ADULT",104,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-03,2017-11,"Singapore General Hospital, Singapore, Singapore"
NCT01791933,The Evaluation of the Effectiveness of CAM Treatments for Lumbar and Cervical Spine Pain Patients Due to Spinal Disease,https://clinicaltrials.gov/study/NCT01791933,COMPLETED,NO,Lumbar and Cervical Pain,DRUG: herbal medicine|PROCEDURE: Chuna manual therapy|PROCEDURE: Acupuncture|PROCEDURE: Bee-venom pharmacoacupuncture/pharmacoacupuncture,Jaseng Hospital of Korean Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",111,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-02,2013-10,"Jaseng Hospital of Oriental Medicine, Seoul, Gangnam-gu, Korea, Republic of"
NCT00110539,Effectiveness of an Internet-Based Curriculum in Increasing Health Care Providers' Knowledge of Herbs and Dietary Supplements,https://clinicaltrials.gov/study/NCT00110539,COMPLETED,NO,Healthy,BEHAVIORAL: Complementary and alternative medicine education,National Library of Medicine (NLM),,ALL,"CHILD, ADULT, OLDER_ADULT",1500,NIH,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: ",2004-02,2004-12,"Northwest Area Health Education Center, Winston-Salem, North Carolina, 27157, United States"
NCT06490289,Clinical Efficiency of Natural Herbal Based Gel.,https://clinicaltrials.gov/study/NCT06490289,COMPLETED,NO,Oral Ulcer,OTHER: Denpro oral gel,Pakistan Institute of Medical Sciences,,ALL,ADULT,202,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-06-15,2024-01-16,"Afsheen Mansoor, Islamabad, 44080, Pakistan"
NCT05668104,Jing Si Herbal Tea for Long-Coronavirus Disease(COVID) Gut-brain Interaction,https://clinicaltrials.gov/study/NCT05668104,COMPLETED,NO,Healthy Subjects|COVID-19 Pneumonia|Irritable Bowel Syndrome|Functional Gastrointestinal Disorders,DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet|DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet Placebo,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",32,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2023-01-01,2023-12-31,"Hualien Tzu Chi Hospital, Hualien City, 970, Taiwan"
NCT03418779,Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD,https://clinicaltrials.gov/study/NCT03418779,ACTIVE_NOT_RECRUITING,NO,IgA Nephropathy at High Risk of Developing ESRD,DRUG: The Yi-Qi-Qing-Jie herbal compound|DRUG: Immunosuppressants|OTHER: Optimized Supportive Care|OTHER: Yi-Qi-Qing-Jie herbal compound placebo,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,China Academy of Chinese Medical Sciences,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-07-04,2024-12-31,"Guang anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT02580942,Efficacy Study of Acupoint Sticking in Summer to Treat Asthma,https://clinicaltrials.gov/study/NCT02580942,COMPLETED,NO,Asthma,DEVICE: Magnetic stickers|DEVICE: Sham magnetic stickers|DRUG: Chinese herbal medicine,Shanghai University of Traditional Chinese Medicine,Shanghai Municipal Health Bureau,ALL,"ADULT, OLDER_ADULT",72,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2015-07,2017-09,"Longhua Hospital Affiliated Shanghai University of TCM, Shanghai, Shanghai, 200032, China"
NCT00097604,Effects of Valerian on Sleep in Healthy Older Adults,https://clinicaltrials.gov/study/NCT00097604,COMPLETED,NO,Sleep Initiation and Maintenance Disorders,DIETARY_SUPPLEMENT: Valerian root extract,University of Washington,National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",18,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2004-09,2008-04,"University of Washington, Seattle, Washington, 98195, United States"
NCT04660175,The Efficacy and Safety of Non-resistance Manual Therapy in Inpatients With Acute Neck Pain Caused by Traffic Accidents: a Randomised Controlled Trial,https://clinicaltrials.gov/study/NCT04660175,COMPLETED,NO,Whiplash Injury of Cervical Spine,OTHER: non-resistance therapy|OTHER: acupuncture|OTHER: chuna|OTHER: pharmacoacupuncture|DRUG: Korean herbal medicine,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2020-11-30,2022-07-26,"Daejeon Jaseng Hospital of Korean Medicine, Daejeon, 35262, Korea, Republic of"
NCT00028964,Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer,https://clinicaltrials.gov/study/NCT00028964,COMPLETED,NO,Breast Cancer|Drug/Agent Toxicity by Tissue/Organ,DIETARY_SUPPLEMENT: Chinese herbs|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|PROCEDURE: adjuvant therapy,"University of California, San Francisco",National Cancer Institute (NCI),FEMALE,"ADULT, OLDER_ADULT",,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: SUPPORTIVE_CARE,2001-02,2005-02,"UCSF Comprehensive Cancer Center, San Francisco, California, 94115-1710, United States"
NCT06140485,A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus,https://clinicaltrials.gov/study/NCT06140485,NOT_YET_RECRUITING,NO,"Diabetes Mellitus, Type 2",DIETARY_SUPPLEMENT: NW Low-Glu®|DRUG: Metformin,Natural Wellness Egypt,,ALL,"ADULT, OLDER_ADULT",400,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-03,2025-10,
NCT04935073,Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle,https://clinicaltrials.gov/study/NCT04935073,UNKNOWN,NO,"Infertility, Female",DRUG: Prescription of traditional Chinese Medicine named Er Zhi Wan combined with Si Wu Tang|DRUG: Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection,Peking University Third Hospital,,FEMALE,ADULT,90,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-06-15,2022-12-30,
NCT05346770,Pharmacist-led Interventions to Improve Medication Use,https://clinicaltrials.gov/study/NCT05346770,UNKNOWN,NO,Pharmacogenomics|Old Age,BEHAVIORAL: Behavioral Intervention|DIAGNOSTIC_TEST: Diagnostic Test|OTHER: Data Analysis,Tabula Rasa HealthCare,,ALL,"ADULT, OLDER_ADULT",25,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-01-25,2024-07-24,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida, 32827, United States"
NCT04905745,The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy,https://clinicaltrials.gov/study/NCT04905745,RECRUITING,NO,"Facial Paralysis, Peripheral",PROCEDURE: Korean integrative medicine,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",100,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-05-25,2025-12-31,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT05656196,VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome,https://clinicaltrials.gov/study/NCT05656196,COMPLETED,NO,Dry Eye Syndrome|Sjogren's Syndrome|Xerophthalmia,OTHER: Chinese herbal tea VGH-DESJS-1,"Taipei Veterans General Hospital, Taiwan",,ALL,"ADULT, OLDER_ADULT",100,OTHER_GOV,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,2023-04-01,2023-12-31,"Ching-Mao Chang, Taipei, 112, Taiwan"
NCT05109104,Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products,https://clinicaltrials.gov/study/NCT05109104,COMPLETED,YES,Sunscreening Agents,DRUG: CAP UnScented|DRUG: CAP Herbal Mint|DRUG: CAP Mountain Berry|DRUG: SPF Standard Sunscreen,HALEON,,ALL,"ADULT, OLDER_ADULT",13,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2021-11-08,2021-12-15,"GSK Investigational Site, Winston-Salem, North Carolina, 27101, United States"
NCT01701804,The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome,https://clinicaltrials.gov/study/NCT01701804,COMPLETED,NO,Failed Back Surgery Syndrome,DRUG: Chuna herbal medicine|PROCEDURE: Chuna manual therapy|PROCEDURE: Acupuncture|PROCEDURE: Bee-venom pharmacoacupuncture,Jaseng Hospital of Korean Medicine,,ALL,"ADULT, OLDER_ADULT",120,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2011-09,2014-09,"Jaseng Hospital of Oriental Medicine, Bucheon, Gyeonggi Province, 420-814, Korea, Republic of|Jaseng Hospital of Oriental Medicine, Seoul, 135-896, Korea, Republic of"
NCT06244277,Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal,https://clinicaltrials.gov/study/NCT06244277,RECRUITING,NO,Traditional Chinese Medicine|Sleep Disorder,DRUG: Suanzaoren Decoction and Huanglian Wendan Decoction|DRUG: Zolpidem,The First Affiliated Hospital with Nanjing Medical University,,ALL,"CHILD, ADULT",106,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-12-22,2025-12-31,"The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 224000, China"
NCT03858556,Effect of Chuna Manipulation Therapy on Gait in Patients With Lumbar Disc Herniation,https://clinicaltrials.gov/study/NCT03858556,WITHDRAWN,NO,Lumbar Disc Herniation|Gait Analysis|Manual Therapy,PROCEDURE: Chuna manipulation|DRUG: Herbal medicine|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|OTHER: Other intervention(s),Jaseng Medical Foundation,,ALL,ADULT,0,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-02-27,2019-02-27,
NCT00079794,Iscar for Supplemental Care in Stage IV Lung Cancer,https://clinicaltrials.gov/study/NCT00079794,COMPLETED,NO,Lung Cancer,DRUG: Iscar|DRUG: mistletoe,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",36,NIH,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2001-09,2004-02,"Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States"
NCT06584786,Therapeutic Effects of Jing Si Herbal Tea for COPD,https://clinicaltrials.gov/study/NCT06584786,RECRUITING,NO,Airway Disease,COMBINATION_PRODUCT: Jing Si herbal tea (JSHT)|OTHER: Placebo,"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation",,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-01-01,2024-12-31,"Taipei Tzu Chi Hospital, New Taipei City, Xindan, 23142, Taiwan"
NCT06636760,Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery,https://clinicaltrials.gov/study/NCT06636760,COMPLETED,NO,COVID 19,OTHER: Placebo|DIETARY_SUPPLEMENT: herbal compound,Indonesia University,,ALL,ADULT,66,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-08-27,2022-03-28,"The National Emergency Hospital for COVID-19, Wisma Atlet, Jakarta, DKI Jakarta, 14360, Indonesia"
NCT05563064,Effect of Herbal Formulation on Thrombocytes Count,https://clinicaltrials.gov/study/NCT05563064,UNKNOWN,NO,Thrombocytopenia,DRUG: Karika Syrup,Shifa Ul Mulk Memorial Hospital,,ALL,"CHILD, ADULT",72,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-01-01,2023-01-01,"Pakistan, Karachi, Sindh, Pakistan"
NCT06331351,Effect of Jing Si Herbal Tea Liquid Packets on Chronic Pharyngolaryngitis,https://clinicaltrials.gov/study/NCT06331351,RECRUITING,NO,Chronic Pharyngitis,OTHER: control group|OTHER: Jing Si herbal tea liquid packets,Dalin Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: OTHER",2024-02-22,2025-12-31,"Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi City, 66247, Taiwan"
NCT05122702,An Innovative Chinese Herbal Formula for Macular Edema,https://clinicaltrials.gov/study/NCT05122702,UNKNOWN,NO,Macula Edema,DRUG: modified Shenling Baizhu San|OTHER: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",70,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-07-12,2025-01-01,"The Chinese University of Hong Kong, Shatin, Hong Kong"
NCT04392141,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,https://clinicaltrials.gov/study/NCT04392141,COMPLETED,YES,COVID-19,DRUG: Standard Treatment|DRUG: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions,Kermanshah University of Medical Sciences,,ALL,"CHILD, ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-04-01,2020-11-01,"Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, 083, Iran, Islamic Republic of"
NCT02878018,Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis,https://clinicaltrials.gov/study/NCT02878018,UNKNOWN,NO,Henoch-Schonlein Purpura Nephritis,DRUG: Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula|DRUG: angiotensin-converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressant,Liaoning University of Traditional Chinese Medicine,First Hospital of China Medical University|Shengjing Hospital,ALL,"CHILD, ADULT",600,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-09,2020-05,"Zhang Jun, Shenyang, Liaoning, 110032, China"
NCT02462993,Local Drug Delivery of Aloe Vera Gel in Chronic Periodontitis,https://clinicaltrials.gov/study/NCT02462993,COMPLETED,NO,Periodontitis,DRUG: Aloe Vera,Dr. D. Y. Patil Dental College & Hospital,,ALL,ADULT,12,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2014-02,2015-05,
NCT04403529,Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer,https://clinicaltrials.gov/study/NCT04403529,UNKNOWN,NO,Triple Negative Breast Cancer,DRUG: Traditional Chinese Medicine Formulation|DRUG: Placebo Formulation,Fudan University,,FEMALE,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-05-25,2024-05-31,"Fudan University Shanghai Cancer Hospital, Shanghai, Shanghai, 200032, China"
NCT00169299,Herbal Alternatives for Menopause Symptoms (HALT Study),https://clinicaltrials.gov/study/NCT00169299,UNKNOWN,NO,Vasomotor Symptoms Associated With Menopause,DRUG: Black cohosh|DRUG: Multibotanical preparation|DRUG: Multibotanical preparation + dietary soy counseling|DRUG: Conjugated equine estrogen +/- medroxyprogesterone acetate,Kaiser Permanente,National Institute on Aging (NIA)|National Center for Complementary and Integrative Health (NCCIH),FEMALE,ADULT,351,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2001-06,2004-09,"Group Health Cooperative, Center for Health Studies, Seattle, Washington, 98101-1448, United States"
NCT00006395,Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers,https://clinicaltrials.gov/study/NCT00006395,COMPLETED,NO,Healthy,DRUG: St. John's Wort,National Institutes of Health Clinical Center (CC),,ALL,"CHILD, ADULT, OLDER_ADULT",12,NIH,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT,2000-10,2001-04,"Warren G. Magnuson Clinical Center (CC), Bethesda, Maryland, 20892, United States"
NCT02069665,Effectiveness Study of Integrative Treatment for Pediatric Pneumonia,https://clinicaltrials.gov/study/NCT02069665,COMPLETED,NO,Pneumonia,OTHER: Fuxiong San|DRUG: Xiyanping injection|DRUG: Ribavirin Injection|DRUG: Xiaoer Qingfei Heji (mixture)|DRUG: Zhi Ke San|DRUG: Hua Tan San|DRUG: Guaifenesin Syrup|DRUG: Ibuprofen Suspension|DRUG: salbutamol,Liaoning University of Traditional Chinese Medicine,Beijing University of Chinese Medicine,ALL,CHILD,451,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2011-12,2013-08,"Affiliated Children's Hospital of Capital University of Medical Sciences, Beijing, Beijing, 100045, China|Guangzhou Children's Hospital, Guangzhou, Guangdong, 510120, China|Affiliated Children's Hospital of Dalian Medical University, Dalian, Liaoning, 116044, China|Affiliated Hospital of Liaoning University of TCM, Shenyang, Liaoning, 110032, China|Affiliated Hospital of Shandong University of TCM, Ji'nan, Shandong, 250011, China|Affiliated Longhua Hospital of Shanghai University of TCM, Shanghai, Shanghai, 200032, China"
NCT04606121,The Benefit of Enhanced Day Care of Traditional Chinese Medicine: A Retrospective Study of Medical Records,https://clinicaltrials.gov/study/NCT04606121,COMPLETED,NO,Chemotherapy-Induced Change,"COMBINATION_PRODUCT: enhanced day care of TCM include acupuncture, massage, tai ji quan, TCM herbal medicine",Taipei City Hospital,,ALL,"ADULT, OLDER_ADULT",401,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-06-11,2020-06-11,"Taipei city hospital, Taipei, 10845, Taiwan"
NCT05124899,Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products,https://clinicaltrials.gov/study/NCT05124899,COMPLETED,YES,Sunscreening Agents,DRUG: CAP UnScented|DRUG: CAP Herbal Mint|DRUG: CAP Mountain Berry|DRUG: SPF Standard Sunscreen,HALEON,,ALL,"ADULT, OLDER_ADULT",15,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2021-11-16,2021-12-18,"GSK Investigational Site, Winston-Salem, North Carolina, 27101, United States"
NCT06393413,To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease,https://clinicaltrials.gov/study/NCT06393413,COMPLETED,NO,Ensure the Legality and Compliance of the Testing Process,DRUG: Jiedu Yizhi Formula|DRUG: Donepezil Hydrochloride Tablets,Changchun University of Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",62,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-12-01,2024-04-01,"Changchun University of Traditional Chinese Medicine, Changchun, Jilin, 130117, China"
NCT02651454,"A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -",https://clinicaltrials.gov/study/NCT02651454,COMPLETED,NO,Metabolic Syndrome|Obesity,DRUG: Daesiho-tang|DRUG: Chowiseungcheng-tang|DRUG: Placebo,Gachon University Gil Oriental Medical Hospital,"Sangji University Oriental Medical Hospital, Korea|DongGuk University",FEMALE,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-12-31,2020-12-02,"Gachon University Gil Oriental Medical Hospital, Incheon, Korea, Republic of"
NCT01636154,Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations,https://clinicaltrials.gov/study/NCT01636154,COMPLETED,NO,Ischemic Stroke,DRUG: Ixeris of sonchifolia Hance|DRUG: Panax notoginseng saponins|DRUG: Ixeris of sonchifolia Hance combined with Panax notoginseng saponins,Yunling Zhang,Shandong University of Traditional Chinese Medicine|Huairou Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT,2012-01,2016-08,"Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine, Beijing, Beijing, 100078, China|Department of Neurology,Huairou Hospital of Traditional Chinese Medicine, Beijing, Beijing, 101400, China|Department of Neurology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250011, China"
NCT01130181,VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients,https://clinicaltrials.gov/study/NCT01130181,COMPLETED,NO,Critical Illness|Vitamin D Deficiency,DRUG: Cholecalciferol|DRUG: Placebo,"Harald Dobnig, MD",,ALL,"ADULT, OLDER_ADULT",480,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-05,2012-09,"Medical University of Graz, Graz, 8036, Austria"
NCT05517993,Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension,https://clinicaltrials.gov/study/NCT05517993,UNKNOWN,NO,Intradialytic Hypotension,DRUG: Gui-Lu-Er-Xian-Jiao-Wan,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2022-09-01,2024-12-31,"Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan"
NCT02981225,Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.,https://clinicaltrials.gov/study/NCT02981225,COMPLETED,NO,Mild to Moderate Depression,DIETARY_SUPPLEMENT: Phytostandard® Rhodiola-Saffron,PiLeJe,,ALL,"ADULT, OLDER_ADULT",59,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-11-08,2017-05-31,"Pileje, Paris, 75015, France"
NCT05452577,Treatment of Chronic Insomnia According to Yin Yang Theory and Its Correlation With Circadian Rhythm,https://clinicaltrials.gov/study/NCT05452577,COMPLETED,NO,Chronic Insomnia|Circadian Rhythm|Traditional Chinese Medicine,DRUG: Suanzaoren Decoction and Huanglian Wendan Decoction|DRUG: Estazolam 1Mg Tab,The First Affiliated Hospital with Nanjing Medical University,,ALL,"ADULT, OLDER_ADULT",187,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-01-22,2023-05-30,"The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 224000, China"
NCT01852331,Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia,https://clinicaltrials.gov/study/NCT01852331,COMPLETED,NO,Schizophrenia|Schizophrenic Disorder|Hyperprolactinemia|Hyperprolactinaemia,DRUG: PGD granules|DRUG: Placebo,The University of Hong Kong,"Kowloon Hospital, Hong Kong|Queen Mary Hospital, Hong Kong|Capital Medical University|Xijing Hospital",FEMALE,ADULT,103,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-01,2014-11,"Xijing Hospital, Xian, Shanxi, 710032, China|Beijing Anding Hospital, Beijing, 100088, China|Department of Psychiatry, Queen Mary Hospital, Hong Kong, China|Department of Psychiatry, Kowloon Hospital, Kowloon, China"
NCT05578638,Comparing Aloe Vera Gel and Rosemary Oil in Pressure Injury Prevention,https://clinicaltrials.gov/study/NCT05578638,RECRUITING,NO,Pressure Injury,COMBINATION_PRODUCT: Aloe Vera rosemary tropical application|COMBINATION_PRODUCT: aloevera tropical application|COMBINATION_PRODUCT: rosemary tropicalapplication,Mansoura University,,ALL,ADULT,128,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2022-11-01,2024-12,"Faculty of Nursing Mansoura University, Mansoura, Egypt"
NCT03911921,RSYR for Fatigue Reduction in Cancer Survivors,https://clinicaltrials.gov/study/NCT03911921,COMPLETED,NO,Cancer-related Problem/Condition,DRUG: RSYRT decoction|DRUG: Astragalus membranaceus,Peking University Cancer Hospital & Institute,,ALL,"ADULT, OLDER_ADULT",92,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-06-01,2019-02-01,
NCT04059367,Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People,https://clinicaltrials.gov/study/NCT04059367,COMPLETED,NO,Healthy Volunteers|Overweight|Obesity,DRUG: NNC9204-1177|DRUG: Cocktail of 5 already approved drugs,Novo Nordisk A/S,,ALL,ADULT,45,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2019-08-15,2020-01-02,"Novo Nordisk Investigational Site, San Antonio, Texas, 78209, United States"
NCT04419584,Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children,https://clinicaltrials.gov/study/NCT04419584,UNKNOWN,NO,Atopic Dermatitis,DRUG: Modified Qing-Ying Decoction|DRUG: Identical looking placebo,Chinese University of Hong Kong,,ALL,CHILD,64,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-09-10,2023-05,"The Chinese University of Hong Kong, Hong Kong, Hong Kong"
NCT06171724,Ashwagandha Pharmacokinetics Study in Older Adults,https://clinicaltrials.gov/study/NCT06171724,RECRUITING,NO,Healthy|Aging,DIETARY_SUPPLEMENT: Shoden,Oregon Health and Science University,National Center for Advancing Translational Sciences (NCATS),ALL,OLDER_ADULT,14,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2024-04-08,2025-08-31,"Oregon Health & Science University, Portland, Oregon, 97239, United States"
NCT05960526,"Nasal Irrigation With Combination of 0.9% NaCl and Binahong Extract (Anredera Cordifolia) 2,5% In Allergic Rhinitis",https://clinicaltrials.gov/study/NCT05960526,ENROLLING_BY_INVITATION,NO,Allergic Rhinitis|Allergic Rhinitis Due to House Dust Mite,DRUG: extract Binahong|DRUG: Isotonic saline nasal irrigation,Gadjah Mada University,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2023-05-06,2024-12-10,"RS PKU Muhammadiyah, Yogyakarta, DIY, 55294, Indonesia"
NCT00800098,"Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee",https://clinicaltrials.gov/study/NCT00800098,COMPLETED,NO,Osteoarthritis,DRUG: herbal topical cream,Stanford University,,ALL,"ADULT, OLDER_ADULT",22,OTHER,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-12,2010-02,"Stanford University School of Medicine, Stanford, California, 94305, United States"
NCT06721884,Herbal Evaluation of Artemisia Annua for Small Intestinal Bacterial Overgrowth,https://clinicaltrials.gov/study/NCT06721884,NOT_YET_RECRUITING,NO,Small Intestinal Bacterial Overgrowth Syndrome (SIBO),DIETARY_SUPPLEMENT: Artemisia Annua Leaf|OTHER: placebo,National University of Natural Medicine,atelier temenos,ALL,"ADULT, OLDER_ADULT",32,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2025-01,2026-01,"Helfgott Research Institute - National University of Natural Medicine, Portland, Oregon, 97201, United States"
NCT02486159,The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture,https://clinicaltrials.gov/study/NCT02486159,COMPLETED,NO,"Rhinitis, Allergic",DRUG: Herbal plaster (Sanfujiu)|PROCEDURE: Acupuncture,Chang Gung Memorial Hospital,,ALL,ADULT,50,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2009-09,2011-08,
NCT05986799,The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging,https://clinicaltrials.gov/study/NCT05986799,RECRUITING,NO,Skin Laxity|Skin Lines,DIETARY_SUPPLEMENT: Amway Herbal Drink|DIETARY_SUPPLEMENT: Placebo Drink,Amway (China) R&D Center,,ALL,ADULT,30,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2023-08-13,2023-11-30,"Ai You Mei Medical Beauty Clinic, Jinhua, Zhejiang, China"
NCT02167516,A Clinical Study of Xin'an Medicine in the Treatment of Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT02167516,COMPLETED,NO,Knee Osteoarthritis,DRUG: glucosamine sulfate|DRUG: Xinfeng capsule,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",268,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-10,,"the First Affiliated Hospital of Anhui University of Chinese Medicine, HeFei, Anhui, 230031, China|The Taihe County Hospital of Chinese Medicine, Taihe, Anhui, 236600, China|The Tianchang City Hospital of Chinese Medicine, Tianchang, Anhui, 239300, China"
NCT03388762,RCT of a Polyherbal Dietary Supplement for Prediabetes,https://clinicaltrials.gov/study/NCT03388762,COMPLETED,NO,Prediabetic State,DIETARY_SUPPLEMENT: GlucoSupreme™ Herbal|OTHER: Placebo,"University of Maryland, Baltimore",Alliance Institute for Integrative Medicine,ALL,"ADULT, OLDER_ADULT",39,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2017-12-05,2020-01-01,"University of Maryland Center for Diabetes and Endocrinology, Baltimore, Maryland, 21201, United States|University of Maryland Family Medicine Associates, Baltimore, Maryland, 21201, United States|University of Maryland School of Medicine, Department of Family and Community Medicine, East Hall, Baltimore, Maryland, 21201, United States|Alliance Integrative Medicine, Cincinnati, Ohio, 45236, United States"
NCT01226524,The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP),https://clinicaltrials.gov/study/NCT01226524,TERMINATED,NO,Childhood Chronic Immune Thrombocytopenia,"DRUG: Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan",Hadassah Medical Organization,,ALL,"CHILD, ADULT",7,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-02,2014-08,"Hadassah Medical Organization, Jerusalem, 91120, Israel"
NCT02227485,Iranian Traditional Mouth Rinse Punica Granatum Pleniflora (Golnaar) in Treatment of Gingivitis in Diabetic Patients,https://clinicaltrials.gov/study/NCT02227485,COMPLETED,YES,Gingivitis,DRUG: Punica granatum Pleniflora (Golnaar) mouth rinse|DRUG: Chlorhexidine (0.2%)|PROCEDURE: Tooth bleaching,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07,2014-12,"Motahhari clinic of Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,https://clinicaltrials.gov/study/NCT04310865,SUSPENDED,NO,COVID-19|Severe Pneumonia|Chinese Medicine,DRUG: Yinhu Qingwen Granula|DRUG: Yin Hu Qing Wen Granula(low does)|OTHER: standard medical treatment,Zhong Wang,Wuhan Leishenshan Hospital|The First Affiliated Hospital of Dalian Medical University|Tanshan People's Hospital|North China University of Science and Technology Affiliated Hospital|Jizhong Energy Fengfeng Group Hospital,ALL,"ADULT, OLDER_ADULT",116,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2021-11,2023-04,"Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, 430071, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, 430071, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, 430071, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, 430200, China"
NCT02008981,Effect of Herbal Products on Platelet Function and Clotting,https://clinicaltrials.gov/study/NCT02008981,COMPLETED,NO,Platelet Function Test,DRUG: Curcuma longa|DRUG: Angelica sinensis|DRUG: Siwu Tang|DRUG: Aspirin,Singapore General Hospital,Singhealth Foundation,ALL,"ADULT, OLDER_ADULT",75,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-12,2014-04,"Singapore General Hospital, Singapore, 169856, Singapore"
NCT00103012,"Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers",https://clinicaltrials.gov/study/NCT00103012,COMPLETED,YES,Healthy,DRUG: Gingko Biloba|DRUG: Echinacea purpurea|DRUG: Panax ginseng,National Institutes of Health Clinical Center (CC),,ALL,ADULT,47,NIH,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: ",2005-01,2011-06,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT04117919,Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath,https://clinicaltrials.gov/study/NCT04117919,UNKNOWN,NO,Psoriasis,DRUG: paper mulberry leaf|DRUG: Triamcinolone (Encort-A) 0.1%15g/Tube,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2019-10-05,2020-03-03,"No. 91, Xueshi Rd., North Dist., Taichung City 404, Taiwan (R.O.C.), Taichung, Taiwan"
NCT01122147,Clinical Evaluation of Fluid Extract of Chamomilla Tincture for Oral Aphthae,https://clinicaltrials.gov/study/NCT01122147,COMPLETED,NO,Recurrent Aphthous Stomatitis,DRUG: chamomilla tincture mouthwash|DRUG: placebo mouthwash,Mashhad University of Medical Sciences,,ALL,"CHILD, ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-04,2011-02,"Mashhad University of Madical Science,Research Center of Mashhad Dental School, Mashhad, Khorasan Razavi, 91735, Iran, Islamic Republic of"
NCT03724448,The Efficacy of a Herbal Supplement in the Prevention of PTSD,https://clinicaltrials.gov/study/NCT03724448,COMPLETED,NO,"PTSD, Post Traumatic Stress Disorder|Diagnosis, Psychiatric|Follow up",DRUG: aleozen|DRUG: Placebo Oral Tablet,Hôpital Universitaire Sahloul,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: DIAGNOSTIC,2018-06-30,2018-09-01,"HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, 4054, Tunisia"
NCT04705753,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",https://clinicaltrials.gov/study/NCT04705753,COMPLETED,NO,Covid19|Viral Infection|Respiratory Viral Infection,DIETARY_SUPPLEMENT: Cretan IAMA,University of Crete,Galenica SA|Olvos Science SA,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-04-01,2020-10-15,"Cretan Medicare, Heraklion, Crete, Greece"
NCT04278963,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,https://clinicaltrials.gov/study/NCT04278963,SUSPENDED,NO,CoVID-19|Chinese Medicine,DRUG: YinHu QingWen Decoction|DRUG: YinHu QingWen Decoction(low dose)|OTHER: Chinese medicine treatment|OTHER: standard western medicine treatment,China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",300,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-10,2023-05,"Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, 434000, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, 430200, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, 441000, China"
NCT05549765,The Effectiveness of Pharmacopuncture on Acute Tension Headache,https://clinicaltrials.gov/study/NCT05549765,COMPLETED,NO,Tension Headache,PROCEDURE: Pharmacopuncture|PROCEDURE: Korean medical treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2022-09-08,2023-04-04,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT05647681,Analgesic Effect of a New Analgesic Based Gel(Douloff) Versus Oral Paracetamol in Acute Soft Injuries,https://clinicaltrials.gov/study/NCT05647681,NOT_YET_RECRUITING,NO,Analgesia,DRUG: Douloff|DRUG: paracetamol,University of Monastir,,ALL,ADULT,1100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2023-07-01,2024-07-31,
NCT02752880,YH1 in Poorly Controlled Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02752880,COMPLETED,YES,Type 2 Diabetes,DRUG: YH1 group|DRUG: placebo group,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",46,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-06,2018-02,"Taoyuan, Taiwan"
NCT02011880,Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer,https://clinicaltrials.gov/study/NCT02011880,TEMPORARILY_NOT_AVAILABLE,NO,Breast Cancer|Bone Metastasis,DIETARY_SUPPLEMENT: Chinese Herbs,Shanghai University of Traditional Chinese Medicine,,FEMALE,"ADULT, OLDER_ADULT",,OTHER,EXPANDED_ACCESS,,,,
NCT00872430,Laxative Effectiveness of a Phytotherapeutic Tea,https://clinicaltrials.gov/study/NCT00872430,COMPLETED,YES,Chronic Constipation,OTHER: Placebo|OTHER: Klein Laxative Tea,Hospital de Clinicas de Porto Alegre,Federal University of Rio Grande do Sul|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Laboratório Klein Ltda.,ALL,ADULT,20,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2002-07,2003-06,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, 90035903, Brazil"
NCT02754089,The Effects of Rhus Coriaria L. on Body Weight,https://clinicaltrials.gov/study/NCT02754089,COMPLETED,NO,Body Weight,DRUG: Rhus Coriaria L.(Rhus)|DRUG: Placebo,Shiraz University of Medical Sciences,,ALL,ADULT,50,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-05,2016-09,"Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT05584046,A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF,https://clinicaltrials.gov/study/NCT05584046,RECRUITING,NO,Plantar Fasciitis,OTHER: CDAM,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-09-20,2025-06-30,"Prince of Wales Hospital, Sha Tin, Hong Kong"
NCT05347329,A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus,https://clinicaltrials.gov/study/NCT05347329,COMPLETED,NO,Erectile Dysfunction,DIETARY_SUPPLEMENT: Tongkat Ali Maca Plus,Natural Wellness Egypt,,MALE,"ADULT, OLDER_ADULT",197,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-09-10,2020-11-30,"Faculty of Medicine, Menoufia University/ Egypt, Shibīn Al Kawm, Menoufia, Egypt"
NCT02295293,The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia,https://clinicaltrials.gov/study/NCT02295293,COMPLETED,NO,Hyperlipidemias,DRUG: Rhus Coriaria L. (Rhus)|DRUG: Placebo,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",74,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-12,2015-05,"Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT02289235,Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM,https://clinicaltrials.gov/study/NCT02289235,COMPLETED,NO,"Fatty Liver|Diabetes Mellitus, Type 2",DRUG: Ginger|DRUG: Placebo,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",76,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-05-01,2020-02-01,"Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT06549582,Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients,https://clinicaltrials.gov/study/NCT06549582,NOT_YET_RECRUITING,NO,Cerebral Infarction|Chinese Herbal Medicine|Clinical Trial|Lipid Metabolism Disorder|Endothelial Injury,OTHER: Taohong Tongluo Xiaoban Prescription|OTHER: Fundamental medical treatment,Yan Zhu,,ALL,"ADULT, OLDER_ADULT",160,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-10,2026-12,
NCT06730282,A Preliminary Study on the Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Patients with Primary Dysmenorrhea,https://clinicaltrials.gov/study/NCT06730282,NOT_YET_RECRUITING,NO,Primary Dysmenorrhea (PD)|Traditional Chinese Medicine (TCM) Approaches,DRUG: Danggui Shaoyao San (DSS)|DRUG: Cuscuta Chinensis (Tu Si Zi)|DRUG: Combination Therapy (DSS + Tu Si Zi)|DRUG: Placebo,Taichung Tzu Chi Hospital,,FEMALE,ADULT,200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-12-01,2026-06-30,"Taichung Tzu Chi Hospital, Taichung City, Taichung, 427, Taiwan"
NCT01604239,To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis,https://clinicaltrials.gov/study/NCT01604239,COMPLETED,NO,Osteoarthritis,DRUG: Shinbaro Capsule,Green Cross Corporation,,ALL,"ADULT, OLDER_ADULT",761,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-05,2013-06,"Kyungpook national university hospital, Daegu, Kyungpook, Korea, Republic of|BundangCha Hospital, Bundang, Korea, Republic of|Inje University Busan Paik Hospital, Busan, Korea, Republic of|Chungbuk National University Hospital, Cheongju, Korea, Republic of|Chonbul National University Hospital, Chonju, Korea, Republic of|Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of|Yeungnam University Hospital, Deagu, Korea, Republic of|Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of|Dongguk University Medical Center, Ilsan, Korea, Republic of|Inha University Hospital, Inchun, Korea, Republic of|Samsung Medical Center, Seoul, 130-710, Korea, Republic of|Asan medical Center, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Korea, Republic of|KyungHee University Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of|Ulsan University Hospital, Ulsan, Korea, Republic of"
NCT02138539,Evaluation of an Herbal-Based De-Pigmenting System,https://clinicaltrials.gov/study/NCT02138539,COMPLETED,NO,Melasma|Hyperpigmentation,OTHER: Herbal depigmenting agent (Epionce)|DRUG: Hydroquinone,Sadick Research Group,"Episciences, Inc.",FEMALE,"ADULT, OLDER_ADULT",28,OTHER,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-10,2014-10,"Sadick Research Group, New York, New York, 10075, United States"
NCT04944966,Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria,https://clinicaltrials.gov/study/NCT04944966,COMPLETED,NO,Malaria,DRUG: Maytenus Senegalensis,Ifakara Health Institute,"Swiss Tropical & Public Health Institute|Muhimbili University of Health and Allied Sciences|National Institute for Medical Research, Tanzania",MALE,ADULT,12,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-06-02,2022-09-25,"Bagamoyo Clinical Trial Facility, Bagamoyo, Tanzania"
NCT01458457,Life Quality and Mental State in Patients With Breast Cancer,https://clinicaltrials.gov/study/NCT01458457,COMPLETED,NO,Breast Cancer,OTHER: Individualized complementary medicine treatment|OTHER: Individualized usual care,"Charite University, Berlin, Germany","Azienda Sanitaria de Sudtirol, Hospital Meran, Meran, Italy",FEMALE,"CHILD, ADULT, OLDER_ADULT",275,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2011-05,2013-07,"Meran Hospital - Dienst fuer Komplementaermedizin, Meran, 39012, Italy"
NCT03009136,Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis,https://clinicaltrials.gov/study/NCT03009136,UNKNOWN,NO,Perennial Allergic Rhinitis,DRUG: SCRT|DRUG: Placebos,Kyung Hee University Hospital at Gangdong,Kyung Hee University Hospital|Pusan National University Hospital|Semyung University Affiliated Oriental Medical Hospital|DongGuk University,ALL,ADULT,154,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2016-12-31,2018-12,"Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of"
NCT01989403,Alternative and Integrative Therapy for Lumbar Disk Herniation,https://clinicaltrials.gov/study/NCT01989403,COMPLETED,NO,Sciatica|Intervertebral Disc Disorder,"OTHER: herbal medicine, acupuncture, bee-venom acupuncture, and Chuna manipulation",Jaseng Hospital of Korean Medicine,,ALL,ADULT,128,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-02,2013-03,"Jaseng Spine and joint Research Institute, Seoul, 135-896, Korea, Republic of"
NCT01152684,Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border,https://clinicaltrials.gov/study/NCT01152684,COMPLETED,NO,HIV Positive,,"University of California, San Diego",National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",541,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2009-09,2013-01,"San Ysidro Health Center, San Ysidro, California, 92173, United States"
NCT01399294,Cross Sectional Study of Constipation in Advanced Cancer Patients,https://clinicaltrials.gov/study/NCT01399294,COMPLETED,NO,Palliative Care|Constipation|Traditional Chinese Medicine,,Yan Chai Hospital,"Hospital Authority, Hong Kong|Hong Kong Baptist University",ALL,"ADULT, OLDER_ADULT",255,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-05,2011-02,"Caritas Medical Centre, Hong Kong, Hong Kong, China|Our Lady of Maryknoll Hospital, Hong Kong, Hong Kong, China"
NCT04272437,TRA for Preventing Symptomatic Urinary Tract Infection Among High-risk Elderly Residing in Nursing Homes,https://clinicaltrials.gov/study/NCT04272437,COMPLETED,NO,Urinary Tract Infections,DRUG: Concentrated herbal extract granules TRA|DRUG: Placebo,Changhua Christian Hospital,"Ministry of Health and Welfare, Taiwan",ALL,OLDER_ADULT,162,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION",2017-06-15,2019-03-03,"Dept. of Traditional Chinese Medicine, Changhua Christian Hospital, Changhua city, 500, Taiwan"
NCT02394366,Topical Salve for Skin Oxygenation and Blood Flow,https://clinicaltrials.gov/study/NCT02394366,COMPLETED,NO,Skin Oxygenation|Peripheral Perfusion,OTHER: Original Healing Salve (OHS)|OTHER: OHS base only,National University of Natural Medicine,,ALL,"ADULT, OLDER_ADULT",16,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2015-03,2015-10,
NCT03025399,Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy,https://clinicaltrials.gov/study/NCT03025399,UNKNOWN,NO,Diabetic Non-proliferative Retinopathy|Type2 Diabetes,DRUG: Tangwang prescription|DRUG: Placebo,Fengmei Lian,Guang'anmen Hospital of China Academy of Chinese Medical Sciences|The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine|Hubei Hospital of Traditional Chinese Medicine|Zhengzhou City Hospital of Traditional Chinese Medicine|Baodin City Hospital of Traditional Chinese Medicine|zi bo wanjie cancer hospital|Shijiazhuang City Hospital of Traditional Chinese Medicine|Zouping Country Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",384,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-02,2020-05,
NCT02359396,"A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics",https://clinicaltrials.gov/study/NCT02359396,COMPLETED,NO,Functional Constipation|Gastrointestinal Disorders,DRUG: MZRW,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",23,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-11,2015-08,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China"
NCT04182919,"""Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients""",https://clinicaltrials.gov/study/NCT04182919,COMPLETED,NO,Allergic Rhinitis,DRUG: Phlai|DRUG: Placebo oral capsule,Chulalongkorn University,Government Pharmaceutical Organization,ALL,ADULT,267,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2020-01-31,2021-12-20,"Minh Phuoc Hoang, MD, Bangkok, 10330, Thailand"
NCT01503645,"Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism",https://clinicaltrials.gov/study/NCT01503645,UNKNOWN,NO,Kidney Diseases,,National Taiwan University Hospital,"Department of Health, Executive Yuan, R.O.C. (Taiwan)",ALL,"CHILD, ADULT, OLDER_ADULT",200,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-05,,"Far Estern Memorial Hospital, Pan-Chiao, Taipei, 22060, Taiwan|National Taiwan University Hospital, Taipei, 10051, Taiwan"
NCT00009542,Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan,https://clinicaltrials.gov/study/NCT00009542,COMPLETED,NO,Healthy,DRUG: kava (Piper methysticum),National Institutes of Health Clinical Center (CC),,ALL,"CHILD, ADULT, OLDER_ADULT",20,NIH,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT,2001-01,2001-04,"Warren G. Magnuson Clinical Center (CC), Bethesda, Maryland, 20892, United States"
NCT06107777,The Effectiveness of Pharmacopuncture on Psychological Stress,https://clinicaltrials.gov/study/NCT06107777,COMPLETED,NO,Psychological Stress,PROCEDURE: Pharmacopuncture|PROCEDURE: Korean medical treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-11-20,2024-06-26,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT03929575,Effects of Herbal Supplements on Endurance Exercise Performance,https://clinicaltrials.gov/study/NCT03929575,COMPLETED,NO,Exercise Performance,DIETARY_SUPPLEMENT: Placebo of calcium|DIETARY_SUPPLEMENT: Rhodiola|DIETARY_SUPPLEMENT: Rhodiola and Cordyceps,California Polytechnic State University-San Luis Obispo,,ALL,ADULT,13,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2019-05-01,2019-12-01,"California Polytechnic State University, San Luis Obispo, California, 93407, United States"
NCT01264068,The Influence of Chinese Medicine on Metabolomics in Menopausal or Postpartum Women,https://clinicaltrials.gov/study/NCT01264068,UNKNOWN,NO,Menopausal Women,"DRUG: Finished Herbal Product such as Suan Tsao Jen Tang, Jia-Wey Shiau-Yau San",Taipei City Hospital,National Taiwan University Hospital,ALL,ADULT,60,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-08,2009-12,"Taipei City Hospital, Taipei City, 111, Taiwan"
NCT01259947,Lippia Alba for Migraine Prophylaxis and Treatment,https://clinicaltrials.gov/study/NCT01259947,COMPLETED,NO,Migraine Disorders,DRUG: Lippia alba (Mill.) N. E. Brown ethanolic extract,Fabio Carmona,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2006-07,2010-10,"Naturoterapia Sinho Mariano, Araxa, MG, Brazil"
NCT01641224,"A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome",https://clinicaltrials.gov/study/NCT01641224,UNKNOWN,NO,Irritable Bowel Syndrome,DRUG: Pinaverium|DEVICE: Atractylodes|DEVICE: Paeonia Lactiflora|DEVICE: Tangerine Peel|DRUG: Ledebouriella Root|DRUG: Radix codonopsitis|DRUG: Radix curcumae|DRUG: Fingered citron|DRUG: Tuckahoe|DRUG: Placebo,University of Minnesota,,ALL,"ADULT, OLDER_ADULT",800,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-05,2014-05,"Second Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, 210017, China|Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, 210029, China|Beijing Xuanwu Hospital of Traditional Chinese Medicine affiliated to Capital Medical University., Beijing, 100050, China|Shanghai First People's Hospital affiliated to Shanghai Tiao Tong University, Shanghai, 200240, China"
NCT05621993,"An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia",https://clinicaltrials.gov/study/NCT05621993,RECRUITING,NO,COVID-19 Respiratory Infection,DRUG: Azvudine,Qianfoshan Hospital,,ALL,"ADULT, OLDER_ADULT",500,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-11-22,2023-12-31,"Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China, Jinan, Shandong, China"
NCT01926834,"The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels",https://clinicaltrials.gov/study/NCT01926834,UNKNOWN,NO,Cerebral Infarction,DRUG: Erigeron Injection|DRUG: placebo,Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-08,2014-03,
NCT00119418,TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management,https://clinicaltrials.gov/study/NCT00119418,COMPLETED,NO,Hot Flashes|Menopause,DRUG: TU 025 Keishi Bukuryo Gan,"Plotnikoff, Gregory A., M.D.","Tsumura and Company, Tokyo, Japan|University of Minnesota",FEMALE,ADULT,180,INDIV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2004-11,2006-02,"University of Minnesota General Clinical Research Center, Minneapolis, Minnesota, 55455, United States"
NCT06805292,Evaluation of Acacia Catechu and Low-Level Laser in the Treatmentof Stage II Periodontitis,https://clinicaltrials.gov/study/NCT06805292,COMPLETED,NO,Chronic Periodontitis,OTHER: Acacia catechu|OTHER: Low Level Laser Therapy|OTHER: phase 1 therapy chronic periodontitis|OTHER: local drug delivary acacia +LLL,Faculty of Dental Medicine for Girls,,ALL,ADULT,60,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-09-20,2024-11-20,"Mona Mansour, Cairo, 12345, Egypt|Mona Mansour, Cairo, Egypt"
NCT02232945,Banlangen Granules Anti-seasonal Influenza Study,https://clinicaltrials.gov/study/NCT02232945,UNKNOWN,NO,Influenza,DRUG: placebo of oseltamivir phosphate|DRUG: oseltamivir phosphate|DRUG: Banlangen (Radix Isatidis) granules|DRUG: placebo of Banlangen(Radix Isatidis) granules,Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited,Guangzhou Institute of Respiratory Disease,ALL,"ADULT, OLDER_ADULT",177,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-04,2016-11,"Guangzhou Institute of Respiratory Disease, Guangzhou, Guangdong, 510230, China"
NCT06089317,Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease,https://clinicaltrials.gov/study/NCT06089317,RECRUITING,NO,Dry Eye Syndromes,DRUG: TCM ultrasonic atomization treatment with herbal Compound Decoction (CD)|DRUG: TCM ultrasonic atomization treatment with Dendrobii Caulis (DC)|DRUG: TCM ultrasonic atomization treatment with Houttuynia Cordata (HC)|DRUG: Placebo TCM ultrasonic atomization treatment (PA)|DRUG: Artificial Tears (AT),Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-07-28,2025-11-30,"The Chinese University of Hong Kong Eye Centre (CUHKEC), Kowloon, 000000, Hong Kong|Hong Kong Eye Hospital, Kowloon, Hong Kong|The CUHK Medical Centre (CUHKMC), Shatin, 000 000, Hong Kong|Prince of Wales Hospital, Shatin, 000000, Hong Kong"
NCT03479346,"Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial",https://clinicaltrials.gov/study/NCT03479346,COMPLETED,NO,Obesity|Metabolic Syndrome,DRUG: GGT|DRUG: Placebo,Gachon University Gil Oriental Medical Hospital,DongGuk University|Wonkwang University Guangju Medical Center|Dongsin University Oriental Hospital|Kyunghee University Medical Center,FEMALE,"ADULT, OLDER_ADULT",140,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-04-28,2020-12-01,"Gachon University Gil Oriental Medical Hospital, Incheon, Korea, Republic of"
NCT06519617,Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage,https://clinicaltrials.gov/study/NCT06519617,ENROLLING_BY_INVITATION,NO,Primary Sjögren Syndrome,DRUG: Yi Qi Yang Yin Decoction|DRUG: Hydroxychloroquine Sulfate,Qingwen Tao,,ALL,"ADULT, OLDER_ADULT",136,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-07-13,2026-12-31,"China-Japan friendship hospital, Beijing, Beijing, 100029, China"
NCT00036517,Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer,https://clinicaltrials.gov/study/NCT00036517,TERMINATED,NO,Colorectal Neoplasms|Diarrhea,DRUG: PHY906,PhytoCeutica,,ALL,"ADULT, OLDER_ADULT",30,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT,2002-02,2003-03,"VA CT Cancer Center, West Haven, Connecticut, 06516, United States|Weill Cornell Medical Center, New York, New York, 10021, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, 29615, United States"
NCT05257174,The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis,https://clinicaltrials.gov/study/NCT05257174,ENROLLING_BY_INVITATION,NO,Arthritis|Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Fatigue,DIETARY_SUPPLEMENT: Jing Si Herbal Tea LIQUID PACKETS|DIETARY_SUPPLEMENT: Placebo,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-06-15,2024-06,"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City, 970, Taiwan"
NCT05664906,Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients,https://clinicaltrials.gov/study/NCT05664906,UNKNOWN,NO,Head and Neck Neoplasms|Oral Mucositis (Ulcerative) Due to Radiation|Chinese Medicine Oral Rinse,DRUG: Chinese Medicine Oral Rinse Formula-I (CMORF-I)|OTHER: Standard Care|OTHER: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-01-31,2024-11-30,"Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong"
NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma,https://clinicaltrials.gov/study/NCT04674527,UNKNOWN,NO,Refractory Glioblastoma,DRUG: Elemene|DRUG: Temozolomide,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Hangzhou Normal University,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-06-01,2023-06-01,"Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China"
NCT02924077,PROTECT Pregnancy Study: An Exploratory Study of Self-reported Medication Use in Pregnant Women,https://clinicaltrials.gov/study/NCT02924077,COMPLETED,NO,Pregnancy,,"Quintiles, Inc.",,FEMALE,"CHILD, ADULT, OLDER_ADULT",2521,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-10,2014-01,
NCT05632068,Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity,https://clinicaltrials.gov/study/NCT05632068,RECRUITING,NO,Hyperlipidemias|Obesity|Body Fat Disorder,DRUG: Xian-Hua-Cha,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2022-12-13,2025-06-30,"Chang Gung Memorial Hospital, Linkou and Taoyuan branch, Taoyuan, 333, Taiwan"
NCT03010241,The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.,https://clinicaltrials.gov/study/NCT03010241,UNKNOWN,NO,Type 2 Diabetes Mellitus,DRUG: Tangbi (prescription)|DRUG: Placebo,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine|Zhengzhou City Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine|Hebei Yiling Hospital|Hubei Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",188,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01,2020-05,
NCT01607307,Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy,https://clinicaltrials.gov/study/NCT01607307,UNKNOWN,NO,Paralytic Ileus,DRUG: Oral/enteral TJ-100 solution|DRUG: Oral/enteral placebo solution,Wakayama Medical University,Epidemiological and Clinical Research Information Network,ALL,"ADULT, OLDER_ADULT",220,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2012-08,2016-08,"Nagoya University, Nagoya, Aichi, Japan|Osaka University, Suita, Osaka, Japan|Hiroshima University, Hiroshima, Japan|Shizuoka Cancer Center Hospital, Shizuoka, Japan|Wakayama Medical University, Wakayama, 641-8510, Japan"
NCT02275468,Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4,https://clinicaltrials.gov/study/NCT02275468,COMPLETED,NO,Stage 3 Chronic Kidney Disease|Stage 4 Chronic Kidney Disease,DRUG: Fu-zheng-qu-zhuo (FZQZ) oral liquid,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,"Fangshan Hospital of Traditional Chinese Medicine,|Peking University First Hospital",ALL,"ADULT, OLDER_ADULT",124,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-06,2014-10,"Guang anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China|Fangshan Hospital of Traditional Chinese Medicine, Beijing, Beijing, China|Guang'an Men Hospital South, Beijing, China"
NCT05815797,Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis,https://clinicaltrials.gov/study/NCT05815797,NOT_YET_RECRUITING,NO,Psoriasis Vulgaris,DRUG: SDD formula|DRUG: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-05,2025-10,
NCT05553587,Symptoms and Physiological Effects of Amara in Functional Dyspepsia,https://clinicaltrials.gov/study/NCT05553587,RECRUITING,NO,Dyspepsia,DRUG: Amara drops,Mark Fox,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-07-22,2025-04-30,"Klinik Arlesheim, Arlesheim, Basel Land, 4144, Switzerland"
NCT04200781,Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke,https://clinicaltrials.gov/study/NCT04200781,UNKNOWN,NO,Hemorrhagic Stroke,DRUG: Granules of Shengdi Dahuang Decoction|DRUG: Placebo,ShuGuang Hospital,,ALL,"ADULT, OLDER_ADULT",464,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-09-01,2022-06-30,"Shanghai seventh People's Hospital, Seventh People's Hospital of Shanghai University of TCM, Shanghai, Shanghai, 200000, China|Shanghai Sixth People's Hospital affiliated to Shanghai Jiaotong University, Shanghai, Shanghai, 200000, China|Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University, Shanghai, Shanghai, 200000, China|Shuguang Hospital affiliated with Shanghai University of TCM, Shanghai, Shanghai, 200000, China|Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200000, China"
NCT01072344,Long Term Chamomile Therapy for Anxiety,https://clinicaltrials.gov/study/NCT01072344,COMPLETED,YES,Generalized Anxiety Disorder,DRUG: Chamomile (Matricaria recutita),University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",180,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-02,2015-06,"Depression Research Unit, Philadelphia, Pennsylvania, 19104-3309, United States"
NCT01315041,"""Pi"" and Hot Flushes",https://clinicaltrials.gov/study/NCT01315041,COMPLETED,NO,Menopausal Symptom Relief,"DRUG: Capsicum frutescens fruits, homeopathic medicine|DRUG: Inert alcoholic solution",Casa Espirita Terra de Ismael,University of Sao Paulo,FEMALE,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-12,2016-01,"Casa Espirita Terra de Ismael, Jardinopolis, SP, 14680-000, Brazil"
NCT04222829,The Effectiveness of Megadose Shinbaro Pharmacopuncture for Patients With Chronic Shoulder Pain,https://clinicaltrials.gov/study/NCT04222829,TERMINATED,NO,Shoulder Joint Disorder,PROCEDURE: Megadose Shinbaro Pharmacopuncture,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",36,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-12-04,2021-06-01,"Haeundae Jaseng Hospital of Korean Medicine, Busan, 48102, Korea, Republic of"
NCT02568644,Ginger Capsules for the Acute Treatment of Migraine Attacks,https://clinicaltrials.gov/study/NCT02568644,COMPLETED,YES,Migraine,DIETARY_SUPPLEMENT: Extract of ginger|OTHER: Cellulose|DRUG: Intravenous ketoprofen,Federal University of Minas Gerais,,ALL,ADULT,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07,2014-10,
NCT05459805,Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine,https://clinicaltrials.gov/study/NCT05459805,UNKNOWN,NO,Cough Variant Asthma,DRUG: traditional chinese medicine Xuanfei-Zhike formula|DRUG: inhaled corticosteroids (ICS) and long-acting β2-agonist (LABA),The First Affiliated Hospital of Zhejiang Chinese Medical University,Xin Hua Hospital of Zhejiang Province|Hangzhou Hospital of Traditional Chinese Medicine|The First People's Hospital of Wenling,ALL,"ADULT, OLDER_ADULT",164,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-03-01,2024-12-31,"Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, China|The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China|Xin Hua Hospital of Zhejiang Province, Hangzhou, China|The First People's Hospital of Wenling, Taizhou, China"
NCT01580358,"Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy",https://clinicaltrials.gov/study/NCT01580358,UNKNOWN,NO,Cancer Patients Undergoing Chemotherapy or Radiotherapy,DRUG: Shen-Mai San|DRUG: Starch,Changhua Christian Hospital,Committee on Chinese Medicine and Pharmacy,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2009-10,2012-09,"Changhua Christian Hospital, Changhua, Taiwan"
NCT03793634,Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus,https://clinicaltrials.gov/study/NCT03793634,UNKNOWN,NO,Oral Lichen Planus,DRUG: topical chamomile,Cairo University,,ALL,"ADULT, OLDER_ADULT",37,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-01-15,2020-03-01,
NCT00856167,Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial,https://clinicaltrials.gov/study/NCT00856167,COMPLETED,NO,Temporomandibular Dysfunction,DRUG: TCM|BEHAVIORAL: Self-care for TMD,University of Arizona,National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",160,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2006-09,2010-12,
NCT06452966,The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients,https://clinicaltrials.gov/study/NCT06452966,RECRUITING,NO,"Organ Failure, Multiple|Indigestion|Delayed Gastric Emptying|Respiratory Failure|Morality",OTHER: traditional Chinese medicine|OTHER: Routine ICU care|OTHER: historical Routine ICU care,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",350,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-05-07,2027-05-30,"China Medical University Hospital, Taichung, 403, Taiwan"
NCT01898091,Herbal Mouthrinse for Oral Mucositis Study,https://clinicaltrials.gov/study/NCT01898091,COMPLETED,YES,Oral Mucositis,DRUG: Neem Mouthrinse|DRUG: Placebo Mouthrinse,Medical University of South Carolina,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2013-07,2015-06,"Medical University of South Carolina, Charleston, South Carolina, 29425-9170, United States"
NCT04747041,Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis,https://clinicaltrials.gov/study/NCT04747041,ACTIVE_NOT_RECRUITING,NO,Cystitis Recurrent,COMBINATION_PRODUCT: CYSCONTROL/PHYTOCYST Herbal tea,Centre Hospitalier Universitaire de Nice,,FEMALE,"ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-05-18,2024-12-01,"Hôpital Archet, Nice, 06202, France"
NCT02653937,The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness,https://clinicaltrials.gov/study/NCT02653937,COMPLETED,NO,Irritable Bowel Syndrome,DRUG: Tsumura's shigyakusan,Nakatani Clinic,Wakayama Medical University,ALL,"CHILD, ADULT, OLDER_ADULT",1,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-03,2015-03,
NCT00786500,Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT00786500,COMPLETED,NO,Type 2 Diabetes,DIETARY_SUPPLEMENT: Gynostemma pentaphyllum tea|DIETARY_SUPPLEMENT: Placebo tea,Hanoi Medical University,Karolinska Institutet|Swedish International Development Cooperation Agency (SIDA),ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2007-02,2007-12,"National Institute of Gerontology, HMU, Hanoi, Vietnam"
NCT05601180,"Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.",https://clinicaltrials.gov/study/NCT05601180,COMPLETED,NO,Asthma|Chronic Obstructive Pulmonary Disease|Long COVID,OTHER: Respicure®|OTHER: Standard of care,Beker Laboratories,,ALL,"ADULT, OLDER_ADULT",402,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2022-10-27,2024-01-15,"CHU Beni Messous/Pneumologie A, Algiers, Algeria|CHU Beni Messous/Pneumologie B, Algiers, Algeria|CHU Annaba/Pneumo-phtisiologie, Annaba, Algeria|EPH Batna/Pneumo-phtisiologie, Batna, Algeria|CHU Constantine/Pneumo-phtisiologie, Constantine, Algeria|EPH Laghouat/Pneumo-phtisiologie, Laghouat, Algeria|CHU Oran/Pneumo-phtisiologie B, Oran, Algeria|CHU Sidi Bel Abbes/Pneumo-phtisiologie, Sidi Bel Abbès, Algeria"
NCT01745302,Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma,https://clinicaltrials.gov/study/NCT01745302,UNKNOWN,NO,Cancer,DRUG: TCM|DRUG: EGFR-TKI,Shanghai University of Traditional Chinese Medicine,Shanghai Chest Hospital,ALL,"ADULT, OLDER_ADULT",470,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2011-11,2016-12,
NCT03038035,The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study,https://clinicaltrials.gov/study/NCT03038035,UNKNOWN,NO,Alzheimer Disease,DRUG: MLC901|DRUG: Placebo,"National University Hospital, Singapore",,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-12,2019-06,"National University Hospital, Sg, 119074, Singapore"
NCT02233439,"Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues",https://clinicaltrials.gov/study/NCT02233439,UNKNOWN,NO,Breastfeeding,DIETARY_SUPPLEMENT: Herbal galactagogue|DIETARY_SUPPLEMENT: Placebo,Università degli Studi dell'Insubria,Milte Italia SpA,FEMALE,"ADULT, OLDER_ADULT",210,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-09,2015-03,"Azienda Ospedaliero-Universitaria Ospedale di Circolo e Fondazione Macchi, Presidio F. Del Ponte, Varese, 21100, Italy"
NCT02027467,Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers,https://clinicaltrials.gov/study/NCT02027467,COMPLETED,NO,Healthy,DIETARY_SUPPLEMENT: StemAlive®|DIETARY_SUPPLEMENT: Placebo (For StemAlive®),Vedic Lifesciences Pvt. Ltd.,Stem Vida International,ALL,"ADULT, OLDER_ADULT",23,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: ",2014-02,2014-04,"Dhanwantari Clinic, Mumbai, Maharashtra, 400072, India"
NCT06467851,Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients,https://clinicaltrials.gov/study/NCT06467851,COMPLETED,NO,Chronic Insomnia|Melatonin|Circadian Rhythm|Suanzaoren Decoction and Huanglian Wendan,DRUG: Suanzaoren Decoction and Huanglian Wenda Decoction,The First Affiliated Hospital with Nanjing Medical University,,ALL,ADULT,19,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-08-31,2024-04-10,"The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210000, China|The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 224000, China"
NCT06402760,Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control,https://clinicaltrials.gov/study/NCT06402760,NOT_YET_RECRUITING,NO,Psoriasis|Diabetes,OTHER: TCM comprehensive treatment|DRUG: Western medicine,Shanghai Yueyang Integrated Medicine Hospital,Shanghai Hongkou District Center for Disease Control And Prevention,ALL,"ADULT, OLDER_ADULT",300,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2024-07-01,2025-12-31,
NCT05645120,Impact of Nutrition Education on Knowledge and Beliefs About Dietary Supplements/Herbal Foods,https://clinicaltrials.gov/study/NCT05645120,COMPLETED,NO,"Knowledge, Attitudes, Practice",OTHER: Education,Hacettepe University,,ALL,"ADULT, OLDER_ADULT",226,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2021-06-01,2022-03-01,"Hacettepe University, Ankara, 06100, Turkey"
NCT03571503,The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for HLD With Radiating Leg Pain,https://clinicaltrials.gov/study/NCT03571503,COMPLETED,NO,Intervertebral Disc Displacement|Sciatica|Sciatic Radiculopathy,PROCEDURE: Doin (conduction exercise)|DRUG: Herbal medicine|PROCEDURE: Chuna manual therapy|PROCEDURE: Bee venom pharmacopuncture|PROCEDURE: Pharmacopuncture|PROCEDURE: Acupuncture|PROCEDURE: Electroacupuncture|PROCEDURE: Cupping|OTHER: Other intervention(s),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",40,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-07-09,2019-09-20,"Daejeon Jaseng Hospital of Korean Medicine, Daejeon, 35262, Korea, Republic of"
NCT02334969,Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM,https://clinicaltrials.gov/study/NCT02334969,COMPLETED,NO,Ischemic Stroke,DRUG: Naoxintong Capsule|DRUG: Placebo,Xiaofei Yu,Shanghai Municipal Science and Technology Commission,ALL,"ADULT, OLDER_ADULT",2200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2016-04,2018-08-30,"Shanghai seventh People's Hospital, Shanghai, Shanghai, 200000, China|Shanghai Ninth People's Hospital affliated to Shanghai Jiao Tong University Shool of Medcine, Shanghai, Shanghai, 200011, China|North Branch of Ruijin Hospital affliated to Shanghai Jiao Tong University, Shanghai, Shanghai, 200020, China|Shanghai Putuo Central Hospital, Shanghai, Shanghai, 200021, China|Shuguang Hospital affliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200021, China|Longhua Hospital affliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200032, China|Zhongshan Hospital affliated to Fudan University, Shanghai, Shanghai, 200032, China|Huashan Hospital affliated to Fudan University, Shanghai, Shanghai, 200040, China|Shanghai fifth People's Hospital affliated to Fudan University, Shanghai, Shanghai, 200040, China|Tongren Hospital affliated to Shanghai Jiao Tong University, Shanghai, Shanghai, 200050, China|Tongji Hospital, Shanghai, Shanghai, 200065, China|Shanghai Chinese Medicine Hospital, Shanghai, Shanghai, 200071, China|Shanghai tenth People's Hospital, Shanghai, Shanghai, 200072, China|Shanghai Hospital of Integrative Medicine, Shanghai, Shanghai, 200082, China|Xinhua Hospital affliated to Shanghai Jiao Tong University Shool of Medcine, Shanghai, Shanghai, 200092, China|Dongfang Hospital affliated to Tongji University, Shanghai, Shanghai, 200120, China|Pudong Gong Li Hospital of Shanghai, Shanghai, Shanghai, 200135, China|Shanghai sixth People's Hospital affliated to Shanghai Jiao Tong University, Shanghai, Shanghai, 200233, China|Changning Tongren Hospital of Shanghai, Shanghai, Shanghai, 200336, China|Changhai Hospital, Shanghai, Shanghai, 200433, China|Pudong Hospital of Traditional Chinese Medicine, Shanghai, Shanghai, 201200, China|East Branch of Shanghai sixth People's Hospital, Shanghai, Shanghai, 201306, China|Qingpu Branch of Zhongshan Hospital affliated to Fudan University, Shanghai, Shanghai, 201700, China|Shanghai third People's Hospital affliated to Shanghai Jiao Tong University, Shanghai, Shanghai, 201999, China"
NCT00522093,Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation,https://clinicaltrials.gov/study/NCT00522093,COMPLETED,NO,Chronic Constipation,DRUG: TJ-100,Showa Inan General Hospital,Tsumura USA,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2007-08,2008-03,"Showa Inan General Hospital, Komagane, 399-4191, Japan"
NCT03053882,Efficacy of Peppermint and Green Tea in Malodor,https://clinicaltrials.gov/study/NCT03053882,COMPLETED,NO,Bad Breath,OTHER: mouthwash,Shahid Beheshti University of Medical Sciences,,ALL,ADULT,88,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2015-01,2016-06,
NCT02330029,Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST),https://clinicaltrials.gov/study/NCT02330029,UNKNOWN,NO,Irritable Bowel Syndrome,DRUG: Pinaverium|DEVICE: Atractylodes|DEVICE: Paeonia Lactiflora|DEVICE: Tangerine Peel|DRUG: Ledebouriella Root|DRUG: Radix codonopsitis|DRUG: Radix curcumae|DRUG: Fingered citron|DRUG: Tuckahoe|DRUG: Placebo,Macrohard Institute of Health,,ALL,"ADULT, OLDER_ADULT",800,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-08,2017-05,"Second Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, 210017, China|Jiangsu Provincial Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, 210029, China|Beijing Xuanwu Hospital of Traditional Chinese Medicine affiliated to Capital Medical University., Beijing, 100050, China|Shanghai First People's Hospital affiliated to Shanghai Tiao Tong University, Shanghai, 200240, China"
NCT03597620,Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis,https://clinicaltrials.gov/study/NCT03597620,COMPLETED,YES,Psoriasis,DRUG: Metaderm,University of Alabama at Birmingham,,ALL,"ADULT, OLDER_ADULT",11,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-11-07,2022-12-13,"Dermatology at the Whitaker Clinic, Birmingham, Alabama, 35249, United States"
NCT04674709,Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers,https://clinicaltrials.gov/study/NCT04674709,UNKNOWN,NO,Flu-like Symptoms,DRUG: Oleander 4X - single|DRUG: Oleander 4X - double|DRUG: Oleander 4X - quadruple|DRUG: Placebo,Avila Herbals,,ALL,"ADULT, OLDER_ADULT",75,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-11-24,2021-01-15,"Dr. William Ball offices, Roanoke, Virginia, 24017, United States"
NCT04228757,A Clinical Study Assessing Efficacy of an Herbal Blend on Menopausal Symptoms and Quality of Life,https://clinicaltrials.gov/study/NCT04228757,UNKNOWN,NO,Menopause,DIETARY_SUPPLEMENT: phytoestrogen herbal blend|OTHER: Placebo,"i-Health, Inc.",ObvioHealth,FEMALE,"ADULT, OLDER_ADULT",130,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-06-28,2020-04-04,"ObvioHealth, Orlando, Florida, 32817, United States"
NCT04940520,Alpha-bisabolol for Onychomycosis Treatment,https://clinicaltrials.gov/study/NCT04940520,COMPLETED,NO,Onychomycosis,BIOLOGICAL: Drug recommended by the Brazilian Society of Dermatology|COMBINATION_PRODUCT: Alpha bisabolol product and laser|BIOLOGICAL: Alpha bisabolol product,Universidade do Vale do Sapucai,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2020-06-01,2021-05-01,"Vale do Sapucaí University, Pouso Alegre, Minas Gerais, 37550-000, Brazil"
NCT04949932,Application of Poly-herbal Powder for Treating Acne Vulgaris,https://clinicaltrials.gov/study/NCT04949932,COMPLETED,NO,Acne Vulgaris,"OTHER: Mixed powder of Lens culinaris, Curcuma longa, Mentha arvensis, Azadirachta indica, and Trigonella foenumgraecum.|OTHER: Cicer arietinum powder",Dr. Md. Shahab Uddin,,ALL,ADULT,42,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-04-03,2021-05-12,"Hamdard University Bangladesh, Munshiganj, 1510, Bangladesh"
NCT04446390,Preventive Regimens With Herbal and Fluoride Toothpaste on Remineralization in High Caries Patients With Initial Lesions,https://clinicaltrials.gov/study/NCT04446390,UNKNOWN,NO,Dental Caries,OTHER: Himalaya complete care toothpaste|OTHER: colgate cavity protection,Cairo University,,ALL,"CHILD, ADULT",32,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2021-01-01,2022-03-01,"Cairo University, Faculty of Oral and Dental Medicine, Cairo, Egypt|Cairo University, Cairo, Egypt"
NCT04537819,Study of Imupret Application in the Technology of Delayed Prescription of Antibiotics in Patients With Acute Tonsillitis,https://clinicaltrials.gov/study/NCT04537819,COMPLETED,NO,Acute Tonsillitis,DRUG: Imupret in addition to local NAID|DRUG: Local NAID (Benzydamin),Ivano-Frankivsk National Medical University,Bionorica SE,ALL,"CHILD, ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-03-20,2020-03-25,"Ivano-Frankivsk National Medical University, Ivano-Frankivs'k, Ivano-Frankivsk, Ukraine"
NCT02638051,Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT,https://clinicaltrials.gov/study/NCT02638051,COMPLETED,YES,Peritoneal Neoplasms|Ascites|Yang Deficiency|Yin Deficiency,DEVICE: Modulated Electro-Hyperthermia (mEHT)|DIETARY_SUPPLEMENT: TCM Herbal Decoction (Shi Pi)|DRUG: IPCI (CDDP+5FU),Galenic Research Institute Ltd,,ALL,"ADULT, OLDER_ADULT",260,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-01,2015-12,"Clifford Hospital, Guangzhou, Guangdong, 511495, China"
NCT03919942,Effect of Oxyflower® Gel as a Coadjuvant in Pericoronitis Treatment,https://clinicaltrials.gov/study/NCT03919942,COMPLETED,NO,Pericoronitis,OTHER: OxyFlower gel|OTHER: Chlorhexidine gel|OTHER: Placebo gel,Federal University of the Valleys of Jequitinhonha and Mucuri,,ALL,ADULT,51,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-04-19,2019-12-01,"Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, 39100000, Brazil"
NCT00100295,Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD),https://clinicaltrials.gov/study/NCT00100295,COMPLETED,NO,Attention Deficit Hyperactivity Disorder,DRUG: Hypericum perforatum|OTHER: Placebo,National Center for Complementary and Integrative Health (NCCIH),,ALL,CHILD,59,NIH,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2005-02,2006-11,"Bastyr University, Kenmore, Washington, 98028, United States"
NCT01800487,The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs,https://clinicaltrials.gov/study/NCT01800487,COMPLETED,NO,Tuberculosis,DRUG: silymarin|DRUG: Placebo,Ramathibodi Hospital,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2012-01,2013-07,"Gastroenterology and Hepatology, Ramathibodi hospital, Bangkok, 10400, Thailand"
NCT00610519,Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Aromatic Plants,https://clinicaltrials.gov/study/NCT00610519,COMPLETED,NO,Viral Pharyngitis|Viral Tonsillitis,DIETARY_SUPPLEMENT: mixture of aromatic essential oils.|DIETARY_SUPPLEMENT: placebo,"HaEmek Medical Center, Israel",,ALL,"ADULT, OLDER_ADULT",33,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-01,2008-05,"Otorhinolaryngology department, Afula, 18101, Israel"
NCT06291883,Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.,https://clinicaltrials.gov/study/NCT06291883,COMPLETED,NO,Coronavirus Disease 2019|Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COMBINATION_PRODUCT: Kang Guan Recipe (Treat)|COMBINATION_PRODUCT: Kang Guan Recipe (Placebo),Sheng-Teng Huang,,ALL,ADULT,26,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2023-02-09,2024-02-08,"China Medical University Hospital, Taichung, North District, 404, Taiwan"
NCT00010725,Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks,https://clinicaltrials.gov/study/NCT00010725,COMPLETED,NO,Cardiovascular Diseases,DRUG: MAK|DRUG: Vitamin Supplements,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",138,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,1999-09,2004-08,"Howard University Medical Center, Washington, Dc, District of Columbia, United States|Maharishi University of Management, Fairfield, Iowa, 52557, United States"
NCT06244550,Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors,https://clinicaltrials.gov/study/NCT06244550,COMPLETED,NO,Non-alcoholic Fatty Liver Disease|Liver Fibrosis|Liver Injury,DRUG: Ganwei|DRUG: Metformin|DRUG: Placebo,Taipei City Hospital,"The One Biopharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",60,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2021-09-22,2023-06-13,"Taipei City Hospital, Taipei, 103212, Taiwan"
NCT03230071,Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia,https://clinicaltrials.gov/study/NCT03230071,COMPLETED,NO,Vascular Dementia,DRUG: TMBCZG|OTHER: placebo,"Dongzhimen Hospital, Beijing",Beijing Union pharmaceutical factory II|Beijing Compete Medical Technology Development Co. Ltd.,ALL,"ADULT, OLDER_ADULT",160,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-07-28,2021-02-05,"Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT00610779,Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants,https://clinicaltrials.gov/study/NCT00610779,COMPLETED,NO,Rhino-Sinusitis,DIETARY_SUPPLEMENT: mixture of aromatic essential oils.|DIETARY_SUPPLEMENT: placebo,"HaEmek Medical Center, Israel",,ALL,"ADULT, OLDER_ADULT",14,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-01,2008-05,"Otorhinolaryngology department, Afula, 18101, Israel"
NCT03447925,Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients,https://clinicaltrials.gov/study/NCT03447925,COMPLETED,NO,Keratosis Plantaris,DRUG: Medicinal Plant|DRUG: Salicylate|DRUG: Vaseline,Universidade do Vale do Sapucai,,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-06-01,2020-01-01,"Beatriz B Martinez, Pouso Alegre, Minas Gerais, 37550312, Brazil"
NCT02777606,The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis,https://clinicaltrials.gov/study/NCT02777606,COMPLETED,NO,Severe Sepsis,DRUG: Si-Ni-Tang,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2016-06,2019-04,"Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510145, China"
NCT05141864,Acmella Oleracea in the Analgesia of the Digital Rectal Examination,https://clinicaltrials.gov/study/NCT05141864,COMPLETED,NO,Analgesia in the Digital Rectal Examination,BIOLOGICAL: Acmella oleracea gel|DRUG: Lidocaine 2 % Topical Cream|OTHER: Ultrasound gel,Universidade do Vale do Sapucai,,MALE,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2021-03-05,2021-11-05,"Universidade do Vale do Sapucaí, Pouso Alegre, Minas Gerais, 37550-000, Brazil"
NCT00611390,Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants,https://clinicaltrials.gov/study/NCT00611390,COMPLETED,NO,Viral Laryngitis|Viral Tracheitis,DIETARY_SUPPLEMENT: mixture of aromatic essential oils.|DIETARY_SUPPLEMENT: placebo,"HaEmek Medical Center, Israel",,ALL,"ADULT, OLDER_ADULT",29,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-01,2008-05,"Otorhinolaryngology department, Afula, 18101, Israel"
NCT06179901,The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents,https://clinicaltrials.gov/study/NCT06179901,RECRUITING,NO,Sciatica|Radiating Pain|Paresthesia|Dysesthesia,PROCEDURE: Integrative Korean Medicine Treatment|PROCEDURE: lower limb motion style acupuncture treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-10-30,2024-12-31,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT02114957,Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM),https://clinicaltrials.gov/study/NCT02114957,COMPLETED,NO,Healthy,DIETARY_SUPPLEMENT: 800mg dietary supplement CognIQTM (4 capsules) by oral at hour 0,Texas Tech University Health Sciences Center,,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2013-01,,"Clinical Research Unit, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, United States"
NCT01232114,Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia,https://clinicaltrials.gov/study/NCT01232114,UNKNOWN,NO,Functional Dyspepsia(FD) Was Studied|Effect of Simotang on FD Was Studied,,Hunan University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",400,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-10,2010-10,"Hunan university of TCM, Changsha, Hunan, 410007, China"
NCT01780181,Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer,https://clinicaltrials.gov/study/NCT01780181,COMPLETED,NO,Cancer,DRUG: TCM|DRUG: Chemotherapy,Shanghai University of Traditional Chinese Medicine,Shanghai Chest Hospital|Fudan University,ALL,OLDER_ADULT,82,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-12,2016-09,"Zhiyi Zhou, Shanghai, Shanghai, 200032, China"
NCT01098318,Rhodiola Rosea Therapy of Major Depressive Disorder,https://clinicaltrials.gov/study/NCT01098318,COMPLETED,YES,Depression,DIETARY_SUPPLEMENT: Herbal extract|DRUG: Sertraline|OTHER: Lactose monohydrate,University of Pennsylvania,National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-06,2013-07,"Depression Research Unit, Philadelphia, Pennsylvania, 19104-3309, United States"
NCT01651468,"The Effect of the Nutraceutical ""Hemofix"" on the Coagulation System",https://clinicaltrials.gov/study/NCT01651468,WITHDRAWN,NO,Von Willebrand Disease|Menorrhagia,DIETARY_SUPPLEMENT: HEMOFIX,Hadassah Medical Organization,HEMOFIX|Yocheved Grossman|Idan Grossman,ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2016-09,2023-12,"Hadassah Medical Organization, Jerusalem, Israel"
NCT02553382,Fibre Grain Herb Trial in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02553382,COMPLETED,NO,Type 2 Diabetes,"DIETARY_SUPPLEMENT: Dietary, Herbal|DIETARY_SUPPLEMENT: Positive Control",Unity Health Toronto,Canadian Diabetes Association,ALL,"ADULT, OLDER_ADULT",104,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-11,2018-04,"St. Michael's Hopsital, Toronto, Ontario, M5B 1M4, Canada|Clinical Centre Vuk Vrhovac, Merkur Hospital, Zagreb, 10000, Croatia"
NCT02468141,Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients,https://clinicaltrials.gov/study/NCT02468141,COMPLETED,NO,Cancer-related Problem/Condition,DRUG: SJDBT|DRUG: Placebo,Kyunghee University Medical Center,,ALL,"ADULT, OLDER_ADULT",32,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2015-07,2016-09,"Dunsan Korean Medicine Hospital, Daejeon, 302-869, Korea, Republic of"
NCT04873089,Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin,https://clinicaltrials.gov/study/NCT04873089,COMPLETED,NO,Acne,OTHER: Cosmetic product,Pierre Fabre Dermo Cosmetique,,ALL,ADULT,37,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-09-17,2018-12-21,"Skin Research Centre, Toulouse, 31300, France"
NCT03115892,Green Tea With Aloe Vera Mouthwash and Chlorohexidine Mouthwash,https://clinicaltrials.gov/study/NCT03115892,UNKNOWN,NO,Halitosis,DRUG: Green Tea With Aloe Vera mouthwash|DRUG: Chlorhexidine mouthwash,Cairo University,,ALL,CHILD,27,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2017-04-01,2017-12-01,"Oral An Dental Medicine Faculty, Cairo, Egypt"
NCT05229029,RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy,https://clinicaltrials.gov/study/NCT05229029,ACTIVE_NOT_RECRUITING,NO,Cancer-related Problem/Condition,DRUG: TCM Formula|DRUG: Placebo,Peking University Cancer Hospital & Institute,,ALL,"ADULT, OLDER_ADULT",196,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-04-02,2024-06-30,"Beijing Cancer Hospital, Beijing, Beijing, 100142, China"
NCT06086899,The Efficacy and Safety of Early MSAT on Radiating Pain in the Upper Extremity,https://clinicaltrials.gov/study/NCT06086899,RECRUITING,NO,Radiating Pain in the Upper Extremity,"PROCEDURE: Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)|PROCEDURE: Korean medical treatment",Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-11-06,2024-12-31,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT06093659,Nicotine Pharmacokinetic Study of Heated Tobacco and Heated Herbal Products,https://clinicaltrials.gov/study/NCT06093659,COMPLETED,YES,Healthy Volunteers,OTHER: Heated tobacco product with heated tobacco sticks (Product A)|OTHER: Heated tobacco product with heated tobacco sticks (Product B)|OTHER: Heated herbal product with nicotine-infused heated herbal sticks (Product C)|OTHER: Heated herbal product with nicotine-infused heated herbal sticks (Product D)|OTHER: Conventional Cigarette (Product E),Imperial Brands PLC,,ALL,"ADULT, OLDER_ADULT",25,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER,2023-07-07,2023-11-03,"Celerion, Belfast, United Kingdom"
NCT03443531,Effects of Traditional Chinese Medicine on Bronchiectasis Patients,https://clinicaltrials.gov/study/NCT03443531,UNKNOWN,NO,Bronchiectasis,DRUG: Bufei Huatan granule|DRUG: Yifei Qinghua granule|DRUG: Placebo Bufei Huatan granule|DRUG: Placebo Yifei Qinghua granule,Henan University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",216,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-03,2020-12,
NCT04113824,The Efficacy and Safety of Trapezius MSAT on Acute Whiplash Injury,https://clinicaltrials.gov/study/NCT04113824,COMPLETED,NO,"Whiplash Injury of Cervical Spine|Neck Pain, Posterior",PROCEDURE: trapezuis motion style acupuncture treatment|PROCEDURE: other Korean medical treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-07-03,2019-12-15,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of|Jaseng Medical Foundation, Seoul, Korea, Republic of"
NCT05493007,The Efficacy and Safety of Sandbag Self Walking-MSAT on Acute Low Back Pain,https://clinicaltrials.gov/study/NCT05493007,COMPLETED,NO,Low Back Pain,PROCEDURE: Sandbag motion style acupuncture treatment|PROCEDURE: Korean medical treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",104,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2021-07-17,2022-09-26,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT03973099,"Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen",https://clinicaltrials.gov/study/NCT03973099,COMPLETED,NO,Stress,DIETARY_SUPPLEMENT: PM011,VTBIO Co. LTD,,ALL,"ADULT, OLDER_ADULT",46,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2007-06-07,2007-12-30,
NCT04956458,The Efficacy and Safety of Lumbar MSAT on Acute Low Back Pain,https://clinicaltrials.gov/study/NCT04956458,COMPLETED,NO,Low Back Pain,PROCEDURE: Lumbar motion style acupuncture treatment|PROCEDURE: Korean medical treatment,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",96,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2021-03-19,2021-12-31,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT06266559,Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease,https://clinicaltrials.gov/study/NCT06266559,NOT_YET_RECRUITING,NO,Non-Alcoholic Fatty Liver Disease,OTHER: Chang Geng Healthy Drink,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-02-15,2025-12-31,
NCT00730158,"A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer",https://clinicaltrials.gov/study/NCT00730158,COMPLETED,YES,Colorectal Neoplasms,DRUG: KD018|DRUG: Irinotecan|DRUG: Placebo,"Edward Chu, MD","Kadmon Corporation, LLC",ALL,"ADULT, OLDER_ADULT",33,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2008-12,2018-06,"Yale University Comprehensive Cancer Center, New Haven, Connecticut, 06520, United States|Hillman CancerCenters, Pittsburgh, Pennsylvania, 15232, United States"
NCT05249777,"A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19",https://clinicaltrials.gov/study/NCT05249777,COMPLETED,NO,COVID-19,DRUG: TD0069 hard capsule|DRUG: TD0069 Placebo,Sao Thai Duong Joint Stock Company,CLINICAL RESEARCH VIET NAM SKILL TRAINING AND CONSULTING COMPANY LIMITED,ALL,"ADULT, OLDER_ADULT",573,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2022-01-06,2022-09-10,"Traditional Medicine Institute in Ho Chi Minh City, Ho Chi Minh City, Ho Chi Minh, Vietnam|Hanoi Hospital of Traditional Medicine, Ha Noi, Vietnam"
NCT00808860,Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT00808860,COMPLETED,NO,Type 2 Diabetes,DIETARY_SUPPLEMENT: GP group|DIETARY_SUPPLEMENT: Placebo group,Hanoi Medical University,Karolinska Institutet|Swedish International Development Cooperation Agency (SIDA),ALL,"ADULT, OLDER_ADULT",25,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-02,2008-12,"National Institute of Gerontology, HMU, Hanoi, Vietnam"
NCT05004272,IOBA - Impact on Body Awareness,https://clinicaltrials.gov/study/NCT05004272,COMPLETED,NO,"Perception, Self|Body Image|Self-Assessment",PROCEDURE: Massage|PROCEDURE: Gymnastics|OTHER: Lecture,Johannes Kepler University of Linz,Medical University of Graz,ALL,"ADULT, OLDER_ADULT",96,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2021-08-16,2021-09-30,"Kepler University Hospital, Linz, 4020, Austria"
NCT06353477,"Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option",https://clinicaltrials.gov/study/NCT06353477,COMPLETED,NO,"Hand, Foot, and Mouth Disease",DRUG: EPs® 7630,Eskisehir Osmangazi University,Abdi Ibrahim Ilac San. ve Tic A.S.,ALL,CHILD,240,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-06-01,2023-01-01,"Istinye University Medicine Faculty Hospital, Esenyurt, İstanbul, 34517, Turkey"
NCT00629161,Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease,https://clinicaltrials.gov/study/NCT00629161,UNKNOWN,NO,Parkinson Disease,DRUG: Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)|DRUG: placebo,Fudan University,,ALL,"ADULT, OLDER_ADULT",144,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-11,,"Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences, Beijing, Beijing, 100053, China|Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200032, China|Zhongshan hospital, Fudan University, Shanghai, Shanghai, 200032, China|Tongji Hospital of Tongji University, Shanghai, Shanghai, 200065, China|Shanghai Chinese Medical Hospital, Shanghai, Shanghai, 200071, China|Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, 200127, China|The Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, Shanghai, 200233, China|Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China|Department of Neurology, The second people's hospital of Wenzhou, Wenzhou, Zhejiang, 325000, China"
NCT03009864,The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage,https://clinicaltrials.gov/study/NCT03009864,UNKNOWN,NO,Diabetic Kidney Disease,DRUG: Tangshen Prescription|DRUG: Placebos,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine|Zhengzhou City Hospital of Traditional Chinese Medicine|Shijiazhuang City Hospital of Traditional Chinese Medicine|Baoding City Hospital of Traditional Chinese Medicine|Hubei Hospital of Traditional Chinese Medicine|Changchun Hospital of Traditional Chinese Medicine|Xingtai City Hospital of Traditional Chinese Medicine|Medicine Zibo Wanjie Tumor Hospital|Zouping Country Hospital of Traditional Chinese Medicine|She Country Hospital of Traditional Chinese Medicine|Beijing Hospital of TCM|Baishi Hospital,ALL,"ADULT, OLDER_ADULT",632,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01,2020-05,"Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT00011063,Effect of Ginkgo Biloba on Phenytoin Elimination,https://clinicaltrials.gov/study/NCT00011063,COMPLETED,NO,Healthy,DRUG: Ginkgo Biloba,National Institutes of Health Clinical Center (CC),,ALL,"CHILD, ADULT, OLDER_ADULT",12,NIH,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT,2001-02,2001-04,"Warren G. Magnuson Clinical Center (CC), Bethesda, Maryland, 20892, United States"
NCT04457531,LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT04457531,UNKNOWN,NO,Diabetic Peripheral Neuropathy|Chinese Medicine|Nerve Conduction,DRUG: LiuWeiLuoBi Granule|OTHER: Standard medical treatment,China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-10-26,2023-12,"Yuquan Hospital of Tsinghua University, Beijing, Beijing, 100000, China"
NCT03708549,Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients,https://clinicaltrials.gov/study/NCT03708549,UNKNOWN,NO,Schizophrenia|Metabolic Syndrome|Berberine|Metformin,DRUG: Berberine|DRUG: Metformin,Tianjin Anding Hospital,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-12-01,2023-12-01,"Tianjin Anding Hospital, Tianjin, Tianjin, 300222, China"
NCT01441752,Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients,https://clinicaltrials.gov/study/NCT01441752,COMPLETED,NO,Non-small Cell Lung Cancer,DRUG: TCM|DRUG: placebo,xuling,,ALL,"ADULT, OLDER_ADULT",349,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-11,2015-03,"ShanghaiUTCM, Shanghai, Shanghai, 200032, China|Xuling, Shanghai, Shanghai, 200032, China"
NCT03907501,Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation,https://clinicaltrials.gov/study/NCT03907501,TERMINATED,YES,Human Microbiome,DIETARY_SUPPLEMENT: Synbiotic|DIETARY_SUPPLEMENT: Probiotic|DIETARY_SUPPLEMENT: Placebo,"University of California, San Diego",,ALL,OLDER_ADULT,75,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2019-02-01,2021-07-12,"University of California, San Diego, La Jolla, California, 92093, United States"
NCT05789186,Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents,https://clinicaltrials.gov/study/NCT05789186,RECRUITING,NO,Depression,DRUG: CAVO aromatherapy patch at 3% concentration+Fluoxetine hydrochloride mimetic|DRUG: Fluoxetine hydrochloride tablet+CAVO aromatherapy patch at 0.1% concentration|DRUG: Fluoxetine hydrochloride mimetic+CAVO aromatherapy patch at 0.1% concentration,Chen Qian,,ALL,"CHILD, ADULT",108,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2023-05-01,2024-01-01,"Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650032, China"
NCT02663479,Nutraceutical Supplement in the Management of Hypertension,https://clinicaltrials.gov/study/NCT02663479,COMPLETED,NO,Hypertension,DIETARY_SUPPLEMENT: Cardiopressin|DIETARY_SUPPLEMENT: Placebo,"Thorne HealthTech, Inc",,ALL,"ADULT, OLDER_ADULT",40,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2015-09,2017-10,"Hypertension Institute of Nashville, TN, Nashville, Tennessee, 37205, United States"
NCT05152498,Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC),https://clinicaltrials.gov/study/NCT05152498,UNKNOWN,NO,Hepatocellular Carcinoma,DRUG: Fu Zheng Jie Du Hua Yu therapy,Beijing Ditan Hospital,,ALL,"ADULT, OLDER_ADULT",142,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-01-01,2023-12-31,"Zhiyun Yang, Beijing, Beijing, 100015, China"
NCT00506337,Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis,https://clinicaltrials.gov/study/NCT00506337,UNKNOWN,NO,"Pancreatitis, Acute Necrotizing",DRUG: Qingyi granules,Tianjin Nankai Hospital,Sichuan University,ALL,"ADULT, OLDER_ADULT",300,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2006-10,2009-10,"The 1st Affiliated Hospital, Dalian Medical Unversity, Dalian, Liaoning, 116011, China|West China Hospital, Sichuan Unversity, Chengdu, Sichuan, 610041, China|Tianjin Nankai Hospital, Tianjin, 300100, China"
NCT04935671,Effects of Saffron and Chamomile in Mild to Moderate Depression,https://clinicaltrials.gov/study/NCT04935671,ACTIVE_NOT_RECRUITING,NO,Depression,DIETARY_SUPPLEMENT: chamomile tea n saffron,Dr Saara (Ahmad) Muddasir Khan,University of Karachi,ALL,"CHILD, ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2020-01-01,2023-12,"Aga Khan University, Karachi, PK, 74800, Pakistan"
NCT03081819,A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer,https://clinicaltrials.gov/study/NCT03081819,COMPLETED,NO,"Solid Tumor, Adult",DRUG: SH003,Kyunghee University Medical Center,,ALL,"ADULT, OLDER_ADULT",11,OTHER,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,2017-03-29,2019-07-25,"Ajou University Hospital, Suwon, 16499, Korea, Republic of"
NCT06271928,A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging,https://clinicaltrials.gov/study/NCT06271928,RECRUITING,NO,Ovarian Aging,DRUG: Yijing Keli,Tongji Hospital,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-10-01,2025-01-01,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"
NCT01356355,Study of Herbmed Plus in Ureteral Stent Discomfort,https://clinicaltrials.gov/study/NCT01356355,COMPLETED,NO,Ureteral Stent Discomfort,DRUG: Herbmed plus|DRUG: Placebo|DRUG: Tolterodine,Dr .S.B.PATANKAR,,ALL,"ADULT, OLDER_ADULT",140,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-04,2014-12,"AMAI Charitable Trust's ACE Hospital Pune, Pune, Maharashtra, 411004, India"
NCT06256783,A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging,https://clinicaltrials.gov/study/NCT06256783,RECRUITING,NO,Ovarian Aging,DRUG: Baozhu Keli,Tongji Hospital,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-08-01,2025-01,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"
NCT03986528,Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC),https://clinicaltrials.gov/study/NCT03986528,UNKNOWN,NO,NSCLC,DRUG: Kanglaite Injection+Chemotherapy|DRUG: Chemotherapy,Jie Li,"Ministry of Science and Technology of the People´s Republic of China|Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences",ALL,"ADULT, OLDER_ADULT",334,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-08-28,2022-05-31,"Anhui Chest Hospital, Hefei, Anhui, 230022, China|Chongqing Cancer Hospital, Chongqing, Chongqing, 400030, China|Gansu Provincial Tumor Hospital, Lanzhou, Gansu, 730050, China|The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guanzhou, Guangdong, 510405, China|Henan Cancer Hospital, Zhengzhou, Henan, 450008, China|Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, Changsha, Hunan, 410013, China|Hunan Provincial Tumor Hospital, Changsha, Hunan, 410013, China|Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, 210029, China|XuZhou Central Hospital, Xuzhou, Jiangsu, 221009, China|The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, 110032, China|The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250014, China|Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200032, China|Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China|Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, 030000, China|The Fourth Military Medical University Tangdu Hospital, Xian, Shanxi, 710038, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, 300060, China|The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, 310006, China"
NCT05626309,Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer,https://clinicaltrials.gov/study/NCT05626309,UNKNOWN,NO,Esophagus Cancer,DRUG: Qizhu Yuling Prescription|DRUG: Placebo,Jie Li,,ALL,"ADULT, OLDER_ADULT",310,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-10-01,2024-11-30,"Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, Beijing, 100010, China|Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100091, China|Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100102, China"
NCT01019889,Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection,https://clinicaltrials.gov/study/NCT01019889,COMPLETED,NO,Upper Respiratory Tract Infections,DRUG: SCRT|DRUG: YPS|DRUG: Placebo,Korea Health Industry Development Institute,,ALL,ADULT,480,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-09,2009-07,
NCT03192748,A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World,https://clinicaltrials.gov/study/NCT03192748,UNKNOWN,NO,Eczema,,China Academy of Chinese Medical Sciences,Xiyuan Hospital of China Academy of Chinese Medical Sciences,ALL,"CHILD, ADULT, OLDER_ADULT",3000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-06-19,2019-06-30,
NCT03105960,Garlic With Lime Juice and Chlorhexidine Mouthwash,https://clinicaltrials.gov/study/NCT03105960,UNKNOWN,NO,Gingival Bleeding,DRUG: garlic with lime mouth wash|DRUG: chlorhexidine,Cairo University,,ALL,CHILD,36,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-03-10,2017-06-01,"Manal Sayed Abdel Latief, Helwan, Cairo, 02, Egypt"
NCT06629246,Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure with Preserved Ejection Fraction,https://clinicaltrials.gov/study/NCT06629246,COMPLETED,NO,"Heart Failure, Diastolic (HFpEF)",DRUG: Conventional heart failure treatment|DRUG: Pogejiuxin decoction combined with conventional heart failure treatment,Chongqing Traditional Chinese Medicine Hospital,Chongqing Science and Technology Commission|Chongqing Health and Family Planning Commission,ALL,"CHILD, ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT,2021-09-01,2023-09-17,"Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing, 400000, China"
NCT03884920,Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation,https://clinicaltrials.gov/study/NCT03884920,COMPLETED,NO,Diabetes Mellitus|Pre Diabetes,DIETARY_SUPPLEMENT: Polyherbal formulation,Islamia University of Bahawalpur,Hashmi Herbal Pharma (HHP) Registered Bahawalpur,ALL,ADULT,57,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-03-20,2021-12-30,"Hashmi Dawakhana, Khairpur Tamewali, Punjab, 63060, Pakistan|University College of Conventional Medicine, Bahawalpur, 63100, Pakistan"
NCT01083381,Is MS14 Helpful in Schizophrenia?,https://clinicaltrials.gov/study/NCT01083381,UNKNOWN,NO,Schizophrenia,DRUG: MS14|DRUG: Risperidone,Farzan Institute,,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-02,2011-04,"Iran Psychiatric Training and Treatment Center, Tehran, Iran, Islamic Republic of"
NCT06771427,Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome,https://clinicaltrials.gov/study/NCT06771427,RECRUITING,NO,Dry Eye Syndrome (DES)|Sjogren's Syndrome|Xerophthalmia,OTHER: acupuncture GB20 or GB20 plus BL2|DRUG: Chinese herbal tea TBDESJS,"Taipei Veterans General Hospital, Taiwan",,ALL,"ADULT, OLDER_ADULT",220,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2025-01-16,2026-12-31,"Ching-Mao, Taipei, 886, Taiwan"
NCT05508516,Shugan Dingtong Decoction in the Treatment of Fibromyalgia,https://clinicaltrials.gov/study/NCT05508516,COMPLETED,NO,Fibromyalgia,DRUG: Shugan Dingtong decoction|DRUG: Duloxetine Hydrochloride,China-Japan Friendship Hospital,,ALL,"ADULT, OLDER_ADULT",72,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-09-01,2024-10-18,"China-Japan Friendship Hospital, Beijing, Beijing, 100029, China"
NCT01126931,Wormwood in Chronic Progressive Disorders With Reduced Appetite,https://clinicaltrials.gov/study/NCT01126931,UNKNOWN,NO,Cancer,,University Hospital Freiburg,,ALL,"ADULT, OLDER_ADULT",300,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-02,2012-12,"University of Freiburg, Medical Faculty, Freiburg, Baden, 79110, Germany"
NCT04842825,Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients,https://clinicaltrials.gov/study/NCT04842825,UNKNOWN,NO,"Infertility, Female",DRUG: Er Zhi Wan combined with Si Wu Tang|DRUG: Recombinant Human Follitropin Alfa 、Fructose 、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder,Peking University Third Hospital,,FEMALE,ADULT,200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-04-15,2022-12-30,"Peking University Third Hospital, Beijing, China, China"
NCT01299870,Catamenial Epilepsy Treatment,https://clinicaltrials.gov/study/NCT01299870,UNKNOWN,NO,Epilepsy,DRUG: AED treatment plus placebo|DRUG: Keishibukuryogan,"Timothy Welty, PharmD",,FEMALE,ADULT,17,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-02,2012-12,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States"
NCT05109923,Onnit Labs New Mood Supplementation in Healthy College Students,https://clinicaltrials.gov/study/NCT05109923,COMPLETED,NO,Mental Health Wellness 1,DIETARY_SUPPLEMENT: Multi-Ingredient Herbal Supplement|DIETARY_SUPPLEMENT: Placebo Supplement,University of Idaho,,ALL,ADULT,56,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2018-09-10,2019-08-02,"University of Idaho, Moscow, Idaho, 83844, United States"
NCT00118833,St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD),https://clinicaltrials.gov/study/NCT00118833,COMPLETED,NO,Anxiety Disorders|Mental Health,DRUG: Hypericum perforatum (St. John's wort),National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",56,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2002-08,2006-06,"Duke University Medical Center, Durham, North Carolina, 27710, United States"
NCT02301052,Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms,https://clinicaltrials.gov/study/NCT02301052,UNKNOWN,NO,Hemorrhoids,DRUG: Leek topical cream|DRUG: placebo topical cream|DRUG: Anti-hemorrhoid topical cream,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",75,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-09,2014-12,"Vice-Chancellery of Research and Technology office, Shiraz University of Medical Sciences, Shiraz, Fars, 009871, Iran, Islamic Republic of"
NCT03643094,Golden Black Seed: Support of Metabolic Health and General Wellness.,https://clinicaltrials.gov/study/NCT03643094,COMPLETED,NO,Hyperlipidemias|Hyperglycemia,DIETARY_SUPPLEMENT: Golden Black Seed,Natural Immune Systems Inc,New Chapter Inc.,ALL,"ADULT, OLDER_ADULT",12,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2018-03-14,2018-10-14,"Gitte Jensen, Klamath Falls, Oregon, 97601, United States"
NCT04230057,Pharmacokinetics Study of Antitumor B in Healthy Volunteers,https://clinicaltrials.gov/study/NCT04230057,UNKNOWN,NO,Healthy Adults,DIETARY_SUPPLEMENT: Antitumor B,University of Houston,,ALL,"ADULT, OLDER_ADULT",12,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-12-12,2021-08-30,"University of Houston, College of Pharmacy, Houston, Texas, 77204, United States"
NCT03197844,Study on Registration of Xinyuan Capsule,https://clinicaltrials.gov/study/NCT03197844,UNKNOWN,NO,Coronary Disease,,China Academy of Chinese Medical Sciences,Xiyuan Hospital of China Academy of Chinese Medical Sciences,ALL,"CHILD, ADULT, OLDER_ADULT",3000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-06-23,2018-12-31,
NCT03192787,A Registry Study of Sanwujiaowan Capsule Used in Clinical Real World,https://clinicaltrials.gov/study/NCT03192787,UNKNOWN,NO,Rheumatism|Osteoarthritis,,Yanming Xie,Xiangya Hospital of Central South University,ALL,"CHILD, ADULT, OLDER_ADULT",3000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-06-19,2018-12-31,
NCT05982262,Naturopathic-pharmacological Consultation in Hematology,https://clinicaltrials.gov/study/NCT05982262,RECRUITING,NO,Hematologic Diseases,OTHER: Naturopathic-pharmacological consultation,Bnai Zion Medical Center,,ALL,"ADULT, OLDER_ADULT",100,OTHER_GOV,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2023-06-15,2028-06,"Bnai Zion Medical Center, Haifa, 3339419, Israel"
NCT05229809,Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer,https://clinicaltrials.gov/study/NCT05229809,UNKNOWN,NO,Gastric Carcinoma,DRUG: Yiqi Wenyang Jiedu prescription|DRUG: Simulation agent of Yiqi Wenyang Jiedu prescription,Jie Li,,ALL,"ADULT, OLDER_ADULT",212,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-03-01,2024-07-31,"Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100021, China|Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100091, China|Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100102, China|The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China|Jiangsu Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, 210004, China|Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China"
NCT05110599,Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth,https://clinicaltrials.gov/study/NCT05110599,TERMINATED,NO,Preterm Labor|Anxiety,DRUG: Bryophyllum 50% chewable tablets|OTHER: Placebo,Christian Haslinger,,FEMALE,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2022-07-12,2023-10-01,"University Hospital Zurich, Zürich, 8091, Switzerland"
NCT03384667,Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer,https://clinicaltrials.gov/study/NCT03384667,UNKNOWN,NO,Postoperative Cough|Lung Cancer,DRUG: Maekmoondong-tang|DRUG: Placebo,Seong-Gyu Ko,,ALL,"ADULT, OLDER_ADULT",96,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-02-22,2019-03-31,"Korea University Guro Hospital, Seoul, 130-701, Korea, Republic of"
NCT04810689,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19",https://clinicaltrials.gov/study/NCT04810689,TERMINATED,NO,Covid19,DRUG: Xuanfei Baidu Granules|OTHER: Placebo,Darcy Spicer,,ALL,"ADULT, OLDER_ADULT",5,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2021-03-01,2022-06-20,"University of Southern California, Los Angeles, California, 90033, United States"
NCT02107469,A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy,https://clinicaltrials.gov/study/NCT02107469,COMPLETED,NO,Diabetic Polyneuropathy|Diabetic Neuralgia|Diabetic Neuropathies|Diabetic Neuropathy,DRUG: Sida cordifolia roots|DRUG: Phyllanthus niruri|DRUG: Sida cordifolia roots extract|DRUG: Phyllanthus niruri extract|OTHER: Sida cordifolia placebo|OTHER: Phyllanthus niruri placebo,Rosenberg European Academy of Ayurveda,EUROPEAN PROFESSIONAL ASSOCIATION OF AYURVEDA PRACTITIONERS AND THERAPISTS,ALL,"ADULT, OLDER_ADULT",98,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-06,2016-02,"P.D. Patel Ayurveda Hospital, Nadiad, Gujarat, 387001, India"
NCT03947554,Ginseng HRG80 in Stress and Fatigue,https://clinicaltrials.gov/study/NCT03947554,COMPLETED,NO,Psychological Stress,DIETARY_SUPPLEMENT: HRG80 Panax ginseng|DIETARY_SUPPLEMENT: Panax ginseng|DIETARY_SUPPLEMENT: Placebo,"EuroPharma, Inc.",Botalys SA,ALL,"ADULT, OLDER_ADULT",50,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: PREVENTION",2019-04-01,2019-07-01,"Sports Medicine and Anti-Doping Service Republican Centre, Yerevan, Armenia"
NCT00327054,Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia,https://clinicaltrials.gov/study/NCT00327054,COMPLETED,NO,Hypercholesterolemia|Hypertension|Diabetes Mellitus|Metabolic Syndrome X,DRUG: Nigella sativa seed,Aga Khan University,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2006-02,2007-03,"Aga Khan University, Karachi, Sindh, 74800, Pakistan"
NCT06624800,The Efficacy and Safety of Shoulder Chuna on in Patients with Shoulder Pain Caused by Traffic Accidents,https://clinicaltrials.gov/study/NCT06624800,RECRUITING,NO,Acute Shoulder Pain,"PROCEDURE: Shoulder chuna treatment(posterior displacement, anterior displacement, or lateral displacement)|PROCEDURE: Korean medical treatment",Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",98,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-11-04,2025-12,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT05729204,Washing COVID-19 Away With a Hypertonic Seawater Nasal Irrigation Solution,https://clinicaltrials.gov/study/NCT05729204,COMPLETED,NO,SARS-CoV2 Infection,OTHER: Hypertonic seawater solution,Larissa University Hospital,,ALL,"ADULT, OLDER_ADULT",56,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER,2022-06-01,2022-12-31,"University Hospital of Larissa, Larissa, Thessaly, 41500, Greece"
NCT04702542,To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.,https://clinicaltrials.gov/study/NCT04702542,ACTIVE_NOT_RECRUITING,NO,Gastritis Chronic|Gastroduodenitis|Peptic Ulcer|Duodenal Ulcer,DRUG: Enteral oxygen therapy,Tashkent Pediatric Medical Institute,,ALL,CHILD,320,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2020-01-04,2028-12-30,"Tashkent Pediatric Medical Institute, Tashkent, 100140, Uzbekistan"
NCT04136639,The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract,https://clinicaltrials.gov/study/NCT04136639,COMPLETED,NO,Dental Caries,OTHER: Miswak|OTHER: Grape Seed Extract Mouthwash|OTHER: fluoride,Al-Azhar University,,ALL,ADULT,30,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION,2019-06-01,2019-10-01,"Al Azhar University, Cairo, Nasr City, Egypt"
NCT06664671,The Effect of Thyme Oil in Asthmatic Patients,https://clinicaltrials.gov/study/NCT06664671,NOT_YET_RECRUITING,NO,Asthma|Asthma Patients,OTHER: Experimental|OTHER: Placebo|OTHER: Control (Standard treatment),Inonu University,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2024-11-01,2025-05-15,
NCT02983669,The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease,https://clinicaltrials.gov/study/NCT02983669,COMPLETED,NO,"Fatty Liver|Fatty Liver, Nonalcoholic",DIETARY_SUPPLEMENT: Thyme|OTHER: Placebo,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",86,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01,2017-05-10,"Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of"
NCT02178215,Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT02178215,COMPLETED,NO,Atopic Dermatitis,OTHER: Placebo shower gel|OTHER: Holly Mangrove Shower Gel,Mahidol University,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07,2016-02,"Siriraj Hospital Mahidol Univeristy, Bangkok, 10700, Thailand"
NCT00522197,ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia,https://clinicaltrials.gov/study/NCT00522197,COMPLETED,NO,Lung Cancer|Precancerous Condition,DIETARY_SUPPLEMENT: multi-herbal agent ACAPHA|DIETARY_SUPPLEMENT: Sugar Pill,British Columbia Cancer Agency,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2002-09,2008-11,
NCT05732441,Therapeutic Study of Prostatitis With Elevated PSA,https://clinicaltrials.gov/study/NCT05732441,UNKNOWN,NO,Prostatitis|PSA,DRUG: Huange capsule,"Second Affiliated Hospital, School of Medicine, Zhejiang University",,MALE,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-08-01,2024-12-31,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, 310000, China"
NCT06145997,Feasibility and Acceptability Study of ACUAWARE,https://clinicaltrials.gov/study/NCT06145997,NOT_YET_RECRUITING,NO,Chronic Pain,OTHER: Acupuncture therapy,University of Utah,Pace University,ALL,"ADULT, OLDER_ADULT",50,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-12-15,2026-11-01,
NCT00442091,Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema,https://clinicaltrials.gov/study/NCT00442091,COMPLETED,NO,Vesicular Palmoplantar Eczema|Pompholyx,DRUG: dandelion juice,Odense University Hospital,,ALL,"ADULT, OLDER_ADULT",4,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-12,2019-12,"Department of Dermatology, Odense University Hospital, Odense, DK-5000, Denmark"
NCT02384928,Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation,https://clinicaltrials.gov/study/NCT02384928,COMPLETED,NO,Sciatica|Intervertebral Disc Displacement,PROCEDURE: Shinbaro pharmacopuncture|DEVICE: Acupuncture|DRUG: Conventional medicine|PROCEDURE: Physical therapy|BEHAVIORAL: Educational program,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-09-09,2017-03-16,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of"
NCT03753113,Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%,https://clinicaltrials.gov/study/NCT03753113,COMPLETED,YES,Androgenetic Alopecia,DRUG: Topical Herbal Solution|DRUG: Topical Minoxidil 5%,Farid Masoud,,MALE,ADULT,24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-11-28,2019-09-02,"Department of Dermatology, Sina Hospital, Tabriz, East Azerbaijan, Iran, Islamic Republic of"
NCT00026013,Effects of St. John's Wort on the Effectiveness of Oral Contraceptives,https://clinicaltrials.gov/study/NCT00026013,COMPLETED,NO,Contraception,DRUG: hypericum perforatum,National Center for Complementary and Integrative Health (NCCIH),,FEMALE,ADULT,25,NIH,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE|Primary Purpose: TREATMENT,2002-01,2004-01,"Columbia University Department of Obstetrics & Gynecology, New York, New York, 10032, United States"
NCT04557267,Dose-ranging Study of SKF7™ for Obesity,https://clinicaltrials.gov/study/NCT04557267,COMPLETED,NO,Obesity,DRUG: low-dose|DRUG: Middle-dose|DRUG: Higher-dose|DRUG: Placebo,Indonesia University,Medika Natura Sdn Bhd,ALL,ADULT,160,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2020-09-30,2021-05-22,"Indonesia Medical Education and Research Institute, Jakarta, DKI Jakarta, 10430, Indonesia|Faculty of Medicine, Krida Wacana Christian University, Jakarta, DKI Jakarta, 11510, Indonesia|Makara Satellite Clinic, Depok, West Java, 16424, Indonesia"
NCT04436913,Evaluation of Preventive Regimens With Different Toothpastes vs Fluoride Varnish & Toothpaste in High Caries Patients,https://clinicaltrials.gov/study/NCT04436913,COMPLETED,NO,Dental Caries,OTHER: Himalaya complete care toothpaste|OTHER: Signal toothpaste|OTHER: Signal toothpaste and fluoride varnish,Cairo University,,ALL,"CHILD, ADULT",54,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2021-01-16,2022-01-31,"Cairo university, Faculty of oral and dental medicine, Cairo, Egypt"
NCT01052025,Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance,https://clinicaltrials.gov/study/NCT01052025,UNKNOWN,NO,Type 2 Diabetes|Pre-diabetes|Insulin Resistance|Cardiovascular Risk,DRUG: Curcumin,Srinakharinwirot University,"Ministry of Health, Thailand",ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION,2009-08,2010-04,"HRH Princess Maha Chakri Sirindhorn Medical Center, Ongkarak, Nakornnayok, 26120, Thailand"
NCT01254084,Effect of Gynostemma Pentaphyllum Tea in Insulin Sensitivity in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT01254084,COMPLETED,NO,Type 2 Diabetes,DIETARY_SUPPLEMENT: Gynostemma Pentaphyllum tea|DIETARY_SUPPLEMENT: Placebo tea,Hanoi Medical University,Karolinska Institutet|Swedish International Development Cooperation Agency (SIDA),ALL,"ADULT, OLDER_ADULT",16,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-02,2010-11,"National Institute of Gerontology, HMU, Hanoi, Vietnam|National Institute of Gerontology, Hanoi, Vietnam"
NCT04245540,Effects of Pau d' Arco in Primary Dysmenorrhea,https://clinicaltrials.gov/study/NCT04245540,COMPLETED,NO,Primary Dysmenorrhea,DIETARY_SUPPLEMENT: Pau d' Arco,National University of Natural Medicine,,FEMALE,ADULT,12,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2019-07-30,2022-12-15,"National University of Natural Medicine, Portland, Oregon, 97201, United States"
NCT05375539,AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients,https://clinicaltrials.gov/study/NCT05375539,ACTIVE_NOT_RECRUITING,NO,Prostate Cancer,DRUG: AGN-CognI.Q,Milton S. Hershey Medical Center,,MALE,"ADULT, OLDER_ADULT",12,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2023-05-02,2025-09-30,"Penn State Cancer Institute, Hershey, Pennsylvania, 17033, United States"
NCT06475027,Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome,https://clinicaltrials.gov/study/NCT06475027,NOT_YET_RECRUITING,NO,Dry Eye Syndrome|Sjogren's Syndrome|Xerophthalmia,OTHER: TBDESJS|OTHER: Acupuncture,"Taipei Veterans General Hospital, Taiwan",,ALL,"ADULT, OLDER_ADULT",220,OTHER_GOV,OBSERVATIONAL,Observational Model: |Time Perspective: p,2024-07-01,2026-12-31,"Ching-Mao Chang, Taipei, 112, Taiwan"
NCT01535417,Efficacy and Safety of Shinbaro Capsule,https://clinicaltrials.gov/study/NCT01535417,COMPLETED,NO,Osteoarthritis,DRUG: Shinbaro Capsule|DRUG: Celebrex,Green Cross Corporation,,ALL,"ADULT, OLDER_ADULT",198,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2009-05,2009-12,
NCT03663881,Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia,https://clinicaltrials.gov/study/NCT03663881,COMPLETED,NO,Toxicity|Safety Issues,DRUG: P2Et extract,Hospital Universitario San Ignacio,Pontificia Universidad Javeriana,ALL,"ADULT, OLDER_ADULT",7,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-04-30,2020-05-15,"Hospital Universitario San Ignacio, Bogotá, 110221, Colombia"
NCT01513070,A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis,https://clinicaltrials.gov/study/NCT01513070,COMPLETED,NO,Coronary Artery Stenosis|Coronary Heart Disease,DRUG: Quick-Acting Heart Reliever|DRUG: Isosorbide Dinitrate|DRUG: Placebo of Isosorbide Dinitrate|DRUG: Aspirin Enteric-coated Tablets|DRUG: Placebo of Quick-Acting Heart Reliever|DRUG: Aspirin Enteric-coated Tablets,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-04,2014-06,"Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China"
NCT00040898,Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed,https://clinicaltrials.gov/study/NCT00040898,COMPLETED,NO,Liver Cancer,DIETARY_SUPPLEMENT: Sho-saiko-to,Memorial Sloan Kettering Cancer Center,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",,OTHER,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT,2001-01,,"Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States"
NCT03569683,"Comparison Between Laser, Synthetic Gel and Herbal Gel as Topical Agents After Gum Surgery",https://clinicaltrials.gov/study/NCT03569683,COMPLETED,NO,Gingival Overgrowth,PROCEDURE: External bevel gingivectomy|DEVICE: Diode laser Biostimulation|OTHER: Hyaluronic acid (Gengigel) topical application.|OTHER: Herbal gel (Hiora SG) topical application,Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre,,ALL,ADULT,30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2018-05-30,2018-10-30,"Panineeya Mahavidyalaya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, 500060, India"
NCT03998735,Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure,https://clinicaltrials.gov/study/NCT03998735,RECRUITING,NO,Smokeless Tobacco,DRUG: Herbal Snuff (Smokeless Tobacco),"Masonic Cancer Center, University of Minnesota",,ALL,"ADULT, OLDER_ADULT",55,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2021-10-19,2026-10,"Masonic Cancer Center, Minneapolis, Minnesota, 55411, United States"
NCT05044650,Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients,https://clinicaltrials.gov/study/NCT05044650,UNKNOWN,NO,COVID-19,DIETARY_SUPPLEMENT: KOVIR capsule combined with background treatment,Sao Thai Duong Joint Stock Company,Big Leap Clinical Research Joint Stock Company,ALL,"ADULT, OLDER_ADULT",1000,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2022-06,2022-06,"Traditional Medicine Institute in Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam"
NCT02324777,Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee,https://clinicaltrials.gov/study/NCT02324777,UNKNOWN,NO,"Osteoarthritis, Knee",DRUG: Cannabis|DEVICE: Volcano® Medic Vapourizer,Prairie Plant Systems Inc.,McGill University Health Centre/Research Institute of the McGill University Health Centre|Dalhousie University|Algorithme Pharma Inc|Research Institute of the McGill University Health Center,ALL,"ADULT, OLDER_ADULT",40,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-06,2019-06,"Pain Management Unit, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|Montreal General Hospital - McGill University Health Centre, Montreal, Quebec, H3G 1A4, Canada"
NCT04565470,Strategies of Self-management of Endometriosis Symptoms,https://clinicaltrials.gov/study/NCT04565470,COMPLETED,NO,Endometriosis,OTHER: online questionnaire,Benno Rehberg-Klug,,FEMALE,"ADULT, OLDER_ADULT",165,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-09-21,2024-06-01,"Hôpitaux Universitaires de Genève HUG, Geneva, 1211, Switzerland"
NCT00219960,The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension,https://clinicaltrials.gov/study/NCT00219960,COMPLETED,NO,Hypertension,DRUG: North American Ginseng (Panax Quinquefolius),Risk Factor Modification Centre,"Ontario Ministry of Agriculture, Food and Rural Affairs|Ontario Ginseng Growers Association",ALL,"ADULT, OLDER_ADULT",52,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT,2001-04,2003-10,"Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, M5C 2T2, Canada"
NCT04385979,Curcumin and Nanocurcumin in Oral Aphthous Ulcer,https://clinicaltrials.gov/study/NCT04385979,COMPLETED,NO,Recurrent Aphthous Ulcer|Recurrent Aphthous Stomatitis,OTHER: Gel,Shahid Beheshti University of Medical Sciences,,ALL,"CHILD, ADULT, OLDER_ADULT",48,OTHER,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-07-15,2020-03-01,"Mahinbakhshi@Sbmu.Ac.Ir, Tehran, 0098, Iran, Islamic Republic of"
NCT02261571,Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer,https://clinicaltrials.gov/study/NCT02261571,UNKNOWN,NO,Cancer,OTHER: Moxibustion,The Comprehensive and Integrative Medicine Institute of South Korea,,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE,2014-10,2015-09,"Deagu Hanny University Medical center, Deagu, 704-123, Korea, Republic of"
NCT06204003,Cannabinoids for Pain Management and Neuroprotection From Concussion,https://clinicaltrials.gov/study/NCT06204003,RECRUITING,NO,Healthy,DRUG: Cannabis/Hemp Isolate Extract,University of Regina,National Football League (NFL)|My Next Health Inc.,MALE,ADULT,35,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-02-15,2026-12,"University of Regina, Regina, Saskatchewan, S4S 0A2, Canada|Pasqua Hospital, Regina, Saskatchewan, S4T 7T1, Canada"
NCT02407262,Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes,https://clinicaltrials.gov/study/NCT02407262,COMPLETED,NO,Asthma,DIETARY_SUPPLEMENT: Black seed oil|OTHER: Placebo,"University College, London",King Abdulaziz University,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-05,2015-12,"King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia"
NCT06795776,Eschscholzia Study,https://clinicaltrials.gov/study/NCT06795776,NOT_YET_RECRUITING,NO,Sleep,DRUG: Eschscholzia tablets|DRUG: Placebo Tablets,A. Vogel AG,DCC Convex Ltd.,ALL,"ADULT, OLDER_ADULT",100,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2025-02-15,2026-02-15,"Diagnostics and Consultation Center Convex, Sofia, 1680, Bulgaria"
NCT02894372,Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort,https://clinicaltrials.gov/study/NCT02894372,COMPLETED,NO,Spraying Behavior|Mouth Diseases|Throat Diseases|Throat Pain,DEVICE: Oral spray 1|DEVICE: Oral spray 2,Lithuanian University of Health Sciences,Klaipėda University|Vita Longa Clinic,ALL,"CHILD, ADULT, OLDER_ADULT",96,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-01,2016-12-30,"Lithuanian University of Health Sciences, Kaunas, Lithuania"
NCT06823544,"A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis.",https://clinicaltrials.gov/study/NCT06823544,NOT_YET_RECRUITING,NO,Alveolar Osteitis,DRUG: Alvogyl|DRUG: Eugenol|DRUG: Nigella Sativa Oil,HITEC-Institute of Medical Sciences,,ALL,"CHILD, ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2025-02-01,2025-08-31,"Department of Oral & Maxillofacial Surgery-Dental College HITEC-IMS TAXILA CANTT, Taxila Cantt, Panjab, 47070, Pakistan"
NCT00795704,Impact of Mulberry Leaf on Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00795704,COMPLETED,YES,Type 2 Diabetes,DRUG: Mulberry Leaf Extract|DRUG: Placebo,University of Mississippi Medical Center,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-04,2010-05,"University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States"
NCT02035644,Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study),https://clinicaltrials.gov/study/NCT02035644,UNKNOWN,NO,Type 2 Diabetes|Dyslipidemia,DRUG: Jinlida granules|DRUG: placebo granules,Shanghai Jiao Tong University School of Medicine,Shijiazhuang Yiling Pharmaceutical Co. Ltd,ALL,"ADULT, OLDER_ADULT",360,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2014-02,,"Guang Ning, Shanghai, Shanghai, 200025, China"
NCT02931162,The Effects of Moxibustion on Ulcerative Colitis,https://clinicaltrials.gov/study/NCT02931162,COMPLETED,NO,Ulcerative Colitis,OTHER: Herb-partitioned moxibustion|OTHER: Sham herb-partitioned moxibustion,"Shanghai Institute of Acupuncture, Moxibustion and Meridian",,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2016-08-23,2019-12-31,"Outpatient department of Shanghai Research Insititute of Acupuncture and Meridian, Shanghai, Xuhui, 20000, China"
NCT06140446,"Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs",https://clinicaltrials.gov/study/NCT06140446,NOT_YET_RECRUITING,NO,Upper Respiratory Tract Infection,DEVICE: FeverApp|DEVICE: DMT App,Max Nieuwdorp,,ALL,CHILD,411,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2023-12,2024-05,"Amsterdam UMC location AMC, Amsterdam, Netherlands"
NCT03992469,"Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease",https://clinicaltrials.gov/study/NCT03992469,RECRUITING,NO,Crohn's Disease,DRUG: EBFAHF-2|DRUG: Placebo,Icahn School of Medicine at Mount Sinai,,ALL,ADULT,28,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2023-02-15,2025-04,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT01336153,Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke,https://clinicaltrials.gov/study/NCT01336153,COMPLETED,NO,Stroke,DRUG: MLC601|DRUG: Placebo,Shahid Beheshti University,Shahid Beheshti University of Medical Sciences,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-08,2010-12,
NCT00031031,Kanglaite Injection Phase I Study,https://clinicaltrials.gov/study/NCT00031031,COMPLETED,NO,Solid Tumors Refractory To Standard Therapy|Neoplasms,DRUG: Kanglaite Injection (KLT),KangLaiTe USA,,ALL,"ADULT, OLDER_ADULT",16,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2001-06,2002-11,"Huntsman Cancer Institue, Salt Lake City, Utah, 84112, United States"
NCT01292720,Vitamin D Supplementation in Chronic Stable Heart Failure,https://clinicaltrials.gov/study/NCT01292720,COMPLETED,NO,Heart Failure|Vitamin D Deficiency,DRUG: Cholecalciferol|DRUG: Placebo,Medical University of Graz,,ALL,"ADULT, OLDER_ADULT",29,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-04,2013-10,"Medical University of Graz, Graz, 8036, Austria"
NCT03403569,Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection,https://clinicaltrials.gov/study/NCT03403569,COMPLETED,NO,HIV-infection/AIDS,DRUG: Triptolide Wilfordii|DRUG: Placebo Oral Tablet,Peking Union Medical College Hospital,,ALL,"ADULT, OLDER_ADULT",353,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-09-01,2021-06-30,"Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, 350025, China|The Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong, 510060, China|The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China|The Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan, 450015, China|Xixi Hospital of Hangzhou, Hangzhou, Zhejiang, 310023, China|Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China|Beijing Ditan Hospital, Capital Medical University, Beijing, 100191, China"
NCT05042141,Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR),https://clinicaltrials.gov/study/NCT05042141,COMPLETED,NO,COVID-19,DIETARY_SUPPLEMENT: KOVIR oral capsule|DIETARY_SUPPLEMENT: Placebo oral capsule,Sao Thai Duong Joint Stock Company,Big Leap Clinical Research Joint Stock Company,ALL,"ADULT, OLDER_ADULT",66,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2021-07-28,2021-09-12,"Traditional Medicine Institute in Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam"
NCT02763280,Efficacy and Safety of Ginseng Extract on Improvement of Bone Metabolism in Menopausal Women,https://clinicaltrials.gov/study/NCT02763280,COMPLETED,NO,Osteopenia,DIETARY_SUPPLEMENT: Ginseng extract 1g|DIETARY_SUPPLEMENT: Ginseng extract 3g|DIETARY_SUPPLEMENT: Placebo,Chonbuk National University Hospital,,FEMALE,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2015-06,2016-09,"Clinical Trial Center for Functional Foods; Chonbuk National University Hospital, Jeonju, Jeollabuk-do, 560-822, Korea, Republic of"
NCT00702858,Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer,https://clinicaltrials.gov/study/NCT00702858,COMPLETED,NO,Breast Cancer|Joint Pain,DRUG: Blue Citrus|DRUG: Placebo,Legacy Health System,,FEMALE,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2008-04,2011-06,
NCT04182750,Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study,https://clinicaltrials.gov/study/NCT04182750,COMPLETED,NO,Pregnancy Early|Emesis|Medication Adherence,OTHER: Pharmacist consultation,Hedvig Marie Egeland Nordeng,,FEMALE,"ADULT, OLDER_ADULT",369,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2018-02-06,2023-11-27,"Department of Pharmacy, University of Oslo, OSlo, 0371, Norway"
NCT01100645,"Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia",https://clinicaltrials.gov/study/NCT01100645,UNKNOWN,NO,Insomnia,DRUG: Sominex|DRUG: Placebo,Azidus Brasil,,ALL,"ADULT, OLDER_ADULT",100,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-10,2011-02,"LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil"
NCT00563004,"The Effect of DBcare, a Food Supplement on Diabetes Control",https://clinicaltrials.gov/study/NCT00563004,COMPLETED,NO,"Diabetes Mellitus, Non-insulin Dependant|Diabetes Mellitus Type 2|Diabetes Mellitus, on Oral Hypoglycemic Treatment|Adult Type Diabetes Mellitus",DIETARY_SUPPLEMENT: DBCARE|DIETARY_SUPPLEMENT: DBCARE,Meir Medical Center,,ALL,"ADULT, OLDER_ADULT",35,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-08,2011-09,"Meir Medical Center, Kfar-saba, 44281, Israel"
NCT02929693,Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma,https://clinicaltrials.gov/study/NCT02929693,UNKNOWN,NO,Cancer,DRUG: gefitinib|DRUG: Yiqi-yangyin-jiedu decoction|DRUG: placebo,Shanghai University of Traditional Chinese Medicine,"Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China",ALL,"ADULT, OLDER_ADULT",198,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-10,2019-06,
NCT05693597,Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients,https://clinicaltrials.gov/study/NCT05693597,COMPLETED,NO,Radiation Dermatitis,DRUG: Imtenan Oil|DRUG: Baraka Capsules,German University in Cairo,Ain Shams University,FEMALE,"ADULT, OLDER_ADULT",132,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2023-01-24,2024-02-20,"Ain Shams University Hospital, Cairo, Egypt"
NCT05720819,Biofeedback-VR for Treatment of Chronic Migraine,https://clinicaltrials.gov/study/NCT05720819,COMPLETED,NO,Chronic Migraine|Behavioral Treatment|Biofeedback|Virtual Reality|Medication Overuse Headache,DEVICE: Combined biofeedback-virtual reality device,University of Washington,"University of California, San Francisco",ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-09-09,2022-03-01,"University of Washington, Seattle, Washington, 98105, United States"
NCT03151603,Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial,https://clinicaltrials.gov/study/NCT03151603,COMPLETED,NO,Urinary Tract Infections,DRUG: Arctuvan|DRUG: Fosfomycin|DRUG: Placebo to Arctuvan|DRUG: Placebo to Fosfomycin,University Medical Center Goettingen,,FEMALE,"ADULT, OLDER_ADULT",398,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-05-03,2019-06-20,"Hausarztpraxis Dr. Raby, Achim, 28832, Germany|General Practice Aden, Braunschweig, Germany|General Practice Scheffer, Braunschweig, Germany|General Practice Coutelle, Bremen, Germany|General Practice Schelp, Bremen, Germany|General Practice Dickow, Burgwedel, Germany|General Practice Kiwit-Putzer, Burgwedel, Germany|Praxis Zietz, Celle, 29221, Germany|General Practice Kutzsche, Emmerthal, Germany|Praxis Dr. Bahr, Gieboldehausen, 37434, Germany|General Practice Müller, Gillersheim, Germany|Institute of General Medicine, University Medical Center Goettingen, Göttingen, 37073, Germany|Praxisgemeinschaft Jacob / Kling, Göttingen, 37083, Germany|General Practice Keske, Göttingen, Germany|General Practice Koch, Göttingen, Germany|General Practice Kolb, Göttingen, Germany|General Practice Lang, Göttingen, Germany|General Practice Lückerath, Göttingen, Germany|Praxis Dr. Egner, Hannover, 30161, Germany|Institute of General Medicine, MHH Hannover, Hannover, 30625, Germany|General Practice Barth, Hannover, Germany|General Practice Löber, Hardegsen, Germany|Gemeinschaftspraxis Dres Schlesier / Eckhardt, Heilbad Heiligenstadt, 37308, Germany|Gemeinschaftspraxis Hartleb / Stöcking, Heilbad Heiligenstadt, 37308, Germany|Praxis Dr. Koch, Heilbad Heiligenstadt, 37308, Germany|Praxisgemeinschaft Seitz / Eckert, Herzberg, 37412, Germany|General Practice Wilde, Hildesheim, Germany|Praxisgemeinschaft Stoltz / Raddatz, Höxter, 37671, Germany|General Practice Beverungen, Höxter, Germany|Gemeinschaftspraxis Kasperczyk / Schindewolf-Lensch, Isernhagen, 30916, Germany|General Practice Franz, Katlenburg-Lindau, Germany|Praxis Dr. Ohlendorf, Langenhagen, 30851, Germany|General Practice Ertel, Langwedel, Germany|General Practice Wehrbein, Lemforde, Germany|General Practice Lindenblatt, Neustadt, Germany|Hausarztzentrum Nörten, Nörten-Hardenberg, 37176, Germany|General Practice Preiskorn, Rehburg-Loccum, Germany|General Practice Meier-Ahrens, Rosdorf, Germany|General Practice Woitschek, Salzgitter, Germany|General Practice Beulshausen, Sattenhausen, Germany|General Practice Schulte, Scheeßel, Germany|General Practice Böttcher, Schwanewede, Germany|General Practice Albrecht, Springe, Germany|General Practice Wolf, Uslar, 37170, Germany|General Practice Schmiemann, Verden, Germany|General Practice Annweiler, Waake, Germany|General Practice Stegemann, Wunstorf, Germany"
NCT05183594,"Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome",https://clinicaltrials.gov/study/NCT05183594,UNKNOWN,NO,Tourette Syndrome,DIETARY_SUPPLEMENT: TSupport (a Traditional Chinese Medicine),"Tasly Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",10,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2022-03,2024-09,"Yale Child Study Center, New Haven, Connecticut, 06520, United States"
NCT04914091,Quality Of Life and Drug Use in Patients With CAR-T Cells,https://clinicaltrials.gov/study/NCT04914091,UNKNOWN,NO,Patients With Diffuse Large B-cell Lymphoma Treated With CART-cells,OTHER: Semi-structured interviews and self-administered questionnaires,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",70,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-03-31,2023-04-30,"Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique, Pierre-Bénite, 69495, France"
NCT00032474,Ginkgo Biloba Extract and the Insulin Resistance Syndrome,https://clinicaltrials.gov/study/NCT00032474,COMPLETED,NO,Type 2 Diabetes Mellitus,DRUG: Ginkgo biloba extract,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",150,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT,2001-12,2005-05,"University of Texas Health Sciences Center, San Antonio, Texas, 78229, United States"
NCT01174511,Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis,https://clinicaltrials.gov/study/NCT01174511,UNKNOWN,NO,ATOPIC DERMATITIS,"DRUG: A -1 Cool Cream,Vaselin ointment",Hadassah Medical Organization,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2011-07,2012-11,
NCT06520527,Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Pressure of Obese Patients,https://clinicaltrials.gov/study/NCT06520527,NOT_YET_RECRUITING,NO,MeSH,DIETARY_SUPPLEMENT: Andrographis paniculata|BEHAVIORAL: Brisk Walking Exercise|OTHER: Combination,Universitas Palangka Raya,,ALL,ADULT,30,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-07-21,2024-09,"Sports Facilities, Palangkaraya, Central Kalimantan, 73111, Indonesia"
NCT01276756,Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV),https://clinicaltrials.gov/study/NCT01276756,COMPLETED,YES,Chronic Hepatitis c,DRUG: Pegylated interferon alfa-2a|DRUG: Nitazoxanide|DRUG: Ribavirin,Cairo University,Egyptian Railway Hospital,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2010-12,2012-11,"Cairo University, Cairo, Egypt"
NCT02417506,Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA,https://clinicaltrials.gov/study/NCT02417506,COMPLETED,NO,Osteoarthritis of Knee,OTHER: E-OA-07 (Lanconone)|DRUG: Ibuprofen,Vedic Lifesciences Pvt. Ltd.,Enovate Biolife Pvt Ltd,ALL,ADULT,72,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2014-08,2015-02,"Mukund Hospital, Mumbai, Maharashtra, 400059, India"
NCT05714670,The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis,https://clinicaltrials.gov/study/NCT05714670,COMPLETED,NO,Lupus Nephritis|SLE Nephritis,DRUG: Curcumin Oral Capsule,Ain Shams University,,ALL,CHILD,72,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-04-01,2024-08-01,"Outpatients Clinic of Pediatric Rheumatology department - Children's Hospital, Ain Shams University, Cairo, Egypt., Cairo, Egypt"
NCT01739842,Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment,https://clinicaltrials.gov/study/NCT01739842,WITHDRAWN,NO,Alcohol Consumption|Cerebral Blood Flow,DIETARY_SUPPLEMENT: Kudzu extract,Mclean Hospital,National Institute on Alcohol Abuse and Alcoholism (NIAAA),ALL,ADULT,0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-11,2015-10,
NCT02870764,The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris,https://clinicaltrials.gov/study/NCT02870764,UNKNOWN,NO,"Angina, Stable|Inflammation",DRUG: Dan-shen extract|DRUG: Placebo|OTHER: Standard medical care,Taizhou Fourth People's Hospital,Shanghai 10th People's Hospital,ALL,"ADULT, OLDER_ADULT",156,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-09,2017-08,"Taizhou Fourth People's Hospital, Taizhou, Jiangsu, 225300, China"
NCT01562470,Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream,https://clinicaltrials.gov/study/NCT01562470,COMPLETED,NO,Thigh Cellulite,OTHER: Cellulite reduction cream,"Nutrasource Pharmaceutical and Nutraceutical Services, Inc.",,FEMALE,"ADULT, OLDER_ADULT",23,NETWORK,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-06,2011-12,"Nutrasource Diagnostics Inc., Guelph, Ontario, N1H1Y3, Canada"
NCT03386149,Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine,https://clinicaltrials.gov/study/NCT03386149,COMPLETED,NO,Lumbar Disc Herniation,DRUG: Bosinji|DRUG: Loxonine tab.|PROCEDURE: Acupuncture,Kyunghee University Medical Center,Kyung Hee University Hospital at Gangdong|DongGuk University|Daegu Korean Medicine Hospital of Daegu Haany University,ALL,"ADULT, OLDER_ADULT",74,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2017-12-28,2020-01-22,"Dongguk University Bundang Oriental Hospital, Seongnam, Gyeonggi, 13601, Korea, Republic of|Daegu Korean Medicine Hospital of Daegu Haany University, Daegu, 42158, Korea, Republic of|Kyunghee University Medical Center, Seoul, 02447, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of"
NCT05243238,Hesperidin and Diosmin Effect on Metabolic Syndrome,https://clinicaltrials.gov/study/NCT05243238,COMPLETED,NO,Metabolic Syndrome and Diabetic Neuropathy,DIETARY_SUPPLEMENT: dietary supplement flavonoids,Beni-Suef University,,ALL,"ADULT, OLDER_ADULT",129,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-03-01,2021-11-12,"University, Fayoum, 13556, Egypt"
NCT01929187,A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis,https://clinicaltrials.gov/study/NCT01929187,UNKNOWN,NO,Onycomycosis,DRUG: Phytonail|DRUG: Loceryl,National Taiwan University Hospital,,ALL,"ADULT, OLDER_ADULT",72,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-02,2014-07,"National Taiwan University Hospital, Taipei, 100, Taiwan"
NCT05092698,The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19,https://clinicaltrials.gov/study/NCT05092698,COMPLETED,NO,SARS-CoV2 Infection,DIETARY_SUPPLEMENT: Vitamin D (cholecalciferol)|DIETARY_SUPPLEMENT: Herbal oil,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",,ALL,"ADULT, OLDER_ADULT",110,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2020-05-01,2022-01-31,"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, 115682, Russian Federation"
NCT01684371,The Effects of Elmore Oil on Patients With Osteoarthritis,https://clinicaltrials.gov/study/NCT01684371,COMPLETED,NO,Degenerative Arthritis|Inflammation,OTHER: Two oily solutions (Blue Dotted and Orange Dotted Elmore Oils),Elmore Oil Company Pty Ltd,,ALL,"ADULT, OLDER_ADULT",60,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-11,2009-06,"Veterans Memorial Medical Centre, Quezon City, Manila, 1100, Philippines"
NCT02270424,Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD,https://clinicaltrials.gov/study/NCT02270424,UNKNOWN,NO,"Pulmonary Disease, Chronic Obstructive",DRUG: Salmeterol / fluticasone (Seretide®)|DRUG: Bufeijianpi granule|DRUG: Bufeiyishen granule|DRUG: Yiqizishen granule|DRUG: Placebo Bufeijianpi granule|DRUG: Placebo Bufeiyishen granule|DRUG: Placebo Yiqizishen granule,Henan University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",564,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-10,2016-12,
NCT04009616,Effect of Aloe Vera Mouthwashes on the Oral Health of Children,https://clinicaltrials.gov/study/NCT04009616,COMPLETED,NO,Oral Health,DRUG: Aloe Vera mouthwash|DRUG: Chlorhexidine mouthwash|DRUG: Placebo mouthwash,Damascus University,,ALL,CHILD,17,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2019-03-01,2019-08-30,"Faculty of Dental Medicine, Damascus University, Damascus, Syrian Arab Republic"
NCT01375101,Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus,https://clinicaltrials.gov/study/NCT01375101,UNKNOWN,NO,Atrophic Oral Lichen Planus|Erosive Oral Lichen Planus,DRUG: placebo|DRUG: Quercetin,Mashhad University of Medical Sciences,,ALL,"CHILD, ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2010-04,2011-09,"Mashhad university of Medical science, Research Center of oral and maxillofacial medicine, Mashhad, Khorasan Razavi, 91735, Iran, Islamic Republic of"
NCT04301466,Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment,https://clinicaltrials.gov/study/NCT04301466,COMPLETED,NO,Vascular Cognitive Impairment|Qi Zhi Tong Luo Capsule|Randomized Controlled Trial,DRUG: Qi Zhi Tong Luo capsule|DRUG: Placebos,"Dongzhimen Hospital, Beijing","Shanxi Zhendong Pharmacy Co., Ltd",ALL,"ADULT, OLDER_ADULT",362,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07-16,2018-05-30,"Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT05343767,Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus,https://clinicaltrials.gov/study/NCT05343767,COMPLETED,NO,Type2 Diabetes Mellitus,DIETARY_SUPPLEMENT: Natural Wellness Low-Glu low dose|DIETARY_SUPPLEMENT: Natural Wellness Low-Glu high dose|OTHER: Metformin,Natural Wellness Egypt,,ALL,"ADULT, OLDER_ADULT",198,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-09-12,2021-05-30,"Natural Welness Egypt, Cairo, Nasr City, 11765, Egypt"
NCT06772584,Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis,https://clinicaltrials.gov/study/NCT06772584,COMPLETED,NO,"Enuresis, Nocturnal",DRUG: Desmopressin Acetate 0.2 mg Tablets|DRUG: Ginkgobiloba,Menoufia University,,ALL,"CHILD, ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-01-01,2024-12-01,"Menofia university, Cairo, State Or Province, 32511, Egypt"
NCT04479657,Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection,https://clinicaltrials.gov/study/NCT04479657,UNKNOWN,NO,Upper Respiratory Tract Infection|Bacterial Infection|Chinese Medicine|Pediatric Acute Upper Respiratory Tract Infection,DRUG: QingFei Granule|DRUG: Cefuroxime,Zhong Wang,,ALL,CHILD,60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-10-17,2024-06,"Dongfang Hospital, Beijing, Beijing, 100078, China"
NCT00010933,Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities,https://clinicaltrials.gov/study/NCT00010933,COMPLETED,NO,Recurrent Abdominal Pain,DRUG: chamomile tea|PROCEDURE: Relaxation/Guided Imagery,National Center for Complementary and Integrative Health (NCCIH),,ALL,"CHILD, ADULT",,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT,1998-09,2004-06,"University of Arizona, Department of Pediatrics, Health Sciences Center, Tucson, Arizona, 85724-5073, United States"
NCT04161404,Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition,https://clinicaltrials.gov/study/NCT04161404,UNKNOWN,NO,Pharmacokinetics|Molecular Mechanisms of Pharmacological Action,DRUG: Brand name: Andrographis paniculata (Shine Hempedu Bumi) 1000mg capsules|DRUG: Brand name: Andrographis paniculata (Shine Hempedu Bumi) 2000mg|DRUG: Metformin (Glucophage) 1000mg,University of Malaya,"Ministry of Health, Malaysia",MALE,ADULT,18,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER,2019-08-21,2020-12-31,"Clinical Investigation Centre, University Malaya Medical Centre, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, 59100, Malaysia"
NCT02123732,Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02123732,UNKNOWN,NO,Type 2 Diabetes Mellitus,DIETARY_SUPPLEMENT: DbXell|DIETARY_SUPPLEMENT: Placebo,Laniado Hospital,KGS Research,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2014-07,,"Laniado Hospital, Diabetes Unit, Netanya, 42150, Israel"
NCT04993794,Additive Anti-inflammatory Action for Critically Ill Patients With Cardiovascular Surgery (Xuebijing) IV,https://clinicaltrials.gov/study/NCT04993794,UNKNOWN,NO,Cardiovascular Disease|Aortic Dissection|Coronary Artery Disease|Valve Heart Disease|Congenital Heart Disease|Critical Illness,DRUG: XueBiJing Injection|DRUG: Normal saline,Nanjing Medical University,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-01-01,2022-12-31,"The first affiliated hospital of nanjing medical university, Nanjing, Jiangsu, 210029, China"
NCT04895800,An Evaluation of the Effects of a Non-Caffeinated Energy Dietary Supplement,https://clinicaltrials.gov/study/NCT04895800,COMPLETED,NO,Health Behavior,DIETARY_SUPPLEMENT: Phytovive|DIETARY_SUPPLEMENT: Placebo|DIETARY_SUPPLEMENT: Caffeine,Nova Southeastern University,,ALL,ADULT,36,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2020-01-03,2021-03-15,"Nova Southeastern University, Davie, Florida, 33314, United States"
NCT04896164,Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting,https://clinicaltrials.gov/study/NCT04896164,RECRUITING,NO,Oral Mucositis (Ulcerative),DRUG: Curcumin Lozenges|OTHER: Placebo Lozenges,Tata Memorial Centre,,ALL,"ADULT, OLDER_ADULT",190,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2018-12-16,2025-05-16,"Tata Memorial Centre, Navi Mumbai, Maharashtra, 410210, India"
NCT04870060,Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant,https://clinicaltrials.gov/study/NCT04870060,COMPLETED,NO,Oral Mucositis (Ulcerative),DRUG: Curcumin Lozenges,Tata Memorial Centre,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2010-10-06,2015-07-03,"Tata Memorial Centre, Navi Mumbai, Maharashtra, 410210, India"
NCT03949816,"The Influence of Doctor-patient Communication on Treatment Expectation, Placebo and Nocebo Response",https://clinicaltrials.gov/study/NCT03949816,UNKNOWN,NO,Healthy Participants,OTHER: medical consultation: different doctor-patient-centered style of communication|OTHER: information letter / no medical consultation,Philipps University Marburg,,FEMALE,ADULT,120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE,2019-05-20,2019-11-01,"Philipps-University Marburg, Faculty psychology, department clinical psychology, Marburg, Hessen, 35032, Germany"
NCT00131885,Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel,https://clinicaltrials.gov/study/NCT00131885,COMPLETED,YES,Contraception,DIETARY_SUPPLEMENT: Placebo Control (Placebo Herb)|DIETARY_SUPPLEMENT: St. John's Wort|DRUG: Levonorgestrel,University of Utah,National Center for Complementary and Integrative Health (NCCIH),FEMALE,ADULT,36,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2005-08,2008-05,"University of Utah, Salt Lake City, Utah, 84112, United States"
NCT01598012,The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea,https://clinicaltrials.gov/study/NCT01598012,COMPLETED,NO,Primary Dysmenorrhea,DRUG: Ayurved Siriraj Prasaplai with or without mefenamic acid|DRUG: Placebo with or without mefenamic acid,Mahidol University,,FEMALE,ADULT,40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-12,2013-08,"Gynecologic Endocrinology Unit, Department of Obstetric and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand"
NCT01901705,A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis,https://clinicaltrials.gov/study/NCT01901705,COMPLETED,NO,Psoriasis,DRUG: Indigo naturalis ointment|DRUG: Placebo,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-02,2014-01,"China Medical University Hospital,, Taichung,, Taiwan"
NCT06463145,Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People,https://clinicaltrials.gov/study/NCT06463145,COMPLETED,NO,Situational Anxiety,DIETARY_SUPPLEMENT: Vanizem|DIETARY_SUPPLEMENT: Placebo,Nektium Pharma SL,Kinetic performance,ALL,ADULT,37,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-03-01,2023-05-20,"Kinetic perfomance SL, Alicante, 3005, Spain"
NCT01913418,Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance,https://clinicaltrials.gov/study/NCT01913418,COMPLETED,NO,Opiate Dependence,DRUG: Suan-Zao-Ren Tang|DRUG: Suan-Zao-Ren Tang placebo,"China Medical University, Taiwan",,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-07,2014-03,"Department of psychiatry, Armed Forces Tao-Yuan General Hospital, No.168 Zhong-Xing Road, Taoyuan, Taiwan, Taoyuan, 325, Taiwan"
NCT03471507,Bonipar for Acute and Chronic Musculoskeletal Pain,https://clinicaltrials.gov/study/NCT03471507,COMPLETED,YES,Chronic Pain|Musculoskeletal Pain,DRUG: Bonipar|DRUG: Diclofenac sodium topical solution 1.5%,"Winston Parris, MD",,ALL,"ADULT, OLDER_ADULT",164,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-12-15,2022-09-22,"Duke University Medical Center, Durham, North Carolina, 27710, United States"
NCT02858856,Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients,https://clinicaltrials.gov/study/NCT02858856,UNKNOWN,NO,Breast Carcinoma,DRUG: Sipjeondaebo-tang,Kyunghee University Medical Center,Catholic Kwandong University,ALL,"ADULT, OLDER_ADULT",48,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION,2017-03-20,2018-06,"International St. Mary's Hospital, Incheon, 22711, Korea, Republic of"
NCT03057899,Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS,https://clinicaltrials.gov/study/NCT03057899,COMPLETED,NO,Hypogonadism,DRUG: TFG capsules (200 mg /capsule)|DRUG: Placebo oral capsule,Pusan National University Hospital,,MALE,"ADULT, OLDER_ADULT",88,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-06,2015-12,"Department of Urology, Pusan National University Hospital, Busan, 602-739, Korea, Republic of"
NCT03960593,Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological Malignancy,https://clinicaltrials.gov/study/NCT03960593,UNKNOWN,NO,Cancer and / or Hematological Malignancy,OTHER: Evaluation of the influence of geriatric factors,Assistance Publique Hopitaux De Marseille,,ALL,OLDER_ADULT,500,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-11-06,2024-05-06,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France"
NCT04810572,Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis,https://clinicaltrials.gov/study/NCT04810572,COMPLETED,NO,Insulin Resistance|Inflammatory Bowel Diseases|Overweight and Obesity|Healthy,DIETARY_SUPPLEMENT: Composition with Silymarin|DIETARY_SUPPLEMENT: Low-mineral composition without Silymarin,University of Sao Paulo General Hospital,University of Sao Paulo,ALL,"ADULT, OLDER_ADULT",162,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2021-05-20,2022-12-19,"USP Medical School, São Paulo, 01246 903, Brazil"
NCT05993416,Treatment of Primary Hyperoxaluria Type 1 With Nedosiran,https://clinicaltrials.gov/study/NCT05993416,AVAILABLE,NO,Primary Hyperoxaluria Type 1 (PH1),DRUG: Nedosiran,"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",,ALL,"CHILD, ADULT, OLDER_ADULT",,INDUSTRY,EXPANDED_ACCESS,,,,
NCT04173754,The Effectiveness of MSAT for Patients With ROM Limitation of the Shoulders,https://clinicaltrials.gov/study/NCT04173754,COMPLETED,NO,Shoulder Joint Disorder,PROCEDURE: Motion Style Acupuncture Treatment(MSAT),Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",80,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-07-04,2021-11-01,"Haeundae Jaseng Hospital of Korean Medicine, Busan, 48102, Korea, Republic of"
NCT02235532,Effects of Aloe Vera Toothpaste on Periodontal Parameters,https://clinicaltrials.gov/study/NCT02235532,COMPLETED,NO,Gingivitis,OTHER: Foramen Herbal Aloe toothpaste|OTHER: fluoride toothpaste,"Islamic Azad University, Sanandaj",,ALL,ADULT,20,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION,2013-09,2014-06,"Tehran Dental Branch, Islamic azad University, Tehran, 19585175, Iran, Islamic Republic of"
NCT06030544,Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY),https://clinicaltrials.gov/study/NCT06030544,RECRUITING,NO,Diabetic Patients|Type II Diabetes Mellitus,DIETARY_SUPPLEMENT: OA-enriched functional olive oil|DIETARY_SUPPLEMENT: commercial olive oil,Spanish National Research Council,Andalusian Health Service|Universidad Pablo de Olavide,ALL,"ADULT, OLDER_ADULT",100,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-02-25,2025-06-30,"Virgen del Rocío University Hospital, Sevilla, Andalicía, 41013, Spain"
NCT02639520,Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs,https://clinicaltrials.gov/study/NCT02639520,COMPLETED,NO,Urinary Tract Infection,DRUG: Canephron® N|DRUG: Fosfomycin trometamol|DRUG: Canephron® N-placebo|DRUG: Fosfomycin trometamol-placebo,Bionorica SE,,FEMALE,"ADULT, OLDER_ADULT",659,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-12,2017-06-29,"Justus-Liebig-Universität, Giessen, Hessen, 35392, Germany"
NCT00006330,Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn,https://clinicaltrials.gov/study/NCT00006330,COMPLETED,NO,Heart Diseases,DRUG: Digoxin|DRUG: Hawthorn,National Center for Research Resources (NCRR),,ALL,ADULT,,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,,,"Univ. of Michigan Medical Center, Ann Arbor, Michigan, 48109-0008, United States"
NCT04695951,Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract,https://clinicaltrials.gov/study/NCT04695951,COMPLETED,NO,"Renal Injury|Kidney Injury|Kidney Calculi|Ureteral Obstruction|Ureteral Calculi|Renal Stone|Ureteral Injury|Renal Disease|Urolithiasis, Calcium Oxalate|Urolithiasis; Lower Urinary Tract|Urolithiasis",DIETARY_SUPPLEMENT: Renalof|OTHER: Placebo,Catalysis SL,,ALL,"ADULT, OLDER_ADULT",155,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2019-08-01,2020-10-01,"Clinica Seniors Managua, Managua, 13035, Nicaragua"
NCT04124276,Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder,https://clinicaltrials.gov/study/NCT04124276,UNKNOWN,NO,Major Depressive Disorder|Depression|Depressive Disorder,DIETARY_SUPPLEMENT: Lycium barbarum polysaccharide|DIETARY_SUPPLEMENT: Placebo,Guangzhou Psychiatric Hospital,Fifth Affiliated Hospital of Guangzhou Medical University,ALL,ADULT,284,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-11-01,2021-06-01,"Guangzhou Brain Hospital (Guangzhou Huiai Hospital), Guanzhou, Guangdong, 510370, China"
NCT04032795,Evaluation of Efficacy of Lycium Barbarum Polysaccharide in People With Subthreshold Depression,https://clinicaltrials.gov/study/NCT04032795,UNKNOWN,NO,Subthreshold Depression|Depressive Symptoms|Anxious Symptoms,DIETARY_SUPPLEMENT: Lycium barbarum polysaccharide|DIETARY_SUPPLEMENT: Placebo,Guangzhou Psychiatric Hospital,Fifth Affiliated Hospital of Guangzhou Medical University,ALL,"CHILD, ADULT",172,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-05-15,2021-12-30,"The Affiliated Fifth Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"
NCT04546607,Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia,https://clinicaltrials.gov/study/NCT04546607,COMPLETED,NO,Asthenia|Cancer,OTHER: Nuvastatic TM (C5OSEW5050ESA) 1000 mg,Natureceuticals Sdn Bhd,,ALL,"ADULT, OLDER_ADULT",110,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-09-02,2019-10-31,"Notrox Research Pvt Ltd, Bangalore, Karnataka, 560062, India"
NCT00295490,Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT00295490,TERMINATED,YES,"Osteoarthritis, Knee|Osteoarthritis, Hip",DRUG: Devil Claw|DRUG: Placebo,University of Southampton,Pascoe Pharmazeutische Praeparate GmbH,ALL,"ADULT, OLDER_ADULT",67,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2004-12,2008-06,"Wellcome Trust Clinical Research Facility, Southampton General Hospital, Southampton, Hants, SO16 6YD, United Kingdom"
NCT06355193,The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study,https://clinicaltrials.gov/study/NCT06355193,COMPLETED,NO,Treatment of Mild Cases of COVID-19,DRUG: Langenlianqiao|DRUG: LianhuaQingWen|OTHER: placebo control group,Central South University,,ALL,"ADULT, OLDER_ADULT",253,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-11-01,2022-12-31,"Changde Hospital, Changde, Hunan, China"
NCT00076609,Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma,https://clinicaltrials.gov/study/NCT00076609,COMPLETED,NO,Hepatocellular Carcinoma|Liver Cancer,DRUG: PHY906|DRUG: capecitabine,PhytoCeutica,,ALL,"ADULT, OLDER_ADULT",31,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2003-10,,"City of Hope National Medical Center, Duarte, California, 91010, United States|Stanford Hospital and Clinics, Stanford, California, 94305, United States|Yale University, New Haven, Connecticut, 06520, United States|VA Connecticut Cancer Center, West Haven, Connecticut, 06516, United States|National Institute of Cancer Research, Taipei, Taiwan"
NCT01637675,Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension,https://clinicaltrials.gov/study/NCT01637675,UNKNOWN,NO,Pulmonary Hypertension|Pulmonary Arterial Hypertension|Cardiovascular Diseases|Lung Diseases|Tanshinone IIA Sulfonate,"DRUG: 20 mg sildenafil citrate by mouth|DRUG: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth",The First Affiliated Hospital of Guangzhou Medical University,"Jiangsu Carefree Pharmaceutical Co., Ltd.|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Guangdong Provincial People's Hospital|Sir Run Run Shaw Hospital|The First Affiliated Hospital of Zhengzhou University|Dongguan People's Hospital|Second Affiliated Hospital of Xi'an Jiaotong University|Beijing Chao Yang Hospital|Beijing Anzhen Hospital|The Affiliated Hospital of Qingdao University",ALL,"CHILD, ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-05,2014-12,"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China"
NCT06804083,Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms.,https://clinicaltrials.gov/study/NCT06804083,COMPLETED,NO,Chronic Prostatitis (CP)|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|Chronic Prostatitis/ Pelvic Pain Syndrome,DRUG: oral combination of colostrum and Serenoa repens extracts (PROSTYM®),Clinica Urologica Molinette - Città della Saliute e della Scienza,A.O.U. Città della Salute e della Scienza - Molinette Hospital,MALE,"ADULT, OLDER_ADULT",42,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-03-01,2023-06-30,"Molinette Hospital, Torino, 10126, Italy"
NCT06352099,Dietary Supplementation and Cognitive Functions in the Elderly,https://clinicaltrials.gov/study/NCT06352099,RECRUITING,NO,Cognitive Impairment|Old Age; Debility,"DIETARY_SUPPLEMENT: Dietary supplement with micronised diosmin, hesperidin and herbal extracts",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,ALL,"ADULT, OLDER_ADULT",36,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2024-05-02,2025-04,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, 00168, Italy"
NCT02470845,Trial of Tian Jiu Therapy for Allergic Rhinitis,https://clinicaltrials.gov/study/NCT02470845,COMPLETED,NO,Allergic Rhinitis (AR),DRUG: herbal patches of Tian Jiu group|DRUG: placebo patches of placebo-control group,Hong Kong Baptist University,,ALL,"CHILD, ADULT, OLDER_ADULT",136,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2014-07,2016-09,"Hong Kong Baptist University Chinese Medicine Clinic, Hong Kong, China"
NCT06257797,Fenugreek: an Emergent Allergen,https://clinicaltrials.gov/study/NCT06257797,COMPLETED,NO,Fenugreek Hypersensitivity - Cross-reactivity - Food Allergy,DIAGNOSTIC_TEST: Skin prick test,Paola Miciullo,,ALL,"ADULT, OLDER_ADULT",15,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-01-01,2023-12-31,"AOU Policlinico Universitario G. Martino, Messina, Sicily/Messina, 98124, Italy"
NCT04115891,Lavender Oil Inhalation Help to Overcome Dental Anxiety Among Children,https://clinicaltrials.gov/study/NCT04115891,COMPLETED,NO,Dental Anxiety|Anxiety Disorder|Aromatherapy,OTHER: Anxiety scale|OTHER: Pain scale - 1|OTHER: Pain scale - 2|BEHAVIORAL: Inhalation,Recep Tayyip Erdogan University Training and Research Hospital,,ALL,CHILD,126,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2019-01-01,2019-09-30,"Nazife Begüm KARAN, Ankara, Merkez, 83TR2WATUF, Turkey|Nazife Begüm KARAN, Ri̇ze, Merkez, 053100, Turkey"
NCT03845959,A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome,https://clinicaltrials.gov/study/NCT03845959,COMPLETED,NO,Syndrome Pain,DRUG: TD0019 oral capsule|DRUG: Placebo oral capsule,Sao Thai Duong Joint Stock Company,Big Leap Clinical Research Joint Stock Company,ALL,"ADULT, OLDER_ADULT",180,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-08-30,2018-02-20,"National Hospital of Traditional Medicine, Hanoi, Vietnam"
NCT06061666,Treatment of Insomnia in Patients With Breast Cancer,https://clinicaltrials.gov/study/NCT06061666,RECRUITING,NO,Breast Cancer|Insomnia,OTHER: Tilia tomentosa Concentrated - Glycerine macerate (C-GM) vs Placebo (1 gtt/10 kg/day before bedtime for 15 days),Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,FEMALE,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2023-06-01,2024-06-30,"Dipartimento di Scienze di Laboratorio e Infettivologiche, Rome, 00168, Italy"
NCT04847518,Assessment of Efficacy of KAN-JANG® in Mild COVID-19,https://clinicaltrials.gov/study/NCT04847518,UNKNOWN,NO,Covid19,DRUG: Kan Jang capsules|OTHER: Placebo capsules,Swedish Herbal Institute AB,Tbilisi State Medical University|Phytomed AB,ALL,"ADULT, OLDER_ADULT",140,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-05-26,2022-03,"The First University Clinic of Tbilisi State Medical University, Tbilisi, 0141, Georgia"
NCT00972803,"The Effects of Pistacia Mutica on De Novo Dental Plaque Formation, Gingival Inflammation and Oral Microorganisms",https://clinicaltrials.gov/study/NCT00972803,COMPLETED,NO,Gingivitis,DRUG: pistacia Mutica extract|DRUG: Placebo|DRUG: Chlorhexidine,Tabriz University,,ALL,"ADULT, OLDER_ADULT",25,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-05,2009-05,"Drug Applied Science Center, tabriz Univ. of Medical Sciences, Tabriz, East azarbaijan, Iran, Islamic Republic of"
NCT06095622,Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels,https://clinicaltrials.gov/study/NCT06095622,COMPLETED,NO,Glucose Metabolism Disorders (Including Diabetes Mellitus),DIETARY_SUPPLEMENT: Fenugreek Seeds and Indian Rennet,University of Management and Technology Lahore,,ALL,"ADULT, OLDER_ADULT",12,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2023-03-15,2023-08-30,"University of Management and Technology, Lahore, Punjab, 54000, Pakistan"
NCT05552625,The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19,https://clinicaltrials.gov/study/NCT05552625,COMPLETED,NO,COVID-19,DRUG: TADIOS|DRUG: Placebo,"Helixmith Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",100,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2021-05-06,2022-02-24,"Vagus Super Specialty Hospital, Bangalore, Karnataka, 560003, India|Sparsh Superspeciality Hospital, Bangalore, Karnataka, 560022, India|Lakshmi Nursing Home, Cochin, Kerala, 683101, India|Chaitanya Hospital, Paravur, Kerala, 683513, India|Gunjkar Multispeciality Hospital, Pune, Maharashtra, 4110019, India|Oxycare Multispecialty Hospital, Pune, Maharashtra, 411033, India"
NCT06657495,To Evaluate the Safety and Efficacy of TD0015 Pilulae in Patients with Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT06657495,RECRUITING,NO,Knee Osteoarthritis,DRUG: TD0015|DRUG: TD0015 Placebo,Sao Thai Duong Joint Stock Company,Big Leap Clinical Research Joint Stock Company,ALL,"ADULT, OLDER_ADULT",90,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-07-01,2024-11,"National Hospital of Traditional Medicine, Hanoi, 100000, Vietnam"
NCT04976023,The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis,https://clinicaltrials.gov/study/NCT04976023,COMPLETED,NO,Allergic Rhinitis,DRUG: Yupingfeng Powder granules|OTHER: Placebo,Prof. Lin Zhixiu,,ALL,"CHILD, ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-04-12,2023-06-20,"The Chinese University of Hong Kong, Shatin, Hong Kong"
NCT00010907,Preliminary Human Trial of NPI-028,https://clinicaltrials.gov/study/NCT00010907,WITHDRAWN,NO,Alcoholism,DRUG: NPI-028,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",0,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,,,
NCT00110669,High-dose Prednisone in Duchenne Muscular Dystrophy,https://clinicaltrials.gov/study/NCT00110669,COMPLETED,NO,Duchenne Muscular Dystrophy,DRUG: Prednisone,Cooperative International Neuromuscular Research Group,,MALE,CHILD,64,NETWORK,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2004-01,2008-02,"Children's National Medical Center, Washington, District of Columbia, 20010, United States"
NCT00755326,Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee,https://clinicaltrials.gov/study/NCT00755326,COMPLETED,YES,Osteoarthritis of the Knee,DRUG: HLXL,"University of Maryland, Baltimore",National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",92,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2007-04,2010-07,"University of Maryland Center for Integrative Medicine Kernan Hospital, Baltimore, Maryland, 21207, United States"
NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,https://clinicaltrials.gov/study/NCT04347382,COMPLETED,NO,Coronavirus Infection|Sars-CoV2,DRUG: Honey|DRUG: Nigella Sativa / Black Cumin|DRUG: Placebos,Sohaib Ashraf,,ALL,"ADULT, OLDER_ADULT",313,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-04-30,2020-08-30,"Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, 54600, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, 54600, Pakistan"
NCT02084186,Moxibustion for Mild and Moderate Ulcerative Colitis,https://clinicaltrials.gov/study/NCT02084186,COMPLETED,NO,Ulcerative Colitis,OTHER: herb-partitioned moxibustion|OTHER: bran-partitioned moxibustion,"Shanghai Institute of Acupuncture, Moxibustion and Meridian",,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2014-03,2015-12,"Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai, 200030, China"
NCT05004753,A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects,https://clinicaltrials.gov/study/NCT05004753,COMPLETED,NO,Covid19,DIETARY_SUPPLEMENT: Artemisinin|DRUG: Dexamethasone,Mateon Therapeutics,Windlas Biotech Private Limited,ALL,ADULT,120,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-09-30,2021-04-30,"Government Medical College & Government General Hospital, Srikakulam, Srikakulam, Andhra Pradesh, 532001, India|Rajarshi Chhatrapati Shahu Maharaj Government Medical college and Chhatrapati Pramila Raje Hospital, Kolhapur, Maharashtra, 431001, India|Seven Star Hospital, Nagpur, Maharashtra, 440009, India"
NCT00405912,St. John's Wort for Tobacco Cessation,https://clinicaltrials.gov/study/NCT00405912,COMPLETED,YES,Smoking|Nicotine Dependence,DRUG: Placebo|DRUG: St. John's Wort-900 mg/day|DRUG: St. John's Wort-1800mg/day,Mayo Clinic,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",118,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2005-09,2008-03,"Mayo Clinic, Rochester, Minnesota, 55905, United States"
NCT06235177,Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues,https://clinicaltrials.gov/study/NCT06235177,NOT_YET_RECRUITING,NO,"Schizoaffective Disorder, Bipolar Type|Bipolar Disorder|ADHD - Combined Type|Dissociative Disorder|Stress Disorder|Dementia|Anxiety|Chronic Fatigue Syndrome",COMBINATION_PRODUCT: Decompartmentalization Framework|DIETARY_SUPPLEMENT: Liquid Herbal TInctures|OTHER: Mental Imagery|DIAGNOSTIC_TEST: Clinical Yoga|DIETARY_SUPPLEMENT: Dietary Supplements|BEHAVIORAL: Applied Relaxation|BEHAVIORAL: Pain Relaxation Techniques|BEHAVIORAL: Comprehensive Theocentric Psychological Assessment,The Essence of Integrative Health and Medicine Practice,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2024-10-10,2025-09-19,
NCT02210156,Effects of a Supplement on Acute Respiratory Infections,https://clinicaltrials.gov/study/NCT02210156,COMPLETED,NO,Respiratory Tract Infection,DIETARY_SUPPLEMENT: Omniplus Supreme|OTHER: Placebo,"Omnilife Manufactura, SA de CV",University of Guadalajara,ALL,ADULT,45,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2012-01,2012-04,"Omnilife, Guadalajara, Jalisco, 44500, Mexico"
NCT04723732,"Antiplaque, Antigingivitis and Anti-inflammatory Effects of Myrrh Mouthwash",https://clinicaltrials.gov/study/NCT04723732,COMPLETED,NO,Gingivitis|Dental Plaque,DRUG: Myrrh mouthwash|DRUG: Chlorhexidine mouthwash|DRUG: Normal saline,King Abdulaziz University,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-08-15,2018-12-15,"King Abdul Aziz University, Jeddah, Makkah, 21589, Saudi Arabia"
NCT06431646,Effectiveness of Web-Based Education on Premenstrual Syndrome and Quality of Life,https://clinicaltrials.gov/study/NCT06431646,COMPLETED,NO,Premenstrual Syndrome|Quality of Life,BEHAVIORAL: A web-based education intervention developed for university students with PMS,Pamukkale University,,FEMALE,"ADULT, OLDER_ADULT",67,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE,2022-01-01,2022-06-13,"Pamukkale University, Denizli, 20160, Turkey"
NCT01646164,Effect of Dill Seed on Uterus Contractions Pattern,https://clinicaltrials.gov/study/NCT01646164,COMPLETED,NO,Uterus Contractions Pattern,,Mashhad University of Medical Sciences,,FEMALE,ADULT,100,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2009-05,2010-08,
NCT00260026,Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer,https://clinicaltrials.gov/study/NCT00260026,COMPLETED,NO,Non-Small Cell Lung Cancer,DRUG: Docetaxel|DRUG: Jin Fu Kang,Memorial Sloan Kettering Cancer Center,,ALL,"CHILD, ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2004-11,2007-01,"Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States"
NCT01529710,Safety and Efficacy of Mirazid for Schistosomiasis Treatment,https://clinicaltrials.gov/study/NCT01529710,COMPLETED,NO,Schistosoma Hematobium Infection|Schistosomiasis Mansoni,DRUG: Myrrh,Pharco Pharmaceuticals,,ALL,"CHILD, ADULT",200,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2011-12,2012-09,"Tanta Health Unit, Gharbiya, Egypt|Health Unit of Atfeeh, Giza, Egypt"
NCT06475001,Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain,https://clinicaltrials.gov/study/NCT06475001,RECRUITING,NO,Chronic Non-specific Low Back Pain,DRUG: VER-01|DRUG: Placebo,Vertanical GmbH,,ALL,"ADULT, OLDER_ADULT",800,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-06-28,2025-07,"St Pancras Clinical Research, London, United Kingdom"
NCT02477163,Ayurvedic Management of Chronic Kidney Disease,https://clinicaltrials.gov/study/NCT02477163,COMPLETED,NO,Diabetic Nephropathy|Hypertensive Nephropathy,OTHER: Ayurveda treatment,J.S. Ayurveda College,,ALL,"ADULT, OLDER_ADULT",521,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-01,2022-04-30,"P D Patel Ayurveda Hospital, Nadiad, Gujarat, 387001, India"
NCT02310373,"Effects of Nicotine-Free Hookah Smoking on Blood Flow to the Heart, Muscle and Skin",https://clinicaltrials.gov/study/NCT02310373,TERMINATED,NO,Nicotine-free Hookah Smoking,OTHER: Nicotine free hookah smoking,Cedars-Sinai Medical Center,,ALL,ADULT,9,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2014-11,2018-12,"Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States"
NCT04452799,Hesperidin and Diosmin for Treatment of COVID-19,https://clinicaltrials.gov/study/NCT04452799,UNKNOWN,NO,Coronavirus Infection,DRUG: Hesperidin and Diosmin mixture,Tanta University,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2020-07-01,2020-10-30,
NCT04395547,Safety and Efficacy of JointAlive™ on the Knee-joint Function in Adults With Knee Arthritis,https://clinicaltrials.gov/study/NCT04395547,COMPLETED,NO,Osteo Arthritis Knee,DIETARY_SUPPLEMENT: JointAlive™|DIETARY_SUPPLEMENT: Placebo,Chenland Nutritionals Inc.,KGK Science Inc.,ALL,"ADULT, OLDER_ADULT",72,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2020-06-15,2022-05-27,"KGK Science Inc, London, Ontario, N6A 5R8, Canada"
NCT00396851,Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00396851,UNKNOWN,NO,Type 2 Diabetes Mellitus,DRUG: Gurmar|DRUG: Metformin,"Post Graduate Institute of Medical Education and Research, Chandigarh",Indian Council of Medical Research|International Clinical Epidemiology Network (INCLEN) TRUST,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2007-01,,"PGIMER, Chandigarh, 160012, India"
NCT00266461,A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus,https://clinicaltrials.gov/study/NCT00266461,COMPLETED,NO,Postoperative Ileus,DRUG: Daikenchuto Extract Granules (TU-100),Tsumura USA,,ALL,"ADULT, OLDER_ADULT",24,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2005-12,2008-01,"Washington University School of Medicine, St. Louis, Missouri, 63110, United States"
NCT03366922,Evaluation of Artemisia Annua and Moringa,https://clinicaltrials.gov/study/NCT03366922,COMPLETED,NO,HIV Infections,"DIETARY_SUPPLEMENT: Artemisia Annua, Moringa oleifera",Mbarara University of Science and Technology,ANAMED,ALL,"ADULT, OLDER_ADULT",250,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2017-12-10,2020-08-10,"Mbarara Regional Referral Hospital, Mbarara, SouthWestern, 00256, Uganda"
NCT02113111,Effects of Fasting on Self Efficacy,https://clinicaltrials.gov/study/NCT02113111,COMPLETED,NO,Chronic Pain|Fibromyalgia|Rheumatoid Arthritis|Gout|Headache|Arthritis|Gastrointestinal Diseases|Irritable Bowel Syndrome|Inflammatory Bowel Disease|Cardiovascular Diseases,BEHAVIORAL: Fasting,Universität Duisburg-Essen,,ALL,"ADULT, OLDER_ADULT",120,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2014-04,2015-09,"Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Essen, 45276, Germany"
NCT02074579,A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome,https://clinicaltrials.gov/study/NCT02074579,COMPLETED,NO,Irritable Bowel Syndrome in Females,DRUG: TU-100|DRUG: Placebo,Tsumura USA,ICON Clinical Research,FEMALE,"ADULT, OLDER_ADULT",101,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07,2016-04,"Oppenheimer Family Center for Neurobiology of Stress Division of Digestive Diseases David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States"
NCT06570668,"Safety, Tolerability and Pharmacokinetics of CDD-2101 in Health Volunteers",https://clinicaltrials.gov/study/NCT06570668,COMPLETED,NO,Constipation - Functional,DRUG: CDD-2101,Centre for Chinese Herbal Medicine Drug Development Limited,,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2024-05-29,2024-07-12,"Biotrial Inc, Newark, New Jersey, 07103, United States"
NCT04410510,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,https://clinicaltrials.gov/study/NCT04410510,UNKNOWN,NO,COVID|Coronavirus Infection|SARS-CoV 2|COVID19,DRUG: P2Et (Caesalpinia spinosa extract)|OTHER: Placebo,Hospital Universitario San Ignacio,Pontificia Universidad Javeriana,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2020-09-30,2021-11-30,"Hospital Universitario San Ignacio, Bogotá, Colombia"
NCT05621590,"MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial",https://clinicaltrials.gov/study/NCT05621590,COMPLETED,NO,Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest,DRUG: MLC 901|DRUG: Placebo,Shahid Beheshti University of Medical Sciences,,ALL,"CHILD, ADULT, OLDER_ADULT",35,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-03-10,2022-08-12,"Shahid Beheshti University of Medical Sciences, Shohada Hospital, Tehran, Iran, Islamic Republic of"
NCT05684523,Feasibility Study on the Use of Redormin®500 on Day-time Cognition,https://clinicaltrials.gov/study/NCT05684523,COMPLETED,NO,"Sleep Disorders, Circadian Rhythm|Cognitive Dysfunction",DRUG: Valerian-Hop Extract|DRUG: Placebo,Max Zeller Soehne AG,University of Basel,ALL,"ADULT, OLDER_ADULT",40,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2023-03-01,2023-12-20,"Research Platform MCN University of Basel, Basel, Baselstadt, 4055, Switzerland"
NCT02919735,"Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)",https://clinicaltrials.gov/study/NCT02919735,COMPLETED,NO,Alopecia,DRUG: CG 428 cutaneous solution|DRUG: Placebo cutaneous solution,Legacy Healthcare SA,,FEMALE,"ADULT, OLDER_ADULT",40,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2016-10,2019-03-01,"CHUV Lausanne, Lausanne, 1011, Switzerland"
NCT01847924,NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects,https://clinicaltrials.gov/study/NCT01847924,COMPLETED,NO,Cognitive Impairment,DRUG: MLC901|DRUG: Placebo,"National University Hospital, Singapore",,ALL,"ADULT, OLDER_ADULT",103,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-03,2018-04,"University of Santo Tomas Hospital, Manila City, Metro Manila, 1015, Philippines|National University Hospital, Singapore, 119074, Singapore|Singapore General Hospital, Singapore, 169608, Singapore|National Neuroscience Institute, Singapore, 308433, Singapore|National Geriatric Hospital, Hanoi, Vietnam"
NCT02750189,The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea,https://clinicaltrials.gov/study/NCT02750189,COMPLETED,NO,COPD|Chronic Obstructive Pulmonary Disease,OTHER: Direct cost|OTHER: Indirect cost,Konkuk University Medical Center,GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",390,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2015-09,2017-01,"Konkuk University Hospital, Gwangjin gu, Seoul, 05030, Korea, Republic of"
NCT00064857,Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors,https://clinicaltrials.gov/study/NCT00064857,COMPLETED,NO,Lymphedema|Breast|Cancer,DRUG: Pycnogenol,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",26,NIH,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2003-08,2007-08,"University of Wisconsin Comprehensive Cancer Center and School of Pharmacy, Madison, Wisconsin, 53706, United States"
NCT06357273,The Effect of White Tea Consumption on Obesity,https://clinicaltrials.gov/study/NCT06357273,COMPLETED,NO,Obesity|Obesity; Endocrine|Obesity Adult Onset,,Recep Tayyip Erdogan University,,ALL,"ADULT, OLDER_ADULT",91,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-07-01,2023-12-15,"Recep Tayyip Erdogan University, Rize, 53100, Turkey"
NCT03091634,The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.,https://clinicaltrials.gov/study/NCT03091634,COMPLETED,NO,Qi Stagnation and Blood Stasis Syndrome,DRUG: xue-fu-zhu-yu capsule|DRUG: xue-fu-zhu-yu capsule simulated agent,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,China Food and Drug Administration|Chinese Academy of Medical Sciences,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-05-06,2018-12-31,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China|Huguosi TCM Hospital Affiliated to Beijing University of CM, Beijing, China|Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China"
NCT05596006,Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia,https://clinicaltrials.gov/study/NCT05596006,COMPLETED,NO,Breastfeeding Mothers,DRUG: ASIMOMMY®|DRUG: Domperidon|DRUG: Placebo,Gadjah Mada University,,FEMALE,ADULT,45,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-12-31,2023-03-24,"Primary Health Center Jetis and Tegalrejo, Yogyakarta, DI Yogyakarta, 55242, Indonesia"
NCT06558071,Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers,https://clinicaltrials.gov/study/NCT06558071,RECRUITING,NO,Lactation Induced,DRUG: Galatonol 300 mg/Striatin 30 mg|DRUG: Placebo,Dexa Medica Group,,FEMALE,ADULT,160,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-10-21,2025-06,"Klinik Pratama Anugrah Sleman, Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Anisa), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Catur), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Istri Utami), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Istri Yuliani), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Kisti), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Mei), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Tutik), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Wati), Sleman, Daerah Istimewa Yogyakarta, Indonesia|Private Midwife Practice (Bidan Widya), Sleman, Daerah Istimewa Yogyakarta, Indonesia"
NCT04199455,Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke,https://clinicaltrials.gov/study/NCT04199455,UNKNOWN,NO,Ischemic Stroke,DRUG: Integrative Treatment (EPACH Recipe Granules + NQABC Recipe Granules)|DRUG: Placebo,Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",500,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-12-04,2021-08-30,"Guangdong Provincial Hospital of Chinese medicine, Guangzhou, Guangdong, 510120, China"
NCT04852120,Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population,https://clinicaltrials.gov/study/NCT04852120,COMPLETED,YES,Bowel Cleansing,OTHER: No intervention,Ferring Pharmaceuticals,DeltaMed,ALL,"CHILD, ADULT, OLDER_ADULT",3000,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-04-01,2022-12-31,"Ferring Investigational Site, Beijing, China|Ferring Investigational Site, Dalian, China|Ferring Investigational Site, Fuzhou, China|Ferring Investigational Site, Jingdezhen, China|Ferring Investigational Site, Nanjing, China|Ferring Investigational Site, Ningbo, China|Ferring Investigational Site, Qiqihar, China|Ferring Investigational Site, Xian, China"
NCT04459754,Fuzheng Yiliu-1010,https://clinicaltrials.gov/study/NCT04459754,UNKNOWN,NO,Colorectal Cancer Stage II and III,DRUG: Fuzheng Yiliu Formulation,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",189,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-06-29,2024-12-31,"Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510000, China"
NCT01066741,"Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer",https://clinicaltrials.gov/study/NCT01066741,TERMINATED,NO,Oropharynx Cancer|Hypopharynx Cancer,DRUG: Homeodent®|DRUG: 1.4% Sodium Bicarbonate solution,Centre Leon Berard,BOIRON,ALL,"ADULT, OLDER_ADULT",78,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION,2009-05,2011-08,"Centre Léon Bérard, Lyon, France"
NCT05497895,The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients,https://clinicaltrials.gov/study/NCT05497895,UNKNOWN,NO,Gingivitis,BIOLOGICAL: 5% thymoquinone (TQ) gel|BIOLOGICAL: SRP and placebo|PROCEDURE: Only SRP-one stage prophylaxis,King Abdulaziz University,,ALL,ADULT,70,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2022-09,2022-11,"Qassim University, Buraydah, 52571, Saudi Arabia"
NCT06482671,Primary Care dySpEpsia rikkuNshiTo,https://clinicaltrials.gov/study/NCT06482671,NOT_YET_RECRUITING,NO,Dyspepsia and Other Specified Disorders of Function of Stomach|Postprandial Distress Syndrome,DRUG: Rikkunshi-to|OTHER: Placebo,Universitaire Ziekenhuizen KU Leuven,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2024-10-01,2026-10-01,"KU Leuven, Leuven, Vlaams-Brabant, 3000, Belgium"
NCT02452749,Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement,https://clinicaltrials.gov/study/NCT02452749,COMPLETED,NO,Hypertension,DIETARY_SUPPLEMENT: Cardiovascular health dietary supplement,National University of Natural Medicine,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2015-05-01,2017-07-28,"Helfgott Research Institute, Portland, Oregon, 97201, United States"
NCT04284449,"Integrative Therapy for Holistic, Natural Cognition and Lifestyle Rehabilitation",https://clinicaltrials.gov/study/NCT04284449,COMPLETED,NO,Cognitive Dysfunction,OTHER: Whole-practice cognitive optimization,National University of Natural Medicine,North County Natural Medicine,ALL,"ADULT, OLDER_ADULT",34,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-02-24,2023-12-15,"North County Natural Medicine, Encinitas, California, 92024, United States"
NCT04029376,Study to Learn More About the Stomach and Intestine Complaints of Children Aged From 3 to 14 Years,https://clinicaltrials.gov/study/NCT04029376,COMPLETED,NO,Functional Gastrointestinal Disorders,DRUG: Iberogast®,Bayer,,ALL,CHILD,1032,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2007-04-01,2008-10-01,"Many locations, Multiple Locations, Germany"
NCT05778409,To Study the Effects of Cordyceps Cicadae on Vision Care,https://clinicaltrials.gov/study/NCT05778409,RECRUITING,NO,Myopia,BIOLOGICAL: Cordyceps cicadae extract,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2023-03-08,2023-12-15,"Asia university, Taichung, 413, Taiwan"
NCT04059783,Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function,https://clinicaltrials.gov/study/NCT04059783,COMPLETED,NO,Functional Gastrointestinal Disorders,"DRUG: STW5 (Iberogast®, BAY98-7411)",Bayer,,ALL,"ADULT, OLDER_ADULT",272,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-06-17,2011-02-20,"Many locations, Multiple Locations, Germany"
NCT02565316,Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial,https://clinicaltrials.gov/study/NCT02565316,COMPLETED,NO,Depression|Anxiety,DRUG: Nepeta menthoides Boiss & Bohse freeze dried extract|DRUG: Sertraline,Shiraz University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",70,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-11,2015-03,
NCT01332747,Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation,https://clinicaltrials.gov/study/NCT01332747,COMPLETED,NO,Hyperlipidemia,DRUG: safoof e muhazzil|DRUG: compressed tablet of safoof e muhazzil|DRUG: Atorvastatin,Jamia Hamdard University,,ALL,"ADULT, OLDER_ADULT",128,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2010-05,2011-05,"Majeedia Hospital, New Delhi, Delhi, 110062, India"
NCT06313905,EVADRY® in the Treatment of Xerostomia in Sjögren's Syndrome,https://clinicaltrials.gov/study/NCT06313905,NOT_YET_RECRUITING,NO,Sjogren's Syndrome,DIETARY_SUPPLEMENT: EVADRY|OTHER: Placebo,University Tunis El Manar,,ALL,"ADULT, OLDER_ADULT",180,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-04-15,2025-12-31,
NCT03819439,Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder,https://clinicaltrials.gov/study/NCT03819439,COMPLETED,NO,Autism Spectrum Disorder,OTHER: Microbiome and Autism Questionnaire,University Hospitals Cleveland Medical Center,,ALL,"CHILD, ADULT, OLDER_ADULT",74,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-01-30,2019-07-23,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States"
NCT02290925,The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study,https://clinicaltrials.gov/study/NCT02290925,COMPLETED,YES,Type 2 Diabetes Mellitus,DRUG: Kothala Himbutu Biscuit|DIETARY_SUPPLEMENT: Placebo Biscuit,"Rajarata University, Sri Lanka",,ALL,"ADULT, OLDER_ADULT",133,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-05,2017-04,"Teaching Hospital Anuradhapura, Anuradhapura, North Central Province, 50000, Sri Lanka"
NCT06499311,Reflexology Versus Acupressure on Sleep Disturbance and Hot Flashes,https://clinicaltrials.gov/study/NCT06499311,RECRUITING,NO,Postmenopausal Flushing|Hot Flashes,OTHER: Foot Reflexology|OTHER: Acupressure,Cairo University,,FEMALE,ADULT,54,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2024-07-01,2024-08-20,"Faculty of Physical Therapy, Giza, 02, Egypt"
NCT02531295,Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study,https://clinicaltrials.gov/study/NCT02531295,TERMINATED,YES,HIV|Human Immunodeficiency Virus,DRUG: Euphorbia kansui extract powder prepared as tea,"University of California, San Francisco","University of Utah|amfAR, The Foundation for AIDS Research",ALL,"ADULT, OLDER_ADULT",5,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2019-05-15,2020-03-19,"University of Utah, Salt Lake City, Utah, 84132, United States"
NCT02526537,Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients,https://clinicaltrials.gov/study/NCT02526537,TERMINATED,NO,NSCLC,,Lunxu Liu,,ALL,"ADULT, OLDER_ADULT",10,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2015-11-11,2016-06-07,"West China Hospital, ChengDu, Sichuan, China"
NCT05081583,Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients,https://clinicaltrials.gov/study/NCT05081583,COMPLETED,YES,"Interaction, Adverse Herb-Drug|Diabetes Mellitus, Type 2",DRUG: Midazolam Hcl 1Mg/Ml Inj|DIETARY_SUPPLEMENT: Goldenseal (Hydrastis canadensis),Washington State University,National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",22,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2021-09-16,2023-08-31,"Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane, Washington, 99202, United States"
NCT05534152,Effect of Sumac on Appetite and Food Intake,https://clinicaltrials.gov/study/NCT05534152,COMPLETED,NO,Appetite|Food Intake,OTHER: sumac,Oxford Brookes University,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE,2018-11-01,2020-03-15,"Oxford Brookes Centre for Nutrition and Health, Oxford, OX3 0BP, United Kingdom"
NCT04766281,MLC901 in Moderate Traumatic Brain Injury,https://clinicaltrials.gov/study/NCT04766281,RECRUITING,NO,Moderate Traumatic Brain Injury,DIETARY_SUPPLEMENT: MLC901|GENETIC: Placebo,University of the Philippines,,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-05-01,2024-07-31,"Mariano Marcos Memorial Hospital and Medical Center, Batac, Ilocos Norte, Philippines|Northern Mindanao Medical Center, Cagayan De Oro, Misamis Oriental, 9000, Philippines|Philippine General Hospital, Manila, 1000, Philippines"
NCT05109299,Antibacterial Effect of Miswak Toothpaste Compared to Fluoride Toothpaste,https://clinicaltrials.gov/study/NCT05109299,UNKNOWN,NO,Caries,OTHER: Miswak toothpaste|OTHER: Fluoride toothpaste,Cairo University,,ALL,ADULT,32,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-12-01,2022-04-30,"Faculty of Dentistry, Cairo University, Cairo, El Manial, 11553, Egypt"
NCT03617900,"Efficacy of Ginger Extract (Compare Between the Ginger Preparation of Ancient Concept of Thai Traditional Practitioner, Standard Drug and Placebo) by Using Pain Score to Evaluate After Pain of Three Groups of First Normal Postpartum Women.",https://clinicaltrials.gov/study/NCT03617900,COMPLETED,NO,Postpartum Disorder,DRUG: Ginger|DRUG: Placebo oral capsule|DRUG: Paracetamol,Thammasat University,,FEMALE,ADULT,99,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-08-29,2019-05-25,"Naphatsaran Roekruangrit, Pathumthani, 12121, Thailand"
NCT04940117,Effects of the Eefooton on eGFR and QoL in Chronic Kidney Disease Patients.,https://clinicaltrials.gov/study/NCT04940117,COMPLETED,NO,Chronic Kidney Diseases,DIETARY_SUPPLEMENT: Eefooton oral solution,Kaohsiung Veterans General Hospital.,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-07-01,2022-10-31,"WU SAM-CHIANG Medical clinic, Kaohsiung, 802, Taiwan"
NCT03468361,Diuretic Effect Evaluation of Petroselinum Crispum (Parsley) in Hypertensive Patients,https://clinicaltrials.gov/study/NCT03468361,WITHDRAWN,NO,Diurnal Enuresis|Hypertension,OTHER: Natural Product Petroselinum crispum (Parsley)|OTHER: Placebo,Universiti Sains Malaysia,Imam Abdulrahman Bin Faisal University,ALL,ADULT,0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-03-01,2020-01-31,"College of Clinical Pharmacy, Dammam, Eastern Province, 31441, Saudi Arabia|FAMCO, Khobar, Eastern, 31441, Saudi Arabia"
NCT06732778,Effectiveness of Pain Neuroscience Education in Women With Menstrual Pain,https://clinicaltrials.gov/study/NCT06732778,RECRUITING,NO,Pain Management|Dysmenorrhea (Disorder),OTHER: Pain Neuroscience Education (PNE)|OTHER: Control Group (CG),Uskudar University,,FEMALE,"ADULT, OLDER_ADULT",74,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2024-10-01,2025-02-01,"Uskudar University, Faculty of Health Sciences, Istanbul, 34000, Turkey"
NCT03709043,Addressing Heavy Alcohol Use Consumption With Kudzu,https://clinicaltrials.gov/study/NCT03709043,ACTIVE_NOT_RECRUITING,NO,Alcohol Use Disorder|Sexually Transmitted Diseases,DRUG: Standardized kudzu|OTHER: Placebo|DIAGNOSTIC_TEST: Sexually transmitted infection testing:|BEHAVIORAL: Medical Management (MM) counseling for alcohol use:|DIAGNOSTIC_TEST: Urinalysis for novel alcohol biochemical markers for recent alcohol use:|DIAGNOSTIC_TEST: Dried Blood Spot (DBS) Testing for PEth:|BEHAVIORAL: Behavioral survey measurements:|BEHAVIORAL: Ecological Momentary Assessment procedure:,Glenn-Milo Santos,National Institute on Alcohol Abuse and Alcoholism (NIAAA),ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-07-11,2024-06-30,"San Francisco Department of Public Health, San Francisco, California, 94102, United States"
NCT02337933,Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome,https://clinicaltrials.gov/study/NCT02337933,COMPLETED,YES,Metabolic Syndrome X,DRUG: Ursolic acid|DRUG: Placebo,University of Guadalajara,,ALL,ADULT,24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2014-09,2015-09,"Instituto de Terapéutica Experimental y Clínica, Guadalajara, Jalisco, 44140, Mexico"
NCT06770491,A Phase 1 Study of Y-3 in US Healthy Volunteers.,https://clinicaltrials.gov/study/NCT06770491,NOT_YET_RECRUITING,NO,Safety|Tolerability|Pharmacokinetic Study in Healthy Volunteers,DRUG: Y-3 for injection|DRUG: Placebo,"Neurodawn Pharmaceutical Co., Ltd.",,ALL,ADULT,20,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2025-01-06,2025-08-30,
NCT06042465,Investigation on Efficacy Between TCM Treatment Using Acupuncture and Tui-na With Physiotherapy on Patellofemoral Pain Syndrome,https://clinicaltrials.gov/study/NCT06042465,RECRUITING,NO,Patellofemoral Pain Syndrome|Acupuncture|Physiotherapy,OTHER: acupuncture and Tui-na manipulations|OTHER: Physiotherapy,Hong Kong Baptist University,Hong Kong Baptist Hospital,ALL,"ADULT, OLDER_ADULT",180,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-10-18,2023-12-31,"Kevin Yue Kin Man, Hong Kong, Hong Kong"
NCT01663922,Boceprevir and Ucalm (St John&Apos;s Wort),https://clinicaltrials.gov/study/NCT01663922,COMPLETED,YES,Hepatitis C,DRUG: Boceprevir|DRUG: St John's Wort,St Stephens Aids Trust,"University of Liverpool|University of Turin, Italy",ALL,"ADULT, OLDER_ADULT",17,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION,2012-08,2012-12,"St Stephen's AIDS Trust, London, SW10 9NH, United Kingdom"
NCT00590564,SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study,https://clinicaltrials.gov/study/NCT00590564,COMPLETED,YES,Hepatitis C,DRUG: Sho-saiko-to,Memorial Sloan Kettering Cancer Center,,ALL,"ADULT, OLDER_ADULT",42,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2002-10,2011-02,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States"
NCT06761339,Clinical Trial Evaluate the Cough-relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children in Outpatient-treated Pharyngitis,https://clinicaltrials.gov/study/NCT06761339,COMPLETED,NO,Cough Severity|Cough Frequency|Cough Duration|Phlegm Accumulation (Nasal and Throat Mucus),DIETARY_SUPPLEMENT: Azka Nasal and Throat for Children|DRUG: Prospan cough Syrup,Haiphong University of Medicine and Pharmacy,,ALL,CHILD,24,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2024-08-12,2024-12-20,"Center for Clinical Trial and Bioequivalence Study, Hai Phong, 180000, Vietnam"
NCT00761930,Compare the Clinical Efficacy of Prototype Toothpastes.,https://clinicaltrials.gov/study/NCT00761930,COMPLETED,YES,Gingival Diseases,DRUG: Fluoride|DRUG: Triclosan and fluoride|DRUG: Herbal Ingredient and fluoride,Colgate Palmolive,,ALL,"ADULT, OLDER_ADULT",103,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2008-03,2008-06,"Eastman Dental Center - University of Rochester, Rochester, New York, 14642-8315, United States"
NCT00160901,Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer,https://clinicaltrials.gov/study/NCT00160901,COMPLETED,NO,Breast Cancer,"DRUG: two complex naturopathic add-on therapies, leaflet 5-a-day",Heidelberg University,"Hector-Stiftung|Cefak KG, Kempten|Ursapharm, Saarbrücken|Schwabe-Wenex International Ltd",FEMALE,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2003-08,2005-12,"Department of Complementary and Integrative Medicine, Heidelberg, Baden-Württemberg, D-69115, Germany"
NCT01670955,The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients,https://clinicaltrials.gov/study/NCT01670955,COMPLETED,NO,Anemia,DIETARY_SUPPLEMENT: Jobelyn|DRUG: Ferrous Sulphate + Folic Acid,Lagos State University,"Health Forever Product Limited. Lagos, Nigeria",FEMALE,"CHILD, ADULT, OLDER_ADULT",73,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2012-12,2013-12,"Lagos State University Teaching Hospital, Ikeja, Lagos, 100001, Nigeria"
NCT05596214,Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (SUDD),https://clinicaltrials.gov/study/NCT05596214,RECRUITING,NO,Diverticulitis,COMBINATION_PRODUCT: Curcumin-Berberine (coptis)|COMBINATION_PRODUCT: Placebo,Dr. Adi Lahat,,ALL,"ADULT, OLDER_ADULT",40,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2022-08-14,2025-05,"Sheba Medical Center, Ramat Gan, 5262000, Israel"
NCT02453932,Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia,https://clinicaltrials.gov/study/NCT02453932,COMPLETED,NO,Vascular Dementia,DRUG: Tianzhi granule and placebo identified to donepezil|DRUG: Donepezil and placebo identified to Tianzhi granule|DRUG: Placebo,"Dongzhimen Hospital, Beijing",,ALL,"ADULT, OLDER_ADULT",543,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2013-10,2017-05,"Dongzhimen Hospital,Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT01136928,Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers,https://clinicaltrials.gov/study/NCT01136928,COMPLETED,NO,Healthy Volunteers,DRUG: American ginseng,Johns Hopkins University,National Center for Complementary and Integrative Health (NCCIH),MALE,"ADULT, OLDER_ADULT",15,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2010-09-28,2011-03-14,"Johns Hopkins University, Baltimore, Maryland, 21287-5554, United States"
NCT06211049,Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea,https://clinicaltrials.gov/study/NCT06211049,ACTIVE_NOT_RECRUITING,NO,Primary Dysmenorrhea,DRUG: Vitex agnus-castus BNO 1095 (20 mg)|DRUG: Placebo,Bionorica SE,FGK Clinical Research GmbH,FEMALE,ADULT,286,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2023-12-12,2025-03-31,"Medizinische Universität Innsbruck, Department Frauenheilkunde, Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, 6020, Austria|Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Wien, 1090, Austria|Centrum ambulantní gynekologie a primární péče s.r.o., Brno Střed, 60200, Czechia|Fakultní nemocnice Brno, Gynekologickoporodnická Klinika, Centrum asistované reprodukce CAR 01 Brno, Brno Střed, 60200, Czechia|GYNEKOLOGIE CHEB s.r.o., Cheb, 35002, Czechia|NEUMED gynekologická ambulance s.r.o, Olomouc, 77900, Czechia|MUDr. Martina Marešová Rosenbergová s.r.o., Plzen, 30100, Czechia|Gyncare MUDr. Michael Švec s.r.o., Plzeň 2-Slovany, 32600, Czechia|Centrum gynekologické rehabilitace s.r.o, Písek, 39701, Czechia|Praxis Dr. Noel, Aachen, 52072, Germany|Klinische Forschung Berlin-Mitte GmbH, Berlin, 10117, Germany|Frauenarztpraxis Dipl. med. Andrea Heweker, Praxis für Gynäkologie, Bernburg, 06406, Germany|Klinische Forschung Dresden GmbH, Dresden, 01069, Germany|Praxis Geseke, Geseke, 59590, Germany|Frauenarztpraxis Dr. Inka Kiesche, Halle, 06110, Germany|Klinische Forschung Hamburg GmbH, Hamburg, 20253, Germany|Frauenarzt-Praxis Dr. med. Klaus Peters, Hamburg, 22159, Germany|Klinische Forschung Hannover Mitte GmbH, Hannover, 30159, Germany|Klinische Forschung Karlsruhe GmbH, Karlsruhe, 76137, Germany|Klinische Forschung Schwerin GmbH, Schwerin, 19055, Germany|Frauenarzt in Stolberg - Wolfgang Clemens, Stolberg, 52222, Germany|Clinexpert Kft., Budapest, 1033, Hungary|Óbudai Egészségügyi Centrum Kft., Budapest, 1036, Hungary|Zatik Med Kft., Debrecen, 4024, Hungary|BKS Research Kft., Hatvan, 3000, Hungary|AXON Kereskedelmi Es Szolgaltato Kft., Kecskemét, 6000, Hungary|IPR Hungary Kft., Miskolc, 3530, Hungary|Centrum Medyczne Mikołowska dr Adam Sipiński, Katowice, 40-065, Poland|Silmedic Sp. z o.o., Katowice, 40-282, Poland|Nzoz Profi-Med, Lublin, 20-880, Poland|Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp. z o.o., Malbork, 82-200, Poland|Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji, Klinika Położnictwa, Chorób Kobiecych i Ginekologii Onkologicznej, Warszawa, 02-507, Poland|Karolinska University Hospital, WHO-centre, Stockholm, SE-171 76, Sweden|Umeå University, Dep. of Clinical Sciences, Obstetrics and Gynecology, Umeå, SE-907 37, Sweden"
NCT01012830,Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia,https://clinicaltrials.gov/study/NCT01012830,UNKNOWN,NO,Schizophrenia|Dementia,DRUG: Huperzine A,VA Nebraska Western Iowa Health Care System,American Legion of Iowa Foundation,ALL,ADULT,15,FED,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2009-12,2011-04,"Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, Nebraska, 68105, United States"
NCT05005767,Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis,https://clinicaltrials.gov/study/NCT05005767,UNKNOWN,NO,Chronic Periodontitis,PROCEDURE: scaling and root planing|PROCEDURE: Frankincense extract gel natural herbal product,Tanta University,,ALL,ADULT,20,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-04-01,2022-03,"Doaa Ahmed yousef bayoumi, Tanta, Gharbiya, 31511, Egypt"
NCT01180374,The Effects of Cannabidiol and ∆-9-THC in Humans,https://clinicaltrials.gov/study/NCT01180374,COMPLETED,NO,Healthy,DRUG: Cannabidiol|DRUG: Delta-9-THC|DRUG: Placebo|DRUG: Placebo,Yale University,,ALL,ADULT,27,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2010-02-01,2014-10-06,"VA Connecticut Healthcare System, West Haven, Connecticut, 06516, United States"
NCT01987622,Acupuncture for Lumbar Spinal Stenosis,https://clinicaltrials.gov/study/NCT01987622,COMPLETED,NO,Spinal Stenosis,PROCEDURE: Acupuncture|PROCEDURE: Usual care,Korean Medicine Hospital of Pusan National University,Korea Institute of Oriental Medicine,ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2013-11,2014-11,"National Clinical Research Center, Korean Medicine Hospital, Pusan National University, Yangsan, Kyungsangnamdo, 626-770, Korea, Republic of"
NCT04795557,Efficacy of Adaptogens in Patients With Long COVID-19,https://clinicaltrials.gov/study/NCT04795557,COMPLETED,NO,Covid19,DIETARY_SUPPLEMENT: ADAPT-232 oral solution|OTHER: Placebo oral solution,Swedish Herbal Institute AB,"National Family Medicine Training Centre, Georgia|Tbilisi State Medical University|Phytomed AB",ALL,"ADULT, OLDER_ADULT",100,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-04-19,2021-12-26,"National Family Medicine Training Centre,, Tbilisi, 0102, Georgia"
NCT06690762,Relaxation Exercise and Education in Patients With Irritable Bowel Syndrome,https://clinicaltrials.gov/study/NCT06690762,NOT_YET_RECRUITING,NO,Irritable Bowel Disease,OTHER: Education,Muş Alparslan University,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-12-02,2025-07-22,
NCT02192645,The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study,https://clinicaltrials.gov/study/NCT02192645,UNKNOWN,NO,Allergic Rhinitis,DRUG: Sanfujiu|DRUG: Placebo,Guangdong Provincial Hospital of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",453,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-07,2017-07,"Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China"
NCT00885599,Efficacy of a Naturally-derived Mouthrinse for Gingival Inflammation,https://clinicaltrials.gov/study/NCT00885599,COMPLETED,NO,Gingivitis,DRUG: Herbal API|DRUG: Cepacol|DRUG: Listerine Antiseptic Mouth Rinse|DRUG: placebo mouthwash,Shaare Zedek Medical Center,,ALL,"CHILD, ADULT, OLDER_ADULT",94,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-06,2010-06,"Shaare Zedek Medical Center, Jerusalem, 91031, Israel"
NCT03722771,Influence of Lavender Oil on Vital Signs in Oral Surgery Patients,https://clinicaltrials.gov/study/NCT03722771,COMPLETED,NO,Dental Anxiety|Sedative; Anxiety Disorder,BEHAVIORAL: Inhalation|OTHER: Anxiety Questionnaires 1|OTHER: Anxiety Questionnaires 2|DIAGNOSTIC_TEST: Vital Signs 1|DIAGNOSTIC_TEST: Vital Signs 2|DIAGNOSTIC_TEST: Vital Signs 3|DIAGNOSTIC_TEST: Vital Signs 4,Nazife Begüm KARAN,,ALL,ADULT,126,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2017-09-01,2018-11-02,"Nazife Begüm KARAN, Ri̇ze, Merkez, 053100, Turkey"
NCT01796795,Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients,https://clinicaltrials.gov/study/NCT01796795,SUSPENDED,NO,Common Wart,DRUG: Vehicle gel|DRUG: SR-T100 gel with 1.0% of SM|DRUG: SR-T100 gel with 2.3% of SM,"G&E Herbal Biotechnology Co., LTD",,ALL,"CHILD, ADULT, OLDER_ADULT",102,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2030-09,2033-08,
NCT06114797,Chamomile Effect on Xerostomia Associated With End-stage Renal Disease in Elderly,https://clinicaltrials.gov/study/NCT06114797,COMPLETED,NO,Xerostomia Due to Hyposecretion of Salivary Gland,OTHER: Chamomile|OTHER: Saline mouthwash,Ain Shams University,,ALL,OLDER_ADULT,88,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-07-01,2023-09-01,"Ain Shams University, Cairo, 3753450, Egypt"
NCT02204826,"Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study",https://clinicaltrials.gov/study/NCT02204826,COMPLETED,NO,Male Infertility,DRUG: Korean Red Ginseng (KRG)|PROCEDURE: Varicocelectomy,Pusan National University Hospital,,MALE,ADULT,80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-04,2013-12,"Department of Urology, Pusan National University Hospital, Busan, 602-739, Korea, Republic of"
NCT03959618,Intravenous Chemotherapy and Plant-based Dietary Supplements,https://clinicaltrials.gov/study/NCT03959618,COMPLETED,NO,Breast Cancer,OTHER: dietary supplements questionary,Institut Cancerologie de l'Ouest,,ALL,"ADULT, OLDER_ADULT",200,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-04-02,2020-05-13,"Institut de Cancerologie de L'Ouest, Saint Herblain, 44805, France"
NCT03375580,Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD,https://clinicaltrials.gov/study/NCT03375580,UNKNOWN,NO,Nonalcoholic Fatty Liver Disease,DIETARY_SUPPLEMENT: TLC|DRUG: metformin|DRUG: Compound Zhenzhu Tiaozhi capsule|DRUG: Simvastatin,The First Affiliated Hospital of Guangdong Pharmaceutical University,,ALL,"ADULT, OLDER_ADULT",196,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2017-12-31,2019-12-31,"First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510080, China"
NCT03680248,Monitoring of Hepatic Fat Metabolism Using Magnetic Resonance Methods,https://clinicaltrials.gov/study/NCT03680248,COMPLETED,NO,Hepatic Fat Content,DIETARY_SUPPLEMENT: Fat|DIETARY_SUPPLEMENT: Fasting|DIETARY_SUPPLEMENT: Fat+Glucose|DIETARY_SUPPLEMENT: Glucose|DIETARY_SUPPLEMENT: Fat+Fructose|DIETARY_SUPPLEMENT: Fructose,Institute for Clinical and Experimental Medicine,,MALE,"ADULT, OLDER_ADULT",18,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2016-04-26,2019-12,"Institute for Clinical and Experimental Medicine, Prague 4, 14021, Czechia"
NCT04184440,The Hypoglycemic Effect of Cyclocarya Paliurus Extract on Hyperglycemic Populations,https://clinicaltrials.gov/study/NCT04184440,UNKNOWN,NO,Hyperglycemia,DIETARY_SUPPLEMENT: Cyclocarya paliurus extract|DIETARY_SUPPLEMENT: Cyclocarya paliurus compounds|DIETARY_SUPPLEMENT: placebo,Huazhong University of Science and Technology,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2020-03,2020-07,"Shiyan Taihe Hospital, Shiyan, Hubei, 442008, China"
NCT05422599,Enhancement of Sleep Quality and Mood Following Supplementation With Lemon Balm in an Adult Population (Lemslp),https://clinicaltrials.gov/study/NCT05422599,COMPLETED,NO,Sleep Disturbance|Mood Disturbance,DIETARY_SUPPLEMENT: Lemon balm|DIETARY_SUPPLEMENT: Placebo,University of Reading,Naturex,ALL,ADULT,99,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2022-05-05,2023-05-23,"School of Psychology and Clinical Languages, University of Reading, Reading, Berkshire, RG6 6AL, United Kingdom"
NCT06551467,Effect of an Innovative Online Ayurveda Program on the Mental and Physical Health of Home-Based Adults,https://clinicaltrials.gov/study/NCT06551467,COMPLETED,NO,Anxiety|Depression,BEHAVIORAL: Online Ayurveda Program for Detox and Lifestyle,Maharishi International University,,ALL,"ADULT, OLDER_ADULT",98,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-03-10,2022-07-25,"The Center for Maharishi AyurVeda and Holistic Medicine, Geboltskirchen, 4682, Austria"
NCT01119391,The Impact of Lifestyle Behaviors on In Vitro Fertilization (IVF) Outcome,https://clinicaltrials.gov/study/NCT01119391,COMPLETED,NO,Infertility,BEHAVIORAL: There was no intervention; this was a survey only study,Boston IVF,,FEMALE,ADULT,118,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2009-07,2010-04,"Boston IVF, Waltham, Massachusetts, 02451, United States"
NCT04767620,Clinical Trial of Ruxian Zengsheng No. 1 Decoction,https://clinicaltrials.gov/study/NCT04767620,UNKNOWN,NO,Mammary Gland Hyperplasia,DRUG: Rugdenzengsheng No. 1 prescription,Jiuda Zhao,,FEMALE,"ADULT, OLDER_ADULT",137,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-03-01,2021-12-31,"Qinghai University Affiliated Hospital, Qinghai, Xining, Qinghai, 810000, China"
NCT02982642,Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment,https://clinicaltrials.gov/study/NCT02982642,WITHDRAWN,NO,Mild Cognitive Impairment,DRUG: 1612 capsule|DRUG: Placebos,"Dongzhimen Hospital, Beijing",,ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01,2018-12,"Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing, Beijing, 100700, China"
NCT02091635,Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method,https://clinicaltrials.gov/study/NCT02091635,COMPLETED,NO,Dyspepsia,DRUG: Placebo (for Motilitone)|DRUG: Motilitone,Samsung Medical Center,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-08,2013-12,"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Korea, Republic of"
NCT06818487,Ganyan-1 in Dry Eye,https://clinicaltrials.gov/study/NCT06818487,NOT_YET_RECRUITING,NO,Dry Eye|TCM,DRUG: Ganyan1|DRUG: Sodium Hyaluronate|DRUG: 1/2Ganyan1|DRUG: Placebo|DRUG: 1/2Placebo,Beijing Tongren Hospital,,ALL,"ADULT, OLDER_ADULT",232,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2025-03-01,2027-02-01,
NCT05996874,A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants,https://clinicaltrials.gov/study/NCT05996874,COMPLETED,NO,Healthy Participants,DRUG: Semaglutide,Novo Nordisk A/S,,MALE,ADULT,121,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-08-12,2024-04-18,"Profil Institut für Stoffwechselforschung GmbH, Neuss, 41460, Germany"
NCT04685005,"""WakeUp"" for Vigilance Following Lunch",https://clinicaltrials.gov/study/NCT04685005,COMPLETED,NO,Fatigue,"DIETARY_SUPPLEMENT: ""Wake Up""|DIETARY_SUPPLEMENT: Caffeine",Carmel Medical Center,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2018-11-01,2019-12-31,"Carmel Medical Center, Haifa, 31096, Israel"
NCT04940676,Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury,https://clinicaltrials.gov/study/NCT04940676,UNKNOWN,NO,Acute Lung Injury|Sepsis,DRUG: Huzhangxiefei Decoction|DRUG: 10% Huzhangxiefei Decoction,"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine",,ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2021-03-10,2022-12-31,"ShanghaiXinhua, Shanghai, 200092, China"
NCT04498013,Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52,https://clinicaltrials.gov/study/NCT04498013,UNKNOWN,NO,Mammographic Breast Density,DRUG: Cyclodynon|BEHAVIORAL: Lifestyl modification,Dr. Struk Tetiana,Bionorica SE,FEMALE,ADULT,150,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-07-22,2022-05-01,"Clinical and diagnostics center, Kharkiv, 61057, Ukraine"
NCT05876988,Chinese Acupuncture for Chemobrain in Elderly Cancer Patients,https://clinicaltrials.gov/study/NCT05876988,RECRUITING,NO,Chinese Acupuncture,DEVICE: Chinese acupuncture,"Nanjing First Hospital, Nanjing Medical University",Jiangsu Health Vocational College,ALL,"ADULT, OLDER_ADULT",168,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2023-09-30,2025-12-31,"Nanjing First Hospital, Nanjing, Jiangsu, 210006, China"
NCT02006498,Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD),https://clinicaltrials.gov/study/NCT02006498,COMPLETED,NO,Non-alcoholic Fatty Liver Disease,DRUG: Sillymarin|DRUG: Placebo,University of Malaya,Rottapharm,ALL,"ADULT, OLDER_ADULT",99,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2012-06,2015-12,"University Malaya Medical Centre, Kuala Lumpur, Federal Territory, 59100, Malaysia"
NCT03440125,Cayenne Pepper Cataplasm - Safety Study,https://clinicaltrials.gov/study/NCT03440125,COMPLETED,NO,Low Back Pain,DRUG: Cayenne Pepper topical|DEVICE: Electrical stimulation|PROCEDURE: Massage,University of Primorska,"S2P, Science to Practice, Ltd.|Comenius University|Wilhelminenspital Vienna|Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation",ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-03-15,2016-12-15,"Facultiy of Physical Education and Sports, Comenius University of Bratislava, Bratislava, 81806, Slovakia|Faculty of Health Sciences, Izola, 6310, Slovenia"
NCT02462746,"The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk",https://clinicaltrials.gov/study/NCT02462746,COMPLETED,NO,Healthy,DIETARY_SUPPLEMENT: L-Cysteine,Centre for Addiction and Mental Health,,FEMALE,ADULT,24,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2015-03,2016-04,"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, M5T 1R8, Canada"
NCT03489681,Acupuncture Treatment for Chronic Sciatica: the Neuroimaging Pain-network Study,https://clinicaltrials.gov/study/NCT03489681,UNKNOWN,NO,"Therapy, Acupuncture|MRI, Functional",DEVICE: acupuncture,"Taipei Veterans General Hospital, Taiwan",Lotung Poh-Ai Hospital,ALL,"ADULT, OLDER_ADULT",80,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-08-01,2020-01-31,"Taipei Veterans General Hospital, Taipei, Taiwan"
NCT04612283,NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain,https://clinicaltrials.gov/study/NCT04612283,COMPLETED,NO,Arthritis Osteoarthritis,OTHER: NGA-01 gel|OTHER: Placebo,Nutrin GmbH,Galaxa Pharma|Mittal Global Clinical Trial Services,ALL,"ADULT, OLDER_ADULT",60,NETWORK,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-10-31,2022-01-25,"Moraya Multispeciality Hospital, Pune, Maharashtra, 411033, India"
NCT04120259,Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics,https://clinicaltrials.gov/study/NCT04120259,COMPLETED,NO,"Diabetes Mellitus, Type 2",DRUG: Metformin Oral Tablet|DIETARY_SUPPLEMENT: Vinegar,Ziauddin University,,ALL,"ADULT, OLDER_ADULT",126,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-04-22,2019-08-26,"Ziauddin University, Karachi, Sindh, 7500, Pakistan"
NCT02232256,The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain,https://clinicaltrials.gov/study/NCT02232256,WITHDRAWN,NO,Chronic Pain|Insomnia,DRUG: CALPXT96,9305-9954 Quebec Inc,McMaster University,ALL,"ADULT, OLDER_ADULT",0,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-12,2016-12,"CPM - Centres for Pain Managemen, Mississauga, Ontario, L5N 3E7, Canada"
NCT01493921,Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment,https://clinicaltrials.gov/study/NCT01493921,COMPLETED,NO,Actinic Keratosis,DRUG: SR-T100 gel|DRUG: Vehicle gel,"G&E Herbal Biotechnology Co., LTD",,ALL,"ADULT, OLDER_ADULT",113,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-10,2015-11,"Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Chi Mei Medical Center YongKang, Tainan, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan"
NCT03831971,The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers,https://clinicaltrials.gov/study/NCT03831971,COMPLETED,YES,Opiod Use Disorder,DRUG: ANS-6637,National Institutes of Health Clinical Center (CC),National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",26,NIH,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2019-03-01,2019-12-30,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States"
NCT03695419,Prevalence of New Psychoactive Substances Use,https://clinicaltrials.gov/study/NCT03695419,UNKNOWN,NO,Addiction,,Assiut University,,ALL,ADULT,50,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-01-01,2021-12-30,
NCT00281723,Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous),https://clinicaltrials.gov/study/NCT00281723,SUSPENDED,NO,"Ulcer, Aphthous",DRUG: Pro-Pe adhesive tablet,Hadassah Medical Organization,"Grant from ""Axiomedic. Advanced Medical Solutions"", Zurich, Switzerland",ALL,"ADULT, OLDER_ADULT",50,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,,2007-05,"Hadassah Medical Organization,, Jerusalem, 91120, Israel"
NCT06452953,Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder,https://clinicaltrials.gov/study/NCT06452953,COMPLETED,NO,Chronic Insomnia Disorder,DRUG: suanzaoren decoction|DRUG: Eszopiclone 1 mg,Central South University,The Third Hospital of Inner Mongolia Autonomous Region,ALL,"ADULT, OLDER_ADULT",85,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-09-10,2024-03-01,"The Second Xiangya Hospital of Central South University, Changsha, China"
NCT00812851,Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS),https://clinicaltrials.gov/study/NCT00812851,COMPLETED,NO,Cramps|Amyotrophic Lateral Sclerosis,DRUG: Dronabinol,Cantonal Hospital of St. Gallen,ALS Association,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2005-04,2008-04,"Kantonsspital St.Gallen, St.Gallen, 9007, Switzerland"
NCT02416128,"Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology",https://clinicaltrials.gov/study/NCT02416128,WITHDRAWN,NO,Iritis,DRUG: Euphrasia|DRUG: Prednisolone acetate,Larkin Community Hospital,Nova Southeastern University,ALL,"ADULT, OLDER_ADULT",0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-04-30,2016-03-25,
NCT00920127,Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study),https://clinicaltrials.gov/study/NCT00920127,UNKNOWN,NO,Obstructive Lung Disease|Chronic Obstructive Pulmonary Disease|Asthma,DIETARY_SUPPLEMENT: AKL1,University of East Anglia,,ALL,"ADULT, OLDER_ADULT",164,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2009-06,2012-02,"University of East Anglia, Norwich, Norfolk, NR47TJ, United Kingdom"
NCT04653727,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,https://clinicaltrials.gov/study/NCT04653727,COMPLETED,NO,Covid19|Influenza A|Respiratory Disease,OTHER: Cross-sectional survey,"Charite University, Berlin, Germany",,ALL,"ADULT, OLDER_ADULT",1287,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-01-06,2021-03-05,"Charite University, Berlin, 14169, Germany"
NCT03002090,Defining the Functional Role of Iron in Aerobic Training and Physical Performance,https://clinicaltrials.gov/study/NCT03002090,COMPLETED,NO,Iron Deficiency Without Anemia,DIETARY_SUPPLEMENT: Iron trained|DIETARY_SUPPLEMENT: Iron Untrained|DIETARY_SUPPLEMENT: BZKL Trained|DIETARY_SUPPLEMENT: BZKL Untrained|DIETARY_SUPPLEMENT: Placebo Trained|DIETARY_SUPPLEMENT: Placebo Untrained,Cornell University,,FEMALE,ADULT,109,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2014-08,2015-06,"Kunming Medical University, Department of Nursing,, Chenggong, Yunnan, China"
NCT06719778,Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease,https://clinicaltrials.gov/study/NCT06719778,RECRUITING,NO,Crohn's Disease,OTHER: Two-stage nutritional therapy concept,Universität Duisburg-Essen,Heidelberg University|German Crohn's and Colitis Association (DCCV e.V.),ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2024-08-01,2027-04,"Sozialstiftung Bamberg, Bamberg, Bavaria, 96049, Germany"
NCT03839719,OSE as a Pre-procedural Mouth Rinse: A Clinical and Microbiological Study.,https://clinicaltrials.gov/study/NCT03839719,COMPLETED,NO,Gingivitis|Periodontitis|Aerosol Disease|Gingival Disease|Periodontal Diseases,PROCEDURE: Group PI|PROCEDURE: Group OC|PROCEDURE: Group CHX,"Government College of Dentistry, Indore",,ALL,ADULT,30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2019-01-09,2019-05-25,"Department of periodontology, GDC Indore, Indore, Madhu Pradesh, 452001, India"
NCT02504151,Cannabidiol Treatment in Patients With Early Psychosis,https://clinicaltrials.gov/study/NCT02504151,COMPLETED,YES,Schizophrenia|Schizoaffective Disorder,DRUG: Cannabidiol|DRUG: Placebo,Yale University,,ALL,"ADULT, OLDER_ADULT",18,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-01-28,2018-03-09,"Connecticut Mental Health Center, New Haven, Connecticut, 06519, United States|VA Connecticut Healthcare System, West Haven, Connecticut, 06516, United States"
NCT05566457,HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC,https://clinicaltrials.gov/study/NCT05566457,UNKNOWN,NO,Breast Cancer,DRUG: Huangqi Guizhi Wuwu decoction (HGWD) infusion packs,Chinese Academy of Medical Sciences,,FEMALE,"ADULT, OLDER_ADULT",92,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-01-01,2023-01-01,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100021, China"
NCT03895307,Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain,https://clinicaltrials.gov/study/NCT03895307,COMPLETED,YES,Chronic Low Back Pain,OTHER: kinesio tape|OTHER: local anesthetic|OTHER: local serum physiologic,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",,ALL,"ADULT, OLDER_ADULT",84,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-04-01,2019-08-01,"Sultan 2.Abdülhamid Han Training and Research Hospital, Istanbul, Eyalet/Yerleşke, 34000, Turkey|Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Eyalet/Yerleşke, 34000, Turkey"
NCT03562429,The Efficacy of TGF for Treating Osteoarthritis of the Knee,https://clinicaltrials.gov/study/NCT03562429,UNKNOWN,NO,"Osteoarthritis, Knee",DRUG: TGF|DRUG: TGFP,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",180,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-08-01,2021-12-31,
NCT04321811,"Behavior, Environment And Treatments for Covid-19",https://clinicaltrials.gov/study/NCT04321811,COMPLETED,NO,Coronavirus,"OTHER: Observation of patients with known, suspected, or at risk for COVID-19 infection",xCures,Genetic Alliance|LunaDNA|Cancer Commons|REDCap Cloud,ALL,"ADULT, OLDER_ADULT",5000,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-03-21,2021-03-20,"BEAT19.org, San Francisco, California, 94022, United States"
NCT02840890,Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer,https://clinicaltrials.gov/study/NCT02840890,COMPLETED,NO,Breast Cancer,PROCEDURE: osteopathic technique|PROCEDURE: Placebo,Centre Georges Francois Leclerc,,FEMALE,"ADULT, OLDER_ADULT",94,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2015-11-05,2018-04-20,"CGFL, Dijon, 21079, France"
NCT00987805,Efficacy of Banhasasim-tang on Functional Dyspepsia,https://clinicaltrials.gov/study/NCT00987805,COMPLETED,NO,Functional Dyspepsia,DIETARY_SUPPLEMENT: Banhasasim-tang|DIETARY_SUPPLEMENT: Corn-starch granules,Korea Health Industry Development Institute,,ALL,"ADULT, OLDER_ADULT",84,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2009-09,2011-01,"Kyung Hee University Medical Center Oriental Hospital, Seoul, 130702, Korea, Republic of|East-West Neo Medical Center, Seoul, 134727, Korea, Republic of"
NCT05022108,Alpha-Bisabolol Gel With Antihistamine Action,https://clinicaltrials.gov/study/NCT05022108,COMPLETED,NO,Wounds and Injuries,BIOLOGICAL: Alpha bisabolol gel,Universidade do Vale do Sapucai,,ALL,ADULT,20,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-04-01,2020-12-20,"Vale do Sapucaí University, Pouso Alegre, Minas Gerais, 37550-000, Brazil"
NCT01652625,Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis,https://clinicaltrials.gov/study/NCT01652625,COMPLETED,NO,Recurrent Aphthous Stomatitis,DRUG: Yunnan Baiyao toothpaste|DRUG: Placebo toothpaste,Peking University,,ALL,"ADULT, OLDER_ADULT",227,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-03,2011-03,
NCT03488719,A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate,https://clinicaltrials.gov/study/NCT03488719,COMPLETED,YES,Phase 1,DRUG: Metoprolol Succinate 25 MG|DRUG: Metoprolol Succinate 50 MG|DRUG: Metoprolol Succinate 100 MG,Saniona,,ALL,ADULT,37,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-07-11,2019-06-06,"Parexel International GmbH; Early Phase Clinical Unit Berlin, Berlin, 14050, Germany"
NCT02467543,The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea,https://clinicaltrials.gov/study/NCT02467543,COMPLETED,NO,Dysmenorrhea,OTHER: 20% Ethanol|OTHER: Viburnum opulus 3X,University of Johannesburg,,FEMALE,ADULT,30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-02,2015-12,"University of Johannesburg, Johannesburg, Gauteng, 2028, South Africa"
NCT02705209,Cayenne Pepper Cataplasm - Effect Study,https://clinicaltrials.gov/study/NCT02705209,COMPLETED,NO,Back Pain|Low Back Pain,OTHER: Cayenne Pepper Cataplasm|OTHER: Placebo Cataplasm,Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation,Comenius University,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-10,2016-02,"Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation, Vienna, 1160, Austria|Facultiy of Physical Education and Sports, Comenius University of Bratislava, Bratislava, 81806, Slovakia"
NCT06136104,The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms,https://clinicaltrials.gov/study/NCT06136104,COMPLETED,NO,Healthy|Premenstrual Dysphoric Disorder|Premenstrual Syndrome,DIETARY_SUPPLEMENT: Mixhers HERTIME|DIETARY_SUPPLEMENT: Placebo,Midwestern University,,FEMALE,ADULT,100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-08-30,2023-12-20,"Midwestern University, Glendale, Arizona, 85308, United States"
NCT06024460,Non-pharmacological Treatment vs Pharmacological Treatment for Non-acute Lumbar Disc Herniation,https://clinicaltrials.gov/study/NCT06024460,RECRUITING,NO,Lumbar Disc Herniation,PROCEDURE: non-pharmacological treatment strategy|PROCEDURE: pharmacological treatment strategy,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-06-09,2030-12-31,"Jaseng Hospital of Korean Medicine, Seoul, Gangnam-Gu, 135-896, Korea, Republic of|Bucheon Jaseng Hospital of Korean Medicine, Bucheon, Gyeonggi, 14598, Korea, Republic of|Haeundae Jaseng Hospital of Korean Medicine, Busan, Korea, Republic of|Daejeon Jaseng Hospital of Korean Medicine, Daejeon, Korea, Republic of"
NCT04420572,Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome,https://clinicaltrials.gov/study/NCT04420572,COMPLETED,YES,Trochanteric Bursitis,DRUG: ozone injection|DRUG: betamethasone,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",,ALL,"ADULT, OLDER_ADULT",63,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-03-11,2021-08-01,"Sultan 2.Abdülhamid Han Training and Research Hospital, Istanbul, Eyalet/Yerleşke, 34000, Turkey"
NCT01129570,Siliphos in Advanced Hepatocellular Carcinoma,https://clinicaltrials.gov/study/NCT01129570,COMPLETED,NO,Advanced Hepatocellular Carcinoma,DRUG: Silybin,Abby Siegel,Lotte & John Hecht Memorial Foundation,ALL,"ADULT, OLDER_ADULT",3,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-02,2013-06,"Columbia University Medical Center, New York, New York, 10032, United States"
NCT02701491,Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children,https://clinicaltrials.gov/study/NCT02701491,COMPLETED,NO,Nausea|Vomiting,DIETARY_SUPPLEMENT: Ginger|OTHER: Placebo,Federico II University,,ALL,CHILD,150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-02,2016-09,"University of Naples Federico II, Naples, 80131, Italy"
NCT03244605,Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients,https://clinicaltrials.gov/study/NCT03244605,UNKNOWN,NO,Non-small Cell Lung Cancer,OTHER: Rehabilitation Training|OTHER: Rehabilitation Education|DRUG: TCM|DRUG: placebo,Shanghai University of Traditional Chinese Medicine,"Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China|Shanghai Cancer Hospital, China|Huadong Hospital",ALL,"ADULT, OLDER_ADULT",236,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-10-01,2019-12-30,"YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China"
NCT03108313,Role of Aloe Vera Versus Fluoride Toothpaste in Changing High to Low Salivary Bacterial Count,https://clinicaltrials.gov/study/NCT03108313,UNKNOWN,NO,"Caries, Dental",DRUG: aloe vera toothpaste|DRUG: fluoride toothpaste,Cairo University,,ALL,"ADULT, OLDER_ADULT",58,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION,2017-03-03,2018-04-30,"Neven Ahmed Ebrahim, Cairo, Heliopolis, 11311, Egypt"
NCT06184685,Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT06184685,COMPLETED,NO,Primary Knee Osteoarthritis,DRUG: Sahasthara Microemulsion|DRUG: Diclofenac Microemulsion,Thammasat University,,ALL,"ADULT, OLDER_ADULT",87,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-10-20,2021-12-08,"Thammasat University, Klong Luang, Pathum Thani, 12120, Thailand"
NCT02262169,DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers,https://clinicaltrials.gov/study/NCT02262169,TERMINATED,NO,Non-Bleeding Peptic Ulcers,DRUG: Omeprazole|DRUG: Placebo caplet of DLBS2411|DRUG: DLBS2411|DRUG: Placebo capsule of Omeprazole,Dexa Medica Group,,ALL,"ADULT, OLDER_ADULT",32,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2014-10,2019-03,"Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Udayana Sanglah General Hospital, Denpasar, Bali, 80114, Indonesia"
NCT02425436,Role of Ginkgo Biloba Extract in IUGR,https://clinicaltrials.gov/study/NCT02425436,COMPLETED,NO,Intrauterine Growth Restriction (IUGR),DRUG: Ginkgo Biloba Extract|OTHER: Placebo,Assiut University,,FEMALE,ADULT,226,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2014-05,2015-12,
NCT03707795,Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study,https://clinicaltrials.gov/study/NCT03707795,COMPLETED,NO,Familial Amyotrophic Lateral Sclerosis,"DRUG: Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days",Edward Kasaraskis,,ALL,"ADULT, OLDER_ADULT",6,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2017-08-21,2019-01-10,"University of Kentucky Medical Center, Lexington, Kentucky, 40475, United States"
NCT02125604,Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany,https://clinicaltrials.gov/study/NCT02125604,COMPLETED,YES,Relapsing-Remitting Multiple Sclerosis,DRUG: dimethyl fumarate,Biogen,,ALL,"ADULT, OLDER_ADULT",214,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-06,2016-03,"Research Site, Augsburg, Germany|Research Site, Bamburg, Germany|Research Site, Bayreuth, Germany|Research Site, Berlin, Germany|Research Site, Bochum, Germany|Research Site, Bonn, Germany|Research Site, Erbach, Germany|Research Site, Erlangen, Germany|Research Site, Freiburg, Germany|Research Site, Hamburg, Germany|Research Site, Leipzig, Germany|Research Site, Marburg, Germany|Research Site, Minden, Germany|Research Site, Mittweida, Germany|Research Site, Munchen, Germany|Research Site, Munster, Germany|Research Site, Osnabruck, Germany|Research Site, Potsdam, Germany|Research Site, Siegen, Germany"
NCT03780621,Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment,https://clinicaltrials.gov/study/NCT03780621,COMPLETED,NO,"Cognitive Impairment, Mild",DIETARY_SUPPLEMENT: Andrographis and Withania|DIETARY_SUPPLEMENT: Placebo,"EuroPharma, Inc.",,ALL,"ADULT, OLDER_ADULT",16,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-04-01,2019-06-01,"Clinical Labors of NeuroCode AG, Wetzlar, D-35578, Germany"
NCT01275521,A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy,https://clinicaltrials.gov/study/NCT01275521,COMPLETED,NO,Prostatic Hyperplasia,DRUG: BONT-A intra-prostatic injection|DRUG: Optimized medical BPH treatment,"University Hospital, Bordeaux",,MALE,"ADULT, OLDER_ADULT",127,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2011-01-10,2015-04-28,"Service d'Urologie - CH du Pays d'Aix - Avenue de Tamaris, AIX-en-PROVENCE, 13616, France|Service d'Urologie, CHU d'Angers 4, rue Larrey, Angers, 49933, France|Service d'urologie, Groupe Hospitalier Pellegrin, place Amélie Raba Léon, Bordeaux, 33076, France|Service d'urologie - APHP Henri Mondor - 51, avenue du Maréchal de Lattre de Tassigny, Creteil, 94000, France|Service d'urologie - CHU de Limoges - 2, avenue Martin Luther King, Limoges, 87052, France|Service d'urologie - Hôpital de la Conception - 147 boulevard Baille, Marseille, 13005, France|Clinique Mutualiste Beausoleil, Montpellier, 33070, France|Service d'Urologie - APHP Hopital Cochin - 27, Rue du faubourg Saint Jacques, Paris, 75014, France|Service d'Urologie - APHP Hôpital Saint Louis - 1, avenue Claude-vellefaux, Paris, 75475, France|Service d'Urologie - Hospices Civls de Lyon - 165 chemin du grand Revoyet, Pierre Benite, 69495, France|Service d'urologie - CHRU Strasbourg - BP 426, Strasbourg, 67091, France"
NCT04718649,Effectiveness and Safety of Celecoxib (Celebrex 200 mg) Combined With Joins in the Treatment of Degenerative Knee Osteoarthritis: a Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT04718649,UNKNOWN,NO,Osteoarthritis,DRUG: Celebrex with Joins or not,The Catholic University of Korea,"SK Chemicals Co., Ltd.",ALL,"ADULT, OLDER_ADULT",216,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2021-01,2022-12,"the Catholic Univerisity of Korea Seoul St Mary's hospital, Seoul, Korea, Republic of"
NCT01530867,Physician-Patient Communication Project,https://clinicaltrials.gov/study/NCT01530867,COMPLETED,NO,Dietary Supplements,,"University of California, Los Angeles",National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",456,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2011-11,2013-05,"Kaiser Permanente LAMC, Los Angeles, California, 90027, United States|Center for East-West Medicine, Los Angeles, California, 90404, United States|LA Net Practice Based Research Network, Los Angeles, California, 90808, United States|Community-based provider offices, Los Angeles, California, United States|University of California, Los Angeles, Santa Monica, California, 90404, United States"
NCT01388933,A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease,https://clinicaltrials.gov/study/NCT01388933,TERMINATED,NO,Crohn's Disease,DRUG: TU-100|DRUG: Matching Placebo,Tsumura USA,Syneos Health,ALL,"ADULT, OLDER_ADULT",79,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2011-09,2013-09,"Preferred Research Partners Inc, Little Rock, Arkansas, 72211, United States|TRIMED Clinical Trials, Corona, California, 92880, United States|Digestive Care Associates, LLC, San Carlos, California, 94070, United States|University of California at San Francisco, San Francisco, California, 94115, United States|Rocky Mountain Gastroenterology Associates, Lakewood, Colorado, 80215, United States|Clinical Research of West Florida, Inc, Clearwater, Florida, 22765, United States|Gastroenterology Group of Naples, Naples, Florida, 34102, United States|Shafran Gastroenterology Center, Winter Park, Florida, 32789, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, 30542-5020, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, 31210, United States|University of Chicago Hospital Medical Center, Chicago, Illinois, 60637, United States|University of Louisville School of Medicine, Louisville, Kentucky, 40202, United States|Metropolitan Gastroenterology Group. PC, Chevy Chase, Maryland, 20815, United States|Endoscopic Microsurgery Associates PA, Towson, Maryland, 21204, United States|MedRACS, Quincy, Massachusetts, 02169, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, 48047, United States|Center for Digestive Health, Troy, Michigan, 48098, United States|Digestive Health Center, Ocean Springs, Mississippi, 39564, United States|St. Louis Center for Clinical Research, St. Louis, Missouri, 63128, United States|Long Island Clinical Research Associates, LLP, Great Neck, New York, 11021, United States|NY Scientific CORP, Hollis, New York, 11423, United States|PMG Research of Salisbury, Salisbury, North Carolina, 28144, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, 27103, United States|Ohio Gastroenterology and Liver, Cincinnati, Ohio, 45014, United States|Consultants for Clinical Research, Cincinnati, Ohio, 45219, United States|Advanced Research Institute, Ogden, Utah, 84405, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States"
NCT05055544,Bearberry in the Treatment of Cystitis,https://clinicaltrials.gov/study/NCT05055544,NOT_YET_RECRUITING,NO,Cystitis,DRUG: Fosfomycin|DRUG: Bearberry,University of Pecs,,FEMALE,ADULT,504,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-10,2025-12,"Institute for Translational Medicine, University of Pécs, Pécs, 7624, Hungary"
NCT00547911,Augmenting Effects of L-DOPS With Carbidopa and Entacapone,https://clinicaltrials.gov/study/NCT00547911,TERMINATED,YES,Parkinson Disease|Multiple System Atrophy|Autonomic Nervous System Diseases,DRUG: Droxidopa|DRUG: Carbidopa|DRUG: Entacapone,National Institute of Neurological Disorders and Stroke (NINDS),,ALL,"ADULT, OLDER_ADULT",14,NIH,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2007-10,2013-04,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT02079571,"Investigation of Pulse Waves, Channel Entries, and Food Attributes in Healthy Subjects With Different Constitutions",https://clinicaltrials.gov/study/NCT02079571,UNKNOWN,NO,Healthy Subjects With Different Constitutions,DIETARY_SUPPLEMENT: Coconut water|DIETARY_SUPPLEMENT: ginger tea,National Taiwan University Hospital,,ALL,"ADULT, OLDER_ADULT",240,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2013-05,,"Kuan-Hung Lu, Taipei, 106, Taiwan"
NCT02075749,Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films,https://clinicaltrials.gov/study/NCT02075749,COMPLETED,NO,Mucositis,DRUG: Triamcinolone Acetonide|DRUG: licorice mucoadhesive films,Isfahan University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2013-05,2014-02,"Omid ( or Sayyed-O-Shohada) Hospital, Isfahan, 8675446355, Iran, Islamic Republic of"
NCT05616429,Alcat Based Elimination Diet for the Treatment of Irritable Bowel Syndrome; a Randomized Double Blind Sham Control Trial,https://clinicaltrials.gov/study/NCT05616429,COMPLETED,NO,IBS - Irritable Bowel Syndrome,DIETARY_SUPPLEMENT: Alcat based personal diet|DIETARY_SUPPLEMENT: Standard balanced diet|OTHER: usual care,Sheba Medical Center,Cell science systems,ALL,"ADULT, OLDER_ADULT",70,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-08-01,2023-05-15,"Sheba Medical Center, Ramat Gan, 5262000, Israel"
NCT04023539,Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04023539,COMPLETED,NO,Type 2 Diabetes,DIETARY_SUPPLEMENT: Cinnamomum zeylanicum|OTHER: Placebo,Universidad de Sonora,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2019-09-04,2020-04-23,"C.A.A.P.S., Hermosillo, Sonora, 83000, Mexico|ISSSTE Family Medicine Clinic, Hermosillo, Sonora, 83140, Mexico"
NCT03552263,Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS),https://clinicaltrials.gov/study/NCT03552263,COMPLETED,NO,Acute Mountain Sickness (AMS),DRUG: T89 capsule|DRUG: Placebo capsule,"Tasly Pharmaceuticals, Inc.",,ALL,ADULT,132,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-06-07,2019-11-10,"Hypoxia Research Lab, UCSF Parnassus Campus, S-256, San Francisco, California, 94143, United States"
NCT06100432,Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males,https://clinicaltrials.gov/study/NCT06100432,RECRUITING,NO,Male Infertility,DRUG: DLBS5055 200mg|DRUG: Placebo DLBS5055|DRUG: Multivitamin (Vitamin C 500mg + Vitamin E 100IU + Beta Carotene 10000IU)|DRUG: Placebo Multivitamin,Duta Wacana Christian University,Dexa Medica Group,MALE,ADULT,90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-11-11,2025-10-31,"Laboratorium Klinik Pramita, Yogyakarta, Indonesia"
NCT02737943,Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft,https://clinicaltrials.gov/study/NCT02737943,UNKNOWN,NO,Burns,DRUG: Moist Exposed Burn Ointment (MEBO)|DRUG: Zagazig,Zagazig University,,ALL,"CHILD, ADULT",40,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2016-03,2019-07,"Zagazig University Hospitals, Zagazig, Alsharkia, 44519, Egypt"
NCT03728634,"Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).",https://clinicaltrials.gov/study/NCT03728634,COMPLETED,YES,Healthy Volunteers|hATTR Amyloidosis,DRUG: ION-682884|DRUG: Placebo|DIETARY_SUPPLEMENT: Vitamin A,"Ionis Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",47,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-12-21,2020-02-20,"Bio Pharma Services, Inc., Toronto, Ontario, M9L 3A2, Canada"
NCT06286735,Effects of Cinnamomum Supplementation in Chronic Kidney Disease Patients,https://clinicaltrials.gov/study/NCT06286735,NOT_YET_RECRUITING,NO,Chronic Kidney Diseases,DIETARY_SUPPLEMENT: cinnamomum|OTHER: Placebo,Universidade Federal Fluminense,,ALL,"ADULT, OLDER_ADULT",30,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2024-06-22,2024-12-22,
NCT01676792,SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma,https://clinicaltrials.gov/study/NCT01676792,COMPLETED,NO,Vulvar Intraepithelial Neoplasia|Genital Warts,DRUG: SR-T100 gel with 2.3% of SM in Solanum undatum plant extract,National Cheng-Kung University Hospital,"G&E Herbal Biotechnology Co., LTD",ALL,"ADULT, OLDER_ADULT",29,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-04,2013-10,"National Cheng Kung University Hospital, Tainan, 744, Taiwan"
NCT02472288,Electroacupuncture on Post-stroke Urinary Retention,https://clinicaltrials.gov/study/NCT02472288,TERMINATED,NO,"Urinary Retention|Stroke, Complication",DEVICE: Electroacupuncture (EA)|DEVICE: Sham electroacupuncture,Kyunghee University,Daejeon University|DongGuk University,ALL,"ADULT, OLDER_ADULT",25,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-04,2016-04,"Cheonan Korean Medicine Hospital of the Daejeon University, Cheonan, Chungcheongnam-do, 331-958, Korea, Republic of|Dongguk University Ilsan Oriental Hospital, Goyang, Gyeonggi-do, 410-773, Korea, Republic of|Kyung Hee University Korean Medicine Hospital, Seoul, 156-853, Korea, Republic of"
NCT02151708,Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method,https://clinicaltrials.gov/study/NCT02151708,UNKNOWN,NO,Dyspepsia,DRUG: Placebo|DRUG: motilitone,Samsung Medical Center,,ALL,"ADULT, OLDER_ADULT",78,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2014-06,2015-02,"Department of Medicine, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, 135-710, Korea, Republic of"
NCT05875233,A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT05875233,ACTIVE_NOT_RECRUITING,NO,Polycystic Ovary Syndrome,OTHER: Elix Daily Harmony|OTHER: Elix Cycle Balance,"Zenchi, Inc.",Citruslabs,FEMALE,ADULT,70,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: OTHER,2023-04-13,2024-08-30,"Citruslabs, Santa Monica, California, 90404, United States"
NCT05953324,"The Effects Of Kiwifruit Consumption On Sleep Quality, Fatigue And BMI Of Saudi Adults",https://clinicaltrials.gov/study/NCT05953324,COMPLETED,NO,Sleep Disturbance|Fatigue|Body Weight,OTHER: Kiwifruit,Umm Al-Qura University,,FEMALE,ADULT,26,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-01-01,2022-04-30,"Umm Al-Qura University, Mecca, 21955, Saudi Arabia"
NCT05456438,Effect of Tea Tree Oil and Coconut Oil on Nipple Crack Formation,https://clinicaltrials.gov/study/NCT05456438,COMPLETED,NO,Nipple Infection,OTHER: İntervention 1|OTHER: İntervention 2,Hitit University,,FEMALE,ADULT,90,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION,2021-02-14,2022-01-16,"Fatma Yıldırım, Çorum, 19600, Turkey"
NCT03763578,Dental Caries Prevention by a Natural Product,https://clinicaltrials.gov/study/NCT03763578,COMPLETED,NO,Dental Caries,OTHER: Licorice,Cairo University,,ALL,ADULT,81,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2020-09-01,2021-12-30,"Conservative and Esthetic Dentistry Department-Faculty of Dentistry- Cairo University, Cairo, Choose Any State/Province, 002, Egypt"
NCT05523180,A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life,https://clinicaltrials.gov/study/NCT05523180,COMPLETED,NO,Chronic Obstructive Pulmonary Disease|Non-cystic Fibrosis Bronchiectasis,DIETARY_SUPPLEMENT: Probiotic|OTHER: Placebo,"ResBiotic Nutrition, Inc.","Nutrasource Pharmaceutical and Nutraceutical Services, Inc.",ALL,"ADULT, OLDER_ADULT",37,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2022-09-01,2023-09-12,"Coral Research Clinic Corp., Miami, Florida, 33186, United States|Premier Medical Associates, The Villages, Florida, 32162, United States"
NCT02162446,68Ga-OPS202 Study for Diagnostic Imaging of GEP NET,https://clinicaltrials.gov/study/NCT02162446,COMPLETED,YES,Gastroenteropancreatic Neuroendocrine Tumors,DRUG: satoreotide trizoxetan,Ipsen,,ALL,"ADULT, OLDER_ADULT",12,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2014-06,2015-06,"University Hospital Basel, Basel, CH-4031, Switzerland"
NCT03965819,A Study to Investigate the Efficacy of Pain Bloc-R in Healthy Participants With Non-pathological Aches and Discomfort,https://clinicaltrials.gov/study/NCT03965819,COMPLETED,NO,Healthy,DIETARY_SUPPLEMENT: Pain Bloc-R|OTHER: Active Comparator - Acetaminophen|OTHER: Placebo,LifeSeasons Inc.,KGK Science Inc.,ALL,"ADULT, OLDER_ADULT",27,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2019-05-30,2019-08-09,"KGK Science Inc., London, Ontario, N6A 5R8, Canada"
NCT01860456,TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study,https://clinicaltrials.gov/study/NCT01860456,RECRUITING,NO,Chronic Myeloid Leukemia,DRUG: Imatinib/Nilotinib,University of Pisa,,ALL,"ADULT, OLDER_ADULT",412,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-05,2024-12-31,"Unit of Hematology, Azienda Ospedaliero Universitaria Pisana, Pisa, 56126, Italy|Division of Hematology and Transplants, University of Siena, Siena, 53100, Italy"
NCT06732518,Evaluation of the Anti-cavity Efficacy of Three Dentifrices Using an Intra-oral Enamel Demineralization - Remineralization In-Situ Model,https://clinicaltrials.gov/study/NCT06732518,NOT_YET_RECRUITING,NO,"Enamel Lesions|Demineralization, Tooth|Remineralization|Dental Cavity",DRUG: Fluoride Toothpaste|DRUG: Fluoride free toothpaste in a chalk base|DRUG: Fluoride free toothpaste in a PCC/RNCC base|DEVICE: Toothbrush,Colgate Palmolive,Federal University of Alagoas,ALL,"ADULT, OLDER_ADULT",36,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER",2025-01-30,2025-03,
NCT04553029,"A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)",https://clinicaltrials.gov/study/NCT04553029,COMPLETED,NO,Menopause,OTHER: No intervention,Astellas Pharma Singapore Pte. Ltd.,,FEMALE,"ADULT, OLDER_ADULT",3399,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-09-09,2020-10-19,"Site CN86002, Beijing, China|Site KR82001, Seoul, Korea, Republic of|Site TW88601, Taipei, Taiwan"
NCT02587910,"Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease",https://clinicaltrials.gov/study/NCT02587910,UNKNOWN,NO,GERD,DIETARY_SUPPLEMENT: Melanole for GERD treatment|DIETARY_SUPPLEMENT: Placebo,Lebanese American University,,ALL,ADULT,170,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-10,2016-09,"Lebanese American University, Beirut, Lebanon|Lebanese American University, Byblos, Lebanon"
NCT04176341,Feasability and Clinical Impact Study of Non Pharmacological Interventions in Management of Chronic Pain,https://clinicaltrials.gov/study/NCT04176341,COMPLETED,NO,Chronic Pain|Slackline|Mindfulness|Adapted Physical Activity|Self-hypnosis|Qi Gong,"OTHER: a systematic proposal for non pharmacological interventions targeting the subject's empowerment among slackline, mindfulness, adapted physical activity, self-hypnosis, and Qi Gong","University Hospital, Grenoble",Hospices Civils de Lyon|Groupe Hospitalier Mutualiste de Grenoble,ALL,"ADULT, OLDER_ADULT",154,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2019-12-18,2023-02-15,"CHU de GRENOBLE ALPES, Grenoble, 38000, France"
NCT05378334,Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients,https://clinicaltrials.gov/study/NCT05378334,RECRUITING,NO,Non-small Cell Lung Cancer,DRUG: ICI|DRUG: Chemotherapy|DRUG: Placebo|DRUG: Bone-protecting and Mass-dispersesing Decoction,Guangzhou University of Traditional Chinese Medicine,,ALL,"ADULT, OLDER_ADULT",82,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-06-15,2025-03-01,"Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China"
NCT00120653,Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS),https://clinicaltrials.gov/study/NCT00120653,WITHDRAWN,NO,Myelodysplastic Syndromes,DRUG: Metoclopramide,"National Heart, Lung, and Blood Institute (NHLBI)",,ALL,"ADULT, OLDER_ADULT",0,NIH,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2005-07-14,2008-06-17,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|University of Washington, Seattle, Washington, 98195, United States"
NCT06370429,Effect of Online Exercises for Premenstrual Syndrome on Couple's Stress and Family Function,https://clinicaltrials.gov/study/NCT06370429,NOT_YET_RECRUITING,NO,Premenstrual Syndrome|Exercises|Stress Level|Family Characteristics,"OTHER: Progressive Relaxation Exercises, randomized pretest-posttest",Suleyman Demirel University,,ALL,ADULT,60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2024-05-15,2024-12-30,"Suleyman Demirel University, Isparta, 32500, Turkey"
NCT00854087,Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis,https://clinicaltrials.gov/study/NCT00854087,COMPLETED,YES,Chronic Hepatitis C Infection,DRUG: Fuzheng Huayu|DRUG: Placebo,Tarek Hassanein,"Shanghai Sundise Traditional Chinese Medicine Co., Ltd.",ALL,"ADULT, OLDER_ADULT",118,INDIV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2010-08,2013-08,"SCTI Research Foundation, Coronado, California, 92118, United States|VA Palo Alto HCS, Palo Alto, California, 94304, United States|Huntington Medical Research Institutes, Pasadena, California, 91105, United States|UC Davis Health System, Sacramento, California, 95817, United States|Southern California Liver Centers, San Clemente, California, 92673, United States|Advanced Medical Research Center, Port Orange, Florida, 32127, United States|St. Luke's Advanced Liver Therapies, Houston, Texas, 77030, United States|University of Utah HSC, Salt Lake City, Utah, 84132, United States"
NCT03619304,"Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line",https://clinicaltrials.gov/study/NCT03619304,UNKNOWN,NO,Oral Squamous Cell Carcinoma,DIETARY_SUPPLEMENT: coffee,Cairo University,,ALL,"CHILD, ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2019-09-01,2020-07-17,
NCT05098990,Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC,https://clinicaltrials.gov/study/NCT05098990,UNKNOWN,NO,Non Small Cell Lung Cancer,DRUG: Jinfukang oral liquid|DRUG: Platinum-based doublet chemotherapy,"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",328,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-10-25,2024-08-15,
NCT05602389,Study to Assess the Effect of Multi-herb Formulae and an Ashwagandha Root Formula on the Modulation of the Stress and Related Symptoms,https://clinicaltrials.gov/study/NCT05602389,COMPLETED,NO,Stress,OTHER: VL-G-A57|OTHER: VL-G-E12|OTHER: Placebo,Vedic Lifesciences Pvt. Ltd.,,ALL,"ADULT, OLDER_ADULT",186,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2022-12-08,2023-07-12,"Vedic Lifesciences PVT LTD, Mumbai, Maharashtra, 400053, India|Stress test clinic, Mumbai, Maharashtra, 400059, India|Shree Polyclinic, Mumbai, Maharashtra, 400067, India|The Kewalramani Clini, Mumbai, Maharashtra, 400068, India|Dr Chandrakant Mishra clinic, Pālghar, Maharashtra, 401209, India"
NCT04590079,Innovative Device for Pain Management by Millimeter Band Radiation : Electronic-Pain Killer.,https://clinicaltrials.gov/study/NCT04590079,COMPLETED,NO,Osteoarthritis|Peripheral|Pain,"DEVICE: Conventional pain treatment with daily sessions with innovative medical device, Remedee One, for pain management by Millimeter Band Radiation","University Hospital, Grenoble",Remedee SA|Clinical Investigation Centre for Innovative Technology Network,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2020-12-14,2022-08-24,"University Hospital, Grenoble, 38043, France"
NCT04153032,Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure,https://clinicaltrials.gov/study/NCT04153032,RECRUITING,NO,Anal Fissure,DRUG: Diltiazem|DRUG: Mebo,American University of Beirut Medical Center,,ALL,"ADULT, OLDER_ADULT",183,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-12-01,2026-01-30,"American University of Beirut, Beirut, Lebanon"
NCT02819336,Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence,https://clinicaltrials.gov/study/NCT02819336,COMPLETED,NO,"Urinary Incontinence|Stroke, Complication",DEVICE: Electroacupuncture (EA)|DEVICE: Sham electroacupuncture,Kyunghee University,Wonkwang University Gwangju Medical Center,ALL,"ADULT, OLDER_ADULT",56,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-06,2017-06-01,"Wonkwang University Gwangju Medical Center, Gwangju, 61729, Korea, Republic of|Kyung Hee University Korean Medicine Hospital, Seoul, 156-853, Korea, Republic of"
NCT03372694,Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients,https://clinicaltrials.gov/study/NCT03372694,UNKNOWN,NO,Non-small Cell Lung Cancer,BEHAVIORAL: Rehabilitation Training|DRUG: TCM|OTHER: Rehabilitation Education|DRUG: placebo,Shanghai University of Traditional Chinese Medicine,"Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China|Shanghai Cancer Hospital, China|Huadong Hospital",ALL,"ADULT, OLDER_ADULT",354,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-10-01,2019-12-30,"YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, 200437, China"
NCT02380794,Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule,https://clinicaltrials.gov/study/NCT02380794,COMPLETED,NO,Peripheral Arterial Disease|Intermittent Claudication,DRUG: Danshen Gegen Capsule|DRUG: Placebo,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",107,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-10-28,2017-06-02,"Prince of Wales Hospital, Shatin, New Territories, Hong Kong"
NCT03260803,Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women,https://clinicaltrials.gov/study/NCT03260803,COMPLETED,NO,Osteopenia,DRUG: Oligopin|DRUG: Placebo,Tehran University of Medical Sciences,Iran University of Medical Sciences,FEMALE,"ADULT, OLDER_ADULT",43,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2018-02-01,2019-03-01,"Tehran University of Medical Sciences, Tehran, 0098, Iran, Islamic Republic of"
NCT01354860,Moxibustion for Knee Osteoarthritis,https://clinicaltrials.gov/study/NCT01354860,COMPLETED,NO,Idiopathic Osteoarthritis,OTHER: Moxibustion treatment plus usual care|OTHER: Usual care alone group,Korea Institute of Oriental Medicine,,ALL,"ADULT, OLDER_ADULT",40,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2010-12,2011-05,"Daejeon University Hospital, Daejeon, Korea, Republic of"
NCT03347188,A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH),https://clinicaltrials.gov/study/NCT03347188,COMPLETED,YES,Post-Traumatic Headache,DRUG: Fremanezumab|DRUG: Placebo,"Teva Branded Pharmaceutical Products R&D, Inc.",,ALL,"ADULT, OLDER_ADULT",87,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2017-12-18,2020-06-03,"Teva Investigational Site 14065, Phoenix, Arizona, 85018, United States|Teva Investigational Site 14069, Scottsdale, Arizona, 85259-5452, United States|Teva Investigational Site 14048, Little Rock, Arkansas, 72205, United States|Teva Investigational Site 30236, Little Rock, Arkansas, 72205, United States|Teva Investigational Site 14052, Long Beach, California, 90806, United States|Teva Investigational Site 14053, Los Angeles, California, 90073, United States|Teva Investigational Site 14060, San Diego, California, 92161, United States|Teva Investigational Site 14054, San Francisco, California, 94109, United States|Teva Investigational Site 14045, Fairfield, Connecticut, 06824, United States|Teva Investigational Site 14063, Miami, Florida, 33136, United States|Teva Investigational Site 14041, North Miami, Florida, 33161, United States|Teva Investigational Site 14056, Tampa, Florida, 33609, United States|Teva Investigational Site 14057, Riverwoods, Illinois, 60015, United States|Teva Investigational Site 14067, Indianapolis, Indiana, 46256, United States|Teva Investigational Site 14058, Louisville, Kentucky, 40207, United States|Teva Investigational Site 14061, Waltham, Massachusetts, 02451, United States|Teva Investigational Site 14051, Kansas City, Missouri, 64128-2226, United States|Teva Investigational Site 14046, Saint Louis, Missouri, 63141, United States|Teva Investigational Site 14043, Springfield, Missouri, 65810, United States|Teva Investigational Site 14119, Albany, New York, 12208, United States|Teva Investigational Site 14229, Amherst, New York, 14226, United States|Teva Investigational Site 14118, Bronx, New York, 10467, United States|Teva Investigational Site 14047, New York, New York, 10021, United States|Teva Investigational Site 14114, Durham, North Carolina, 27713, United States|Teva Investigational Site 14059, Salisbury, North Carolina, 28144, United States|Teva Investigational Site 14049, Portland, Oregon, 97225, United States|Teva Investigational Site 14064, Philadelphia, Pennsylvania, 19107, United States|Teva Investigational Site 14040, Pittsburgh, Pennsylvania, 15236, United States|Teva Investigational Site 14230, Nashville, Tennessee, 37203, United States|Teva Investigational Site 14055, Dallas, Texas, 75390-8565, United States|Teva Investigational Site 14050, Waco, Texas, 76711, United States|Teva Investigational Site 14113, Spokane, Washington, 99202, United States|Teva Investigational Site 14044, Morgantown, West Virginia, 26506, United States"
NCT04470401,The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A,https://clinicaltrials.gov/study/NCT04470401,COMPLETED,NO,Shoulder Pain,DRUG: AbobotulinumtoxinA|DRUG: Saline,Faculdade de Ciências Médicas da Santa Casa de São Paulo,,ALL,"ADULT, OLDER_ADULT",24,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2019-06-05,2021-03-05,"Santa Casa SP, São Paulo, Sao Paulo, 09040330, Brazil"
NCT02510118,Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients,https://clinicaltrials.gov/study/NCT02510118,UNKNOWN,NO,Colon Cancer,DRUG: mFOLFOX6|DRUG: XELOX|DRUG: Placebo ChangTai Keli|DRUG: ChangTai Keli,"Nanjing NingQi Medicine Science and Technology Co., Ltd.",Jiangsu Province Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",360,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-06,2018-06,"Jiege Huo, Nanjing, Jiangsu, China"
NCT02354092,Paracervical Block for Pain Control With Osmotic Dilator Placement,https://clinicaltrials.gov/study/NCT02354092,TERMINATED,YES,Abortion Late|Pain,PROCEDURE: Local anesthetic for tenaculum placement|PROCEDURE: Sham|PROCEDURE: Paracervical Block|PROCEDURE: Dilator Placement|BEHAVIORAL: Post-procedural assessment|DRUG: Preprocedural pain control,"University of California, San Diego",Planned Parenthood Federation of America,FEMALE,"ADULT, OLDER_ADULT",14,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2015-04-02,2015-08-25,"Planned Parenthood of the Pacific Southwest: First Avenue Family Planning Michelle Wagner Center, San Diego, California, 92101, United States|UCSD Medical Offices South: Women's Health Services, San Diego, California, 92103, United States"
NCT04780061,Dietary Supplements for COVID-19,https://clinicaltrials.gov/study/NCT04780061,TERMINATED,YES,Covid19,"DRUG: Vitamin D3 50,000 IU|DIETARY_SUPPLEMENT: Vitamin C/Zinc|DIETARY_SUPPLEMENT: Vitamin K2/D|OTHER: Microcrystalline Cellulose Capsule|OTHER: Medium Chain Triglyceride Oil",The Canadian College of Naturopathic Medicine,Ottawa Hospital Research Institute|Vitazan Professional|New Roots Herbal,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-07-12,2022-07-07,"The Centre for Health Innovation, Ottawa, Ontario, K2P0M7, Canada"
NCT02175004,Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP),https://clinicaltrials.gov/study/NCT02175004,COMPLETED,YES,FAP|Familial Amyloid Polyneuropathy|TTR|Transthyretin|Amyloidosis,DRUG: Inotersen,"Ionis Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",135,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-06-26,2021-01-07,"University of California, Irvine, Orange, California, 92868, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|Johns Hopkins University Bayview Medical Center, Baltimore, Maryland, 21205, United States|Boston University School of Medicine - Amyloid Treatment & Research Program, Boston, Massachusetts, 02118, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Mount Sinai Medical Center, New York, New York, 10029, United States|Columbia University Medical Center - The Neurological Institute, New York, New York, 10032, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, 19104, United States|FLENI, Buenos Aires, Argentina|Federal University of Rio de Janeiro - University Hospital, Rio de Janeiro, CEP 21941913, Brazil|AACD, Sao Paulo, Brazil|CHU Henri Mondor - Department of Neurology, Creteil, 94000, France|CHU Bicetre Aphp French Referral Center for FAP/Cornamyl Network, Le Kremlin Bicetre, 94275, France|UKM; Universitätsklinikum Münster, Klinik für Transplantationsmedizin, Munster, 48149, Germany|Universita Degli Studi Di Messina - Azienda Ospedaliera Universitaria Policlinico ""Gaetano Martino"", Messina, Sicily, 98124, Italy|Centro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|CHLN - Hospital de Santa Maria, Lisbon, 1649-035, Portugal|CHP-HGSA, Unidade Clinica de Paramiloidose, Porto, 4099-001, Portugal|Hospital Universitari Vall D' Hebron, Barcelona, 08035, Spain|Hospital Clinic, Barcelona, 08036, Spain|University College London - National Amyloidosis Centre, London, NW3 2PF, United Kingdom"
NCT06153199,Self-management of Low Back Pain in Horticulture Workers,https://clinicaltrials.gov/study/NCT06153199,RECRUITING,NO,Back Pain,BEHAVIORAL: Self-management videos|BEHAVIORAL: Check lists for ergonomic options|BEHAVIORAL: Text reminders|BEHAVIORAL: Video review,University of Florida,,ALL,"ADULT, OLDER_ADULT",164,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION,2024-06-06,2028-06-30,"University of Florida, Gainesville, Florida, 32608, United States"
NCT05092113,The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis,https://clinicaltrials.gov/study/NCT05092113,UNKNOWN,NO,Mucositis|Chemotherapeutic Toxicity,DRUG: a compound glutamine capsule/a compound glutamine capsule simulated placebo,Meng Qiu,,ALL,"ADULT, OLDER_ADULT",108,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2021-06-30,2022-12-31,"Meng Qiu, Sichuan, China"
NCT04252625,"Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis",https://clinicaltrials.gov/study/NCT04252625,TERMINATED,NO,Prostate Adenocarcinoma,DRUG: Q-Urol|DRUG: Placebo,University of Utah,"Farr Labs, LLC",MALE,"ADULT, OLDER_ADULT",10,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-11-14,2024-01-25,"Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, 84112, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States"
NCT05267301,AlmegaPL CV Health Open Label Study,https://clinicaltrials.gov/study/NCT05267301,COMPLETED,NO,Cholesterol|Triglycerides|Omega-3|Eicosapentaenoic Acid,DIETARY_SUPPLEMENT: AlmegaPL (FDA NDIN # 826),Qualitas Health,Arizona State University,ALL,"ADULT, OLDER_ADULT",250,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2022-05-11,2022-12-01,"Arizona State University, Tempe, Arizona, 85281, United States|Qualitas Health, Houston, Texas, 77057, United States"
NCT05121103,"A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma",https://clinicaltrials.gov/study/NCT05121103,TERMINATED,NO,"Multiple Myeloma, Refractory|Diffuse Large B-Cell Lymphoma|Diffuse Large B Cell Lymphoma Refractory|Multiple Myeloma in Relapse",DRUG: EZM0414,"Epizyme, Inc.",,ALL,"ADULT, OLDER_ADULT",13,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-05-31,2024-04-30,"City of Hope, Duarte, California, 91010, United States|Astera Cancer Care, East Brunswick, New Jersey, 08816, United States|Weill Cornell Medicine, New York, New York, 10021, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Baylor University Medical Center (Texas Oncology), Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Virginia, Fairfax, Virginia, 22031, United States"
NCT03738917,"Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis.",https://clinicaltrials.gov/study/NCT03738917,COMPLETED,NO,Acute Bronchitis,DRUG: Dextromethorphan 15 milligrams|DRUG: Ipratropium Bromide 20Micrograms Inhaler|DIETARY_SUPPLEMENT: Honey 30 g (full tablespoon)|OTHER: Usual clinical practice,Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina,Spanish Clinical Research Network - SCReN,ALL,"ADULT, OLDER_ADULT",668,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-02-01,2021-12-31,"Nova Lloreda Health Center, Badalona, Catalonia, 08910, Spain|Martí i Julià Health Center, Badalona, Catalonia, 08911, Spain|Balaguer Health Center, Balaguer, Catalonia, 25600, Spain|Via Roma Health Centre, Barcelona, Catalonia, 08015, Spain|La Marina Health Center, Barcelona, Catalonia, 08027, Spain|CAP Passeig Maragall (EAP Camp de l'Arpa), Barcelona, Catalonia, 08041, Spain|Cornellà - La Gavarra Health Center, Cornellà De Llobregat, Catalonia, 08940, Spain|Pineda de Mar Health Center, Pineda De Mar, Catalonia, 08397, Spain|Ca n'OriacHealth Center, Sabadell, Catalonia, 08027, Spain|Molí Nou Health Center, Sant Boi De Llobregat, Catalonia, 08830, Spain|Singuerlin Health Center, Santa Coloma De Gramenet, Catalonia, 08924, Spain|CAP Jaume I, Tarragona, Catalonia, 43005, Spain"
NCT06004362,Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19,https://clinicaltrials.gov/study/NCT06004362,RECRUITING,NO,Post-COVID Syndrome,"BEHAVIORAL: Complementary and Integrative Medicine online intervention, routine care and book|BEHAVIORAL: Routine care and book","Charite University, Berlin, Germany",,ALL,"ADULT, OLDER_ADULT",120,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-09-04,2025-12,"Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Berlin, 14109, Germany"
NCT04460417,Chicago Community Health Study,https://clinicaltrials.gov/study/NCT04460417,COMPLETED,NO,Smoking,BEHAVIORAL: Enhanced Care|BEHAVIORAL: TAU,University of Chicago,,ALL,"ADULT, OLDER_ADULT",204,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2017-10-01,2018-10-31,"University of Chicago, Chicago, Illinois, 60637, United States"
NCT06795568,Complex Fertility Awareness Study - Hungary,https://clinicaltrials.gov/study/NCT06795568,NOT_YET_RECRUITING,NO,"Infertility, Sterility, Reproductive, Reproductive Sterility, Sterility, Subfertility, Sub-Fertility",,University of Pecs,University of Debrecen|Dunamenti REK Reproduction Center,ALL,ADULT,750,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2025-02-15,2026-12-31,
NCT00851591,Effect of Fenugreek on Milk Production,https://clinicaltrials.gov/study/NCT00851591,TERMINATED,YES,Lactation,DRUG: fenugreek|DRUG: Placebo (Psyllium),Texas Tech University Health Sciences Center,,FEMALE,ADULT,3,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2008-09,2012-08,"Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, 79106, United States"
NCT06505681,Pharmacopuncture Therapy for Chronic Knee Pain,https://clinicaltrials.gov/study/NCT06505681,COMPLETED,NO,Chronic Knee Pain,PROCEDURE: Pharmacopuncture|PROCEDURE: Physical therapy,Jaseng Medical Foundation,,ALL,"ADULT, OLDER_ADULT",40,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2022-12-28,2023-11-30,"Daejeon Jaseng Hospital of Korean Medicine, Daejeon, 35262, Korea, Republic of"
NCT06246383,Effectiveness of Cucumber Extract on Joint Pain,https://clinicaltrials.gov/study/NCT06246383,NOT_YET_RECRUITING,NO,Joint Pain,DIETARY_SUPPLEMENT: Q Actin,Jacksonville University,,ALL,"ADULT, OLDER_ADULT",80,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2024-02,2024-07,
NCT05921487,Time Restricted Eating to Mitigate Obesity in Veterans With Spinal Cord Injury,https://clinicaltrials.gov/study/NCT05921487,ENROLLING_BY_INVITATION,NO,Spinal Cord Injury|Obesity,BEHAVIORAL: Time Restricted Eating,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",15,FED,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2023-09-01,2025-09-30,"Syracuse VA Medical Center, Syracuse, NY, Syracuse, New York, 13210-2716, United States"
NCT06040190,Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome,https://clinicaltrials.gov/study/NCT06040190,RECRUITING,NO,Burning Mouth Syndrome,DRUG: topical placebo tablet|DRUG: topical clonazepam tablet|DIETARY_SUPPLEMENT: oral alpha-lipoic acid capsule|OTHER: topical phytotherapic capsaicin gel|RADIATION: local photobiomodulation,Federal University of Minas Gerais,,ALL,"ADULT, OLDER_ADULT",150,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2023-11-01,2024-10-01,"Federal university of minas gerais, Belo Horizonte, Minas Gerais, Brazil"
NCT02847117,Bioavailability of the Microconstituents of Natural Chios Mastiha in Healthy Adults.,https://clinicaltrials.gov/study/NCT02847117,COMPLETED,NO,Biological Availability,OTHER: Mastiha,Harokopio University,,MALE,ADULT,20,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2016-07,2021-03-10,"Harokopio University, Athens, 17671, Greece"
NCT05784402,A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants,https://clinicaltrials.gov/study/NCT05784402,COMPLETED,NO,Healthy Participants,DRUG: Semaglutide J|DRUG: Semaglutide C,Novo Nordisk A/S,,ALL,ADULT,264,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2023-03-16,2024-03-28,"Altasciences Clinical LA, Inc., Cypress, California, 90630, United States|Altasciences Clinical Company, Inc, Montreal, Quebec, H3P 3P1, Canada"
NCT02498327,The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency,https://clinicaltrials.gov/study/NCT02498327,COMPLETED,NO,Venous Insufficiency,OTHER: Gelatine Capsule|OTHER: Venavine Intensive®,University of Johannesburg,,FEMALE,ADULT,40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: ",2015-01,2015-10,"University of Johannesburg, Johannesburg, Gauteng, 2028, South Africa"
NCT06385626,The Effects of Raspberry Leaf Tea on Blood Glucose Control,https://clinicaltrials.gov/study/NCT06385626,RECRUITING,NO,Type II Diabetes,DIETARY_SUPPLEMENT: Raspberry leaf tea,University of Reading,,ALL,"ADULT, OLDER_ADULT",20,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION,2023-12-18,2024-12-23,"Hugh Sinclair Unit of Human Nutrition, University of Reading, Reading, Berkshire, RG6 5SG, United Kingdom"
NCT02221089,Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans,https://clinicaltrials.gov/study/NCT02221089,COMPLETED,NO,Imparied Retinal Vascular Reactivity|Healthy Subjects,DRUG: Escherichia coli Endotoxin|DIETARY_SUPPLEMENT: Retaron®|OTHER: Placebo,Medical University of Vienna,,MALE,ADULT,40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE",2013-01,2014-07,"Department of clinical Pharmacology, Medical University of Vienna, Vienna, 1080, Austria"
NCT06798948,"Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial",https://clinicaltrials.gov/study/NCT06798948,NOT_YET_RECRUITING,NO,Metabolic-associated Fatty Liver Disease (MAFLD),"DIETARY_SUPPLEMENT: Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabra|OTHER: Placebo maltodextrin","Li Lab,MD",Xin Hua Hospital of Zhejiang Province,ALL,"ADULT, OLDER_ADULT",100,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2025-03-01,2027-12-31,"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Select..., 310053, China|Zhejiang Xinhua Hospital, Hangzhou, Zhejiang, 310005, China"
NCT05396651,"Effect of Low Fermentable Oligosaccharides, Disaccharides ,Monosaccharides and Polyols (FODMAP) Diet on Control of Pediatric Irritable Bowel Syndrome and Quality of Life",https://clinicaltrials.gov/study/NCT05396651,COMPLETED,NO,Irritable Bowel Syndrome,OTHER: low fodmap diet|OTHER: NICE guidelines for IBS,Sarah Abdelrahman El Ezaby,,ALL,CHILD,80,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2020-10-02,2022-01-30,"Faculty of Medicine Ain Shams University, Cairo, Abbasia, 1234, Egypt"
NCT00814177,Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients,https://clinicaltrials.gov/study/NCT00814177,COMPLETED,YES,Atrial Fibrillation|Venous Thromboembolism|Ischemic Stroke|Myocardial Infarction,DRUG: warfarin|DRUG: warfarin,Hamilton Health Sciences Corporation,,ALL,"ADULT, OLDER_ADULT",160,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2006-07,2009-04,"Thrombosis Service, HHS-General Hospital, Hamilton, Ontario, L8L 2X2, Canada"
NCT03382145,A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic,https://clinicaltrials.gov/study/NCT03382145,RECRUITING,NO,Postmenopausal Bleeding,OTHER: No intervention,Chinese University of Hong Kong,,FEMALE,"CHILD, ADULT, OLDER_ADULT",18000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-02-01,2026-12-31,"The Chinese University of Hong Kong, Hong Kong, Hong Kong"
NCT02038452,Injection Versus Splinting in Carpal Tunnel Syndrome,https://clinicaltrials.gov/study/NCT02038452,COMPLETED,YES,Carpal Tunnel Syndrome (CTS),DRUG: Depo-Medrone|DEVICE: Wrist Splint,Keele University,Arthritis Research UK,ALL,"ADULT, OLDER_ADULT",234,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-04,2019-02-26,"Staffordshire and Stoke on Trent Partnership NHS Trust, Newcastle under Lyme, Staffordshire, ST5 1QG, United Kingdom"
NCT02384655,Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content,https://clinicaltrials.gov/study/NCT02384655,UNKNOWN,NO,Preterms|Lactation,DRUG: Fenugreek seed meal,Tel-Aviv Sourasky Medical Center,,FEMALE,ADULT,30,OTHER_GOV,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-03-11,2021-09,"Department of Neonatology Tel Aviv Medical Center, Tel Aviv, 64239, Israel"
NCT03528538,The Efficacy of Fenugreek Supplementation on Men's Health,https://clinicaltrials.gov/study/NCT03528538,COMPLETED,NO,Aging|Testosterone Deficiency,DIETARY_SUPPLEMENT: AlphaFen fenugreek 400 mg|DIETARY_SUPPLEMENT: AlphaFen fenugreek 500 mg|OTHER: Placebo,Jacksonville University,SPECNOVA LLC,MALE,ADULT,58,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2017-09-19,2017-12-15,"Jacksonville University, Jacksonville, Florida, 32211, United States"
NCT05043142,Epidemiological Study of the COVID-2019 in Participating Organizations.,https://clinicaltrials.gov/study/NCT05043142,COMPLETED,YES,Covid19,DIAGNOSTIC_TEST: ELISA test for the antibodies to COVID-2019.,Yuria-Pharm,Pharmaxi LLC,ALL,"ADULT, OLDER_ADULT",3632,INDUSTRY,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-03-16,2021-06-23,"SI National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky, Kyiv, 03038, Ukraine|Institute Hyalual LLC, Kyiv, 03151, Ukraine|Yuria-Pharm LLC, Kyiv, 03151, Ukraine|Medical Center M.T.K. LLC, Kyiv, 03680, Ukraine|Infuzia PJSC, Kyiv, 04073, Ukraine|Diatom LLC, Kyiv, 04215, Ukraine|InterChem SLC, Odessa, 65000, Ukraine"
NCT06698601,Wild Blueberries in Colitis,https://clinicaltrials.gov/study/NCT06698601,RECRUITING,NO,Ulcerative Colitis (UC)|Crohn Disease (CD),DIETARY_SUPPLEMENT: blueberry-rich diet|OTHER: Control diet,Universität Duisburg-Essen,UniversitÃ¤t Duisburg-Essen|German Crohn's and Colitis Association (DCCV e.V.)|Wilhelm Doerenkamp Foundation,ALL,"ADULT, OLDER_ADULT",60,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2024-09-24,2027-04,"Sozialstiftung Bamberg, Bamberg, Bavaria, 96049, Germany"
NCT02594124,A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies,https://clinicaltrials.gov/study/NCT02594124,COMPLETED,YES,Spinal Muscular Atrophy,DRUG: nusinersen,Biogen,,ALL,"CHILD, ADULT, OLDER_ADULT",292,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-11-04,2023-08-21,"David Geffen School of Medicine at UCLA, Los Angeles, California, 90095-8344, United States|Stanford University School of Medicine, Palo Alto, California, 94305, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Connecticut Children's Medical Center, Hartford, Connecticut, 06106, United States|Nemours Children's Clinic, Orlando, Florida, 32827, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, New York, Illinois, 60611, United States|The Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, 55101, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Columbia University Medical Center, New York, New York, 10032, United States|Duke University School of Medicine, Durham, North Carolina, 27710, United States|Duke University School of Medicine, Miyagi, North Carolina, 27710, United States|Oregon Health Sciences University, Durham, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Medical Center, Dallas, Texas, 75235, United States|University of Utah, Obu, Aichi, Utah, 84112, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Sydney Children's Hospital Clinical Research Centre, Sydney, New South Wales, 2031, Australia|Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Universitair Kinderziekenhuis Koningin Fabiola, Brussels, 1020, Belgium|BC Children's Hospital / UBC, Vancouver, British Columbia, V6H 3V4, Canada|Children's Health Research Institute, Brussel, Ontario, N6A 5W9, Canada|McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada|Armand Trousseau Hospital, I-Motion, Paris, Paris 9, 75012, France|LMU-Campus Innenstadt, Muenchen, Bayern, 80337, Germany|Universitatsklinikum Essen, Essen, 45147, Germany|Universitaetsklinikum Freiburg, Freiburg, 79106, Germany|The University of Hong Kong, Hong Kong, Hong Kong SAR, 999077, Hong Kong|Pediatric Neurology Unit, Catholic University, Essen, 00168, Italy|Istituto Giannina Gaslini, Centro Traslazionale di Miologia, Genova, 16147, Italy|Department of Neuroscience, Università di Messina, AOU Polic, Messina, 98125, Italy|Aichi Children's Health and Medical Center, Obu, Aichi, 474-0038, Japan|Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan|Tokyo Women's Medical University, Shinjuku-ku, Tokyo, 162-8666, Japan|Kumamoto University Hospital, Kumamoto, 860-8556, Japan|Miyagi Prefectural Children Hospital, Miyagi, 989-3126, Japan|University of Miyazaki Hospital, Miyazaki, 889-1692, Japan|Seoul National University Hospital, Seoul, Korea, 3080, Korea, Republic of|Hospital Sant Joan de Deu, Barcelona, 08950, Spain|Hospital Universitario Vall de Hebron, Hebron, 08035, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|The Queen Silvia Children's Hospital, Gothenburg, SE 416 86, Sweden|Uníversity of Hacettepe, Ankara, 6100, Turkey|Marmara University Pendik Training and Research Hospital, Istanbul, 34662, Turkey|MRC Centre for Neuromuscular Diseases at Newcastle, Newcastle, Northumberland, NE1 3BZ, United Kingdom|UCL Institute of Child Health, London, WC1N 1EH, United Kingdom"
NCT00321061,Phase I Study of Vaccination Schedule of Experimental HIV Vaccines,https://clinicaltrials.gov/study/NCT00321061,COMPLETED,NO,HIV Infections,"DRUG: VRC-HIVDNA016-00, VRC-HIVADV014-00",National Institute of Allergy and Infectious Diseases (NIAID),,ALL,ADULT,60,NIH,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT,2006-04-25,2009-12-02,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT06324370,Exploratory Pharmacokinetic Study of Virgin Coconut Oil (VCO),https://clinicaltrials.gov/study/NCT06324370,ACTIVE_NOT_RECRUITING,NO,Pharmacological Action,DIETARY_SUPPLEMENT: Virgin Coconut Oil,"Food and Nutrition Research Institute, Philippines",Ateneo de Manila University|De La Salle Medical and Health Sciences Institute,MALE,ADULT,16,OTHER_GOV,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2023-04-13,2024-12-30,"Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI), Taguig, Metro Manila, 1630, Philippines"
NCT02796339,A Study on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases.,https://clinicaltrials.gov/study/NCT02796339,COMPLETED,NO,Inflammatory Bowel Diseases,DIETARY_SUPPLEMENT: Mastiha|DIETARY_SUPPLEMENT: Placebo,Harokopio University,,ALL,"ADULT, OLDER_ADULT",100,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2016-05,2021-03-10,"Harokopio University, Athens, 17671, Greece"
NCT05058092,Evaluation of the Effectiveness of the Remedee Solution in Fibromyalgia,https://clinicaltrials.gov/study/NCT05058092,COMPLETED,NO,Fibromyalgia,DEVICE: Immediate Remedee Solution|DEVICE: Delayed Remedee Solution,Remedee SA,,ALL,"ADULT, OLDER_ADULT",170,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2021-11-15,2023-02-28,"University Hospital of Grenoble Alps, Grenoble, France|CHU de Montpellier, Montpellier, France|Cabinet libéral Dr. Lorenzi-Pernot, Mornant, France|Hôpital Lariboisière - Assistance Publique Hôpitaux de Paris, Paris, France|CHU de Rouen, Rouen, France|Hôpital Foch, Suresnes, France|Centre Hospitalier de Valenciennes, Valenciennes, France|Médipôle hôpital mutualiste, Villeurbanne, France"
NCT05240573,Strong Kidney Initiative Trial for Dialysis Care Quality,https://clinicaltrials.gov/study/NCT05240573,ACTIVE_NOT_RECRUITING,NO,Hemodialysis Complication,OTHER: SKI App,China Medical University Hospital,"Ministry of Science and Technology, Taiwan",ALL,"ADULT, OLDER_ADULT",1200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2023-05-01,2025-11-30,"China Medical University Hospital, Taichung City, 404, Taiwan"
NCT05658692,Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome,https://clinicaltrials.gov/study/NCT05658692,UNKNOWN,NO,Acute Respiratory Distress Syndrome,DEVICE: protective ventilation|BEHAVIORAL: prone position ventilation|DRUG: glucocorticoid therapy|OTHER: restrictive fluid resuscitation|BIOLOGICAL: Thymosin Alpha|DRUG: Muscle relaxant therapy|OTHER: Integrated Chinese and Western Medicine Treatment|DRUG: statin therapy|COMBINATION_PRODUCT: anti-infective treatment|DEVICE: Extracorporeal Membrane Oxygenation（ECMO）|GENETIC: stem cell therapy|DRUG: Sedative analgesia/muscle relaxant therapy|DRUG: inotropes therapy|DRUG: Vasoactive drug therapy,"Second Affiliated Hospital, School of Medicine, Zhejiang University","Renmin Hospital of Wuhan University|The Second Affiliated Hospital of Harbin Medical University|West China Hospital|The First Affiliated Hospital of Zhengzhou University|Peking Union Medical College Hospital|Wuhan Union Hospital, China|Fudan University|Guangdong Provincial People's Hospital|Ningbo No. 1 Hospital|Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University",ALL,"ADULT, OLDER_ADULT",1000,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-10-01,2023-12,"Peking Union Medical College Hospital, Beijing, China|West China Hospital，Sichuan University, Chengdu, China|Guangdong Provincial People's Hospital, Guangdong, China|The Second Affiliated Hospital of Harbin Medical University, Harbin, China|Lanxi People's Hospital, Lanxi, China|Ningbo First Hospital, Ningbo, China|Zhognshang hospital, Fudan University, Shanghai, China|Taizhou Hosptial of Zhejiang Province, Taizhou, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China|Wuhan University Renmin Hospital, Wuhan, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"
NCT02260817,Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer,https://clinicaltrials.gov/study/NCT02260817,COMPLETED,YES,Metastatic Prostate Cancer,DRUG: 11C-choline Injection,"Global Isotopes, LLC d/b/a Zevacor Molecular",,MALE,"ADULT, OLDER_ADULT",109,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2014-10,2018-06,"Decatur Memorial Hospital, Decatur, Illinois, 62526, United States"
NCT01714271,Promotora-based Latino Family CVD Risk Reduction,https://clinicaltrials.gov/study/NCT01714271,COMPLETED,NO,Heart Disease|Cancer,BEHAVIORAL: Home environs-based lifestyle counseling|BEHAVIORAL: Cancer early detection,"University of California, Los Angeles","University of Southern California|National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",204,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION,2010-10,2014-10,"Roybal Comprehensive Health Center, Los Angeles, California, 90022, United States"
NCT04810299,Effect of Aromatherapy Massage on Symptom Control,https://clinicaltrials.gov/study/NCT04810299,COMPLETED,NO,Colorectal Cancer,OTHER: Aromatherapy|OTHER: Classical foot massage,Sakarya University,,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER,2021-04-16,2023-03-23,"Sakarya University, Sakarya, Serdivan, 54050, Turkey"
NCT01724619,Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT,https://clinicaltrials.gov/study/NCT01724619,TERMINATED,NO,Prostate Cancer,DRUG: [F-18] fluorinated dihydrotestosterone (FDHT),Wake Forest University Health Sciences,,MALE,"ADULT, OLDER_ADULT",7,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2012-11,2013-03,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States"
NCT06013735,Effects of Three Different Mouth Rinses on Dental Plaque in Children,https://clinicaltrials.gov/study/NCT06013735,COMPLETED,NO,Gingival Diseases,DRUG: sodium fluoride solution|DRUG: guava leaves aqueous extract|DRUG: pomegranate peel aqueous extrac|OTHER: Distilled water,Suez Canal University,,ALL,CHILD,40,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: PREVENTION",2020-02-17,2021-06-22,"faculty of dentistry Suez canal university, Ismailia, Egypt"
NCT06510530,Astragalus for Symptomatic Alleviation in High-grade Lymphoma,https://clinicaltrials.gov/study/NCT06510530,NOT_YET_RECRUITING,NO,High-grade Lymphoma,DIETARY_SUPPLEMENT: Astragalus|DIETARY_SUPPLEMENT: Placebo,Bnai Zion Medical Center,,ALL,"ADULT, OLDER_ADULT",60,OTHER_GOV,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2024-08,2032-08,"Bnai Zion Medical Center, Haifa, 3339419, Israel"
NCT02834078,Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome,https://clinicaltrials.gov/study/NCT02834078,COMPLETED,NO,Pre Diabetes,DIETARY_SUPPLEMENT: BGG|OTHER: Placebo,Vedic Lifesciences Pvt. Ltd.,"Healthy Directions, LLC",ALL,ADULT,126,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-09,2016-07,
NCT04988971,The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis,https://clinicaltrials.gov/study/NCT04988971,UNKNOWN,NO,Mucositis|Chemotherapeutic Toxicity,DRUG: a compound glutamine capsule|DRUG: a compound glutamine capsule simulated placebo,Meng Qiu,,ALL,"ADULT, OLDER_ADULT",90,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",2021-06-30,2022-12-31,"Meng Qiu, Sichuan, China"
NCT03114176,Effects of Ketogenic Diet in Divers Breathing Enriched Air Nitrox,https://clinicaltrials.gov/study/NCT03114176,COMPLETED,NO,Overweight and Obesity|Exertion; Excess|Oxygen Toxicity,DIETARY_SUPPLEMENT: Ketogenic Diet,University of Padova,,MALE,"ADULT, OLDER_ADULT",6,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2016-05-25,2016-07-10,
NCT05921149,Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer,https://clinicaltrials.gov/study/NCT05921149,NOT_YET_RECRUITING,NO,Ovarian Cancer|Chemotherapeutic Toxicity,DIETARY_SUPPLEMENT: Fasting Mimicking Diet (Xentigen by L'Nutra)|DRUG: Carboplatin|DRUG: Paclitaxel|DIETARY_SUPPLEMENT: Standard diet,NorthShore University HealthSystem,L-Nutra Inc,FEMALE,"ADULT, OLDER_ADULT",170,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-05-25,2031-06-01,"NorthShore University HealthSystem, Evanston, Illinois, 60201, United States"
NCT02071225,A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia,https://clinicaltrials.gov/study/NCT02071225,COMPLETED,YES,Chronic Lymphocytic Leukemia,DRUG: bendamustine|DRUG: obinutuzumab,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",72,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-04-09,2018-11-19,"Hospital De Txagorritxu; Servicio de Hematologia, Vitoria, Alava, 01009, Spain|Hospital General Universitario de Elche; Servicio de Hematologia, Elche, Alicante, 03203, Spain|Hospital de Cabueñes; Servicio de Hematología y Hemoterapia, Gijon, Asturias, 33203, Spain|Hospital Univ. Central de Asturias; servicio de Hematologia, Oviedo, Asturias, 33011, Spain|Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia, Badalona, Barcelona, 08915, Spain|Hospital Mutua de Terrassa; Servicio de Hematologia, Terrassa, Barcelona, 08221, Spain|Hospital de Navarra, Servicio de Hematología, Pamplona, Navarra, 31008, Spain|Complejo Hospitalario Nuestra Señora de la Candelaria; Servicio de Hematologia, Santa Cruz de Tenerife, Tenerife, 38010, Spain|Hospital Universitari Vall d'Hebron; Servicio de Hematologia, Barcelona, 08035, Spain|Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, 08036, Spain|Hospital General de Castellon; Servicio de Hematologia, Castellon, 12004, Spain|Hospital Universitario Virgen de las Nieves; Servicio de Hematologia, Granada, 18014, Spain|Hospital de Gran Canaria Dr. Negrin; Servicio de Hematologia, Las Palmas, 35020, Spain|Hospital Universitario la Paz; Servicio de Hematologia, Madrid, 28046, Spain|Hospital Universitario Puerta de Hierro; Servicio de Hematologia, Madrid, 28222, Spain|Hospital Costa del Sol; Servicio de Hematologia, Malaga, 29600, Spain|Hospital Universitario Virgen Macarena; Servicio de Hematologia, Sevilla, 41009, Spain|Hospital Univ. Nuestra Señora de Valme; Servicio de Hematologia, Sevilla, 41014, Spain|Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, 46010, Spain|Hospital Universitario Dr. Peset; Servicio de Hematologia, Valencia, 46017, Spain|Hospital Clinico Universitario Lozano Blesa; Servicio de Hematologia, Zaragoza, 50009, Spain"
NCT06575335,Triphala Tooth Wipes in Reduction of Streptococcus Mutans Colonies,https://clinicaltrials.gov/study/NCT06575335,NOT_YET_RECRUITING,NO,Plaque Control,OTHER: Triphala Tooth Wipe|OTHER: Chlorhexidine Tooth Wipe,Dow University of Health Sciences,,ALL,CHILD,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2024-09,2025-10,
NCT01692093,KM110329 in Adult Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT01692093,UNKNOWN,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: KM110329|DIETARY_SUPPLEMENT: Placebo,Kyunghee University Medical Center,"St Mary's Hospital, London|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|Kyung Hee University Hospital at Gangdong",ALL,"ADULT, OLDER_ADULT",66,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2012-09,2014-09,"Kyung Hee University, Seoul, 130-701, Korea, Republic of"
NCT03512496,Metabolic and Genetic Impacts of Energy Drinks in Youth,https://clinicaltrials.gov/study/NCT03512496,WITHDRAWN,NO,"Nutrition|Pediatric Obesity|Pediatric|Caffeine|Metabolism Disorder, Glucose|Health Behavior|Glucose Intolerance",DIETARY_SUPPLEMENT: Acute energy drink - Placebo|DIETARY_SUPPLEMENT: Acute energy drink - Caffein|DIETARY_SUPPLEMENT: Acute energy drink - Decaf,University of Calgary,"Natural Sciences and Engineering Research Council, Canada",ALL,"CHILD, ADULT",0,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2014-12-01,2015-06-01,"University of Calgary, Calgary, Alberta, T2N 1N4, Canada"
NCT00217594,A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome,https://clinicaltrials.gov/study/NCT00217594,COMPLETED,YES,Myelodysplastic Syndromes,DRUG: Alemtuzumab (Campath),"National Heart, Lung, and Blood Institute (NHLBI)",,ALL,"ADULT, OLDER_ADULT",40,NIH,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2005-07-21,2017-02-06,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT01001637,Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease,https://clinicaltrials.gov/study/NCT01001637,TERMINATED,NO,Alzheimer Disease,DIETARY_SUPPLEMENT: Curcumin Formulation|DIETARY_SUPPLEMENT: Placebo,Jaslok Hospital and Research Centre,"Pharmanza Herbal Pvt Ltd|Verdure Sciences|University of California, Los Angeles",ALL,"ADULT, OLDER_ADULT",26,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2009-10,2010-11,"Jaslok Hospital and research centre, Mumbai, Maharashtra, 400026, India"
NCT02044211,Blended Collaborative Care for Heart Failure and Co-Morbid Depression,https://clinicaltrials.gov/study/NCT02044211,COMPLETED,NO,"Heart Failure, Systolic|Depression|Cardiovascular Disease",BEHAVIORAL: Collaborative Care for Heart Failure|BEHAVIORAL: Collaborative Care for Depression,University of Pittsburgh,"National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",756,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2014-02,2020-07,"University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States"
NCT00074503,PET Imaging of DHA Metabolism,https://clinicaltrials.gov/study/NCT00074503,COMPLETED,NO,Healthy,,National Institute on Alcohol Abuse and Alcoholism (NIAAA),,ALL,"ADULT, OLDER_ADULT",85,NIH,OBSERVATIONAL,Observational Model: |Time Perspective: p,2003-12-12,2010-07-13,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT02034916,"A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)",https://clinicaltrials.gov/study/NCT02034916,TERMINATED,YES,Breast Neoplasms|BRCA 1 Gene Mutation|BRCA 2 Gene Mutation,DRUG: talazoparib,Pfizer,"Myriad Genetic Laboratories, Inc.|Medivation, Inc.",ALL,"ADULT, OLDER_ADULT",84,INDUSTRY,INTERVENTIONAL,Allocation: |Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-12-13,2018-10-31,"Marin Cancer Care, Inc., Greenbrae, California, 94904, United States|UCLA West Medical Pharmacy Attn: Steven L. Wong, PharmD, Los Angeles, California, 90095-1772, United States|UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles, California, 90095-7349, United States|TRIO-US Central Administration, Los Angeles, California, 90095, United States|Stanford Women's Cancer Center, Palo Alto, California, 94304, United States|UCLA Hematology Oncology- Porter Ranch, Porter Ranch, California, 91326, United States|Torrance Health Association, DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach, California, 90277, United States|University of California, San Francisco: Helen Diller Comprehensive Cancer Center, San Francisco, California, 94115, United States|UCLA Hematology-Oncology, Santa Monica, California, 90404, United States|Stanford Cancer Institute, Stanford, California, 94305, United States|Stanford Hospital and Clinics, Stanford, California, 94305, United States|Sylvester at Deerfield Beach, Deerfield Beach, Florida, 33442, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Memorial Regional Hospital, Hollywood, Florida, 33021, United States|University of Miami Hospital & Clinics, Miami, Florida, 33136, United States|Memorial Breast Cancer Center at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Sylvester at Plantation, Plantation, Florida, 33324, United States|ICRC, Indianapolis, Indiana, 46202-5116, United States|Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Investigational Drug Services, Indianapolis, Indiana, 46202, United States|IU Health University Hospital, Indianapolis, Indiana, 46202, United States|Sidney & Lois Eskenazi Hospital, Indianapolis, Indiana, 46202, United States|Springmill Medical Clinic, Indianapolis, Indiana, 46290, United States|Anne Arundel Medical Center (AAMC), Annapolis Oncology and Hematology, Annapolis, Maryland, 21401, United States|Anne Arundel Medical Center (AAMC), Research Pharmacy, Annapolis, Maryland, 21401, United States|Anne Arundel Medical Center (AAMC), Annapolis, Maryland, 21401, United States|Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Baltimore, Maryland, 21231, United States|Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Green Spring Station, Lutherville, Maryland, 21093, United States|Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, 11570, United States|University of Tennessee Medical Center, Knoxville, Tennessee, 37920, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Centre Oscar Lambret, Lille Cédex, 59020, France|Centre Leon Berard, Lyon Cedex 08, 69373, France|Institut Paoli Calmettes, Marseille, 13273 Cedex 9, France|Hopital Prive du Confluent, Nantes BP 20215, 44202 Cedex 2, France|Hopitaux Universitaires de Strasbourg - Hopital Civil, Strasbourg, 67091Cedex, France|Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, 31059 Cedex 9, France|CHU Bretonneau Centre Henry Kaplan, Tours Cedex 9, 37044, France|Universitaetsklinikum Erlangen, Erlangen, Bavaria, 91054, Germany|IOZ Muenchen - lnerdisziplinaeres Onkologisches Zentrum, Muenchen, Bavaria, 80336, Germany|Klinikum rechts der Isar der TU Muenchen, Muenchen, Bavaria, 81675, Germany|University of Munich (LMU) Grosshadern Hospital, Munich, Bavaria, 81377, Germany|Klinikum Mutterhaus Der Borromaeerinnen Ggmbh, Trier, Rheinland-pfalz, 54290, Germany|University Hospital Carl Gustav Carus, Dresden, Saxony, 01307, Germany|Helios Klinikum Berlin-Buch, Berlin, 13125, Germany|University Hospital Duesseldorf, Duesseldorf, 40225, Germany|Kliniken Essen Mitte Klinik fuer Gynaekologie und Gynaekologische Onkologie, Essen, 45136, Germany|Universitaetsklinikum Schleswig-Holstein, Kiel, 24105, Germany|g.SUND Gynaekologie Kompetenzzentrum Stralsund, Stralsund, 18435, Germany|Universitaets-Frauenklinik, Tuebingen, 72076, Germany|Complejo Hospitalario Universitario A Coruna, A Coruna, 15006, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Complejo Hospitalario de Jaen, Jaen, 23007, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|MD Anderson Cancer Center International Espana, Madrid, 28033, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario San Juan de Alicante, San Juan de Alicante, 03550, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Cambridge University Hospital NHS Foundation Trust, Cambridge, England, CB2 0QQ, United Kingdom|Sarah Cannon Research Institute UK, London, England, W1G 6AD, United Kingdom|Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, PR2 9HT, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|The Royal Marsden NHS Foundation Trust, Sutton, SM2 5PT, United Kingdom"
NCT02559765,"Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.",https://clinicaltrials.gov/study/NCT02559765,COMPLETED,NO,Progressive Multiple Sclerosis,,University of Glasgow,NHS Ayrshire and Arran|AKM,ALL,"ADULT, OLDER_ADULT",1298,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2015-08,2015-11,"The University of Glasgow, Glasgow, G12 8LL, United Kingdom"
NCT05370313,The Impact of Innovative Tax Proposals on Purchase Patterns,https://clinicaltrials.gov/study/NCT05370313,RECRUITING,NO,Cigarette Smoking,BEHAVIORAL: Market Price Condition (control)|BEHAVIORAL: Tobacco Parity Tax Condition|BEHAVIORAL: Nicotine-Content Tax Condition|BEHAVIORAL: Harm-Reduction Tax Condition|BEHAVIORAL: Modified Risk Tobacco Product (MRTP) Tax Condition,Virginia Polytechnic Institute and State University,Roswell Park Cancer Institute,ALL,"ADULT, OLDER_ADULT",280,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2023-04-11,2025-03-31,"Roswell Cancer Research Institute, Buffalo, New York, 14263, United States|Fralin Biomedical Research Institute, Roanoke, Virginia, 24016, United States"
NCT04980053,The Impact of Back and Breast Massage,https://clinicaltrials.gov/study/NCT04980053,UNKNOWN,NO,Premature Birth,OTHER: massage,Seyma Kilci Erciyas,,FEMALE,ADULT,60,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2021-08-06,2022-06-10,"Zonguldak Gynecology and Pediatrics Hospital, Zonguldak, Center, Turkey"
NCT02485847,IRIS Registry: Intelligent Research in Sight Registry,https://clinicaltrials.gov/study/NCT02485847,RECRUITING,NO,Eye Diseases,PROCEDURE: Ophthalmology,American Academy of Ophthalmology,,ALL,"CHILD, ADULT, OLDER_ADULT",20000000,OTHER,OBSERVATIONAL,Observational Model: |Time Perspective: p,2014-03,2100-01,"American Academy of Opthalmology, San Francisco, California, 94109, United States"
NCT02007694,Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants,https://clinicaltrials.gov/study/NCT02007694,COMPLETED,NO,Phobic Disorders,BEHAVIORAL: Virtual Reality Exposure Therapy (VRET),VU University of Amsterdam,,ALL,"ADULT, OLDER_ADULT",56,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-03,2014-12,"University of Amsterdam, Amsterdam, Nord Holland, 1018XA, Netherlands"
